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Preface
Stem cell research is one of the fascinating areas of contemporary biology, but, as with many 
expanding fields of scientific inquiry, research on stem cells raises scientific questions as 
rapidly as it generates discoveries. Research on stem cell treatment continues to advance 
knowledge about how an organism develops from a single cell and how healthy cells replace 
damaged cells in adult organisms. The most important potential application of human stem 
cells is the generation of cells and tissues that could be used for cell-based therapies, especially 
oncology.
The Faculty of Medicine, Universitas Sumatera Utara, collaborated with the center of 
excellence and innovation (Pusat Unggulan Inovasi /PUI). The Stem Cell center of the 
Universitas Sumatera Utara (USU) organized an International Conference. The International 
Stem Cell and Oncology Conference (ISCOC) 2017 was an comprehensive academic 
conference in the field of stem cell and oncology research and also tropical medicine and 
related scientific topics.
We expect this conference will benefit academics and practitioners in the field of health 
sciences in Indonesia. During the two day conference, researchers presented the most recent 
discoveries in stem cell and oncology and also general medical topics, and served as well in 
establishing networking for joint researchers and collaboration among participants.
The editors and the scientific committee would like to thank the participants and express 
their gratitude to Faculty of Medicine of the Universitas Sumatera Utara for their support 
to ISCOC 2017. Lastly, we are most indebted for the generous support given by Universitas 
Sumatera Utara, Medan, Sumatera Utara, Indonesia.
February 2018 
Editors
Prof. Dr. dr. Delfitri Munir, Sp.T.H.T.KL(K)
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Association of the Anal Position Index (API) with constipation
H.A. Sinuhaji, E. Azlin, Supriatmo, A. Rahmad, A. Sinuhaji & A.B. Sinuhaji
Department of Child Health, Faculty of Medicine, Universitas Sumatera Utara, Medan, 
North Sumatera, Indonesia
ABSTRACT: Constipation is one of the most common chronic disorders of childhood. 
Anterior displacement of the anus is one of the organic causes of constipation. Reisner et al. 
proposed an objective method to determine the normal position of the anus using the Anal 
Position Index (API). An API of less than 0.46 in boys and less than 0.36 in girls indicates 
anterior displacement of the anus. A cross-sectional study of 66 children was conducted. 
Subjects were chosen using consecutive sampling. Study data were collected by conducting 
demographic data and by using the API. The API, which is the ratio of anus-scrotum dis-
tance in boys and anus-fourchette in girls between the coccyx and fourchette/scrotum, was 
calculated in this study. Girls were more likely to develop constipation than boys. There was 
no relationship between the API and constipation (PR 0.825; 95% CI 0.201 to 3.394).
Keywords: anal position index, anterior displacement anus, constipation
1 INTRODUCTION
Constipation is one of the most common chronic disorders of childhood, affecting 1% to 
30% of children worldwide. Consti pation is responsible for 3% of all primary care visits for 
children and 10% to 25% of paediatric gastroenterology visits (Nurko & Zimmerman, 2014). 
Constipation is a symptom rather than a disease (Karami & Shokohi, 2013).
According to the aetiology, constipation can be classified into two categories: functional 
and organic. The functional type is also called idiopathic, as there is no identified pathology, 
and organic aetiology. In the organic type, constipation is part of the symptoms of an under-
lying pathology or disease (Hammo et al., 2012).
Although most constipation is functional, congenital anatomic malformations in an anorectal 
area may be responsible in some of these cases. Similar to many other abnormalities, congenital 
anorectal malformations occur in a wide spectrum of severity. Slight anterior displacement of 
the anus is the less severe form of anorectal malformation. These abnormalities in the neonate 
are easily diagnosed at birth by a simple inspection, yet ectopic anterior anus is very difficult to 
diagnose without using diagnostic measurement tools (Davari & Nazem, 2004).
Today, despite controversies, many researchers believe that anterior anus gives rise to up 
to one-third of childhood chronic constipations and the diagnosis of it remains uncertain. 
In 1978, Leape and Ramenofsky stated that the usual anal position is midway between the 
vaginal fourchette and coccyx. Reisner et al. (1984) presented a simple method, the Anal Posi-
tion Index (API), to define the normal position of the anus in a neonate (Davari & Nazem, 
2004). The aim of the present study is to determine the association of the API with anterior 
displacement of the anus.
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2 METHODS
A cross-sectional study of children under four years of age was conducted in Simalingkar 
community healthcare centre, Medan, Indonesian. Subjects were chosen using consecutive 
sampling. Subjects with warning signs (delayed passage of meconium, failure to thrive, 
bloody stools, severe abdominal distention, perianal fistula, absent anal wink, sacral dimple), 
congenital anomalies or syndromes, and taking medical treatment that affects constipation 
were excluded from this study. Study data were collected by conducting demographic data 
and by using the API. The child was held in the lithotomy position, and adhesive transpar-
ent tapes were used on the longitudinal axis of the mid-perineum. The fourchette/scrotum, 
anus centre and lower margin of the coccyx were marked on it. The strip was removed and 
flattened out onto a flat surface, and the distances were measured using a flexible measuring 
tape. The API, which is the ratio of anus-scrotum distance in boys and anus-fourchette in 
girls between the coccyx and fourchette/scrotum, was calculated. The association of the API 
and demographic data with constipation were tested. Results were considered to be statisti-
cally significant for P values <0.05. This study was approved by the Ethics Committee of the 
Faculty of Medicine at the Universitas Sumatera Utara.
3 RESULTS
Sixty-six children were included in this study, of which 34 were males and 32 were females. 
The incidence of constipation in this study was 16.7%. Demographic characteristics are 
detailed in Table 1.







N = 55 P CI 95%
Age, months (SD) 25.7 (13.39) 16.5 (12.88) 0.040*
Body weight, 
kg (SD)
8.48 (5.37) 6.98 (4.05) 0.042*































*Mann-Whitney test; **T independent test; ***Chi-squared; ****Kruskal−Wallis test.
Table 2. Association of anterior anus and constipation.
Constipation
P PR CI 95%Yes No
Anterior anus 2 (18.2) 12 (21.8) 0.574 0.825 0.201–3.394
Normal anus 9 (81.8) 43 (78.2)
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4 DISCUSSION
A systematic review conducted in 2011, resulting from 19 articles, investigated the prevalence 
of constipation in children. The median value rate was 12% (Mugie et al., 2011). A review 
article from China found that the mean value of prevalence rate in the paediatric population 
was 18.8% (Chu et al., 2014). In this study, the incidence of constipation was 16.7%.
The peak age of the onset of childhood constipation and the age category in which con-
stipation is most common could not be assessed with certainty. Possibly, constipation in dif-
ferent age categories has various aetiologies. Approximately half  of the affected children 
developed constipation within the first year of life. The transition from breast to formula 
feeding was considered to be a possible cause of constipation in this age group. Also, consti-
pation was found to be significantly more prevalent in children between 2 and 4–5 years old. 
On the other hand, Olaru et al. (2016) found that the average age of the onset of constipation 
was 26.39 months. These prevalence data suggest the highest prevalence to be around the 
preschool age. The time of toilet training is thought to be a critical period in which constipa-
tion may occur. Difficulties with toilet training are associated with childhood constipation. 
It is, however, unclear whether difficulties with toilet training are the result or the cause of 
constipation (Berg et al., 2006; Olaru et al., 2016).
Conflicting data about the gender ratio in the occurrence of constipation have been 
reported. Some outcome studies have reported a higher number of constipated boys com-
pared with girls. A study in children younger than four years found a 1:1 ratio (Berg et al., 
2006). In this study, we found that girls were more likely to develop constipation than boys.
The aetiology of constipation in childhood may be multifactorial. In most children, con-
stipation is functional, without objective evidence of a pathological condition. Otherwise, the 
congenital abnormality of the anus position was considered to be a possible cause of con-
stipation, especially in infancy and early childhood. In previous studies, the diagnosis of an 
anterior anus has usually relied on inspection; therefore, the incidences vary widely, according 
to the experience of the physician. However, in less severe cases, slight anterior displacement 
was very difficult to diagnose without using diagnostic measurement tools. The quantitative 
measurement to define the normal position of the anus was first proposed in 1984. Reisner 
et al. presented a simple method using the API, which is the ratio of anal-fourchette distance 
to coccyx-fourchette distance for females and the ratio of anal-scrotum distance to coccyx-
scrotum distance for males, to define the normal position of the anus in the newborn. They 
suggested that an API of less than 0.46 in boys and less than 0.34 in girls was indicative of an 
anterior displacement of the anus (Rerksuppaphol, 2010; Shahin & Abdelsalam, 2011).
The association between an anterior displacement of the anal opening and constipation 
is still controversial. In a large case study involving 134 patients with ADA, nearly all of the 
patients had constipation from birth or from the time of weaning from breastfeeding and 
required surgical correction. A comparative study in two European healthcare centres found 
that 31% of newborns with anterior anus presented constipation in their first months of life. 
However, studies that are more recent do not describe any association between anal position 
and constipation (Shahin & Abdelsalam, 2011; Ramoz et al., 2011). In this study, we found 
that there was no association between API and constipation.
This study had some limitations. This was a cross-sectional study so we could not assess 
precisely the association between API and constipation. This was the first study in Indonesia 
that measured API in children. Further research should be done by considering the methods, 
whether case-control or cohort, grouping the age or gender, determining the centre of the 
anal, or using the digital calliper.
5 CONCLUSION
Although constipation in most children is functional, organic causes, such as anterior 
displacement of the anus, might be considered in children with constipation. API is a sim-
ple method of defining anterior displacement of the anus in children. We should consider 
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measuring the API in children with constipation. Based on this result, there is no association 
between the API and constipation.
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Comparison of thyroid hormone levels between severe 
and mild-moderate malnutrition
W. Mondana, T. Sembiring, Y. Dimyati, T. Faranita & W. Pratita
Department of Child Health, Faculty of Medicine, Universitas Sumatera Utara, Medan, 
North Sumatera, Indonesia
ABSTRACT: Malnutrition is one of the major health problems in developing countries 
and contributes to child mortality throughout the world. Thyroid hormones play a crucial 
role in the metabolism, which is used for growth and maturation. Objective: To understand 
the differences in thyroid hormone levels between severe and mild-moderate malnutrition. 
Methods: This was a cross-sectional study between April and May 2016 at the Adam Malik 
General Hospital, Medan. The subjects are 1–5 years old with severe and mild-moderate 
malnutrition. Children with hypothyroid/hyperthyroid who took medicine that could affect 
their thyroid hormone levels were excluded. Data were analysed using independent T and 
Mann-Whitney U tests with 95% CI. P value <0.05 were considered statistically significant. 
Result: The level of T3 was different between severe and mild-moderate malnutrition. 
The level of T3 was lower in cases of severe malnutrition than in cases of mild-moderate 
malnutrition (p < 0.001, 95% CI 0.29–1.00) but the T4 level was not lower (p 0.065, 95% CI 
−0.32–3.00). Conclusion: There was a significant difference in the T3 level between severe and 
mild-moderate malnutrition, where the T3 level was lower in cases of severe malnutrition.
Keywords: Malnutrition, Thyroid hormones, T3, T4, TSH
1 INTRODUCTION
Malnutrition remains a major health problem in developing countries and accounts for more 
than 54% of the mortality of children under five year of age and 10.8 million of the annual 
mortality rate (Susanto et al., 2011). Approximately 9% of children in sub-Saharan Africa 
and 15% in South Asia suffer from severe malnutrition and mild to moderate malnutrition. 
In developing countries, there are approximately 2% of children suffering from Severe Acute 
Malnutrition (SAM). In India, 2.8% of children under five years of age are severely wasted. 
In underdeveloped countries, such as Malawi, SAM remains the major cause for hospitalisa-
tion (Schaible et al., 2007). In Indonesia, based on basic health research Riset kesehatandasar 
(Riskesdas) for the year 2007, the number of children with severe malnutrition and mild to 
moderate malnutrition is still approximately 18.4, which is registered as third in the world for 
severe malnutrition (Lenters et al., 2013).
The thyroid hormone plays an important role in the regulation of lipid and carbohy-
drate metabolism for normal growth and maturation. Mild to moderate malnutrition cor-
relates with a deficiency of iodine, vitamin A and iron, which can cause anaemia. In mild to 
moderate malnutrition, there are changes in the growth, development and decrement of all 
systems and organ functions, with impairment in metabolism and secretion of the thyroid 
hormone from the thyroid glands, therefore causing a reduction of thyroid gland activity, 
and a reduction of triiodothyronine (T3), thyroxine (T4) and Thyroid Stimulating Hormone 
(TSH) are noted. This entity will affect iodine metabolism and decrease protein circulation. 
This mechanism affects protein and energy malnutrition metabolism (Brinker et al., 2005).
ISCOC17_Book.indb   5 3/21/2018   2:04:03 PM
6
The close association between thyroid hormone metabolism disorders with mild-moderate 
malnutrition and severe malnutrition has led to a growing number of studies on the use of 
thyroid hormones as biochemical markers in mortality rates in malnutrition patients (Brent, 
2012). A study in India in January 2016 showed that 43% of malnourished children showed 
a decrease in the value of T3 and T4 without a decrease of TSH (Sandeep & Krishnamurthy, 
2016). However, in Indonesia there has never been any similar research; therefore, we wanted 
to assess the relationship of severe malnutrition status and mild-moderate malnutrition to 
thyroid hormone levels in children aged 1–5 years.
2 METHODS
A cross-sectional study was conducted between April and May 2016 in the paediatrics ward 
at the Adam Malik Hospital, Medan, North Sumatera. Subjects were collected by consecu-
tive sampling. The criteria for inclusion was children who were 1–5 years old with severe 
and mild-moderate malnutrition. Children with hypothyroid or hyperthyroid, or who took 
medicine that could affect their thyroid hormone levels, were excluded. Anthropometry was 
used to determine nutritional status. Blood samples were taken from all of the subjects to 
determine their thyroid hormone levels (T3, T4 and TSH). A physical examination was con-
ducted on the children. Body Weight (BW) was measured using Camry scales with 0.1 kg 
precision. Body Height (BH) was measured using a microtome with 0.1 cm precision, with 
the children standing up straight, feet parallel, and heels, buttocks and the back of the head 
touching the wall. Nutritional status was assessed using the WHO growth chart. The nutri-
tional status classification was based on body weight/body height (BW/BH). Blood samples 
were obtained from peripheral veins, and the serum levels of triiodothyronine (T3), thyroxine 
(T4) and Thyroid Stimulating Hormone (TSH) were measured by radioimmunoassay (RIA). 
A Mann-Whitney test and independent T-test were done to analyse the comparison of the 
thyroid hormone levels between severe and mild-moderate malnutrition in 1–5 year olds. The 
results were considered to be statistically significant for P values <0.05.
3 RESULTS
Two groups of children (severe malnutrition and mild-moderate malnutrition) were stud-
ied. Of the 64 children initially recruited, seven children were rejected for inclusion in this 
research and four children who took medicine that could affect their thyroid hormone levels 
were excluded. From the remaining 53 children, we found 38 children with severe malnutri-
tion and 15 children with mild-moderate malnutrition (Figure 1).
Figure 1. Consort diagram.
ISCOC17_Book.indb   6 3/21/2018   2:04:03 PM
7
The subjects’ characteristics are shown in Table 1. In 1–5 year olds, severe malnutrition was 
more commonly found than mild-moderate malnutrition. Leukaemia was more commonly 
found in severe malnutrition.
Table 2. There were significantly different levels of T3 between severe and mild-moderate 
malnutrition (P < 0.001). Meanwhile, T4 and TSH showed no significant difference between 
the two groups.
4 DISCUSSION
Severe and mild malnutrition are suffered by almost 20 million children worldwide. Most 
of them are in the preschool age group and live in African and South East Asian countries. 
Severe malnutrition has become a major contributor to mortality in under-fives (Sandeep & 
Krishnamurthy, 2016).
Thyroid hormones enhance the metabolism in almost all body tissues, including growth 
and development, oxygen consumption, energy formation, neural function, fat, carbohy-
drate, protein, nucleic acid, vitamin, and organic ions metabolism (Depkes, 2012). The mean 
metabolism velocity rate increases by 60% to 100% over its normal value when the thyroid 
hormone is secreted (Bone et al., 1992).







1−2 years 16 4
2−3 years 10 5
3−4 years 10 3
4−5 years 2 2
Co-morbid
Leukaemia 18 5
Heart failure 7 0
Chronic kidney disease 5 0








Mean height, cm (SD) 78.1 (10.02) 86.8 (10.13)
Mean body weight kg, 
median (min−max)
8 (2.13−4) 10 (3.01−5)









T3 median 1.4 (0.29−4.97) 0.67 (0.26−2.15)  0.29−1.00 0.65 <0.001**
T4 mean 7.21 ± 2.80 5.64 ± 0.48 −1.01−3.23 1.56   0.065***
TSH median 2.51 (0.61−12.76) 2.33 (0.07−7.16) −0.32−3.00 1.34   0.17**
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A study in India in 2001, which took 80 severely malnourished and mild-moderately mal-
nourished children as subjects, found that there was a decreasing T3 value without a decline 
in the values of  T4 and TSH (Abrol et al., 2001). Other studies in Bangladesh and Turkey 
obtained similar results (Klein & Delbert, 1981). Such results were also observed in this 
study, which found that in 38 severely malnourished children and 15 mild-moderately mal-
nourished children, abnormalities in T3, T4 and TSH were observed, as shown in Table 2.
The decline of the value of T3 in severe and mild-moderate malnutrition patients is asso-
ciated with the reduction of protein biosynthesis in the liver. After the decline of thyroid 
hormone values, there will be a decreasing free thyroxine level, which results in a decline in 
thyroid hormone values (Monig et al., 1995).
Another study in India in 2016 of 250 severely malnourished children aged 1–5 years, with 
139 girls and 111 boys, found a T3 and T4 decline with p < 0.001 without a decline in the TSH 
level (Sandeep & Krishnamurthy, 2016). This study also took children of 1–5 years old as 
subjects and showed that boys with severe and mild-moderate malnutrition were more preva-
lent than girls, which was 27 children. This study also found that there was a decline in the 
T3 hormone level. In the relationship analysis between the T3 level and malnutrition, there 
was a significant relationship between the T3 level and malnutrition (CI 95% 0.29−1.00) with 
a p < 0.001. The reason for the low T3 serum level is a diminished production or increased 
excretion. In this state, the body will always attempt to compensate by lowering the body’s 
metabolism, so that the serum T3 level falls and a reverse T3 (rT3) level arises, thus energy 
becomes well balanced. With a progressive natural history of the disease, the serum T4 level 
is much more likely to be decreased.
Another study found that there was a non-thyroidal illness in critically ill patients, which 
included a condition where there was a decline in serum T3 levels when the TSH and T4 
levels were normal. This condition is called the ESS type 1 or the low T3 syndrome. This 
study showed evidence of ESS type 1 or low T3 syndrome in the most critically ill patients 
and in chronic disease patients with slow progressivity and long continuity, such as leukae-
mia, asthma, cerebral palsy, diabetes, heart failure, renal failure and HIV. This study also 
showed that patients with chronic diseases, such as heart failure, renal failure, HIV and cen-
tral nervous system infection, were at a greater risk of a decline of thyroid hormone levels 
(Burmeister, 1995).
There are some limitations to the present study. The sample size is too small to properly 
evaluate the comparison of thyroid hormone levels between severe and mild-moderate mal-
nutrition in children, the authors did not evaluate the antibodies of thyroid peroxidase or 
thyroglobulin and did not consider the family history of thyroid disease. Therefore, further 
evaluation of thyroid functions with larger sample sizes and long-term follow-up will be 
needed to address the influence of thyroid hormones.
5 CONCLUSION
There is a relationship between the decline of T3 levels in severe and mild-moderate malnu-
trition without T4 and TSH disturbance. Children aged 1–3 years with chronic diseases are 
at risk of becoming malnourished and experience a decline in T3 level. Changes in thyroid 
hormone metabolism that occur probably represent adaptive changes to the illness; treat-
ment with 1-thyroxine to restore serum thyroid concentrations to the normal range is not 
indicated.
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Identification of HPV types 6 and 11 in skin tags using PCR
J. Karayana, N.K. Jusuf & I.B. Putra
Department of Dermatovenereology, Faculty of Medicine, Universitas Sumatera Utara, Medan, 
North Sumatera, Indonesia
ABSTRACT: The Human Papilloma Virus (HPV) infection is suspected to be one of the 
causes of skin tag lesions. In order to identify HPV types 6 and 11 in skin tag lesions using 
the Polymerase Chain Reaction (PCR) technique, this study is a descriptive study with a 
cross-sectional design involving 30 skin tag lesions. PCR examination of skin tag lesions was 
performed to identify HPV types 6 and 11. The collected data was processed and presented 
descriptively. In this study we found that eight (26.7%) skin tag lesions identified with HPV 
type 6, and six (20%) skin tag lesions identified with HPV type 11. From a total of 30 skin 
tag lesions that were examined using the PCR technique, 14 (46.7%) of the lesions identified 
with HPV types 6 and 11.
Keywords: skin tag, HPV, polymerase chain reaction
1 INTRODUCTION
A skin tag is a benign lesion composed of loose fibrous tissue that occurs mainly on the neck 
and major flexures as a small, soft, pedunculated protrusion (Quinn & Perkins, 2010). Skin 
tags may present singly or as multiple lesions, they tend to grow progressively and they do 
not involute spontaneously. These lesions are commonly found in the adult population over 
40 years of age, and increase in incidence in the elderly (Tamega et al., 2010). Skin tags can 
manifest clinically as three types: multiple small papules, single or multiple filiform, and bag-
like pedunculated growths (Shashikala et  al., 2014). Histological findings show epidermis 
slight acanthosis and papillomatosis with a fibrovascular connective tissue core (Heenan, 
2005; Ko, 2012).
To date, the aetiology or pathogenesis of skin tags is still unclear. Obesity, ageing, dyslipi-
demia, diabetes mellitus, pregnancy and Human Papilloma Virus (HPV) have been proposed 
as a potential aetiological or associated factor of the skin tag (Tamega et al., 2010; Erkek 
et al., 2011). The HPV infection has been suggested to be one of the factors involved in the 
pathogenesis of skin tags, and the first study to correlate this theory was conducted by Dian-
zani et al. in 1998. Dianzani and his colleagues were able to detect HPV DNA 6 and 11 in 
88% of the samples of skin tags by using the Polymerase Chain Reaction (PCR) technique 
(Dianzani et al., 1998).
HPV is a small non-enveloped virus (50–55 nm) that contains a double-stranded closed circu-
lar DNA genome associated with histone-like proteins and protected by a capsid formed by two 
late proteins, L1 and L2 (Fermandes, 2012). Over 100 HPV types have been identified to date. 
HPV is an epitheliotropic virus that can induce squamous epithelial tumours (benign cutaneous 
and mucosal lesions) in many different associated anatomical localisations, which produces cyto-
pathic effects in infected keratinocytes (Dianzani et al., 1998; Morshed et al., 2014).
HPV DNA can be detected in biopsy specimens by various methods, such as hybridisation 
procedures and PCR. PCR is the most widely used method for amplification of nucleic acids, 
and has a high sensitivy and specifity (Moljin et al., 2005). In this study, PCR was used to 
detect HPV DNA types 6 and 11 genomes in skin tag lesions.
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2 METHOD
This study aimed to detect HPV DNA in skin tags by using the PCR technique. This study 
was performed on skin tag patients with a clinical and anamnesis diagnosis. Thirty skin tag 
biopsy specimens were obtained under local anaesthesia from body sites (colli, axillaris, 
auricularis, and femoralis). The specimens were preserved at below –20°C, and DNA was 
then extracted from the skin tag samples using a commercial DNA isolation kit from tissue 
(GeneAid®) according to the manufacturer’s instructions.
All of the samples were subjected to PCR, using primers specific to the HPV genome. 
The presence of HPV type 6 was investigated by PCR amplification of 258−361 bp (base 
pairs) target from the locus control region (LCR) using the sequence forward primer 5’-TAG-
GGGACGG TCCTCTATTC-3’ and reverse primer 5’-GCAACAGCCTCTGA GTCACA-3’. 
The presence of HPV type 11 was investigated by PCR amplification of 356 bp target from 
the L1 region using the sequence forward primer 5’-GAATACATGCGCCATGTGGA-3’ 
and reverse primer 5’-AGCAG ACGTCCGTCCTC GAT-3’. The reaction was carried out in 
a volume of 20 μl containing 12 ul PCR fast ready mix (KAPA 2G®), 2.5 μl forward primer, 
2.5 μl reverse primer, and 5 ul DNA isolate. The amplification cycles comprised 1 min at 
95°C for initial denaturation, 15 seconds at 95°C for denaturation, 15 seconds at 55–65°C for 
annealing, 5 seconds/kb at 72°C for extension, and 10 mins at 72°C for the final extension 
using a thermocycler (Applied BiosynthesisTm Veriti 384®).
For analysis of the PCR product, 5–7 μl amplification product were electrophoresed on 
2.5% agarose gel (Bioron®) in Tris Acetate EDTA (TAE) buffer with 1 ul ethidium bro-
mide (Invitrogen®). Gel was visualised on an ultraviolet transilluminator; visualising the 
258–361 bp fragment was interpreted as a positive result for HPV type 6 and visualising the 
356 bp fragment was interpreted as a positive result for HPV type 11. Precautions to avoid 
cross-contamination and false-positive results were taken in every assay.
3 RESULT
In this study, 30 samples of skin tag lesions were obtained from 16 skin tag patients (6 men 
and 10 women), who were in the age group 20 to 60 years. Samples from patients were taken 
from the following areas: 20 (66.7%) samples from the colli region, 7 (23.3%) samples from 
the axilla region, 2 samples (6.6%) from the auricularis region, and 1 (3.3%) sample from the 
femoralis region.
Analysis of the presence of HPV DNA by PCR showed that 14 (46.7%) of the 30 positive 
samples contained HPV DNA, 8 (26.7%) of the positive samples contained HPV type 6 with 
restriction band level at 258 bp (Figure 1), and 6 (20%) of the positive samples contained 
HPV type 11 with restriction band level at 356 bp (Figure 2).
Figure 1. Gel electrophoresis PCR with HPV type 6. Line 1 weight marker 50 bp ladder, line 2 is positive 
control, line 3 is negative control. Sample nos. 1, 5 and 8 showed a positive band (258 bp).
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4 DISCUSSION
HPV is epitheliotropic and host-specific, with infection across the species being uncommon 
(Androphy & Kirnbauer, 2012). HPV infection occurs through inoculation of the virus into 
a viable epidermis through breaks in the epithelial barrier. Maceration of the skin is probably 
an important predisposing factor. Animal models using HPV virions demonstrate that attach-
ment to heparan sulfate proteoglycans on the basement membrane is a required initial step 
in natural infection. A furin protease then cleaves L2, inducing a conformation change that 
allows binding to an unidentified basal cell receptor. This experimental model explains how 
PV reserva indection for and specifically target epithelial basal cells (Androphy & Kirnbauer, 
2012).
Suzuki and his co-workers demonstrated the high association between the presence of 
HPV DNA types and other benign tumours, such as laryngeal papillomas (Al-Shaiji & 
Al-Buainian, 2005). The clinical condition of skin tags is closely similar to that of muco-
cutaneous papillomatosis and their clinical behaviour may be reminiscent of that of laryn-
geal papillomas, which might raise the suggestion of a common aetiology. Since HPV has 
been detected in many papillomas, they may consequently be responsible for the development 
of skin tags (Sallam et al., 2003)
The result of this study was in accordance with a study by Gupta et al. (2008), who previ-
ously reported the presence of HPV 6/11 DNA in 48.6% of biopsies; however, the results of 
this study were lower in comparison with the study conducted by Dianzani et al. (1998), who 
reported the presence of HPV type 6/11 in 88% of skin tag samples, and the study by Sallam 
et al. (2003), who reported that 23 (76.6%) out of 30 positive samples contained HPV DNA 
type 6/11.
The finding of HPV DNA types 6 and 11 in biopsies of the skin tag lesions suggests that 
this virus may be involved in the pathogenesis of these cutaneous lesions. It has been known 
that skin tags or fibroepithelial polyps are developed in areas of skin that are prone to rub-
bing or friction (Pezeshkpoor et al., 2012) and can lead to disruption of the skin, which might 
serve as a route of entry for the virus. The presence of HPV DNA and mechanical friction 
seem to be significant co-factors in the pathogenesis of skin tags (Shashikala et al., 2014).
It has been postulated that HPV infection begins with the inoculation of the virus into the 
interrupted epithelium and the interaction with a putative specific cellular receptor (Gupta 
et al., 2008). HPV infection involves squamous epithelium and can cause growth stimulation, 
cell proliferation and the formation of pathologic cells (Morshed et al., 2014) through the 
role of E5 oncoprotein, which can activate growth factor receptors, epithelial hyperplasia, 
papillomatosis, hyperkeratosis and koilocytic change that are regarded as cytopathic effects 
of HPV (Shashikala et al., 2014).
Figure 2. Gel electrophoresis PCR with HPV type 11. Line 1 weight marker 50 bp ladder, line 2 is positive 
control, line 3 is negative control. Sample no. 4 showed a positive band (356 bp).
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5 CONCLUSION
In this study the presence of HPV types 6 and 11 genomes in the skin tag lesions from differ-
ent sites could support the viral aetiology theory, but cannot be considered as proof of the 
aetiological role, because the results of this study are not of a high percentage. The presence 
of HPV DNA that can affect cellular differentiation and mechanical friction seem to be sig-
nificant co-factors in the pathogenesis of skin tags.
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Ferritin levels after ferrous fumarate supplementation 
in the 2nd trimester of pregnancy
L.S. Lintang
Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Sumatera Utara, 
Medan, North Sumatera, Indonesia
ABSTRACT: This study is to determine the comparison of ferritin levels after ferrous fuma-
rate supplementation in the second trimester of pregnancy. This study was an experimental 
study with a pre-/post-test design. All of the subjects’ ferritin serum levels were compared 
after one month of ferrous fumarate consumption. The study began in April 2015. Blood 
sampling was conducted on all mothers who met the inclusion criteria; they were given ferrous 
fumarate for one month and then they were re-examined. The mean rate of ferritin in mater-
nal serum after iron supplementation measured after one month was 28.7689 ± 20.77 ng/ml 
higher than before treatment, that is, 17.5 ± 19.09 ng/ml. A Wilcoxon test gave p-value < 0.05. 
There is a significant increase in the serum levels of pregnant women’s ferritin after iron 
supplementation.
Keywords: Ferritin, Ferrous Sumarate Supplementation, Pregnancy
1 INTRODUCTION
Anaemia during pregnancy is a risk factor for both the mother and the foetus. The serum 
concentrations of ferritin will continue to decline progressively during pregnancy, although 
erythropoiesis is increased (Cunningham, 2010). Haemoglobin (Hb) concentration and 
haematocrit (Ht) slightly decreased during normal pregnancy, resulting in the overall blood 
viscosity decreasing. Also, plasma concentrations of various substances decreased during 
pregnancy (Schmitt, 2005).
Examination for iron deficiency includes serum iron, red blood cells, serum total iron bind-
ing capacity, serum transferrin saturation, serum transferrin serum levels and serum ferritin 
levels. Several studies have shown that the test for serum ferritin is the best and most useful 
non-invasive test and gives a reliable index of iron storage during pregnancy with a low-grade 
interpretation that indicates iron deficiency (Pena-Rosas & Viteri, 2006).
Other examinations to prove the occurrence of iron deficiency include red blood cells, iron 
serum, total iron binding capacity serum, serum transferrin saturation, transferrin serum 
levels and ferritin serum levels. Microcytosis is a sensitive iron deficiency index whose value 
is limited by the physiologic increase in Mean Corpuscular Volume (MCV) that often occurs 
during pregnancy.
Transferrin-iron irradiance is often abnormal in pregnancy (Fai & Lao, 1999) The 
transferrin saturation is less sensitive with regards to day-to-day fluctuations to iron serum 
hours is less efficient than serum ferritin levels to diagnose iron deficiency (Mast, 2001). 
Several studies have proved that the test for serum ferritin is the best non-invasive test and 
it has the greatest benefits for the iron storage index, especially during pregnancy, with low 
levels indicating iron deficiency (Hou et al., 2000).
The best parameter for measuring maternal iron status is serum ferritin concentration. Fer-
ritin is the largest iron storage protein, which is found not only in the lymph, liver and bone 
marrow, but also in the small intestinal mucosal cells, in the placenta, kidneys, testes, skeletal 
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muscles and in the blood circulation. Prenatal minerals and vitamin supplementation in the 
first trimester will keep serum ferritin at higher concentrations (Cunningham, 2010). This 
study assessed whether, after supplementation of iron ferrous fumarate, there is an increase 
in ferritin in the second trimester of pregnancy after one month of supplementation therapy.
2 METHOD
This study was an experimental study with pre- and post-test design in which all of the sub-
jects were compared with routine ferritin and blood tests before and after one month of fer-
rous fumarate consumption. This research was conducted in an outpatient clinic at RSUP H. 
Adam Malik, Medan, Department of Obstetrics & Gynaecology and at a specialist private 
office. The study was conducted from April 2015 until the number of samples was complete.
The target population in this research were pregnant women who came for antenatal care 
at polyclinic RS H. Adam Malik, Medan, and at the obstetrician’s private office. The subjects 
of this study were pregnant women in the second trimester who met the acceptance criteria 
and were willing to participate in this study.
The inclusion criteria of this study were pregnant women 20–35 years old, in the second 
trimester of pregnancy, with a clear history of the first day of their last menstrual period or 
the presence of Crown-Rump Length (CRL) data in the first trimester, and who were willing 
to participate in this study. The exclusion criteria were pregnant woman with major congeni-
tal abnormalities, twin foetuses, pregnancy infections, placenta that implanted too deeply, 
pregnancy with chronic disease, smokers, and those who declined to join this study.
2.1 Research procedures
After obtaining approval from the ethics committee of the Faculty of Medicine, Universitas 
Sumatera Utara to conduct the research, research began with anamnesis, physical examina-
tion, gynaecological examination, and ultrasound.
After the diagnosis was established, the patients signed the informed consent. The data 
were collected for characteristic and demographic data, the physical diagnosis of vital signs 
(consciousness, blood pressure, pulse, respiratory rate and body temperature), general cir-
cumstances, localised status and genital status. All mothers who met the inclusion criteria 
were given serum tests of ferritin, then given ferrous fumarate for one month and then 
re-examined.
3 RESULTS
Research has been conducted on 70 pregnant women who visited the gynaecological outpa-
tient clinic at RSUP H. Adam Malik, Medan, and the specialist practice.
Table 1 shows that the average amount of ferritin content in maternal serum (Ferritin 1) 
compared with ferritin serum after one month of treatment with iron supplementation 
(Ferritin 2), measured after one month, was 28.7689 ± 20.77 ng/ml higher than before treat-
ment, that is, 17.5 ± 19.09 ng/ml.
Table 1. The average value of ferritin levels before and after iron supplementation.
Ferritin N Mean SD Min Max p*
Ferritin 1 70 17.5 19.094 2 99
0.001Ferritin 2 70 28.7689 20.7717 4.4 99.9
*Wilcoxon test.
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Because the data is not normally distributed based on the Kolmogorov−Smirnov test, 
then the Wilcoxon statistical test was performed and got the p-value < 0.05. This suggests 
that there is a significant increase in serum levels of ferritin in pregnant women after iron 
supplementation.
4 DISCUSSION
Ferritin is a protein that is present in almost all cells. The water-soluble iron-containing 
protein comprises a protein (apoferritin) shell, which is a combination of ferric salts with 
proteins and inticristalin comprising thousands of ferrioxihydroxide molecules (Fleming & 
Bacon, 2005). Free iron is toxic, and the body is able to protect itself  by binding the free iron. 
In the cells, iron is stored in bonded form with ferritin proteins. Ferritin serves to store iron in 
a dissolved and nontoxic form. The level of ferritin in blood serum is correlated with the total 
amount of body iron deposits. Ferritin contains about 23% iron; one ferritin complex can 
store ± 3,000–4,500 Fe3e + ions therein. Ferritin is stored and acquired in the liver, spleen, 
skeletal muscle and bone marrow (Wallace et al., 2005).
During pregnancy, iron is needed for foetal development, the placenta, and increasing 
maternal erythrocyte mass, as well as the normal daily requirements for non-pregnant women. 
The ability of pregnant women to provide for extrinsic needs will depend on what they eat, 
their efficiency of iron absorption and their levels of iron reserves. The absorption of iron 
increases during pregnancy. In theory, the mechanism should be able to accommodate all or 
most of the extra needs of pregnancy. However, the concentration of serum ferritin decreases 
progressively during pregnancy, and it is recognised that serum ferritin describes iron depos-
its in non-pregnant, progressive drop in concentrations during pregnancy suggests decreasing 
iron reserves. Conversely, plasma concentrations of many substances decrease during preg-
nancy, often reflecting physiologic regulation rather than efficiency (Svanberg et al., 1975).
Iron deficiency anaemia or sideropenic anaemia is usually caused by poor iron intake, 
pregnancy, parasite infection, menorrhagia, metrorrhagia, menstruation, premenopause, 
peptic ulcer, long-term use of drugs, and so on. If  the body loses iron beyond its intake, 
then the body will disassemble and use iron stored in ferritin in the liver, spleen, muscle and 
bone marrow, which is the body’s reserves. The reduced iron reserves cannot meet the needs 
for the formation of erythrocytes, and the resulting amount of erythrocytes results in fewer 
haemoglobin decreases and anaemia develops. The body will be compensated, and the bone 
marrow replaces iron deficiency by accelerating cell division and producing erythrocytes of 
a very small (microcytic) size, which is a characteristic of iron deficiency anaemia. During 
pregnancy, the need for iron is not always the same, and this affects the degree of iron absorp-
tion by pregnant women.
5 CONCLUSION
There was a significant increase in the levels of ferritin in pregnant women after the supple-
mentation of ferrous iron.
Iron supplementation may be given to pregnant women in the second trimester to signifi-
cantly increase levels of ferritin.
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The relationship of HER2 overexpression to the histopathologic 
grading of breast cancer
S. Indriani, K. Siregar & Suyatno
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North Sumatera, Indonesia
ABSTRACT: Human Epidermal Growth Factor Receptor 2 (HER2) has a close relationship 
with the histopathologic grading of breast cancer that is thought to be associated with 
prognosis and recurrence. The data was taken from 2011–2014 tissue histopathology, grading, 
and HER2 medical records data. An immunohistochemistry examination for HER2 with 
values of +1 or +2 is said to be negative (unexpressed), and for +3 is said to be overexpressed; 
the grades were grouped into low grade (grades 1 and 2) and high grade (grade 3). From this 
study, we obtained a prevalence ratio of 7.667. Thus it can be said that HER2 expression was 
eight times more likely to have a high grading when compared with negative HER2 results. 
There was a significant association between HER2/neu overexpression and the histopatho-
logic grading of breast cancer.
Keywords: Breast cancer, HER2, Histopathologic grading
1 INTRODUCTION
Breast cancer is still the leading cause of death in woman to date, with as many as 522,000 
deaths by 2012, and it is the most commonly diagnosed cancer in 184 countries around the 
world. In 2012, as many as 1.7 million women worldwide were diagnosed with breast cancer 
and there were 6.3 million women alive who had been diagnosed with breast cancer in the 
previous five years. Since 2008, the incidence of breast cancer has increased by more than 
20%, while the mortality rate has increased by 14%. In Indonesia, there were an estimated 
133.52 cases of cancer per 100,000 adults in 2012, and an estimated 299,673 cases in total 
(IARC, 2012).
Due to the high number of cases there is an urgent need for cancer control. Currently, it 
is necessary to develop an effective and affordable approach to early detection, diagnosis, 
and the treatment of breast cancer. With regards to breast cancer treatment approaches, a 
variety of predictive and prognostic factors of breast cancer were used. The most currently 
used examination is HER2, an Epidermal Growth Factor Receptor (EGFR) that acts in cell 
proliferation and differentiation. The overexpression of this protein in breast cancer tissue is 
associated with a lack of oestrogen receptors and increased histopathology grading. Other 
routine examinations are hormonal status through Oestrogen Receptor (ER) and Proges-
terone Receptor (PR), a body steroid receptor acting as a nuclear receptor in a suppressor 
gene and an oncogene transcription modulator against a targeted gene (Walf, 2013; Axilbund 
et al., 2011). Overexpression in HER2/neu is associated with histopathologic grading, where 
histopathologic grading itself  is a classification of breast cancer representing the potential 
aggressiveness of the tumour. The low classes have a low aggressiveness compared to the high 
classes. In the case of overexpression of HER2, there is an increase in the proliferative activ-
ity of the cancer cells, so it has a very strong correlation with high-grade histopathology of 
breast cancer tumours (AJCC, 2012).
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The breast cancer therapy approaches range from hormonal therapy to chemotherapy and, 
currently, hormone receptor therapy depends on hormonal expression and growth factors 
(ER/PR, HER2, EGFR), not only as therapeutic guidelines but also as a monitoring method 
to detect recurrences (Rakha et al., 2010).
Some researchers have suggested HER2/neu relationships with histopathologic grading, 
such as Fisher et al. (2004), Huang et al. (2005), Menard et al. (2004), Rile et al. (1991), Tsuda 
et al. (1990) and Hoff et al. (2002).
The strong association of HER2/neu overexpression with histopathologic grading gives 
meaning to the treatment and the prognostics associated with worsening, as well as with high 
rates of recurrence (Wood et al., 2005).  Relevant to this, no studies have been done on the 
association of HER2/neu overexpression with the histopathologic grading of breast cancer 
patients at RSUP H. Adam Malik. For that reason, the author wanted to study the relation-
ship of the HER2/neu protein with histopathologic grading in breast cancer patients.
2 RESEARCH METHODS
This research used descriptive analytic design with a cross-sectional approach. In this study, 
we did not provide treatment but only saw the results or expression of immunohistochemistry 
HER2/neu that existed in the medical records. This research was conducted in the Oncology 
Division of the Surgical Department of RSUP Haji Adam Malik in co-operation with the 
Anatomical Pathology Department of RSUP H. Adam Malik, Medan. Immunohistochem-
istry examinations for HER2 with values of +1, and +2 are said to be negative/unexpressed, 
and +3 is said to be overexpressed. The histopathologic grading was done according to the 
Nottingham Histologic Score system (Johns Hopkins University, 2012). However, the grades 
were grouped into low grade (grades 1 and 2) and high grade (grade 3). The data were then 
analysed to find the relationship between HER2 overexpression with the histopathologic 
grading of breast cancer.
3 RESULTS
From the results of the analysis, the mean age in this study was 50 years old. The highest age 
was 77 years old and the lowest was 30 years old. HER2 with a result of +1 was found in 50 
people (55.6%), HER2 with a result of +2 was found in 13 people (14.4%), and HER2 with a 
result of +3 was found in 27 people (30.0%) (Table 1).
The frequency of the histopathologic grading of breast cancer in RSUP H. Adam Malik 
was: grade 1 in 40 patients (44.42%), grade 2 in 39 patients (43.3%), and grade 3 in 11 patients 
(12.2%) (Table 2). From this study, we obtained a prevalence ratio of 7.667. Thus it can be 





Table  2. Frequency distribution of subject’s 
histopathologic grading.
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said that HER2 expression was eight times more likely to have a high grading when com-
pared with negative HER2 results.
4 DISCUSSION
In this study, the HER2/neu examination was done by immunohistochemistry staining on 90 
breast carcinoma patients who came to RSUP H. Adam Malik between 1 June 2011 and 1 June 
2014. The mean age of the patients was 50 years old. From the HER2/neu frequency that was 
obtained (Table 1), there were 50 (55.6%) patients with HER2 +1, 13 (14.4%) patients with HER2 
+2 and 27 (30.0%) patients with HER2 +3. The number of breast cancer patients with negative 
HER2/neu was 63 (70.0%), and 27 patients (30.0%) had HER2 overexpression. This corresponds 
to the literature’s incidence of HER2/neu overexpression in 10–30% of breast carcinomas.
In several studies at Surabaya Oncology Hospital from 2007 until 2010 with 844 patients, 
216 (25.6%) patients with breast carcinoma were found to have an overexpression rate of 
HER2/neu. Other studies by Huang et al. (2005) obtained 149 (10.9%) patients with overex-
pression of HER2/neu out of 1,362 respondents. Another study conducted by Naqvi et al. 
(2002) reported an incidence rate of 33% of HER2/neu overexpression in patients with breast 
carcinoma (Naqvi et al., 2002).
Histopathologic grading was obtained from Elston–Ellis, which was modified from 
Scarff–Bloom–Richardson. This study obtained 29 (32.2%) grade 1, 47 (52.2%) grade 2 and 
14 (15.6%) grade 3 patients (Table 2).
From the statistical analysis of this study, we found a significant relationship between 
HER2/neu overexpression with histopathologic grading of breast cancer patients, in which 
the prevalence ratio was 7.667 (Table 3), therefore it can be concluded that overexpression of 
HER2 was eight times more likely to have a high grading when compared to negative HER2. 
This is shown by the existing literature in several studies, both domestically and internation-
ally. In their study, Bartlett et al. (2007) reported a significant association between HER2/neu 
overexpression and histopathologic grading as a predictor of breast carcinoma, where over-
expression was found in high-grade breast tumours. These studies were reanalysed by Neven 
et al. (2008) and they reported a high recurrence rate in patients with overexpression of HER2.
In Indonesia, it was reported that there was a significant association of overexpression 
with histopathologic grading of breast carcinoma in which high HER2/neu overexpression 
was found, such as the research conducted at Surabaya Education Centre/Surabaya Oncol-
ogy Hospital by Octovianus and Ariodjatmiko (2012), in a study involving 1,426 patients, 
which reported a significant association between HER2/neu overexpression and breast can-
cer histopathologic grading. In that study 34.6% overexpression of HER2/neu was present in 
grade 3, and the study also stated that grade 3 had 3.9 times more risk compared with grades 
1 and 2 for the occurrence of HER2/neu expression.
The existence of the relationship of HER2 overexpression with histopathologic grading 
was a predictor factor and prognosis factor of breast cancer, in addition to therapy. There-
fore, the examination should be able to follow the guidelines that have been agreed. False pos-
itives or false negatives may occur on HER2 examination with IHC or HER2 +2 equivalent 
results, requiring further examination with Fluorescent In Situ Hybridisation (FISH) as the 
gold standard (Prati et al., 2005). Similarly, the results of this study had many shortcomings, 
one of which is mentioned above.






Lower−upper PLow grade High grade
Negative (no expression) 36 27
7.667 2.372−24.781 0.000Positive (overexpression)  4 23
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5 CONCLUSION
There was a significant association between HER2/neu overexpression with histopathologic 
breast cancer grading. Overexpression of HER2/neu was eight times more likely to have a 
high grading when compared to unexpressed HER2.
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ABSTRACT: The ratio of trans-3′-hydroxicotinine (3′-OH) to cotinine (COT) is referred 
to as the Nicotine Metabolite Ratio (NMR). Faster metabolisers of nicotine increase the risk 
of lung cancer. The aim of this study was to identify the association between the urinary 
NMR and lung cancer patients. Consecutive sampling and case-control study were applied. 
All of the samples were men and were either smokers or ex-smokers. We investigated NMR 
by using the Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) technique. 
Statistical analysis was performed by chi-squared analysis using SPSS. This study involved 
46 samples, consisting of 23 cases of lung cancer and 23 healthy controls. There was a sig-
nificant association between urinary NMR levels and lung cancer incidence (p = 0.00). Fast 
metabolisers were 0.115 times more susceptible to lung cancer incidence than the slow metab-
oliser group (95% Confidence Interval (CI): 0.03–0.5). There was a significant association 
between urinary NMR levels with lung cancer incidence among smokers.
Keywords: Nicotine, Nicotine Metabolite Ratio, Lung Cancer
1 INTRODUCTION
Lung cancer in the broad sense involves all of the malignant diseases in the lung, including 
malignancies originating from the inside of the lung and malignancies outside of the lung 
(Jusuf et  al., 2011). The incidence of lung cancer is highly correlated with smoking, and 
about 10% of smokers will usually be diagnosed with lung cancer in the long term. Continu-
ally consuming tobacco is a major cause of lung cancer (Silvestri et al., 2015).
Nicotine is a psychoactive component in tobacco. The variant of genetics effect of the 
nicotine pharmacokinetics and pharmacodynamics is associated with cigerette consumption 
and lung cancer risk. The most widely used nicotine biomarkers are blood, urine, saliva, hair 
and nails (Yildiz, 2004).
Nicotine is primarily metabolised to cotinine (COT) and trans-3′-hydroxycotinine (3HC) 
by liver enzyme cytochrome p450 2A6 (CYP2A6). The Nicotine Metabolite Ratio (NMR) 
(3HC/COT) is commonly used as a biomarker of CYP2A6 enzymatic activity, the rate of 
nicotine metabolism and total nicotine clearance (Benowitz et al., 2010).
A faster nicotine metabolism (greater CYP2A6 activity) can lead to more smoking being 
necessary in order to maintain the desired level of nicotine in the body. This could lead to a 
greater intake of tobacco smoke and a high risk of tobacco-related diseases. The CYP2A6 
activity is also associated with the bioactivity of tobacco-specific nitrosamine, which is a 
potent carcinogen that contributes to cigarette-related cancers (Pelkonen & Raounio, 1995; 
Yamazaki et al., 1992).




Forty-six subjects with a history of cigarette smoking were recruited in this study: 23 subjects 
with lung cancer as sample cases and 23 healthy people with a smoking habit as the control. 
All of the subjects were patients in Adam Malik General Hospital from October 2016 to 
March 2017. The inclusion criteria for this sample were lung cancer patients diagnosed by 
cytology/histopathology, aged between 25 and 75 and of male gender. The exclusion criteria 
in both groups were pulmonary tuberculosis patients who consumed antituberculosis drugs 
and dexamethasone, and mistakes of data collection (ravage from the beginning isolation). 
This study was approved by the Ethical Committee of Faculty of Medicine, Universitas 
Sumatera Utara, and obtained informed consent from each participant.
2.2 Urine acquisition
Before the sample was taken, the subjects should chew on nicotine gum (4 mg) for 10 minutes. 
Afterwards, the urine subject of 15 ml was collected in a standard container of urine. Samples 
taken can be stored in a refrigerator at a temperature of −70°C. Samples should be mixed well 
and placed in the appropriate vials (Corning 50 ml polypropylene tubes), and the tube should 
be sealed properly. The sample will be analysed by LC-MS/MS (Liquid Chromatography-
Mass Spectrometry Tandem Mass Spectrometry).
2.3 Statistical analysis
The chi-squared test was used to compare NMR between the cases and control. The OR and 
95% CI were calculated to determine the association between the variables and the risk of 
lung cancer with regards to the NMR in both the cases and control. Statistical analyses were 
conducted using the statistical software SPSS 17.0 and a p-value of < 0.05 was required for 
statistical significance.
3 RESULTS
The demographic characteristics of the subjects of this study, based on age, cigarette type, 
Brinkman index and Body Mass Index (BMI), are shown in Table 1. There were statistically 
significant differences in the age mean between the two groups (p <  0.001). The smoking 
Table 1. Demographic characteristics of the study subjects.
Lung cancer Healthy people
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history of the samples and controls for this study was categorised according to the Brinkman 
index. There was no statistically significant difference between the Brinkman index of the 
two groups (p = 0.523). The nutritional status of the sample and control groups in this study 
was categorised according to the BMI. There was a significant difference in the BMI averages 
between the two groups (p = 0.01).
Nicotine metabolism rates in this study based on the NMR (cotinine and trans-3’-hydrox-
icotinine ratio) were categorised into fast metabolism (≥0.51) and slow metabolism (0–0.50). 
The mean of NMR ± SD in the lung cancer group was 0.29 ± 0.28, while the control group 
obtained a mean of NMR ± SD of 0.85 ± 0.78 (Table 2). Based on statistical analysis using 
the Mann–Whitney test, it was found that there was a significant difference between the two 
groups related to NMR (p < 0.001).
Based on statistical analysis using the chi-square test method, it was shown that there was a 
significant relationship between NMR in urine and lung cancer incidence (p < 0.001). A fast 
metabolism was 0.115 times more susceptible to lung cancer incidence, compared with a slow 
metabolism (95% Confidence Interval (CI): 0.03–0.5).
From multivariate analysis it was found that significant variables, such as NMR, age and 
BMI (p = 0.03, p = 0.01, and p = 0.03, respectively), contributed to lung cancer incidence.
4 DISCUSSION
Based on statistical analysis, this study showed that there is a significant difference in the 
mean of age between the case and control groups. The case group (lung cancer) obtained the 
highest average at ≥ 60 years old (47.8%) with a smoking history. Thun et al. (1997) reported 
that among the male sex, mortality rates between the ages of 35 and 59 were three times 
higher in smokers than in non-smokers.
Based on statistical analysis, this study revealed a significant difference in the average BMI 
between the two groups. A previous study by Koh et al. (2010), showed that smoking and the 
number of years since quitting smoking, and low BMI were associated with a significantly 
increased risk of lung cancer.
In this study, the heaviest Brinkman index is the most common category of lung cancer 
(46.7%). Zhang et al. (2001) reported that most of the patients with Lung Cancer-Combined 
Pulmonary Fibrosis and Emphysema (LC-CPFE) were smokers and had an average Brink-
man index of 1131.7 ± 490.8.
Based on statistical analysis, this study showed significant differences between the two 
groups in relation to NMR (p < 0.001). Statistical analysis showed that there is a significant 
association between NMR in urine and lung cancer incidences (p < 0.001). Fast metabolisers 
are 0.115 times more susceptible to lung cancer incidence than the slow metaboliser group 
(95% Confidence Interval (CI): 0.03–0.5). This is in contrast to the previous study under-
taken by Strasser et al. (2011), which reported that a faster nicotine metaboliser based on 
NMR values showed a significant increase in total daily cigarette smoking volume and total 
NNAL (as a carcinogen biomarker). Ellard et  al. (1995) reported that significant results 
were obtained that described the estimated capacity of  nicotine metabolite with 12-hour 
urine samples to predict the risk of  lung cancer. Park et al. (2017) evaluated the relation-
ship between urinary biomarkers to nicotine consumed (Total Nicotine Equivalent/TNE) 
and CYP2A6 activity (NMR) with lung cancer risk in multi-ethnic smoker subjects. It was 
Table 2. Nicotine metabolite ratio of both groups.
Lung cancer Healthy people
p OR 95% CIn % n %
Fast  3 13.0 13 56.5
0.002 0.115 0.027−0.500Slow 20 87.0 10 43.5
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found that both TNE and CYP2A6 activities were associated with an increased risk of  lung 
cancer.
5 CONCLUSION
This study consisted of case subjects and control subjects with a large total of 46 subjects, 
consisting of a case group, which was a group of lung cancer patients with a smoking history, 
and a control group, which was a group of smokers who did not have lung cancer. There are 
significant differences between NMR in urine and lung cancer incidence (p < 0.001). Fast 
metabolisers are 0.115 times more susceptible to lung cancer incidence than the slow metabo-
liser group (95% Confidence Interval (CI): 0.03–0.5).
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Relationship between habitual snoring and primary enuresis 
in children
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ABSTRACT: Obstructive sleep disorder breathing is assumed to be associated with 
primary enuresis in children. Prolonged enuresis may cause developmental disorders, 
poor school performance and emotional disorders. A cross-sectional study was conducted 
in the Muara Batang Gadis district, North Sumatera in April 2016. The samples of the 
study were children aged from 5 to 14 years old. The Sleep Disturbance Scale for Children 
(SDSC) questionnaire was used for measuring the symptoms of sleep disorder breathing 
and the International Relationship Child and Adolescent Psychiatry and Allied Professions 
(IACAPAP) questionnaire for the presence of primary enuresis. Data were analysed using a 
chi-square test and logistic regression. The p-value of <0.05 was considered significant. Out 
of the 110 children, 27 (24.5%) snored more than three nights per week (habitual snorers), 
and 18 (16.4%) had primary enuresis. The habitual snorers with a history of primary enuresis 
outnumbered non-habitual snorers (9.1% versus 15.4%) with a p-value <0.05. There is a sig-
nificant relationship between habitual snoring and primary enuresis.
Keywords: enuresis, habitual snoring, children
1 INTRODUCTION
Enuresis is strongly related to sleep disorder breathing (snoring), which frequently occurs in 
children (Von Gontard, 2012; Baird et al., 2014). Enuresis has long-term effects if  it is not 
managed seriously (Heba et al., 2013; Kalorin et al., 2010) and may cause an impact on chil-
dren’s development (Khaleghipour et al., 2013). Children may experience internal or external 
behavioural disorders. Children will develop low esteem, get low grades in school and even 
develop emotional disturbances (Maternik et al., 2015; Prasetyo, 2015).
Habitual snoring is associated with enuresis. Snoring is the most common clinical manifes-
tation occurring in children with Obstructive Sleep Apnoea (OSA) (Jeyakumar et al., 2012). 
Children with OSA do not have a good quality of sleep, resulting in decreased Antidiuretic 
Hormone (ADH).
ADH secretion will cause micturition at night (nocturnal enuresis) (Yousefichaijan et al., 
2015).
Sex, age, poorly educated parents, low socioeconomic status, and a history of enuresis in 
the family are the variables that are associated with enuresis and habitual snoring in children 
(Alexopoulos et al., 2014). The relationship between enuresis and habitual snoring is becom-
ing a problem in developing countries, including Indonesia, especially in the Muara Batang 
Gadis district.
2 METHODS
This is a cross-sectional analytic study to determine the relationship between enuresis and 
habitual snoring in children. This study was conducted in the Muara Batang Gadis district, 
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Mandailing Natal regency. This study was conducted in April 2016. The target population 
in this study was children aged between 5 and 14 years. The eligible population was children 
aged between 5 and 14 years in the Muara Batang Gadis district, Mandailing Natal regency. 
The sample was obtained using a simple random sampling method. The inclusion criteria 
was children aged between 5 and 14 years, and the exclusion criteria were spina bifida, cer-
ebral palsy, and diabetes mellitus. Informed consent was obtained from each parent or person 
who was responsible for the sample. This study was approved by the Health Research Ethical 
Committee, Medical School, Universitas Sumatera Utara.
3 RESULTS
A total of 110 samples were enrolled in this study. The mean age of the samples was 9.23 
years (SD 2.16). Based on sex, the number of male and female samples were equal. From a 
physical examination it was seen that 57.3% of the samples had normal tonsils. Urinalysis 
using a rapid urine test was conducted to exclude urinary tract infections. Blood glucose level 
was measured using a rapid bedside test (GlucoDr) to exclude hyperglycaemia in this study. 
There was no sample with neurological, urinary tract or metabolic disorders. There was also 
no history of medication usage, which may affect diuresis.
The sample distribution based on sex in the snoring group was equal. In the snoring group, 
there was a predominance of females (13.6%), while in the non-snoring group we found a 
male predominance (39.1%). Tonsillar examination showed that 15 (13.6%) samples in the 
snoring group had enlarged tonsils (T3-T3). In the non-snoring group, most samples (54.5%) 
had normal tonsils. There was a variation in sample distribution based on the history of enu-
resis in siblings, father and mother. In the snoring group, a history of enuresis in siblings and 
father is more frequent, whereas a history of enuresis in a mother is smaller. The non-enuresis 
group showed a different pattern. Most samples had no enuresis history in siblings, father or 
mother. There were two samples in this study who had obesity and they were in the snoring 
group and non-enuresis group.
In the enuresis group, 10 (9.1%) of the samples were male, while the non-enuresis group 
was dominated by females (42.7%). In both groups, physical examination revealed normal 
tonsils (T1-T1) in the samples in different proportions (6.4% and 50.9%, respectively). A 
history of enuresis in the father and mother of those in the non-enuresis group was higher 
compared to the enuresis group (40.0% vs 9.1% and 25.5% vs 9.1%) and a history of enuresis 
in siblings of the enuresis group was higher than in the non-enuresis group (11.8% vs 4.5%). 
Based on obesity status, sample characteristic distribution did not differ significantly in both 
groups.
Logistic regression was conducted to determine the risk factors of enuresis and snoring in 
this study. Age, sex, obesity, number of siblings, history of enuresis in siblings, fathers and 
mothers, number of house dwellers, and tonsils were the risk factors analysed in this study.
Table 1. Risk factors for enuresis in habitual snoring samples.
Constant Wald P-value*
Age 0.973 0.012 0.912
Sex 6.037 2.456 0.117
Number of siblings 1.751 0.510 0.475
History of enuresis in siblings 2.721 1.060 0.303
History of enuresis in fathers 0.117 2.879 0.900
History of enuresis in mothers 18.132 5.420 0.020
Number of house dwellers 0.459 0.833 0.361
Obesity 0.000 0.000 1.000
Tonsil size 0.140 8.488 0.004
*Regression logistic test.
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The results showed that a history of enuresis in mothers and tonsil size were related to 
enuresis in the samples with snoring (p-values of 0.020 and 0.004, respectively). Of the two 
factors, one of them was a protective factor. The protective factor was tonsil size. Based on 
statistical analysis, we found that the incidence of enuresis in the samples with snoring was 
decreased 0.14 times along with increasing tonsil size. On the other hand, the risk factor for 
enuresis in the samples with snoring in this study was the history of enuresis in mothers. If  
the samples had mothers with a history of enuresis, the rate of enuresis would increase 18.132 
times compared to samples without that risk factor.
A chi-squared test was done to determine the relationship between snoring and enuresis. 
The result showed that there was a statistically significant relationship between snoring and 
enuresis in children with a p-value of 0.001.
4 DISCUSSION
Enuresis is a frequently neglected problem, mainly in children and adolescents. Several 
recent studies have shown that the prevalence of enuresis in children and adolescents is high 
enough. Penbegül et al. (2013) conducted a study involving 4,203 children and reported a 
prevalence of enuresis of 25.9%. Another study reported a lower prevalence rate. Solanki 
et  al. (2013) found that the prevalence of enuresis in children in rural areas in India was 
11.13%. Karnicnik et al. (2012) conducted a study in Slovenia and reported a prevalence of 
12.8%. A similar result was reported by Makrani et al. (2015) in Iran with a prevalence rate 
of 11.01%. The prevalence of enuresis in Indonesia from several studies was about 10.9% 
(Windiani & Soetjiningsih, 2010).
The risk factors of enuresis are socioeconomic, psychological and genetic. Von Gontard 
(2012) stated that 70–80% of children with enuresis had genetic disorders. In their study, 
Solanki and Desai (2014) had a different opinion. They found that the risk factors of enuresis 
were socioeconomic status and the presence of a urinary tract infection. The latter result was 
similar to a report from Makrani et al. (2015), who found that psychological factors, socio-
economic levels and urinary tract infections were the risk factors of enuresis.
In this study, we found 18 out of 110 children with enuresis based on the International 
Relationship for Child and Adolescent Psychiatry and Allied Professions questionnaire. The 
prevalence of enuresis was 16.4%, with 10 (9.1%) male and 8 (7.3%) female.
Snoring is an important sign that leads to airway problems. Habitual snoring needs to be 
managed further because it can develop into Obstructive Sleep Apnoea Syndrome (OSAS) 
and causes serious problems in children. The incidence of OSAS is approximately 0.1%−5.7% 
and increases along with age, obesity, tonsil enlargement, and the other risk factors (Brock-
mann et al., 2012).
Nafiu et al., in their study in the United States that enrolled children aged 6–18 years, 
reported a prevalence rate of 27.3% for snoring. A similar result was reported by this study. 
The prevalence rate for snoring in children aged 5–14 years in this study was 24.5% (Nafiu 
et al., 2011).
The relationship between habitual snoring and enuresis in children is still debatable. Sakel-
laropoulou et al. (2012) conducted a study with 42 children aged from 3.5 to 14.5 years who 
Table 2. Relationship of habitual snoring and enuresis.
Enuresis No enuresis
P-value*n % n %
Snoring 10  9.1 17 15.4
0.001No snoring  8  7.3 75 68.2
Total 18 16.4 92 83.6
*Chi-squared test.
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had sleep disturbances. In their study they used polysomnography as the gold standard in 
measuring sleep quality to identify habitual snoring, and reported that seven children (16.7%) 
had enuresis. This concluded that there was a relationship between habitual snoring and 
enuresis in children.
Alexopoulos et al. (2006) did a study to determine the relationship between habitual snor-
ing and enuresis in children. The samples in this study were 1,821 children aged 5–14 years. 
The study reported that 135 (7.3%) children had habitual snoring and 7.4% of them had 
nocturnal enuresis. The study found that habitual snoring was related to enuresis.
Satti et al. (2015) examined 290 children with tonsillar hypertrophy in Saudi Arabia. The 
study aimed to determine the relationship between tonsillar hypertrophy accompanied by 
snoring with enuresis. From the study, they reported that 114 (39.3%) children with tonsillar 
hypertrophy had enuresis. They concluded that children with enuresis must be examined for 
tonsillar enlargement.
Ahmadi et al. (2013) conducted a study in Iran to determine the prevalence of enuresis in 
children who had undergone a tonsillectomy. A total of 420 children were enrolled, and 92 of 
them had a history of enuresis. After a tonsillectomy was done, each sample was discharged 
and was followed for three months. Enuresis was not found in 51 (60.7%) children who had 
a tonsillectomy and 22 (26.2%) children had improved enuresis symptoms (p <0.001). The 
study concluded that the prevalence of enuresis would decrease after a tonsillectomy.
In our study, we found a relationship between habitual snoring and enuresis in children. In 
this study, 18 (16.4%) children who had habitual snoring also had enuresis. It was proven that 
there was a relationship between habitual snoring and enuresis in this study.
Snoring may cause a non-deep state sleep. This will cause a decrease in ADH secretion. 
The decreased ADH disrupts water retention so that urine production will be increased. 
That is the pathophysiology on how habitual snoring in children can cause enuresis. This was 
observed in our study where habitual snoring caused enuresis in children (Alexopoulos et al., 
2006; Kaditis et al., 2015).
Despite all of these results, this study still has weaknesses. The sample in this study is not 
large enough and this makes the results different from the previous studies.
5 CONCLUSION
There is a relationship between habitual snoring and enuresis in children in this study. A 
history of enuresis in mothers and tonsil size are risk factors of enuresis in this study. In 
contrast, a history of enuresis in fathers and siblings and tonsillar hypertrophy are not risk 
factors of enuresis.
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ABSTRACT: The prevalence of hypertension in children, particularly those of school age, 
is increasing and is related to a change in the quality of life. To assess the relationship between 
hypertension and the quality of life in adolescence, a cross-sectional study was conducted in 
13–18 year old adolescents in Singkuang, North Sumatra. Anthropometry and blood pres-
sure measurements were done. The quality of life was assessed using the PedsQL question-
naire. From a total of 79  samples, 19 (24.1%) children were hypertensive and 60 (75.9%) 
were not. There were 67 (84.8%) children with good and 12 (15.2%) with poor quality of life. 
There were 14 (17.7%) hypertensive children with good and 5 (6.3%) with poor quality of life. 
A chi-squared test was done with a value of p = 0.121 (PR = 2.256 and CI 95% = 0.809−6.287). 
There is no relationship between hypertension and quality of life in adolescents.
Keywords: adolescent hypertension, health-related quality of life
1 INTRODUCTION
Hypertension is one of the most common chronic diseases and is a major cause of morbidity 
and mortality worldwide (Berendes et al., 2013). Hypertension can occur in children. Often 
hypertension that occurs in adults started in childhood (Sekarwana et al., 2011).
The prevalence of hypertension amounts to more than one billion people worldwide and 
hypertension in children, especially those of school age, has increased (NHBP, 2004). In chil-
dren and adolescents aged from 3 to 18 years, the prevalence of hypertension is 3.6% and of 
prehypertension is 3.4%. From a cross-sectional study of adolescents, there was a prevalence 
of hypertension of 3.2% and a prevalence of prehypertension of 15.7% (Falkner, 2010).
Primary hypertension is more often diagnosed in adolescence than in childhood. Data from 
the National Childhood Blood Pressure found that in adolescents with 2- and 4-year interval 
blood pressure measurements showed 14% prehypertensive adolescents, which progressed to 
hypertension in 2 years: about 7% per year (Falkner, 2010). In Indonesia, according to basic 
health research (Riskesdas), in 2007 the prevalence of hypertension at age 15–17  years is 
8.3%.5 A study in RSU Zainal Abidin Banda Aceh found a hypertension prevalence of 23.4% 
in children aged 4–16 years (Infodatin Pusat, 2016).
Childhood hypertension should receive serious attention, because the disease can carry on 
into adulthood, so early detection is required every year after a three-year-old child (Lurbe 
et  al., 2016). Childhood hypertension is asymptomatic hypertension, which is associated 
with changes in Health-Related Quality of Life (HRQoL) and which remains controversial 
(Erickson et al. 2001). Therefore, this study aims to investigate the HRQoL in children with 
hypertension, including aspects such as their physical condition, emotions and social aspects 
related to health, and research will be conducted in Singkuang Village, Muara Batang Gadis 
sub-district, Mandailing Natal, North Sumatra Province (village assisted by the Department 
of Health Sciences Faculty of Medicine, University of North Sumatra).
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2 METHOD
The design of  this study is a cross-sectional comparative study to determine the relationship 
between hypertension with the quality of  life of  adolescents. This study was conducted at 
Al-Fath Integrated Islamic Boarding Junior High School, Singkuang Village, Muara Batang 
Gadis Sub-district, Mandailing Natal Regency from 18 June 2016 until 31 September 2016.
The population that met the inclusion criteria were given a PedsQL questionnaire regard-
ing the quality of life of the child. Anthropometric measurements and blood pressure meas-
urements were performed. The collected data were analysed statistically to obtain sample 
characteristics and the relationship of the quality of life with hypertension in adolescents. 
Bivariate analysis was conducted on this research data. Data analysis of each of the nominal 
dichotomous variables was undertaken using a chi-square test to determine the relationship 
of hypertension with the quality of life of adolescents. Data processing was done with SPSS 
software, where p <0.05 was considered significant.
3 RESULTS
The number of samples collected in this study were 103 people from three classes in the school. 
Of the total of 103 students, there were 24 children who did not meet the inclusion criteria for 
being under 13 years old, so that the number of samples aged 13–18 years was 79 children.
Table 1 shows that the mean age of the adolescents who became respondents in the study 
was 13.86 (SB 0.91). The most respondents were male (42.42%) and female (37.8%). There 
were 22 (27.8%) grade 7 adolescents, 23 people (29.1%) were grade 8 and 34 people (43.0%) 
were grade 9. The mean body weight was 38.34 (SB 8.17) kg. The mean height was 143.34 (SB 
7.16) cm with a mean systolic pressure of 110.58 (SB 9.74) mmHg and a diastolic pressure 
of 72.23 (SB 6.59) mmHg. The number of hypertensive adolescent children was 27 persons 
(34.2%) and there were 52 people (65.8%) without hypertension. Using PedsQL, the quality 
of life of adolescents report assessment that was done covered physical aspects, emotional, 
social, and school aspects, with the result showing that 64 people (81.0%) had a good quality 
of life and 15 people (19.0%) had a poor quality of life, with a mean score of 80.04 (SB 12.11).
Table  2  shows the results of a chi-squared test used to assess the relationship between 
hypertension and the quality of life in adolescents. Hypertension is divided into two groups: 
hypertensive and not hypertensive. Quality Of Life (QoL) is divided into two groups: good 
Figure 1. Study profile.
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and poor. Based on the results of the chi-squared test, there is no relationship between hyper-
tension and quality of life, with P = 0.257 (RP = 1.685 and CI 95% = 0.684−4.151).
4 DISCUSSION
Primary hypertension can be detected in childhood and adolescence if  there are family 
factors of hypertension, obesity and lifestyle. The death and disability of children due to 
hypertension does not occur, but organs can be damaged from childhood onwards, such as 
left ventricular hypertrophy, thickening of the carotid blood vessel walls, changes in retinal 
vessels and cognitive changes. Asymptomatic hypertension occurs in more than 3% of chil-
dren and less than 3% of children are prehypertensive, so hypertension in childhood is a long-


































Mean age, years (SD) 13.86 (0.91)
Mean weight, kg (SD) 38.34 (8.17)
Mean height, cm (SB) 143.34 (7.16)





Mean QoL score, (SB) 80.03 (11.34)
Table 2. Association between hypertension and quality of life.
Quality of life
P PR CI 95%Poor Good Total
Hyper tension 0.121 2.256 0.809−6.287
Yes  5 14 19
No  7 53 60
Total 12 67 79
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The prevalence of hypertension in the world varies by region. The lowest prevalence is 
0.9%. The prevalence of obese children with hypertension has reached 7.1% (Trevisol et al., 
2012). The prevalence of hypertension and prehypertension is 3.6% and 3.4% in children 
aged 3–18 years (Falkner, 2010).
A cross-sectional study in Aligarth in 2007, which examined 5–17 year old children, found 
a higher prevalence of females with hypertension (9.4%) than males (9.36%).
Another study in Germany showed a prevalence of boys with hypertension of 6% and 
girls of 1.4% at age 14–17 years, whereas by the age of 16.5–19 years, the prevalence of boys 
with hypertension was 5.5% and girls was 1.9%.11 In Indonesia, according to basic health 
research (Riskesdas) in 2007, childhood hypertension in 15–17 year olds had a prevalence of 
8.3%.5 Research in Zainal Abidin Hospital Banda Aceh found a prevalence of hypertension 
of 23.4% in children aged 4–16 years. The prevalence of hypertension with quality of life and 
psychological disorders at the age of 11–17 years was around 10.7% (Berendes et al., 2013).
The prevalence of hypertension is influenced by weight, increased physical activity and 
diet or nutritional modification (Lurbe et al., 2016). Body mass index affects physical and 
emotional health and blood pressure (Neuhauser et al., 2009). In adults, a 4 mmHg increase 
in blood pressure causes a 20% risk of death due to stroke (Neuhauser et al., 2011).
There are four aspects related to the phenomenon of quality of life in children with hyper-
tension among other factors 1) belief  in the effect of hypertension on the concerns of serious 
illness, 2) a feeling of condition that tends to worsen, 3) the relationship between pain and 
social role, and 4) an illustration that the disease will cripple (Bardage & Isacson, 2001)
In this study, which was conducted in children aged 13–18 years, it was found that the aver-
age adolescent weight was 38.34 kg and height was 143.34 cm with a mean of 109.05 mmHg 
systolic pressure and diastolic pressure of 71.32  mmHg. Fourteen people (17.7%) with a 
good quality of life were affected by hypertension and five people (6.3%) with a poor quality 
of life were affected by hypertension.
Each hypertensive patient has an impact and influence on the quality of  life (Korhonen 
et al., 2011). The quality of  life of  individuals with hypertension is slightly worse than that 
of  those with normotension (Trevisol et al., 2011). The quality of  life of  individuals who 
are treated for hypertension is better because this will decrease the symptoms over time. 
Optimal drug therapy is an important goal in everyday clinical practice (Kjellgren et al., 
1998). But other studies have shown that hypertensive patients with antihypertensive use 
will have fewer symptoms and quality of  life. This is caused by a disturbance of  the physical 
symptoms that may be associated with hypertension. Hypertension lowers quality of  life in 
physical and social areas but does not decrease the emotional aspects (Erickson et al., 2001).
The quality of  life of  hypertensive patients in terms of  physical roles, such as body pain, 
social function and emotional roles, is higher than for normotensive individuals (Trevisol 
et al., 2011). A study that assessed the physical activity of  a child with hypertension found 
that the child had no activity disorders and had few behavioural dimension problems (Wang 
et al., 2009). Another study found the physical capacity of  children with lower hyperten-
sion (Kjellgren et  al., 1998). In addition, psychological and psychophysiological aspects 
are associated with baroreceptors, which play a role in the response to pain (Rau & Elbert, 
2001) However, most studies show that hypertension can interfere with vitality, social func-
tion, mental health, mood and psychological function. Hypertension is also associated with 
symptoms such as headache, dizziness, depression, anxiety and fatigue (Wang et al., 2009).
One study showed an association of quality of life with hypertension where the results 
showed no difference in the symptoms of hypertension and not hypertension. Symptoms asso-
ciated with hypertension may not be diagnosed by the same conditions as the symptoms of 
normotension. These symptoms emerged after more than 16 years (Korhonen et al., 2011).
In this study, assessing the quality of life of adolescents based on PedsQL reports covering 
the physical, emotional, social, and school aspects, found that hypertensive children had the 
same quality of life as children with normotension.
This study still has many limitations because it does not examine other aspects related to 
hypertension. Many aspects that can affect hypertension with quality of life include socio-
demography, personal and environmental characteristics, physical omission or weight stabi-
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lisation symptoms associated with hypertension, continued comorbidities and other related 
diseases. This study also has a high prevalence of hypertension rates in the study sites so that 
further research is needed on the causes of these figures.
5 CONCLUSION
The results of this study indicate that there is no relationship between quality of life with 
hypertension in adolescents.
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ABSTRACT: Cigarette smoke contains free radicals. This condition can lead to the decrease 
of antioxidants. This study aims to determine the effect of cigarette smoking on Superoxide 
Dismutase Antioxidant (SOD) levels in Diabetes Mellitus (DM) with pulmonary Tubercu-
losis (TB) patients. The study was conducted on 30 male patients with DM with pulmonary 
TB. Smoking data was obtained by questionnaire. The SOD level was determined according 
to the ELISA technique. The mean values of SOD were analysed using SPSS software. There 
was no significant difference (p  = 0.56) in the SOD levels of DM with pulmonary TB patients 
in non-smoker groups compared to those in smoker groups. The level of SOD had significant 
differences (p = 0.000) in smoker subjects by Brinkman index classification. Cigarette smok-
ing can affect the SOD level in DM with pulmonary TB patients depending on the length of 
time a person has been smoking and the number of cigarettes per day that are smoked.
Keywords: smoking, SOD, DM, TB
1 INTRODUCTION
Smoking has become a community lifestyle; a habitual thing in Indonesian society. Smoking 
behaviour can cause a negative impact on health. The estimation of the number of deaths 
that will be caused by smoking in 2030 could reach 10,000,000 people every year and 80% 
of deaths happen in the developing countries (WHO, 2008). The data shows that Indonesia 
is in third position of the ten countries with the most smokers in the world. Various serious 
effects of smoking can happen in the early days. The damage to organs can happen from the 
time that the first cigarette is consumed (Barber et al., 2008).
Cigarette smoke is one of the exogenous sources of free radicals (oxidants). This is a factor 
in the occurrence of systemic disease and organ damage, including the pancreas. It happens via 
the pathway of the phosphatidylinositol-3-kinase enzyme. Inhibition of this enzyme causes 
a decrease of adiponectin secretion. This process can decrease the insulin sensitivity, which 
directly disrupts the process of glucose metabolism (Hilawe et al., 2015). Oxidative stress also 
increases the levels of the hormones epinephrine and norepinephrine. These hormones affect 
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the sympathetic nervous system and increase the rate of gluconeogenesis and glycogenolysis 
that causes hyperglycaemia (Vu et al., 2014). Both of these pathways will cause metabolic 
disorders such as Diabetes Mellitus (DM) (Hilawe et al., 2015; Vu et al., 2014). The condition 
of hyperglycaemia in people with DM will lead to auto oxidative glucose reactions, protein 
glycation and the activation of polyol metabolism pathways that will accelerate the formation 
of free radicals, and this can cause damage to the organs.
Since the beginning of the 20th century, researchers have found a risk of TB in patients 
with DM. The data of WHO shows that DM will increase the risk of pulmonary TB infec-
tion to three times larger than that of the normal population (WHO, 2011). This condition 
triggers the formation of free radicals.
Naturally, there are antioxidant defence systems of enzymes against free radicals, such 
as Superoxide Dismutase (SOD), catalase and glutathione peroxidase enzymes, in the body. 
Based on previous studies, it was reported that SOD is the leading line of defence against free 
radical compounds (Alvarez, 1987).
In normal circumstances there is an appropriate balance between free radicals and anti-
oxidants. However, this balance can shift when the production of free radicals is increased. 
The decreasing of antioxidants in the SOD of smokers has been found in a previous study 
(Pasupathi et al., 2009). In other research, the decrease of SOD antioxidant activity was also 
found in the conditions of DM and pulmonary TB (Moses et al., 2008; Mohod et al., 2011; 
Taheri et al., 2012). Therefore, the aim of this study was to evaluate the effect of cigarette 
smoking on SOD levels in DM in pulmonary TB patients. Previous research regarding the 
effect of cigarettes on the level of SOD of healthy subjects has been done. But there was 
no research regarding the effect of cigarettes on the level of SOD in DM in pulmonary TB 
patients.
2 METHODS
This study was conducted after getting permission from the ethical committee of the Faculty 
of Medicine of the University of Sumatera Utara (North Sumatra) No.327/KEPK FK USU-
RSUP HAM/2017. This research was conducted on 30 male DM with pulmonary TB patients 
from the clinic, in Medan, who were aged over 20 years. Patients were excluded as study 
participants if  they were: 1) using enzymatic antioxidant supplements (superoxide dismutase, 
catalase, glutathione peroxidase) as well as non-enzymatic antioxidants (vitamin A, vitamin C, 
carotenoids, flavonoids, curcumin); 2) suffering from HIV infection.
Patients that agreed to participate in the study were required to fill out and sign the 
informed consent after being given an explanation about the purposes and benefits of the 
research. The status of smoking and the level of smoking were determined by using ques-
tionnaires. The participants were grouped by smoking category: non-smoker and smoker 
groups. The level of smoking was determined by using the Brinkman Index (BI). BI values 
were calculated as the number of cigarettes smoked per day multiplied by the number of 
years of smoking. The categories of smoking of the smokers were mild if  the BI value was 
<200, moderate if  the BI value was 200−600 and severe if  the BI value was >600 (Brinkman & 
Coates, 1963).
The blood samples were collected (5 mL) through peripheral venipuncture after at least 
12 hours of fasting. The serum over the blood was separated in a plain vacuum tube, aliq-
uoted and stored at -20 °C and used for the following assays of blood glucose and SOD. 
The blood glucose and SOD levels of the subjects in this research were conducted at the 
Integrated Laboratory of the Faculty of Medicine, University of North Sumatra. The blood 
glucose level was determined by using a spectrophotometer with a wavelength of 546 nm 
using the GOD-PAP method. SOD activity was determined according to the Enzyme-Linked 
Immunosorbent Assay (ELISA) technique using a human ELISA kit manufactured by the 
bioassay technology laboratory.
The mean and standard deviation values of SOD that were obtained from the subjects 
were calculated. The mean value of SOD was compared between the non-smoker group and 
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the smoker group using a Mann−Whitney U-test by SPSS statistical software. The mean of 
SOD on the smoker BI group was compared using a Kruskall−Wallis test in SPSS software.
3 RESULTS AND DISCUSSION
In the present study, Table 1 presents the information regarding the characteristics of the 
subjects.
Thirty subjects who met the inclusion and exclusion criteria were obtained. The average 
age of the subjects was 53.26 years old, and these consisted of 20 smoker subjects and ten 
non-smoker subjects. The mean value of blood glucose of the subjects was 291.20  mg%. 
The mean value of the blood glucose of the subjects of this study is above the normal value. 
In healthy people, normal blood glucose levels are below 120  mg%. Blood glucose levels 
above 120 mg% are referred to as hyperglycaemia. This condition occurs in patients with DM 
(Murray et al., 2012).
Persistent hyperglycaemia in patients with DM is a risk factor of increasing free radi-
cals. The increase of free radical production will affect the level and function of endogenous 
enzymatic antioxidants. Endogenous enzymatic antioxidants work as the first line antioxi-
dant defence of SOD. Excessive free radical production affects the production of SOD. The 
decrease of SOD production means that the scavenger function does not work optimally 
(Alvarez, 1987; Dembinska-Kiec et al., 2008). In this research, the mean value of SOD was 
136.71 U/L. The value of SOD in the subjects in this study were classified at low ranges 
because they were based on the kit used in this study, where normal SOD levels were in the 
range of 3−900 U/L. This was possible because the subjects in this study were DM patients 
with pulmonary TB, the group who were at risk of getting decreasing SOD levels.
DM is one of the most important risk factors for pulmonary TB. The mechanisms under-
lying the association of DM with TB are still not understood today, although there have been 
a number of hypotheses about the role of proinflammatory cytokines in DM patients as an 
important molecule in the human defence mechanisms against pulmonary TB. This condi-
tion will increase the production of free radicals (Podell, 2014).
Smoking will worsen the condition of DM with pulmonary TB patients. Blood glucose 
levels will increase and the free radicals formed cannot be offset by the production of 
antioxidants such as SOD. The effects of cigarettes on the SOD levels of patients with DM 
who are also infected with pulmonary TB can be seen in Table 2.
The normality of the distribution of SOD data was analysed by the Shapiro−Wilk test. 
The Shapiro−Wilk test results get p < 0.05, which means that the data was considered to be an 
abnormal distribution. There was a differentiation in the SOD levels of DM with pulmonary 
Table 1. Characteristics of study population.
Variable Mean, SD Min; Max
Age (year) 53.26 ± 1.74 36.00; 77.00
Smoker (N) 20
Non-smoker (N) 10
Blood-glucose (mg%) 291.20 ± 11.29 20.00; 460.00
SOD (U/L) 136.71 ± 20.97 70.34; 532.20
Table 2. The mean difference test between superoxide dismutase 
in non-smoker and smoker subjects.
Non-smoker Smoker p*
SOD (U/L) 148.57 ± 44.08 30.79 ± 23.26 0.56
*Mann−Whitney U.
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TB patients in non-smoker groups (the mean value of SOD is 148.57  U/L) compared to 
smoker groups (the mean value of SOD is 130.79 U/L), but the Mann−Whitney U-test of the 
groups shows no significance (p  = 0.56).
The results of this study are different from the results of the research in India that showed 
that the SOD levels of saliva and blood from non-smokers were higher than those of the smok-
ers, with a significance of p < 0.05 (Gavali et al., 2013). In addition, research was also done in 
Saudi Arabia, Iraq and Taiwan, which stated that the level of SOD in smokers was lower than 
that in non-smokers (Ahmed, 2013; Abdul-Rasheed et al., 2013; Jenifer et al., 2015).
The main ingredient in cigarettes is tobacco. Tobacco contains approximately 4,000 ele-
ments and at least 200 of them are harmful to health. The main toxins of tobacco that are 
capable of adverse health effects are nicotine, tar, carbon monoxide gas and various heavy 
metals. Cigarette smoke generated from tobacco burning can increase the production of free 
radicals in body cells. Free radicals are molecules containing unpaired electrons in their out-
ermost orbits. This unpaired electron makes it very reactive, because free radicals can attack 
important molecules, such as DNA, enzyme proteins and lipids, causing cell damage such as 
to the pancreatic cells and other cells (Britton & Edwards, 2007).
Free radicals from cigarette smoke can be suppressed by antioxidant activity. The difference 
in the results of this research compared with the previous research can be analysed if  levels of 
other antioxidant endogenous enzymes in the body are known. There are endogenous anti-
oxidants in addition to SOD in the body, such as catalase and glutathione peroxidase (Murray 
et al., 2012). Antioxidant catalase and peroxydase glutathione also play a role in tackling the 
free radicals in the body. The amount of antioxidant activity against the free radicals can 
decrease the SOD levels in the smokers that were not significant than non-smokers.
The characteristics of the smoker groups in this study, based on BI category, can be seen 
in Table 3.
Table 3 shows that the mean value of the smoking period on smoker subjects was 16.30 
years and the mean value of the number of cigarettes smoked/day were 15.80 cigarettes. 
Based on BI, 10 subjects in this group of smokers are categorised as heavy smokers. Nicotine 
in cigarettes is addictive, although the concentration in cigarettes is only about 1−1.3 mg. 
Nicotine will increase levels of dopamine in the brain and if  nicotine levels drop in the smok-
er's brain, there will be induced anxiety and stress on the smokers. To handle these things, 
the tendency of people to keep enjoying cigarettes is very large. With the recurrent exposure 
to nicotine in the smoker, the ability of the brain to adapt to nicotine begins to increase 
(Benowitz, 2010). This could be the cause of the high number of heavy smokers in this study. 
The longer the period that a person is a smoker, the greater the increase in the number of 
cigarettes per day.
The effect of cigarettes based on the length of years of smoking and the number of ciga-
rettes smoked on SOD levels can be seen in Table 4.
There was a difference in the SOD levels in the smoker DM with pulmonary TB patients 
based on BI group. The mean value of SOD in mild smokers (274.9 U/L) was higher com-
pared to moderate smokers (116.94 U/L). The mean value of SOD in mild and moderate 
smokers was higher compared to severe smokers (81.72 U/L). Based on the Kruskal-Wallis 
test, the mean values of SOD were compared between mild, moderate and severe smokers 
and the result was significant differences (p = 0.000).
Table 3. Characteristics of smoker subjects.
Variable Mean, SD Min; Max
Smoking period (yr) 16.30 ± 8.14 3.00; 3.00
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Determined by using the BI, a severe smoker was a smoker whose BI value was >600. 
This means that the subjects in the severe smoker groups were smoking for long periods and 
had taken a lot of cigarette smoke per day (Brinkman & Coates, 1963). The consequences 
of this condition create more free radical production due to the effects of tobacco burning. 
A higher production of free radicals will correlate negatively to the amount of antioxidants. 
The length of time that a person has been smoking and the number of cigarettes per day that 
are taken by a person affect the levels of SOD (Pasupathi et al., 2009).
4 CONCLUSIONS
In this research on DM with pulmonary TB patients, it was found that the SOD levels of 
smokers were lower than those of non-smokers. The SOD levels were the lowest in severe 
smokers compared to mild smokers and moderate smokers. Nevertheless, statistical analysis 
showed that there was no effect of cigarettes on the level of SOD in DM with pulmonary 
TB patients compared to normal subjects. Cigarette smoking can affect SOD levels in DM 
with pulmonary TB patients depending on the length of time a person has smoked and the 
number of cigarettes per day that are taken by a person.
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ABSTRACT: This study aims to test the association between family support, coping strat-
egies and anxiety at Dr. Pirngadi General Hospital, Medan. The samples are 102 cancer 
patients undergoing chemotherapy who were assessed, and the results of the bivariate analysis 
showed a significant positive association (p = 0.001 < 0.05) and strong correlation (r = 0.612) 
between family support and the Problem-Focused Coping (PFC) strategy, while there was 
a significant negative association (p = 0.001) and moderate correlation (r = −0.462) with the 
Emotion-Focused Coping (EFC) strategy. A significant negative association (p = 0.001) and 
strong correlation (r = −0.646) was found between family support and anxiety. The multivari-
ate analysis showed a dominant association (p = 0.001) between family support and the PFC 
strategy (Odds Ratio = 12.2), EFC (OR = 0.142) and anxiety (OR = 0.039). The conclusion 
was that there is an association between good family support and effective coping strategies 
and lower anxiety levels in cancer patients undergoing chemotherapy.
Keywords: Family support, Cancer, Coping strategies, Chemotherapy
1 INTRODUCTION
Over half  of cancer patients are treated with chemotherapy (Prawirohardjo, 2010). Chemo-
therapy leads to various physiological and psychological side effects. The psychological side 
effects that may occur include stress, anxiety and depression. This stress leads to individuals 
using coping strategies to prevent further psychological disorders (Karabulutlu et al., 2010).
A study by Muhamad et al. (2011) stated that support from all family members, especially 
the spouse, plays an important role in decision-making and survival strategy.
The objective of this study is to test the association between family support, coping 
strategies and anxiety in cancer patients undergoing chemotherapy at Dr. Pirngadi General 
Hospital, Medan.
2 METHODS
This is a quantitative study using a correlational descriptive design with a cross-sectional 
approach. The study population is cancer patients undergoing chemotherapy in Dr. Pirngadi 
Hospital, Medan, Indonesia, with a purposive sampling technique resulting in 102 individuals. 
Data collection was performed directly from the respondents by using questionnaires about 
family support, coping strategies and anxiety.
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3 RESULTS
3.1 Characteristics of subjects
Table 1, which shows the characeristics of cancer patients, shows that most of the patients 
were women, which is related to the highest prevalence being of breast cancer.
Table  2  shows that, of the 102 cancer patients undergoing chemotherapy, as many as 
70  subjects (68.6%) had good family support, while poor family support was observed in 
32 subjects (31.4%).
Table  3  shows that, of the 102 cancer patients undergoing chemotherapy, as many as 
67 subjects (65.7%) were highly likely to use the Problem-Focused Coping (PFC) strategy, 
while the remaining 35 subjects (34.3%) were less likely to use the PFC strategy.
Table  4  shows that, of the 102 cancer patients undergoing chemotherapy, as many as 
71 subjects (69.6%) were less likely to use the Emotion-Focused Coping (EFC) strategy, while 
the remaining 31 subjects (30.4%) were highly likely to use the EFC strategy.
Table 1. Characteristics of cancer patients undergoing chemother-
apy (n = 102).
No Characteristics Freq. (%)
1 Age (Years)
26−45 (Adult)  32  31.3
46−65(Pre-elderly)  58  56.9
>65 (Elderly)  12  11.8
2 Sex
Male  39  38.2
Female  63  61.8
3 History of chemotherapy
1−3  65  63.7
>3−6  37  36.3
4 Cancer type
Breast cancer  45  44.1
Colorectal cancer  27  26.5
Ovarian cancer  15  14.7
Nasopharyngeal cancer (NPC)  13  12.7
Prostate cancer   2   2.0
Total 102 100
Table 2. Frequency distribution of family support (n = 102).
Family support Freq. (%)
Good  70  68.6
Poor  32  31.4
Total 102 100
Table 3. Frequency distribution of the Problem-Focused Coping 
(PFC) strategy (n = 102).
PFC strategy Freq. (%)
High  67  65.7
Low  35  34.3
Total 102 100
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Table  5  shows that, of the 102 cancer patients undergoing chemotherapy, as many as 
53 subjects (52.0%) experienced moderate anxiety, and only 2 subjects (2.0%) experienced 
severe anxiety.
This study showed that there was a significant association with PFC strategy (p < 0.05). 
The value of 0.612 for the correlation coefficient (r) indicated a strong positive correlation, 
which means that subjects receiving better family support were more likely to use the PFC 
strategy. Similarly, a significant association was observed with the EFC strategy (p < 0.05).
There was a significant association with anxiety (p < 0.05). The value of −0.646 for the 
correlation coefficient (r) indicated a strong negative correlation, which means that subjects 
receiving better family support experienced milder anxiety.
This study showed that family support is a dominant variable that is significantly associ-
ated with the use of the PFC strategy, with an Odds Ratio (OR) of 12.2, indicating that can-
cer patients undergoing chemotherapy with good family support are 12.2 times more likely 
to use the PFC strategy.
Family support is a dominant variable that is significantly associated with the use of the 
EFC strategy, with an OR of 0.142 (OR < 1 = negative association), indicating that cancer 
patients undergoing chemotherapy with good family support are 0.142 times more likely to 
not use the PFC strategy.
Family support is a dominant variable that is significantly associated with anxiety, with an 
OR of 0.039 (OR < 1 = negative association), indicating that cancer patients undergoing chem-
otherapy with good family support were 0.039 times more likely to experience mild anxiety.
4 DISCUSSION
4.1  Association between family support and coping strategies in cancer patients undergoing 
chemotherapy
A significant association between family support and the PFC strategy indicated a strong pos-
itive correlation, which meant that subjects receiving better family support were more likely to 
use the PFC strategy. A significant association between family support and the EFC strategy 
at Dr. Pirngadi General Hospital, Medan, indicated a moderate negative correlation, which 
meant that subjects receiving better family support were less likely to use the EFC strategy.
These findings are similar to a study by Tan (2007), which stated that there is an asso-
ciation between social support and coping strategies in cancer patients, with a positive 
correlation between social support and the PFC strategy and a negative correlation between 
Table 4. Frequency distribution of the Emotion-Focused Coping 
(EFC) strategy (n = 102).
EFC strategy Freq. (%)
High  31  30.4
Low  71  69.6
Total 102 100
Table 5. Frequency distribution of anxiety at Dr. Pirngadi Gen-
eral Hospital, Medan, in 2017 (n = 102).
Anxiety Freq. (%)
Severe   2   2.0
Moderate  53  52.0
Mild  47  46.0
Total 102 100
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social support and the EFC strategy. The support from all family members, particularly the 
spouse, greatly affected decision-making and survival strategies in managing emotions (emo-
tional support), providing information on health, lifestyle and diet, as well as supporting the 
provision of facilities (instrumental support), which are very helpful for breast cancer patients 
undergoing therapy and help to increase the survival of cancer patients (Muhamad et al., 2011).
Potter and Perry (2009) stated that individual coping strategies are determined by the type 
of stress experienced by the individual, the individual’s life goals, beliefs about oneself  and 
the world, and personal individual resources. An individual tends to use the PFC strategy 
when he/she believes that the demands from a situation or stressor can be changed, and to 
use the EFC strategy when he/she believes that only little or no changes can be conducted 
with regards to the pressure of the situation. However, in a stressful situation, an individual 
generally combines the PFC and the EFC strategies (Sarafino & Smith, 2011).
Effective coping strategies when facing a chronic disease such as cancer, particularly for 
those undergoing treatment such as chemotherapy, will greatly affect the compliance of the 
patient in routinely attending chemotherapy sessions and the presence of physical and psy-
chological symptoms. From the results of this study, it can be concluded that good family 
support is one of the personal resources that contribute to the effectively high use of the PFC 
strategy and the effectively low use of the EFC strategy, thereby increasing the compliance of 
cancer patients in undergoing chemotherapy.
4.2  Association between family support and anxiety in cancer patients 
undergoing chemotherapy
Subjects with better family support were more likely to experience lower anxiety levels. These 
findings are similar to a study by Lekka et al. (2014), which stated that there was a moderate 
negative correlation between family support and anxiety, which meant that better family sup-
port was associated with lower anxiety levels in lung cancer patients. Meanwhile, the study 
by Sadeghi et al. (2015) found that there was a moderate negative correlation between social 
support (emotional support, instrumental support and information support) and anxiety in 
patients undergoing haemodialysis. A study by Ng et al. (2015) stated that social support is an 
important factor for cancer patients undergoing treatment in order to decrease their anxiety 
levels and to increase their quality of life.
From the study results, it can be concluded that good family support for cancer patients 
undergoing intense, cyclic and long chemotherapy requiring repeated admissions, along with 
the physiological and psychological side effects that may appear, such as moderate anxiety, 
will help to decrease the anxiety levels and increase the quality of life and survivability of 
cancer patients.
4.3  Variables dominantly associated with coping strategies in cancer patients 
undergoing chemotherapy
These results are similar to the findings by Kim et al. (2010), which stated that social support 
for breast cancer patients is associated with the use of coping strategies. Nasir and Muhith 
(2011) stated that an effective coping strategy is one that helps an individual to tolerate and 
accept a psychologically stressful situation and ignore the stressors that cannot be managed.
From these results, it can be concluded that in a cancer patient undergoing intense, cyclic 
and long chemotherapy requiring repeated admissions, good family support will increase the 
compliance of the cancer patient in undergoing chemotherapy to increase the quality of life.
4.4  Variables dominantly associated with anxiety in cancer patients 
undergoing chemotherapy
This result showed that only family support had a significant negative association with anxi-
ety, indicating that cancer patients undergoing chemotherapy with a lack of family support 
experienced severe anxiety.
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The results are similar to that from a study by Aberha et al. (2016), which stated that the 
lack of social support in patients with hypertension was the factor most associated with anxi-
ety. Social interaction plays a role in the adaptation of a patient towards a chronic disease. An 
individual with anxiety will show poor physical, cognitive and emotional responses and is at 
risk of maladaptive behaviour that will prevent the individual from learning various methods 
to alleviate anxiety, and therefore social support, particularly from the family, may influence 
the individual to form new adaptive behaviours to help him/her adapt and learn (Videbeck, 
2008).
From the results, it can be concluded that in a cancer patient undergoing intense, cyclic 
and long chemotherapy requiring repeated admissions, good family support will help the 
patient to adapt and decrease their anxiety towards chemotherapy, in order to increase their 
quality of life.
5 CONCLUSIONS
From the study results, it can be concluded that family support is significantly associated 
with coping strategies (PFC and EFC) as well as with anxiety in cancer patients undergoing 
chemotherapy. It is hoped that the results of this study are used as an input for providing 
health education for the family members of patients on the importance of family support, 
which would increase the quality of life of the patients.
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ABSTRACT: Previous studies have not been able to show with certainty the effect of vita-
min D supplementation in tuberculosis patients. The objective of this study is to determine 
whether vitamin D supplementation to patients with tuberculosis could influence 25-hydroxy-
vitamin D (25(OH)D) and calcium serum levels. Results: after 28 days, the vitamin D supple-
mentation showed significant increase of 25(OH)D serum level at the end point (p  = 0.001), 
but not for the calcium serum level (p  = 0.3). Conclusions: supplementation with 1,000 IU 
vitamin D per day increased the 25(OH)D serum level but there was no association with the 
calcium serum level. These results suggest a.
Keywords: Calcium, Tuberculosis, Vitamin D
1 INTRODUCTION
Vitamin D supports the induction of pleiotropic antimicrobial responses in tuberculosis 
patient, resulting from an immunomodulatory effect (Coussens et  al., 2012). Vitamin D 
supplementation accelerates sputum smear conversion and enhanced tuberculosis treatment 
(Martineau et al., 2011; Siempos et al., 2008).
Vitamin D is also known to be essential to Mycobacterium tuberculosis containment and 
killing through the activation of 25-hydroxyvitamin D (25(OH)D) receptors, present in all 
immune cells (Liu et al., 2006).
Deficiency in vitamin D is found in healthy people, especially women in tropical countries 
(Sari et al., 2017a, 2017b). Low sunlight exposure, vitamin D intake, physical activity, and 
vitamin D receptor gene polymorphism are risk factors for vitamin D deficiency (Sari et al., 
2017c). However, low 25(OH)D serum level does not affect calcium serum level (Sari et al., 
2017d).
Calcium signalling in tuberculosis infection plays a significant role in the pathogenesis of 
tuberculosis (Sharma, 2017). Calcium is also known to be a ubiquitous second messenger, 
which can control multiple processes and is included in cellular activities like division, 
motility, stress response, and signalling. However, Ca is thought to be a regulative molecule 
regarding tuberculosis infection but its binding relation with proteins which are influenced 
by Ca concentrations in host pathogen (Chan, 2017).
We therefore conducted a clinical trial to determine the effect of 1,000 IU vitamin D for 
28 days on the 25(OH)D and calcium serum levels.
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2 METHODS
The objective of this study is to determine the effect of 1,000 IU per day vitamin D sup-
plementation for 28 days on the 25(OH)D and calcium serum levels in tuberculosis patients 
who lived in three community health centre areas in Medan City, North Sumatera, Indonesia 
between June and September 2017. This is a randomised control trial involving 48 patients: 
24 tuberculosis patients for vitamin D supplementation, and a placebo group.
The subjects of this study consisted of tuberculosis patients from community health 
centres with a higher tuberculosis prevalence, in Medan, North Sumatera, Indonesia. The 
32 men and women studied had various occupations, and were sampled purposively. The 
inclusion criteria were tuberculosis patients in the age range of 18–60 years. Exclusion crite-
ria were subjects with a history of diabetes mellitus, myocardial infarction, and renal or liver 
dysfunction. In addition to those exclusion criteria, subjects who were pregnant and lactating 
were also excluded.
We measured 25(OH)D serum concentration by Chemiluminescent Immunoassay (CLIA) 
technology (Diasorin, Stillwater, MN). Measures were between 4.0 and 150 ng/mL. The low-
est value was 4.0  ng/mL, which is based on an inter-assay precision of 3.90% CV. Refer-
ence ranges were <20  ng/mL, categorised as deficiency, 20–30  ng/mL (insufficiency), and 
30–100 ng/mL (sufficiency) (Holick, 2007). To convert ng/mL to nmol/L, multiply by 2.496. 
Calcium serum was measured by ADVIA Bayer Assayed Chemistry Controls, with principal 
procedure: calcium ions form a violet complex with o-cresolphthalein complexone in an alka-
line medium. The reaction is measured at 545/658 nm, and normal concentration of calcium 
was 8.3–10.6 mg/dL.
Continuous variables were expressed as continuous variables as means ± standard devia-
tions (SDs). Categorical variables were expressed as percentage proportions, using chi-
squared to express significant differences between two groups, and the Fischer test if  the data 
did not meet the criteria. Values of p <0.05 were considered statistically significant. We used 
the SPSS program (version 11.5; SPSS Inc., Chicago, IL) to perform the analysis.
This study was carried out after ethical approval was obtained from the Health Research 
Ethics Committee of Sumatera Utara University Medical School (No. 264/TGL/KEPK FK 
USU-RSUP HAM/2017) and all participants gave written informed consent to the study 
procedures.
3 RESULTS
3.1 Characteristics of subjects
Table 1 shows the characteristics of the two groups, one receiving vitamin D supplementation 
and the other a placebo; there were no significant differences between the two groups.
Table 2 shows the difference before and after intervention in the intervention group. After 
supplementation, there was a significant increase in vitamin D intake, while there was no 
significant difference in any of the nutrient intakes in the control group.









Age (years) 37 ± 2.5 33.8 ± 9.1 0.4
Body mass index (kg/m2) 19.8 ± 3.9 20.3 ± 3.1 0.2
Serum 25(OH)D (ng/mL) 19.7 ± 6.6 19.3 ± 4.6 0.1
Serum calcium (mg/dL) 9.0 ± 0.5 9.1 ± 0.5 0.3
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Table 3 shows the difference before and after intervention in both groups. After supple-
mentation, there was a significant increase in vitamin D intake, while there was no significant 
difference in any of the nutrient intakes in the control group.
4 DISCUSSION
Vitamin D helps the body to effectively absorb calcium; there is an interaction between vita-
min and mineral. Calcium is known to be a ubiquitous second messenger that can control mul-
tiple processes, has a role in tuberculosis infection, and a significant role in pathogenesis.
Calcitriol, the active metabolite of vitamin D, induces innate antimicrobial responses and 
suppresses proinflammatory cytokine responses in vitro (Martineau, 2007). This microbial 
activity is mediated via induction of reactive nitrogen intermediates, reactive oxygen inter-
mediates, antimicrobial peptides, and autophagy (Hewison, 2011). These studies report sim-
ilar findings to previous studies of tuberculosis patients that found vitamin D deficiency 
(Martineau et al., 2011; Salahuddin et al., 2013). However, after vitamin D supplementation, 
baseline patients categorised in deficiency, resulting in greater weight gain and a more rapid 
radiographic clearing of disease, as compared to the placebo (Salahuddin et al., 2013; Sari 
et al., 2017d). The previous study showed that high dose of vitamin D (which in that study 
was 600.000 IU vitamin D intramuscular) accelerated clinical, radiographic improvement in 
all tuberculosis patients and increased host immune activation, but the study lasted 12 weeks 
(Salahuddin et al., 2013). In this study, the length was 28 days (4 weeks), and the tuberculosis 
patients received 1,000 IU oral vitamin D supplementation per day. However, this study also 
showed an increase of 25(OH)D serum level at the end point.
Hypercalcaemia found in tuberculosis patient; the previous study confirmed that serum 
calcium is raised in tuberculosis, but the effect may be reduced by a low calcium intake and a 
low parathyroid hormone level. Although the calcium and vitamin D metabolism appeared 
to be altered in tuberculosis, no direct relationship between serum calcium and 1,25(OH)2D, 
was found (Chan, 2017). Our study reported normal calcium serum levels and no significant 
difference before and after vitamin D supplementation. But we found that serum
Table 2. Energy and nutrient intake of subjects before and after 
intervention in the D group.
Nutrient intake
Intervention (D) group (n = 24)
Before After p-value
Energy (kcal) 710.3 760.9 0.25
Protein (g)  25.4  28.3 0.10
Calcium (mg) 219.1 198.4 0.47
Vitamin D (μg)  3.6  31.1 0.01
Table  3. Mean serum 25(OH)D and calcium levels before and 
after intervention.
Variable Baseline Endpoint p-value
Serum 25(OH)D (ng/mL)
Intervention (D) group 19.7 ± 6.6 27.3 ± 3.1 0.04
Control (C) group 19.3 ± 4.6 21.9 ± 2.4 0.01
p-value 0.01
Serum calcium (mg/dL)
Intervention (D) group 9.0 ± 0.5 8.9 ± 0.3 0.34
Control (C) group 9.1 ± 0.5 8.9 ± 0.4 0.1
p-value 0.5
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Our study had limitations. We did not assess parathyroid hormone, nor other clinical 
tuberculosis parameters such as chest X-ray or blood examination (C-reactive protein).
5 CONCLUSION
From the study results, it can be concluded that in tuberculosis patients there were vitamin 
D deficiency and insufficiency, but the calcium serum level was normal. No association was 
found between 25(OH)D and calcium serum level.
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ABSTRACT: Currently, adult stem cells can be obtained not only from the spinal cord and 
peripheral vessels, but also from fat tissues of the human body, where they can be isolated as 
adherent stem cells: Mesenchymal Stem Cells (MSCs). Fat tissue is considered as the source 
of MSCs for autologous tissue engineering because it is readily available in abundant quanti-
ties through minimally invasive procedures, as well as being easily cultured and propagated. 
Further, the fat tissue is a type of Adult Stem Cell (ASC) that is capable of metamorphosis/
trans differentiation into various strains, because of its nature of high plasticity. Therefore, it 
is possible to proliferate in the desired direction of the network. The purpose of this research 
was to investigate the effect of different media on Adipose-Derived Stem Cell (ADSC) pro-
liferation from human subcutaneous adipose tissue.
Keywords: Different Media, Adipose-Derived Stem Cells (ADSCs), Proliferation
1 INTRODUCTION
Mesenchymal Stem Cells (MSCs) are a prospective object for use in cell therapy and are 
intensely studied by many research groups. MSCs are characterised primarily by the expres-
sion of surface markers and differentiation potential. MSCs express a series of specific 
markers (e.g. CD44, CD90, CD105, and CD13) and should differentiate into cells of meso-
dermal origin, such as adipocytes, osteoblasts, and chondrocytes. Due to the prospective 
clinical application, MSCs from different sources are actively studied. For example, MSCs 
are isolated from the bone marrow and fat tissue (Musina et al., 2006). Because of the easily 
accessible anatomical location and the abundant existence of subcutaneous adipose tissue, 
Adipose-Derived Stem Cells (ADSCs) hold the advantage of allowing a simple and, above 
all, less invasive harvesting technique.
Adipose is a complex tissue: its constituents are mostly adult adipose cells (90%) and the 
stromal vascular fraction, which are pra adipocytes, fibroblasts, smooth muscle, endothelial 
cells, monocytes/macrophages, implicit, and ADSCs (Mizuno, 2012). ADSCs can be isolated 
from adipose tissue using the ‘lipectomy’ method. Almost 1 × 107 to 6 × 108 stem cells with 
>90% survival potency can be isolated from 300 ml. Lipectomy has been known as being a 
safe procedure and a well-tolerated method, with very little chance of complication (<0.1%) 
(Locke, 2009). Adipose tissue produced by lipectomy will be treated as medical waste (Kang, 
2003). It has been known that adipose tissue can produce more stem cells than the other part 
(Mizuno, 2012).
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The composition of mesenchymal stem cell culture media is one of the key factors in 
the process of stem cell expansion. Chen et al. (2009) compared the growth of MSCs using 
Dulbecco’s Modified Eagle’s Medium (DMEM) and Minimum Essential Medium (MEM) 
culture media. Experimental results based on stem cell proliferation after culturing for 
21 days, showed that proliferation cell on MEM culture media is bigger than on DMEM 
culture medium. Nakamura et al. (2008) measured the growth rate of MSCs in Mesenchymal 
Stem Cell Basal Medium (MSCBM) and DMEM culture medium. The experimental results 
showed that MSCs cultured in both media showed relatively similar growth rates.
2 METHOD
2.1 Isolation of adipose-derived stem cells
Human ADSCs were isolated from fat tissue, which was obtained from JMB Clinic in 
Jakarta, Indonesia. The contaminating layers were removed, and the remaining adipose tis-
sue was washed using an autoclaved phosphate-buffered saline (PBS). The washed adipose 
was transferred into a sterile tube; then enzyme digestion was used. The mixture was incu-
bated in 5% CO2 and 37°C incubator for an hour. The layers formed at the end of incubation 
time: an upper adipose layer and an infranatant of the enzyme. The upper layer was aspirated 
off, and the remainder was transferred into a new sterile tube.
The filtered infranatant was then centrifuged at 1,200 rpm for 10 minutes. The supernatant 
was discarded, and the pellet was collected. The pellet was resuspended in lysis buffer and 
was centrifuged at 1,200 rpm for 10 minutes. The Stromal Vascular Fraction (SVF) pellet was 
resuspended in 1 ml of culture media. Stem cells in SVF were seeded in 75 cm2 flasks con-
taining 10 ml of culture media. The cells were incubated in 5% CO2 and 37°C incubator, and 
allowed to grow confluently.
2.2 Cell counting using haemocytometer
Stem cells were trypsinised, then plated to 96 well-plates after confluently. This proc-
ess was  initiated by removing the culture media from the flask, and adding 2 ml of PBS. 
The flask was gently shaken, and then the liquid was discarded. Stem cells were trypsinised 
with trypsin-EDTA. Subsequently, stem cells were incubated in a 5% CO2 and 37°C 
incubator  for 5 minutes. The culture media served as a stop solution to cease the trypsin 
activity.
Following the addition of stop solution, stem cells were transferred into a new tube and 
centrifuged at 1,200 rpm for 10 minutes at 20°C. The resulting supernatant was discarded, 
and the pellet was resuspended in culture media. A 10 μl volume was taken from the resus-
pended pellet and mixed with 10 μl of  trypan blue. The mixture was loaded into a haemo-
cytometer, and then counted under a microscope. The desired concentration of cells was 105 
cells per 100 μl, for MTT assay.
2.3 Plating and culture of ADSCs
The ADSCs were plated on 96 well-plates for MTT assay. Stem cells were plated on 96 well-
plates at 1 × 105 cells/well. The 96 well-plates were incubated in a 5% CO2 and 37°C incubator 
for 24 hours to allow the stem cells to the adherent.
2.4 Analysis of cell proliferation
The cells were incubated for 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 24, 48, 72, 96, 120, 144, and 168 hours. 
Hence, MTT reagent was added directly to the cells, and the cells incubated. The insoluble 
coloured formazan was dissolved in sodium dodecyl sulfate (SDS) and incubated overnight. 
The cells were processed on an enzyme-linked immunosorbent assay (ELISA) reader for 
absorption at 595 nm.
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3 RESULTS
3.1 Isolation of ADSCs
Adipose tissue is considered to be a rich source of stem cells, especially with the increased 
incidence of obesity in modern populations (Kuhbier et al., 2010). For example, 1 g of adi-
pose tissue has a greater number of MSCs than 1 g of bone marrow (Kitagawa et al., 2006; 
Fraser et al., 2006). Isolation of ADSCs involves centrifugation, digestion, and filtration, 
Figure 1. ADSCs isolated using enzyme digestion.
Figure 2. Proliferation rates of mesenchymal stem cells using MTT assay: (A) Sample 1; (B) Sample 2; 
(C) Sample 3.
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resulting in an adherent cell population containing MSCs. The digestion process involves 
collagenase enzyme, which has been known to act as a protease with specificity to degrade 
the triple-helical native collagen fibrils commonly found in connective tissue.
Figure 1 shows the ADSCs, which are isolated using enzyme digestion and incubated for 
four days, as observed under an inverted microscope. These cells were mostly detached, grew 
well, had normal spindle shape, and were fibroblastic.
3.2 Effects of the different media on ADSC Proliferation
The MTT results for Sample 1 shows that ADSC growth began to increase at 4 hours after 
incubation, with absorbance values: of 0.56 with MEM-alpha medium; 0.47 with DMEM/
high-glucose medium; 0.47 with DMEM/low-glucose medium. However, the DMEM/
F12 medium shows that the growth of ADSCs after 4 hours’ incubation was 0.22, where 
ADSCs have not shown stable growth because ADSC growth is still increasing and decreas-
ing. After 46 hours’ incubation, ADSC growth shows a more stable growth rate. However, 
from the absorbance value it is found that ADSC growth with MEM-alpha medium is more 
stable compared to other culture media.
The MTT results for Sample 2 show that ADSC growth began to increase after 96 hours’ 
incubation, with absorbance values: on MEM-alpha medium of 0.37; on DMEM/high-glucose 
medium of 0.64; on DMEM/low-glucose medium equal to 0.67; and on DMEM/F12 medium 
equal to 0.32. Measurement of proliferation in Sample 2  shows the growth of ADSCs has 
increased and decreased. It seems that ADSC proliferation is not stable and needs further study.
The MTT results for Sample 3 show that ADSC growth increased after 71 hours’ incu-
bation with absorbance values: on MEM-alpha medium of 1.30; on DMEM/high-glucose 
medium of 0.94; on DMEM/low-glucose medium of 0.88; and on DMEM/F12 medium of 
0.65. Growth began to increase steadily over the next hour.
4 CONCLUSION
The absorbance value in Sample 2 appears smaller than in Samples 1 and 3. However, all 
three absorbance values of the three samples used varied. This may be due to the three sam-
ples being from different human/patient sources, so that the ADSC properties obtained also 
differ according to the character of the stem cell source. Further studies are required to inves-
tigate the metabolism of ADSC proliferation.
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ABSTRACT: Among the meningiomas of the posterior fossa, the Foramen Magnum (FM) 
meningioma deserves special consideration because of its characteristics in symptomatology, 
intriguing surgical anatomy, unique operative requirements, and outcome. When all meningiomas 
are considered, the FM meningioma has the worst outcome in terms of surgical results and 
operative morbidity. We report a 53-year-old female diagnosed as having FM meningioma, who 
had tumour removal surgery performed using a far lateral approach. Finally, a detailed technical 
operation and a classification system from various literature will also be explained.
Keywords: Foramen magnum meningioma, Far lateral approach
1 INTRODUCTION
Meningiomas represent 20% of all primary intracranial tumours and 75% of benign tumours 
of the Foramen Magnum (FM). However, FM meningiomas account for only 1.5 to 3.2% of 
all meningiomas (Bruneau & George, 2008; Bydon et al., 2014). FM meningiomas are cat-
egorised by their relative location to the medulla in the axial plane: anterolateral is the most 
common, posterolateral is the second most common, purely posterior lesions are the third, 
and the least common are entirely anterior (Bruneau & George, 2008; DeMonte et al., 2011). 
FM can be approached through transoral, suboccipital craniotomy, and far lateral approaches 
(Bruneau & George, 2008). For anterior midline, the FM meningioma transcondylar approach 
is preferred because it can give better visibility anterior to the brainstem, and also decreases 
the need for brainstem, cerebellar, and upper cervical retraction (Dobrowolski et al., 2016).
2 CASE REPORT
A 53-year-old female presented with chronic headache, numbness from the neck down, and 
weakness in both upper and lower extremities. Motor strength was 4 for all extremities and 
cape distribution of hypaesthesia was found. MRI showed a solid enhancing mass attached 
to the midline anterior FM, from the distal of clinoid to C1. The patient had undergone 
microsurgical resection (Simpson grade I) through a far lateral approach.
3 DISCUSSION
FM meningioma arises from the arachnoid at the craniospinal junction. The borders of this 
zone, as defined by George et al. (1997), range anteriorly from the lower third of the clivus, to 
the upper margin of the body of C2, laterally from the jugular tubercle to the upper margin 
of the C2 laminae, and posteriorly from the anterior edge of the squamous occipital bone to 
the C2 spinous process (George et al., 1997).
3.1 Surgical anatomy
When approximating FM meningioma, a precise affection of the normal anatomy is very 
important. Regional anatomy of the Vertebral Artery (VA) and the lower cranial nerves, and 
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their displacement by space-occupying lesions, must be well recognised by the surgeon to 
ensure their protection.
The FM contains several critical neuroanatomical and vascular structures. The neural 
structures include the cerebellar tonsils, inferior vermis, fourth ventricle, caudal aspect of the 
medulla, lower cranial nerves (IX through XII), rostral aspect of the spinal cord, and upper 
cervical nerves (C1 and C2). (George & Lot, 1997; Kano et al., 2010).
Major arterial structures located within the FM include the VAs, Posterior Inferior 
Cerebellar Arteries (PICAs), anterior and posterior spinal arteries, and meningeal branches of 
the vertebral, external, and internal carotid arteries (George & Lot, 1997; Kano et al., 2010).
For an anatomic description, the VA is divided into four segments (Kano et al., 2010).
The first, ‘pretransverse’ (ostial, proximal) segment extends from its origin to the transverse 
process of the C6 vertebra (Kano et al., 2010).
The second ‘transverse’ segment runs inside the transverse processes of C6 through the 
axis (Kano et al., 2010).
Of special interest for surgery around the FM are the third and fourth segments. 
The  V3  segment is also called the ‘suboccipital segment’ and extends from the transverse 
process of the axis to the dural penetration of the VA (Kano et al., 2010).
Anatomical relations of the VA are modified by head movements of rotation, as well as 
during surgical positioning. In neutral position, the vertical and horizontal portions of the 
V3 segment are perpendicular. On the contrary, after head rotation, as required during an 
anterolateral approach, both segments are stretched and run parallel, only separated by the 
posterior arch of the atlas, because the C1 transverse process is pushed anteriorly by this 
movement, away from the C2 transverse process. (Kano et al., 2010).
3.2 Classification system
The definitive objective of a classification system is to define preoperatively the surgical 
strategy, based on preoperative imaging characteristics of the lesion. The surgical strategy in 
cases of FM is the surgical approach, but also the anticipation of the modified vital structure 
position. In this classification system, FMs can be classified according to their compartment 
of development, their dural insertion, and to their relation to the VA (Komotar et al., 2010).
According to the compartment of development, FMs can be subdivided into: intradural, 
extradural, and intra-extra dural. According to the insertion on the dura, FM can be defined 
in the antero-posterior plane as: anterior, if  insertion is on both sides of the anterior midline; 
lateral, if  insertion is between the midline and the dentate ligament; and posterior, if  inser-
tion is posterior to the dentate ligament (Nader et al., 2014).
Surgical strategies vary according to the relation to the VA, FM having the possibility to 
develop: above the VA, below the VA, or on both sides of the VA (Nader et al., 2014).
3.3 Key steps of surgical procedure
The goal of this approach is to allow a tangential view of lesions located ventrally and vent-
rolaterally to the brainstem and upper cervical cord. This approach, along with control and 
Figure 1. MRI shows solitary mass, enhanced with contrast in cranio-cervical junction.
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mobilisation of the VA, allows better visibility anterior to the brainstem, thus influencing 
favourably the safety and completeness of the operation. The advantages are: provides expo-
sure of the lower third of the clivus, the FM, and the upper cervical spine; and decreases the 
need of brainstem, cerebellar, and upper cervical cord retraction, required to visualise the 
lower clivus and anterior FM (Pamir et al., 2010).
The patient is placed in the lateral recumbent position on the operating table, with the head 
positioned in the Mayfield holder. The head is laterally flexed −30 degrees, contralateral to 
the lesion, and flexed anteriorly so that the chin is 1 cm from the sternum.
The incision starts at the mastoid process, descending in a curve dorsal to the sternocleido-
mastoid muscle and down to the level of C4. The dissection is carried through the subcutane-
ous tissues, the muscular fascia, and the fatty plane (Nader et al., 2014; Pamir et al., 2010).
Dissection through these anatomic layers, detaching each muscle from its lateral attachment, 
and displacing them medially and inferiorly, provides access to the transverse process of C1 and 
the lateral masses of the lower cervical vertebrae (Nader et al., 2014; Pamir et al., 2010).
By exposing the ipsilateral lamina of C2, and the posterior arch of C2, one can identify the 
VA with its venous plexus, located in the sulcus arteriosus lateral to the posterior arch of Cl, 
ventral to the C2 nerve root, and caudal to the inferior border of the inferior oblique muscle 
(Nader et al., 2014; Pamir et al., 2010).
A small craniotomy is performed with a high-speed drill, removing 1 cm of suboccipital 
bone from the FM. It is important to take this bony exposure far lateral to the junction with 
the occipital condyle. The posterior portion of the occipital condyle is drilled, while protect-
ing the VA. The amount of resection of the condyle depends on the exact location (ventral or 
ventrolateral), size, nature of the lesion, the shape of the FM, and the relation of the VA to 
the lesion (Nader et al., 2014; Pamir et al., 2010).
A high-speed drill or rongeurs are used to remove the posterior arch of Cl. The foramen 
transversarium of Ct is unroofed with a drill. Using a subperiosteal dissection of the lamina 
and lateral mass, the VA is freed from the sulcus arteriosus of C1, and isolated to its entrance 
into the dura (Nader et al., 2014; Pamir et al., 2010).
Following isolation of the VA and appropriate bone removal, the dura is opened in a cur-
vilinear fashion. The dural edges are retracted with sutures and the neurovascular structures 
are identified. The artery can be mobilised posteriorly and dissected from the lesion. After 
resection of the lesion, the dura can rarely be closed in a watertight fashion; therefore, a dural 
graft may be used (pericranium or fascia) and the defect covered with oxidised cellulose (Sur-
gicel) and fibrin glue (Nader et al., 2014; Pamir et al., 2010).
3.4 Outcomes and postoperative complications
Yaşargil et  al. (1980), in their review of the 114 operative cases reported in the literature 
between 1924 and 1976, found an operative mortality of approximately 13%, a good outcome 
in 69%, fair outcome in 8%, and a poor outcome in 10%. A low preoperative Karnofsky Per-
Figure 2. Classification of FM according to its location relative to the VA: below VA; above VA; on 
both sides of VA. Based on the compartment of development: intradural, extradural, or intra-extradural.
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formance Score (KPS), progressive clinical course, and quadriparesis were associated with 
increased operative risk and poor prognosis (Yaşargil et al., 1980). Recurrence is a major 
problem in skull base meningiomas (Yaşargil et al., 1980).
The most common complications are VA injuries, vertebral venous plexus bleeding (source 
of potential complication during surgery), neurologic disability from retraction of the neu-
raxis or arterial insult, delayed spinal cord and brainstem symptomatology from compromise 
of venous drainage, cerebral spinal fluid (CSF) leakage that leads to meningitis and pseudo-
meningocele, and C2 root neurapraxia from stretch injury (Pamir et al., 2010).
4 CONCLUSION
The far lateral approach has been used as the approach for the majority of the lesions located 
ventrolateral to the brainstem and in the upper cervical spinal cord. This approach pursues to 
remove the occipital bone, including the posterior aspect of the ipsilateral condyle and pos-
terior arch of C1. Anatomical landmarks may be recognised for the neurosurgeon to avoid 
neurovascular injuries, especially to the VA and hypoglossal nerve.
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Figure 3. Plan of incision, craniotomy site and mass of the tumor with VA vertebral artery crossed over it.
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ABSTRACT: Hypertension is still becoming a global health problem. Body Mass Index 
(BMI) and Neck Circumference (NC) are anthropometric measurements to assess obesity, 
and are also reported to correlate with the risk of hypertension, to determine the relationship 
between NC, BMI, and hypertension in children. A cross-sectional study was conducted in 
North Sumatra, Indonesia. Samples were children aged 12–15 years old. The chi-square test 
was used to see the relationship between NC, BMI, and hypertension. Logistic regression 
was used to compare which one has a bigger influence on the increase in blood pressure. 
A p-value < 0.05 was significant. 264 children were included. Hypertension occurred in 9.8% 
of children with NC above the 90th percentile, and in 11.4% of children with overweight/
obese BMI status. Children with overweight/obese BMI status showed a higher risk of hyper-
tension. NC and BMI have been correlated with hypertension in children.
Keywords: Body Mass Index, Neck Circumference, Hypertension
1 INTRODUCTION
Obesity and being overweight are increasingly prevalent among children all over the world 
(WHO, 2015). Increased prevalence of obesity is also followed by an increase in comorbid-
ity prevalence, such as hypertension, dyslipidaemia, and metabolic syndrome (IDAI, 2014; 
Mohammed, 2015; Haris & Tambunan, 2009).
The Body Mass Index (BMI) is an anthropometric index for assessing obesity in screening 
for regional body fat distribution (Androutsos et al., 2012), whereas the Neck Circumference 
(NC) is used to assess central obesity (Kuciene et al., 2015; Nafiu et al., 2014). The NC is also 
reported to have a positive correlation with the risk of hypertension and obesity (Nafiu et al., 
2014; Hatipoglu et al., 2010; Guo et al., 2012).
2 METHODS
This study used cross-sectional design in Singkuang Village, North Sumatra. This research 
was conducted from March to May 2016. Inclusion criteria were all students of junior high 
school aged 12–15 years old, and parents signed the informed consent for research participa-
tion. The exclusion criterion was children with a deformity in the neck.
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Body Weight (BW) was determined using the GEA body weight scale. Body Height (BH) 
was measured using a metal stadiometer. Next, BMI was assessed by using the BMI formula. 
NC was measured at the level of the thyroid cartilage, with the subject in the standing position 
and the head held erect. The measurements of the NC were projected on percentile for NC in 
Turkish children table for children aged six to 18 years. Then, a blood pressure measurement 
was performed using a mercury sphygmomanometer with cuff  size adjusted to age. Blood 
pressure tables from The Fourth Report from the NHBPEP Working Group on Children and 
Adolescents (2004) were used.
Data processing used SPSS statistical software (version 19.0). Descriptive statistical 
analysis, mean and standard deviation (SD), was calculated for variables such as age, 
gender, weight, height, BMI, NC, and systolic and diastolic blood pressure. Univariate 
analysis was performed by using cross tabulation. Bivariate analysis was undertaken using 
chi-squared tests. Furthermore, multivariate analysis was analysed by using a logistic 
regression test.
3 RESULTS
There was a total of 278 students in both schools. The number of students in the junior high 
school was 170, and there were 108 students and in pesantren. There were 264 people eligible 
for the inclusion criteria, and 14 students were excluded from the study. The students who 
were excluded were made up of five students who were not present during the data collection, 
one student with a neck deformity, and eight students aged over 15 years.
Table 1 shows that the mean age of adolescents as subjects in the study was 13.8 years. 
Increased values of BMI, blood pressure, and NC were also found, but more in female sub-
jects. Table 2 illustrates the relationship between risk factors such as age, gender, NC, and 
BMI, with blood pressure in subjects. There is a significant relationship between gender, NC, 
BMI, and increased blood pressure (p < 0.05). Table 3 shows the multivariate analysis. This 





Mean age, years (SD) 13.9 (0.95) 13.7 (1.04) 13.8 (1.00)
Mean weight, kg (SD) 39.8 (8.59) 42.2 (9.75) 41.1 (9.20)
Mean height, cm (SD) 149.0 (9.35) 144.6 (7.74) 146.4 (8.77)
NC, n (%)
 < P 90th 99 (37.6) 89 (33.8) 188 (71.2)
 > P 90th 24 (8.7) 52 (19.8) 76 (28.8)
BMI, n (%)
 Underweight 27 (10.3) 22 (8.4) 49 (18.6)
 Normal weight 83 (31.4) 62 (23.5) 145 (54.9)
 Overweight 6 (2.3) 36 (13.7) 42 (15.9)
 Obese 7 (2.7) 21 (8.0) 28 (10.6)
Blood pressure, n (%)
 Normal blood pressure 106 (40.3) 69 (26.2) 176 (66.70)
 Pre-hypertension 12 (4.6) 38 (14.4) 50 (18.90)
 Hypertension 4 (1.5) 34 (12.9) 38 (14.40)
Mean NC, cm (SD) 30.64 (2.44) 30.6 (2.33) 30.6 (2.37)
Mean BMI, kg/m2 (SD) 17.8 (2.37) 20.5 (4.00) 19.1 (3.53)
Mean systolic, mmHg (SD) 102.1 (10.2) 109.7 (14.2) 106.1 (13.07)
Mean diastolic, mmHg (SD) 65.5 (7.46) 70.6 (9.97) 68.2 (9.21)
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4 DISCUSSION
The study found that the average increase in systolic and diastolic blood pressure was higher 
in female than in male subjects. Increased values in BMI, blood pressure, and NC were also 
experienced more by female subjects. Gender can indirectly affect blood pressure, although 
this is still under review (Azhim et al., 2007). The results of this study are in line with the 
research conducted by Ejike et al., which found that the BMI of girls was greater than that of 
boys, and that it increases as their age progresses, causing an increase in blood pressure, with 
the diastolic blood pressure of girls being higher than that of boys (Ejike, 2011).
Gender difference results in different body size. Body size affects arterial haemodynamic 
function, which is also influenced by blood flow velocity that indicates the vascular resistance 
and the elasticity of the blood vessels, which ultimately will affect blood pressure (Azhim 
et al., 2007).
It was found that there was a significant correlation between increased BMI and blood 
pressure. The results of this study are consistent with a study in Egypt involving adolescents 
aged 11 to 19, which found a significant correlation between increased BMI and the inci-
dence of hypertension in children (Abolfotouh et al., 2011). Obesity and being overweight 
are two of the major global challenges, and are risk factors for cardiovascular disease (Hendy 
et al., 2013). Pathophysiology of hypertension in obesity is a highly complex matter. Some of 
the major mechanisms to consider include insulin resistance and hyperinsulinaemia, both of 
which are present in obesity (Flynn, 2013).
The results of this study are in line with a cross-sectional study conducted in the United 
States, showing that NC alone, or along with being obese/ overweight, is correlated with 
increased risk of high blood pressure in children and adolescents (Kuciene et  al., 2015). 











12–13 74 (28.1) 36 (13.6) 0.860 1.05 (0.62–1.76)
14–15 102 (38.6) 52 (19.7)
Gender
Boys 107 (40.5) 16 (6.1) 0.001 6.97 (3.75–12.97)
Girls 69 (26.1) 72 (27.3)
NC
< P 90th 151 (57.2) 37 (14.0) 0.001 8.32 (4.57–15.14)
> P 90th 25 (9.5) 51 (19.3)
BMI
Under-/Normal weight 159 (60.2) 35 (13.3) 0.001 14.16 (7.33–27.33)
Overweight/Obese 17 (6.4) 53 (20.1)
*Chi-squared.
Table  3. The effect of NC, BMI, and gender with risk of 
pre-hypertension and hypertension.
P OR 95% CI
NC (P > 90th) 0.001 4.436 2.14–9.21
Overweight/obese 0.001 5.871 2.79–12.32
Girls 0.001 4.964 2.41–10.22
*logistic regression.
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Some  epidemiological studies have shown a relationship between increased NC and high 
blood pressure in children and adolescents (Ferreti et al., 2015).
The mechanism that can explain the relationship between NC and cardiometabolic risk is 
still under review. A size of NC above the 90th percentile leads to an increase in subcutaneous 
body fat. That is responsible for the release of most of the systemic fatty acids, especially in 
obese individuals. High concentrations of free fatty acids increase as a marker of oxidative 
stress. This provokes vascular endothelial injury and may play a role in the development of 
hypertension (Guo et al., 2012; Ferreti et al., 2015; Mazicioglu et al., 2010).
There are limitations in this study. There are a number of other factors that may effect an 
increase in blood pressure, such as lifestyle and unhealthy eating habits (e.g. high salt intake), 
lack of physical activity/having a sedentary life, history of parents suffering from hyperten-
sion, cholesterol, sleep disturbances, and stress conditions not analysed in adolescents who 
are overweight and obese with hypertension. In conclusion, this study found that there was a 
relationship between NC and BMI with hypertension in children.
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Trigeminal cardiac reflex in post-operative spheno-orbital 
meningioma
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ABSTRACT: The Trigeminal Cardiac Reflex (TCR) is a phenomenon that is composed 
of bradycardia, arterial hypotension, apnoea, and gastric hypermobility. It mostly occurs 
during skull base surgery, at or around structures that are innervated by any sensory branch 
of the trigeminal nerve. We report a 48-year-old female who was diagnosed as having left 
spheno-orbital meningioma and had used a cranio-orbitozygomatic approach to remove the 
tumour. Six hours post-operatively, she had a sudden decrease in Heart Rate (HR), 31% 
decrease from baseline, and also a Mean Arterial Blood Pressure (MABP) decrease of 35% 
from baseline. Laboratory finding was normal, oxygen saturation was 100%, and no hyper-
carbia occurred. She was suspected as having TCR. Intravenous administration of atropine 
abolished the reflex, and her HR and MABP slowly increased to normal.
Keywords: Spheno-orbital meningioma, Trigeminal cardiac reflex
1 INTRODUCTION
The Trigeminal Cardiac Reflex (TCR) happens in 10–18% of patients who have undergone 
skull base surgery (Gharabaghi et al., 2006). TCR leads to an immediate decrease in the Mean 
Arterial Blood Pressure (MABP) and Heart Rate (HR) of more than 20%, compared to the 
baseline levels with surgical-mechanical, electrical or chemical stimulation of the central part 
of any sensory branches of the trigeminal nerve, and to apnoea and gastric hypermobility 
coinciding with the surgical manipulation at or around any branch of the trigeminal nerve 
(Gharabaghi et al., 2006).
Since the 20th century, TCR has earned much clinical attention. The Oculocardiac Reflex 
(OCR) is the cardiac response (mainly bradycardia) associated with stimulation of the 
ophthalmic division of the trigeminal nerve during ocular surgeries (Schaller et al., 2009). 
Then, Schaller for the first time demonstrated that a similar reflex occurs with stimulation 
of the intracranial portion of the trigeminal nerve. Since then, much discussion has taken 
place about the reflex itself  and treatment of TCR when it occurs during intracranial or 
extracranial procedures. Until now though, there has been no clear provision as to how to 
manage TCR.
2 CASE REPORT
A 48-year-old female presented with left proptosis bulbi as the chief  complaint. This hap-
pened since six years. She could no longer see through her left eye, but its movement was still 
good. There was no history of headache, vomiting spit, convulsion, or one-sided paresis. 
She was diagnosed as having left spheno-orbital meningioma, and required a craniotomy 
tumour removal. A cranio-orbitozygomatic approach was used. She was transferred to 
intensive care for post-operative care with a stable haemodynamic profile. Six hours post-
operatively, her HR suddenly decreased (baseline 80–88) to 55–60 beats per minute (31% 
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decrease). The ECG showed sinus rhythm. The MABP also decreased to 52 mmHg (baseline 
80 mmHg; 35% decrease). Post-operative haemoglobin was 11 g/dL, central venous pressure 
was 12 mmHg, and other laboratory findings were normal. Her oxygen saturation was 100%, 
and no hypercarbia occurred. She was suspected of suffering TCR. Intravenous administra-
tion of atropine (2 mg) abolished the reflex, and HR and MABP slowly increased to normal.
3 DISCUSSION
The proposed mechanism for the development of TCR is that the sensory nerve endings of 
the trigeminal nerve send neuronal signals via the Gasserian ganglion to the sensory nucleus 
of the trigeminal nerve, forming the afferent pathway of the reflex arc (Schaller et al., 1999; 
Schaller, 2004). This afferent pathway continues along the short internuncial nerve fibres 
in the reticular formation to connect with the efferent pathway in the motor nucleus of the 
vagus nerve. Several lines of experimental evidence demonstrate that trigeminally induced 
cardiovascular reflexes could be mediated initially in the trigeminal nucleus caudalis and sub-
sequently in the parabrachial nucleus, the rostral ventrolateral medulla oblongata, the dorsal 
medullary reticular field, and the paratrigeminal nucleus in animal models (Schaller et al., 
2009).
TCR cases were defined as a drop in MABP and HR, both more than 20% from baseline 
levels, and had to fulfil at least two major criteria in plausibility and reversibility and two 
minor criteria in repetition and prevention, as described earlier by Schaller (Kumada et al., 
1977). These points would help in clinical practice to assess whether the observed haemody-
namic changes are related to a TCR phenomenon. In daily clinical practice, not all the cri-
teria must or can always be required to confirm a TCR. However, the more of these criteria 
that are present, the more confirmed is a TCR.
3.1 Type of TCR
A central (proximal) TCR is triggered by the stimulation of the intracranial part of the trigem-
inal nerve, and thus upon the section which is located after the Gasserian ganglion. A periph-
eral (distal) TCR is therefore triggered by stimulation upon the extracranial course of the 
trigeminal nerve, distal to the Gasserian ganglion (Abdulazim et al., 2012). The peripheral 
Figure 1. Orbital CT, T1, T1 contrast, and T1 contrast coronal MRI scans of patient with spheno-
orbital meningioma.
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TCR is further subdivided, based on the branch of the affected trigeminal nerve into the 
oculocardiac reflex (V1) and the maxillo-mandibular cardiac reflex (V2–V3). A TCR trig-
gered at the Gasserian ganglion has, according to the latest studies (Abdulazim et al., 2012),.
3.2 Risk factor
As there is a lack of detailed knowledge of the physiology of TCR, the risk factors gain 
increased importance. The risk factors already known to increase the incidence of TCR include: 
(i) hypercapnia; (ii) hypoxaemia; (iii) light general anaesthesia; (iv) age (more pronounced in 
children); (v) the nature of the provoking stimulus (stimulus strength and duration); (vi) drugs 
(Schmeling et al., 1989; Blanc et al., 1983). Drugs known to increase TCR include: (i) potent 
narcotic agents (sufentanil and alfentanil) (Schmeling et al., 1989; Blanc et al., 1983); (ii) beta-
blockers; (iii) calcium-channel blockers (Schmeling et al., 1989; Blanc et al., 1983).
3.3 Risk of TCR
Risk of TCR may range from mild bradycardia that responds to simple cessation of the 
stimulus to asystole and severe bradycardia requiring additional intervention with vagolytic 
Table 1. Major criteria (plausibility and reversibility) and minor criteria 
(repetition and prevention).
Evidence of TCR by Cause-Effect Relationship
Plausibility   The appearance of TCR must be explainable by an 
adequate stimulation of the trigeminal nerve.
  TCR appears promptly after the stimulus is applied.
Reversibility   Stimulus cessation abolishes the reflex, and 
cardiopulmonary parameters return to baseline.
Repetition   Reapplication of the stimulus on cranial nerve V will 
result in similar haemodynamic changes.
Prevention   A lighter stimulus of the same type does not result 
in the same severe TCR.
  Trigeminal nerve block abolishes the TCR.
  Application of anticholinergic drugs blocks the 
occurrence of the reflex.
Table 2. The new classification of TCR.




Stimuli Pressure on globe V2 and V3 
stimulation
Direct stimulation Stimulation beyond 
ganglion










Respiration Apnoea Apnoea Apnoea Apnoea





Fracture reduction Percutaneous 
ganglion 
ablation
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drugs (Schmeling et al., 1989). In some rare but serious cases, it may lead to death if  not 
detected early and appropriate measures taken. Also, hypotension that occurs during TCR 
may lead to myocardial and cerebral infarction in those who are at risk of these conditions 
(Schmeling et al., 1989).
3.4 Management of TCR
The best action in managing TCR is to prevent the risk factors above (Schaller, 2004). Intra-
venous anticholinergics, atropine and glycopyrrolate IV, may be used to treat and prevent 
TCR during operation (Hunsley et al., 1982). Hunsley et al. (1982) evaluated the efficacy 
of  IV atropine and glycopyrrolate in the prevention of  OCR in children operated on for 
strabismus. They tested different doses of  the two drugs, glycopyrrolate 5 and 7.5 mg/kg 
and atropine 10 and 15 mg/kg. Overall, there was a reduction in the rate of  bradycardia of 
between 23.8% and 33.3%. However, they noticed that even higher doses of  the two drugs, 
atropine 15 mg/kg, and glycopyrrolate 7.5 mg/kg i.v., given five minutes before induction 
of  anaesthesia, were not sufficient to protect completely against OCR in children (Hunsley 
et al., 1982).
4 CONCLUSION
TCR was defined as a drop in MABP and HR, both more than 20% from baseline levels, 
and had to fulfil at least two major criteria in plausibility and reversibility, and two minor 
criteria in repetition and prevention. The best management is prevention of the risk factor, 
and cholinergic agents are best to treat TCR during and post operation.
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ABSTRACT: Across the world, the prevalence of overweight and obese children is high. 
The influences of several factors have been extensively described; this includes genetic, 
cultural, and environmental factors, such as sedentary activity in children. This study aims 
to determine the association between sedentary activities and parental obesity with obesity 
in children. A case-control study was carried out at ten elementary schools in Medan. The 
data about sedentary lifestyle and parental obesity was obtained by giving questionnaires to 
parents or guardians. Data was analysed by chi-squared tests, with p < 0.05 being considered 
as statistically significant. There were 212 children recruited, aged 6–12 years—105 children 
with obesity as the case group and 107 normal-weight children as a control group. This study 
found a significant association between parental obesity and sedentary activities with obesity 
in children (p < 0.01). It is important to make efforts to prevent obesity in children.
Keywords: Childhood obesity, sedentary behaviour, parental obesity
1 INTRODUCTION
In recent years, being overweight and obese have been increasing dramatically in many devel-
oping countries, particularly in urban settings and amongst high Socio-Economic Status 
(SES) groups. Overweight and obese children are likely to maintain their status into adult-
hood and are at higher risks of developing chronic diseases, such as hypertension, dyslipidae-
mia, type-2 diabetes, heart disease, stroke, gall bladder disease, osteoarthritis, sleep apnoea 
and respiratory problems, and certain cancers (Wang & Lim, 2012).
Obesity tends to run in families. Genetics plays a major role. A common explanation is 
that family members share a common attitude towards food, eating habits, and exercise. 
Children of heavier parents have been found to exhibit lower levels of physical activity, have 
a greater preference for high-fat foods, and a lower preference for healthier foods. The risk 
of obesity is low in children where neither parent is obese, greater when one parent is obese, 
and greatest when both parents are obese. An estimate says that heredity contributes about 
5–25% of the risk of obesity (Kumar et al., 2010).
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Obesity has been considered to result from lifestyle changes, especially in food consumption, 
physical activity, and sedentary tendencies, because the environment has grown more 
obesogenic in recent decades (Fuemmeler et al., 2013). The causes of children being over-
weight and obese are complex. The decrease in physical activity and increased time spent in 
sedentary pursuits, such as television viewing and other electronic media use, are considered 
major contributors. With increasing levels of sedentary behaviour, there is reduced energy 
expenditure while energy intake remains unaltered. This will lead to a rising prevalence of 
overweight and obese children (Saliba, 2015). The objectives of this study were to determine 
the relationships between parental obesity and sedentary activities, with obesity in children.
2 METHODS
A case-control study was conducted in ten elementary schools in Medan, Sumatera Utara, 
Indonesia. Schools were selected from the school list, provided by the education department, 
by using simple random sampling. The case group was children with obesity and the control 
group was normal-weight children, aged 6–12 years. The study included a questionnaire for 
parents or guardians, and anthropometric measurements. The questionnaires requested infor-
mation about the onset of obesity, date of birth, parental obesity, and sedentary behaviour.
Sedentary behaviour can be considered over multiple dimensions: time (amount of time 
spent in activity) and type (Must & Tybor, 2005). Respondents were asked to report the 
number of hours in a typical week over the past three months they spent watching television 
(including videos), and using a computer (including playing computer games and using the 
Internet). They were instructed to report leisure-time hours only and to exclude time spent 
on these activities at work or school. Respondents reported their weekly hours for sedentary 
activities in five categories: 5 or fewer, 6 to 10, 11 to 14, 15 to 20, or more than 20 hours 
(Shields & Tremblay, 2008). Children who were under steroid treatment, had chronic infec-
tion or disease, endocrine disorder, genetic disease, or short stature were excluded from this 
study. This study was approved by the Ethics Committee of the Medical School, University 
of Sumatera Utara, Medan, Indonesia. All children and parents gave written informed con-
sent to the results of this study being used for scientific research purposes.
Anthropometric measurements included body weight (in kg), which was measured to the 
nearest 0.1 kg by a digital machine. Height (in cm) was measured to the nearest 0.1 cm by 
using a stadiometer. All instruments were validated following the manufacturer’s protocol. 
Waist circumference (in cm) was determined at the midpoint between the iliac crest and 
lowermost margin of  the ribs, by using a non-stretchable measuring tape while the child was 
in a standing position and after expiration. Body Mass Index (BMI) was calculated as 
weight (in kg) /height (in m) (Ogden & Flegal, 2010). Children who had a BMI of  more 
than P95 based on age and gender-specific BMI (CDC Standards, 2000) were considered 
obese, and those who had a BMI of  P3 to 85, by the same standards, were considered to 
have normal weight.
Data was analysed using SPSS software, version 24 (SPSS Inc., Chicago, IL, USA). Quan-
titative variables were expressed as mean ± Standard Deviation (SD). Descriptive statistics 
were used to analyse socio-demographic characteristics of the subjects. Anthropometric 
measurements between case and control groups were compared using student’s t-test.
3 RESULTS AND DISCUSSION
There were 212 children recruited, aged 6–12 years, 105 children with obesity as the case 
group and 107 normal-weight children as the control group.
Characteristics of children in this study are shown in Table 1. Children in the case group 
had significantly higher levels of BMI and body weight. There was a significant association 
between age, body weight, height, waist circumference, and BMI, with nutritional status, 
p < 0.05. However, we did not find an association between sex and nutritional status.
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There are many possible causes of obesity amongst children, and the scope to make causal 
inferences based solely on parental weight is limited. However, it seems reasonable to suggest 
that adult attitudes and behaviours that affect their weight are likely to influence their chil-
dren’s weight (McLoone & Morrison, 2012). Parental obesity has been identified as being a 
predominant risk factor for childhood obesity, probably owing to a combination of genetic, 
epigenetic, social, and environmental factors. Children with two obese parents have a higher 
risk of obesity than those with one or no obese parent (Svensson et al., 2011). Some recent 
studies have found a significant association between parental obesity with obesity in children 
(Bralić et al., 2005; Bahreynian et al., 2017; Devakumar et al., 2016). These results are con-
sistent with our study; we reported the significant association between parental obesity and 
obesity in children (p < 0.05), and we found that the parental history of obesity was present 
for 72 (34%) of children with obesity and 33 (15.6%) of normal-weight children (Table 2).
Lifestyle changes in high-income countries have led to a decrease in the energy expendi-
ture needed for daily life, and an increase in sedentary activities and weight gain. Sedentary 
behaviour is not simply a lack of physical activity but is also a cluster of individual behav-
iours, where sitting or lying is the dominant mode of posture and energy expenditure is very 
low; it is a multi-faceted behaviour that might take place at work, school, or home. Child-
hood and adolescence are crucial stages of development where lifestyle habits are formed and 
set (Al-Nakeeb et al., 2012).
Some studies reported a significant association between sedentary activities and obes-
ity in children (Alqahtani et  al., 2015; Shields & Tremblay, 2008). Other studies reported 
that normal-weight children spend less time in sedentary activities than children with obes-
ity (Vilchis-Gil et al., 2015; Baruki et al., 2006; Kreuser et al., 2013). In our study, we also 
reported that most of the obese children had sedentary activities for more than 20 hours 
in a week; for normal-weight children, most of them had sedentary activities 6–10 hours a 
week. We found a significant association between sedentary activities and obesity in children 
(Table 2).
Table 1. Characteristics of children in study.
Case Control p
Age (years) 9.87 ± 1.49 9.17 ± 1.62 0.01
Sex: Male 67 (63.8) 64 (59.8) 0.55
  Female 38 (36.2) 43 (40.2)
Body weight (kg) 46.60 ± 10.44 27.90 ± 5.81 0.01
Body height (cm) 136.50 ± 9.90 130.68 ± 9.86 0.01
Waist circumference (cm) 76.39 ± 8.83 57.76 ± 6.96 0.01†
BMI (kg/m2) 24.73 ± 2.96 16.15 ± 1.48 0.01
BMI: Body mass index. Data are means ± SD, or percentages. Associations are 
considered significant when p < 0.05.
Table 2. Association between parental obesity and sedentary behaviour with BMI.
Case Control p
Family history of obesity:
Yes 72 (34.0) 26 (12.3) 0.01
No 33 (15.6) 81 (38.2)
Sedentary lifestyles
<5 hours 13 (6.1) 37 (17.5) <0.001†
6–10 hours 11 (5.2) 45 (21.2)
11–14 hours 10 (4.7) 14 (6.6)
15–20 hours 34 (16.0) 6 (2.8)
>20 hours 37 (17.5) 5 (2.4)
†Kolmogorov−Smirnov.
ISCOC17_Book.indb   73 3/21/2018   2:04:11 PM
74
The American Academy of Pediatrics (2001) recommends some guidelines for parents 
regarding television use by children. These include a limitation of children’s total media 
time to no more than one or two hours of quality programming per day, the removal of 
electronic media gadgets from children’s bedrooms, discouraging television viewing for chil-
dren younger than two years, monitoring of things children are doing with electronic gadg-
ets, viewing programmes along with children and discussing the contents, and encouraging 
alternative entertainment for children, including reading, athletics, hobbies and creative play 
(Saliba, 2015).
Our study has several limitations. We use self-reported data for children’s sedentary activi-
ties and parental obesity. However, the questionnaire has previously demonstrated satisfac-
tory reliability and validity, and honest reporting was encouraged by ensuring confidentiality 
during data collection. The sedentary activities considered in this study were limited to 
screen-behaviours. Despite these limitations, our findings contribute to our understand-
ing of  the relationship between parental obesity, sedentary activities, and obesity amongst 
children.
Parents need to be involved in obesity prevention programmes. The health authorities 
need to launch public campaigns for the awareness of obesity amongst children and the 
importance of healthy nutrition and physical activity. Healthcare workers including fam-
ily, doctors, and paediatricians, need to facilitate parental awareness of obesity. In addition, 
intervention studies are needed to establish the effectiveness of reducing obesity amongst 
children through increasing physical activity, in tandem with reducing sedentary behaviours, 
especially screen time.
4 CONCLUSION
This study shows a significant association between parental obesity and sedentary behaviour, 
with obesity in children. The reduction in childhood obesity is regarded as a public health 
priority, and our findings suggest that parental obesity and sedentary behaviour are respon-
sible for childhood obesity. Family-based interventions are recommended to treat childhood 
obesity, aiming to change attitudes and behaviours towards food and physical activity within 
a family. Public health strategies to prevent childhood obesity by targeting overweight and 
obese parents are recommended to prevent childhood obesity.
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ABSTRACT: The diagnostic test C-Reactive Protein (CRP) and haematological scoring 
system provide results in a shorter time than cultures, and have been used to help to determine 
the diagnosis of neonatal sepsis. Objective: To evaluate the diagnostic value of CRP and 
haematological scoring systems in relation to positive blood culture results. The CRP test 
showed sensitivity and specificity of 92.8% and 62%, respectively. The haematological 
scoring system showed a sensitivity of 100% and specificity of 82.7%. Both the CRP 
and haematological scoring system were sensitive to prediction of positive blood culture. 
However, the haematological scoring system showed better specificity than CRP. Both tools 
can be used to assist in the diagnosis of neonatal sepsis in resource-limited settings.
Keywords: C-reactive protein, haematological scoring system, neonatal sepsis
1 INTRODUCTION
Sepsis is an infection (confirmed or suspected) evidenced by a systemic manifestation of the 
infection associated with haemodynamic changes and other clinical manifestations. Sepsis 
in neonates is classified into early-onset infection when it appears within the first 72 hours 
of life, and late-onset infection if  infections occur after seven days of age (Gotoff, 2002; 
Shane et al., 2017). Premature infants are more vulnerable to infections, due to the impaired 
immune system, and sepsis becomes the second most common cause of neonatal death in 
preterm birth (Lawn et al., 2005; Shane & Stoll, 2014). The burden of neonatal sepsis varies 
between geographic region and income levels (Shane et al., 2017). In Indonesia, the incidence 
ranges between 20.7 and 38.7% (Zaidi et al., 2005).
The definitive diagnosis of neonatal sepsis is made by isolating the causative pathogens, 
commonly from blood cultures (Gotoff, 2002). Nevertheless, bacterial growth in culture 
requires time and it is not always possible to isolate the causative agents (Shane & Stoll, 
2014). Other commonly used diagnostic tests include total and differential White Blood Cell 
(WBC) count, absolute and immature neutrophil counts, the ratio of Immature-to-Total neu-
trophils (IT ratio), Procalcitonin (PCT) and C-Reactive Protein (CRP) (Shane et al., 2017; 
Stocker et al., 2010; Canpolat et al., 2011). However, the availability of some of these tests 
is often limited to central hospitals. Another approach is to use a Haematological Scoring 
System (HSS), developed to facilitate the diagnosis of neonatal sepsis (Shane et al., 2017). 
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This scoring system incorporates different parameters, including leukocyte count, total neu-
trophil (polymorphonuclear cells, PMN) count, IT ratio, Immature-to-Mature neutrophil 
(IM ratio), total immature PMN, platelet count, and degenerative PMN. Each item is given 
an average weight of value 1 if  it indicates an infection, and interpreted as having a sepsis 
when the score is ≥ 5, possible sepsis for a score of 3 to 4, and not having a sepsis for a score 
below 2 (Pal et al., 2014; Narasimha & Kumar, 2011).
The aim of this study is to evaluate the diagnostic value of CRP and HSS in relation to 
blood culture results for the diagnosis of neonatal sepsis.
2 METHOD
Patients were neonates admitted to the Neonatology Unit at Haji Adam Malik General Hos-
pital, Medan, between April and August 2015. Neonates suspected of sepsis were examined, 
and had performed laboratory tests including complete blood count, IT ratio, IM ratio, PMN 
and degenerative PMN, CRP and blood culture. The laboratory results were then evaluated 
to calculate the score in the haematological scoring system. The score was then compared 
to the CRP value and against the blood culture results. Diagnosis of sepsis was made by 
physicians based on physical examination and laboratory results before blood culture results. 
Written informed consent was obtained from the parents or legal guardians. The study was 
approved by the Ethics Committee of the University of Sumatera Utara, Indonesia.
3 RESULTS
A total of 154 neonates were treated in the Neonatology Unit during the study period. 
Amongst them, 51 were suspected of sepsis and 43 were enrolled in the study. The incidence 
of suspected neonatal sepsis in the study was 33.1%.
CRP was positive in 24 (55.8%) out of 43 neonates, and blood cultures demonstrated bac-
terial growth in 13 neonates (Table 2). The sensitivity and specificity for CRP were 92.8% and 
62%, respectively. The numbers of neonates with a haematological score above 4, suggesting 
a sepsis, were 19 (44.2%), with 14 neonates showing positive results in the blood cultures 
(Table 2). The sensitivity and specificity of the haematological scoring system were 100% and 
82.7%, respectively.
Both positive results of CRP (OR 21.2; 95% CI 2.4−185.9; P < 0.001) and haematological 
scoring system (OR 3.8; 95% CI 1.8–8.1; P < 0.001) were highly associated with the positive 







Female (%)  7 (50.0) 17 (58.6)
Gestational age (%)
<37 weeks  6 (42.9) 20 (68.9)
≥ 37 weeks  8 (57.1)  9 (31.0)
Age on admission (%)
<72 h  6 (42.9) 25 (86.2)
>72 h  8 (57.1)  4 (13.8)
Birth weight (%)
<2500 g  2 (14.2) 20 (68.9)
2500–4000 g 12 (85.7)  9 (31.0)
*Confirmed sepsis is declared when blood culture is positive.
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4 CONCLUSIONS
The incidence of neonatal sepsis between April and August 2015  in Haji Adam Malik 
General Hospital was 33.1%. This study showed that the CRP and haematological scoring 
system were highly sensitive in predicting positive blood cultures, although the scoring sys-
tem showed better specificity. With the lack of a more sensitive tool, such as PCT, to guide 
antibiotic use for patients with suspected sepsis in resource-limited settings, HSS has shown 
excellent sensitivity and specificity in predicting positive blood culture results.
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Table 2. Diagnostic value of CRP & HSS in relation to blood culture results.
Blood culture
Sensitivity Specificity PPV* NPV**Positive Negative
CRP
Positive 13 11 92.8% 62% 54.1% 94.7%
Negative  1 18
HSS
Positive 14  5 100% 82.7% 73.6% 100%
Negative  0 24
*PPV: Positive Predictive Value; **NPV: Negative Predictive Value.
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ABSTRACT: Post-Stroke Depression (PSD), characterised by mood abnormality, self-
blame, and grief, is diagnosed in 40–72% of stroke patients. It can inhibit the healing of 
stroke patients and increase mortality rate. The aim is to investigate the difference in 
C-Reactive Protein (CRP) value between depression levels in ischaemic stroke patients. 
Forty-five consecutive ischaemic stroke patients at Adam Malik and affiliated hospitals 
had their CRP values assessed, and 15 days later, the Beck Depression Inventory (BDI) 
questionnaire was used to classify their depression levels. 51.1% of the PSD patients were 
men aged 60.71 ± 10.3 years old, and 64.4% were smokers and high school graduates. The 
mean CRP level in post-stroke patients with mild depression was 0.7 mg/dl, with moderate 
depression was 3 mg/dl, and with major depression was 9.4 mg/dl. There were significant dif-
ferences in CRP value between depression levels in ischaemic stroke patients (p = 0.001). The 
highest CRP level occurred in cases of severe depression, followed by moderate depression, 
and then mild depression.
Keywords: BDI, CRP, Ischaemic Stroke, Post-Stroke Depression
1 INTRODUCTION
Depression is a mood disorder characterised by sadness, loss of interest or pleasure, guilt, 
trouble concentrating, disturbed sleep, change of appetite, and low energy. This problem can 
be chronic or recurrent (50–65%) and may disrupt a person’s ability to perform daily activities. 
In severe cases, depression can cause a person to commit suicide (Canan et al., 2012).
Stroke is the second leading cause of death after coronary heart disease, and is a 
persistent source of disability worldwide. About 6.7 million people die from stroke every 
year, and it represents 12% of global deaths. As a disease associated with the ageing proc-
ess, stroke prevalence has been rising significantly across the globe in recent years, especially 
in populations over 65 years of age (reaching approximately nine million people per year) 
(Van Eeden et al., 2015).
Post-Stroke Depression (PSD) is one of the most common stroke complications, 
characterised by mood abnormalities, self-blame, and sadness; it is diagnosed in 40–72% of 
stroke patients. PSD is a major factor that can inhibit the healing function of neurologic stroke 
patients and increase mortality. Depression will affect patient behaviours, such as medical 
rehabilitation, smoking, diet, medication adherence, and physical activity. Depression also 
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affects physiological factors such as autonomic nervous system disorders and inflammation 
(Solnek & Seiter, 2002; Schuyler, 2000).
C-Reactive Protein (CRP) is an important biomarker in cardiovascular disease and 
ischaemic strokes. CRP concentrations increase rapidly in people with severe neurological 
deficits. Research by Wang et al. (2017) in China reported that CRP levels were positively 
correlated with the incidence of depression associated with dysfunction of the Hypotha-
lamic-Pituitary-Adrenal (HPA) axis, the involvement of pro-inflammatory cytokines, such 
as TNF-α, IL-6, IL-1 and cortisol, which induce mood disorders that cause the symptoms of 
depression. The inflammatory cytokines circulating in the vessel may also decrease levels of 
serotonin and other neurotransmitters in the brain, and lead to depression (Winbeck et al., 
2002; Kupfer et al., 2013; Craven et al., 1988; Valkanova et al., 2013). This study aims to 
determine the differences in CRP value between different levels of depression in patients with 
ischaemic stroke at Haji Adam Malik Hospital and affiliated hospitals (Universitas Sumatera 
Utara hospital and Pirngadi hospital).
2 METHODS
2.1 Data collection
This cross-sectional study of 45 consecutive PSD patients at Adam Malik Hospital and affili-
ated hospitals from April–July 2017 on ischaemic stroke patients, was based on history finding, 
neurological physical examination, and CT head scan. CRP levels were examined in patients 
with ischaemic stroke and then, on the 15th day, the Beck Depression Inventory (BDI) ques-
tionnaire was used to classify depression levels into mild, moderate and severe depression. The 
inclusion criteria were ischaemic stroke patients with depression, aged over 18 years old, and 
who had signed the informed consent. Ischaemic stroke patients were excluded from this study 
if they had a history of fever before onset, a history of blood disorders or malignancy, had used 
corticosteroids or anti-inflammatory drugs before, or had a previous history of depression.
2.2 Statistical methods
All data was analysed with SPSS statistical software (version 22). Demographic data was 
described as number and percentage. Data with normal distribution is reported as mean ± 
standard deviation, whereas with abnormal distribution is reported with the median value 
(minimum−maximum). Comparison of CRP levels between different levels of depression 
in ischaemic stroke patients is analysed using the Kruskal−Wallis test. When p < 0.05, it 
indicates a statistically significant value.
3 RESULTS
This study followed 45 patients who had met the inclusion criteria: 23 patients (51.1%) were 
male, and 22 patients (48.9%) were female; the mean age of all patients was 60.71 years. The 
majority ethnicity was Bataknese (71.1%). The majority of patients who became respondents 
in this study were entrepreneurs (37.8%), followed by retirees (17.8%), civil servants/soldiers 
(15.6%), and housewives (15.6%). The results of this study showed that 64.4% of patients 
were smokers and 35.6% were non-smoking patients. The mean Body Mass Index (BMI) 
of the respondents was 21.8 kg/m2. The median value of serum CRP was 3.0 mg/dl, with a 
minimum value of 0.2 mg/dl and a maximum value of 21.6 mg/dl.
Based on the characteristics of research subjects in Table 1, it is known that there is no sig-
nificant relationship between sex, age, ethnicity, occupation, education level, smoking status 
and BMI, with depression level in patients with ischaemic stroke, as indicated respectively 
by p-values of p = 0.537; p = 0.909; p = 0.547; p = 0.850; p = 0.866; p = 0.066; and p = 0.271.
Using the Kruskal−Wallis test, Table 2 shows that there was a significant difference of CRP 
value between different levels of depression in ischaemic stroke patients. CRP was highest in 
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Table 1. Characteristics of research subjects.
Characteristic n = 45 p-value
Sex, n (%)
Male 23 (51.1) 0.537
Female 22 (48.9)
Age (mean ± SD) 60.71 ± 10.3 0.909
Ethnicity, n (%)




Entrepreneur 17 (37.8) 0.850
Retiree 8 (17.8)
Civil servant/Soldier 7 (15.6)
Housewife 7 (15.6)
Private employee 4 (8.9)
Unemployed 2 (4.4)
Education level, n (%)
Senior High School 11 (24.4) 0.866
No School 10 (22.2)
College 9 (20)
Primary School 8 (17.8)
Junior High School 7 (15.6)
Smoking status, n (%)

















Mild 0.7 0.2  3.0 0.001*
Moderate 3.0 0.8 19.3
Severe 9.4 2.8 21.6
*p < 0.05.
Figure 1. Boxplot comparison of CRP values between depression levels in ischaemic stroke patients.
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patients with severe depression, followed by CRP with moderate depression, and then CRP 
with mild depression (p < 0.05).
4 DISCUSSION
PSD is a complication of stroke characterised by mood disorder, which will greatly affect 
the outcomes of the medical rehabilitation processes that patients will undergo. There will 
be an increased mortality, and a decrease in the quality of life associated with the inhibition 
of healing processes of neurology and daily activity in stroke patients (Wang et al., 2017; 
Zuidersma et al., 2011).
The results of this study showed that the median CRP levels in patients with post-stroke mild 
depression was 0.7 mg/dl, moderate depression was 3.0 mg/dl, and severe depression was 9.4 
mg/dl. Using the Kruskal−Wallis test, there were significant differences of CRP value between 
different levels of depression in stroke ischaemic patients: CRP levels were significantly higher in 
severe depression, followed by moderate depression, and then mild depression, with p = 0.001.
The inflammatory process after the onset of ischaemic stroke has a complex role in the 
brain ischaemia. Induction of pro-inflammatory genes can occur very early after onset and 
may aggravate tissue damage. Acute phase response is an important mechanism of host reac-
tion to tissue injury, which promotes the severity of organ involved through the mechanism 
of inflammation or thrombosis. This response is triggered by cytokines, and local defence 
cells such as microglia, which are activated and marked with the synthesis of acute phase 
proteins such as pro-coagulants and pro-inflammatories. CRP, globulin and fibrinogen are 
major acute phase proteins, which will trigger the collection/aggregation of erythrocytes. 
CRP will cause a decrease in the production of monoamine agents, affecting turnover of neu-
rotransmitters (a decrease in serotonin, epinephrine, dopamine) and eventually resulting in 
behavioural changes, an impaired atmosphere, and the feeling and presentation of depressive 
symptoms (Miller et al., 2009; Shaikh et al., 2011; Ballantyne et al., 2015; Geng et al., 2016).
Wang et al. (2017) reported that CRP levels were positively correlated with the incidence of 
depression (r = 0.28 with p = 0.003) in 114 patients in China, associated with HPA dysfunction, 
involvement of pro-inflammatory cytokines, such as TNF-α, IL-6, IL-1 and cortisol, which 
cause a mood disorder resulting in the appearance of symptoms of depression. Increased 
inflammatory cytokines circulating in the circulation may also decrease levels of serotonin 
and other neurotransmitters in the brain, and trigger a depression condition (Valkanova 
et al., 2013; Wang et al., 2017).
A cross-sectional study by Brethour et al. (2011) in Alabama reported that high CRP levels 
at the time of ischaemic stroke were a significant predictive factor for the incidence of depres-
sion with p = 0.009, and decreased quality of life for patients with p = 0.002. Another study by 
McKechnie et al. (2010), involving 28 ischaemic stroke patients, showed that a median CRP 
of 16.04 mg/dl (7.12–36.14 mg/dl) was associated with PSD (p = 0.025) (Feng et al., 2014).
Emotional behaviour is governed by neurotransmitters such as monoamine, and monoam-
ine dysfunction can cause various symptoms including depression. This hypothesis explains 
the location of the lesion being the pathogenesis of PSD. Cerebral lesions lead to discon-
nected ascending projections from the midbrain and brainstem, passing thalamus and basal 
ganglia, and reaching the frontal cortex, leading to decreased biogenic amine bioavailability, 
including serotonin (5-HT), Dopamine (DA) and Norepinephrine (NE), and resulting in 
depressive symptoms. The ischaemic lesions that interfere with the ascending axons contain 
biogenic amines from the brainstem to the cerebral cortex, leading to the decreased biogenic 
availability of amines in limbic structures of the frontal and temporal lobes, as well as in the 
basal ganglia. Monoamine theory states that depression is associated with low monoamine 
levels, in particular 5-HT, NE and DA, and the high density of global receptors for Monoam-
ine Oxidase (MAO-A) that metabolises these neurotransmitters. Serotonergic and noradren-
ergic fibres, originating from the brainstem nuclei and conserving the limbic system, the 
prefrontal cortex, and other structures, are associated with mood regulation. The cholinergic 
system, through nicotinic acetylcholine receptors, is thought to be involved in the aetiology 
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of major depression. Mesolimbic dopaminergic dysfunction can cause anhedonia. All of 
these pathways can be cut off  by a stroke lesion, resulting in depression (Valkanova et al., 
2013; Wang et al., 2017; Brethour et al., 2011).
5 CONCLUSION
There was a significant difference in CRP levels between different levels of depression in 
ischaemic stroke patients, in which cases, CRP levels were significantly higher in post-stroke 
severe depression, followed by moderate depression, and then mild depression.
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Management of palpebral epidermoid cyst with Tenzel 
semicircular flap procedure
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Department of Ophthalmology, Faculty of Medicine, Universitas Sumatera Utara, Medan, 
North Sumatera, Indonesia
ABSTRACT: The epidermal cyst is a benign cyst that develops out of the ectodermal 
tissue. The epidermal cyst may have no symptoms. The definitive diagnosis is made after an 
excisional biopsy based on microscopic appearance. A 49-year-old woman presented with a 
painless left lower eyelid mass. Examination revealed a firm, globular mass that was fixed 
to the tarsal plate of the lower eyelid. An excisional biopsy was performed that revealed an 
epidermal cyst. As with epidermal cysts in other locations, surgical excision is the treatment 
of choice. The Tenzel semicircular flap procedure is selected for eyelid reconstruction in this 
case. Histopathologic sections demonstrated a cyst line by a squamous epithelium containing 
keratin, consistent with the diagnosis of an epidermal cyst. The moderately sized epidermal 
cyst of the lower eyelid was successfully managed by surgical excision using the Tenzel semi-
circular flap procedure, which gives the best outcome for palpebral epidermal cysts, especially 
those of moderate size.
1 INTRODUCTION
Epidermoid cysts represent the most common cutaneous cysts. While they may occur any-
where on the body, they occur most frequently on the face, scalp, neck, and trunk (Handa 
et al., 2002).
The term epidermal inclusion cyst refers specifically to an epidermoid cyst that is the result of 
the implantation of epidermal elements in the dermis (Aloi et al., 1993; Barr et al., 1986). Studies 
have suggested that Human Papillomavirus (HPV) and exposure to ultraviolet (UV) light may 
play a role in the formation of some epidermoid cysts (Egawa et al., 1998). Epidermal cysts are 
benign slow-growing tumours, resulting from the proliferation of epidermal cells. A cyst of the 
eyelid typically presents during adolescence and late adulthood, as a solitary, elevated, round, 
freely mobile subcutaneous mass with smooth overlying skin (Swygert et al., 2007).
Epidermoid cysts are usually asymptomatic; however, they may become inflamed or sec-
ondarily infected, resulting in swelling and tenderness (Braun-Falco, 2000). Here we are 
reporting a case of an epidermal cyst of the upper eyelid.
A reconstructed lid requires three main elements: an outer layer of skin, an inner layer 
of the mucosa, and a semirigid skeleton between the two. The lid should be well-opposed to 
the globe, with neither entropion nor ectropion. The tumours of the lid necessitate careful 
judgement and planning to provide the therapy. The choice of treatment depends on several 
factors. Among these are the type, size and location of the lesion, with particular emphasis 
on the possible involvement of any adnexal structures (Stewart, 1994).
2 CASE
A 49-year-old female patient visited H. Adam Malik Hospital with a left lower eyelid mass. 
The patient gave the history of this swelling for last two months, for which she had been 
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treated elsewhere. There was no associated pain or redness. There was no history of any 
ocular trauma. On examination, the right upper eyelid showed a large round swelling of 
around 1.6 cm in diameter. On palpation, the swelling was well-defined, cystic but firm in 
consistency, and was free from skin and bony margins. There was no sign of inflammation, 
and the overlying skin was normal. The posterior segment was normal. Examination of the 
right eye was normal. We planned for the surgery, keeping in mind that the cyst was an epi-
dermal cyst. Repair of lower eyelid defects involving the eyelid margin, and extending from 
two thirds of the horizontal length of the eyelid margin, require advancement of adjacent 
tissue to effect the closure.
The author’s choice to repair defects of moderate size (size defect 33%–75%) is the Tenzel 
semicircular rotation flap procedure, with minimal disturbance of the periorbital tissues and 
provision for adequate lid support.
A pentagonal-wide excision was required to remove the mass, including the margin of the 
left lower eyelid.
Reconstruction of the lower eyelid commenced with a semicircular incision, beginning 
at the lateral canthus, then curving superiorly and temporally. The diameter of the flap was 
about 3 cm, or twice the size of the defect. The flap was undermined subcutaneous widely 
to allow closure. A lateral canthotomy was performed, and the inferior limb of the lateral 
canthal tendon, the orbital septum, and the retractors were severed to allow maximal rota-
tion movement. The tarsus, grey line, lid border was closed. Closure the lid margin, the tarsus 
was closed with 5–0 VICRYL, 5–0 PROLENE was passed at the grey line, and skin with 6–0 
PROLENE.
The lateral canthal angle newly formed lid was splinted with a deep 5–0 VICRYL. Enough 
tension should be placed on the lower eyelid to prevent laxity. The skin flap was anchored to 
the periosteum of the lateral orbital rim. The tissue of the lateral canthal was then sutured 
Figure 1. A lower eyelid mass, 1.5 cm in diameter.
Figure 2. Closure of the lateral canthal area.
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with 5–0 VICRYL and the skin closed at the lateral canthal area with 6–0 PROLENE. Anti-
biotic ointment was applied to the eye being operated upon. Two days after the operation, the 
patient was discharged from hospital.
Five days after the operation, the patient returned to H. Adam Malik Hospital. We evalu-
ated the left eye. The sutures were good, there was no bleeding or pus, and the swelling of the 
inferior eyelid was reduced.
All sutures were removed after seven days, except for the lid margin sutures, which were 
left in place for 14 days. Histopathological examination revealed that the incised mass was 
an epidermal cyst.
3 DISCUSSION
Various mechanisms have been proposed for epidermoid cyst formation. It can be due to 
occlusion of the pilosebaceous follicles or surface epidermis, or can be due to implantation 
of epidermal elements that may be because of trauma or surgery. However, in recent studies 
human papillomavirus has been associated, but it is more commonly associated with epider-
moid cysts of a plantar surface (Egawa et al., 2005).
The small asymptomatic epidermoid cyst can be managed with intralesional triamcinolone 
injection. Incision and drainage may be performed if  a cyst wall is inflamed. Injection of 
triamcinolone into tissue surrounding the inflamed cyst results in faster improvement of the 
symptoms. However, it does not eradicate the cyst. The large symptomatic cyst should be 
excised in total, as in our case (Lucarelli et al., 2008).
4 CONCLUSION
A moderately sized epidermal cyst of the lower eyelid was successfully managed by surgical 
excision using the Tenzel semicircular flap procedure. The Tenzel semicircular flap procedure 
gives the best outcome for the palpebral epidermal cyst, especially for those of moderate 
size.
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The correlation between smoking and olfactory function 
using Sniffin’ Sticks test
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ABSTRACT: This was an analytical observational study with a cross-sectional design, 
to determine the correlation between smoking and olfactory function. The population in 
this study is all employees, staff, residents, and family of patients present in the Ear, Nose 
and Throat Department, Haji Adam Malik Hospital in September 2016. Subjects had to be 
between 20–50 years old, currently smoking cigarettes, and not meet the following exclu-
sion criteria: a medical history of recent viral infection, nasal/sinus surgery, nasal/brain 
tumours, head trauma, radiotherapy, chronic rhinitis in exacerbation, or tracheostomy. Out 
of 45 smokers, the proportion of olfactory dysfunction was 37.8%, while 62.2% did not suffer 
from olfactory dysfunction. The Threshold, Discrimination and Identification (TDI) score 
average was 30.80, with the lowest score average of 22.12 and the highest of 40. The results 
of this study indicate a significant correlation (p < 0.05) with olfactory dysfunction between 
the number of sticks per day and the number of years smoking.
Keywords: Smokers, Sniffin’ Sticks
1 INTRODUCTION
The sense of smell is one of the several special senses that are essential for health (Shu et al., 
2007). Olfactory disturbances can affect a person’s safety (e.g. not being able to detect stale 
food, or smoke from a fire) and discomfort to the body itself, because the scent cannot be 
perceived, which sometimes affects the hygiene of a person (Hummel et al., 2010). Smoking is 
a risk factor for the smell dysfunction disorder. Many types of research suspected that there 
were side effects of smoking on the ability to sniff  (Katotomichelakis et al., 2007).
The biological basis for decreased olfactory abilities associated with smoking is unclear. 
Inflammation and trigeminal stimulation due to exposure to cigarette smoke may inhibit the 
activation of the olfactory nerve and, in turn, odour perception. Long-term effects of smok-
ing on the sense of smell may be caused by the influence of chemicals contained in cigarette 
smoke on the olfactory receptor cells in the olfactory mucosa. The role of apoptosis, the cel-
lular mechanism responsible for the clearing of dead cells, can be triggered by a response to 
trauma. Some studies have shown an increase in apoptosis in olfactory nerve sinusitis and in 
ageing, but it is also found in animals exposed to tobacco smoke. Apoptosis is mediated by 
the caspase-3 enzymes, which show an increase in the epithelial activity of animals exposed 
to cigarette smoke, representing apoptotic cell death in the olfactory nerve. It has been men-
tioned as a cause of a loss of ability to smell (Katotomichelakis et al., 2007; Ishimaru & Fujii, 
2007; Danielides et al., 2009).
The Sniffin’ Sticks tools are an examination of nasal chemosensory function by using a 
pen-shaped tool that can emit odours. This examination consists of threshold scrubbing, 
discrimination of smell, and identification of smell. The result of these three subtests is the 
Threshold, Discrimination and Identification (TDI) score, which ranges from 0 to 48, with 
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values ≤15 with anosmia, ≥ 30 for normosmia, and 16–29 for hyposmia (Orhan et al., 2011). 
This study aims to determine the correlation between smoking and olfactory function.
2 SUBJECTS AND METHOD
This research is an observational analytic research with the cross-sectional method to assess 
TDI for smokers at the Ear, Nose and Throat (ENT) polyclinic in Haji Adam Malik General 
Hospital, Medan, by using the Sniffin’ Sticks extended test.
The research subjects chosen were smokers aged 20–50 years, performed history taking the 
procedure, routine examination of ENT, and who were willing to participate in the study by 
signing a letter of approval. The male and female inclusion criteria were: aged 20–50 years, 
having no sinonasal disease, no history of nasal trauma, no history of nasal surgery, no 
masses and polyps in the nasal cavity, and willing to participate in the study. The criteria for 
the exclusion of subjects was those who at the time of examination did not understand the 
instructions from the examiner.
3 RESULTS
Table 1 presents the results of the Sniffin’ Sticks examination on all subjects. The mean of 
the subjects’ threshold is 6.15 (SD = 3.48), with the smallest threshold value of 3.25, and 
the largest of 23.75. The mean discrimination value is 12.54 (SD = 2.32), with the smallest 
discrimination value of 3.8, and the largest of 16. The average identification value is 12.67 
(SD = 1.72), with the smallest identification value of 7, and the largest of 15.5. The average 
value of TDI is 30.79 (SD = 3.54), with the smallest discrimination value of 22.12, and the 
largest of 40.
Table 2 presents the total mean number of sticks per day by subjects with olfactory dysfunc-
tion. There are as many as 11.06 sticks per day, with SD = 5.73 sticks per day. However, those 
subject groups who did not have any olfactory dysfunction had a mean total cigarette con-
sumption of as many as seven sticks per day, with SD = 4.97 sticks per day. The mean score for 
number of years smoking in subjects with olfactory dysfunction is 10.41 years, with SD = 4.36 
years. As for the group of subjects who did not have any olfactory dysfunction, the mean score 
for the number of years smoking is 7.21 years, with SD = 5.28 years. That is, the number of 
sticks per day p = 0.008 (p <0.05), and number of years smoking p = 0.007 (p < 0.05).
Table 1. Olfactory function in relation to smoking.
Mean Median SD Min–Max
Threshold  6.15  5.25 3.48 3.25–23.75
Discrimination 12.54 13 2.32 3.8–16
Identification 12.67 13 1.72 7–15.5
Composite TDI score 30.79 31 3.54 22.12–40
Table 2. Relationship between olfactory dysfunction and number 
of sticks per day and number of years smoking.
Olfactory dysfunction
p*Yes No
Number of sticks per 
day, mean (SD)
11.06 (5.73) 7 (4.97) 0.008
Number of years smoking, 
mean (SD)
10.41 (4.36) 7.21 (5.28) 0.007
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Based on the analytics using the Mann−Whitney test, it was found that there was a signifi-
cant relationship between olfactory dysfunction and the number of sticks per day and the 
number of years smoking.
4 DISCUSSION
4.1 Olfactory function in relation to smoking
From this research, the average score of TDI is 30.80, with the lowest mean of 22.12 and the 
highest of 40. The same thing was also found in Katotomichelakis et al. (2007), where the 
numbers obtained were almost the same; that is, the average value of TDI in smokers is 36.3, 
the lowest 34.3, and the highest 38.3. Thus, in this study the scores of TDI subject smokers 
are still within the normal range.
4.2  Correlation between olfactory dysfunction and number of sticks per day 
and number of years smoking
The results of this study indicate that the average of the number of sticks per day is as much 
as 8.53  sticks, with the smallest consumption of two sticks, and the highest of 23  sticks. 
Katotomichelakis et al. (2007) found that the average number of sticks per day was 15 sticks, 
with a smallest number of five sticks, and a highest of 20 sticks.
The results of this study indicate that the average number of years smoking in the subjects 
is 8.42 years; the shortest consumption is two years and the longest is 23 years. In Japan, 
Katotomichelakis et al. (2007) found that the average number of years of smoking was ten, 
with a shortest time of one year, and a longest time of 45 years.
The results of this study indicate a significant correlation (p <0.05) with olfactory dys-
function between the number of sticks per day and the number of years smoking. Frye et al. 
(1990) found that the correlation between olfactory dysfunction and number of sticks per 
day and number of years smoking, was statistically significant, with p-value of 0.03. The 
same was also reported by Da Silva and Panganiban (2006), who had a similar result in which 
the number of sticks per day and the number of years smoking had a significant correlation 
with olfactory dysfunction, with p-value of 0.019.
This is based on the fact that smoking has a dose−response relationship to the disturbance 
of smell (Vennemann et al., 2008). Long-term effects that can be caused by chemicals con-
tained in cigarettes (acrolein, acetaldehyde, ammonia, and formaldehyde), can cause damage 
to receptors and mucous membranes, which occur in dose-related patterns (Frye et al., 1990).
5 CONCLUSION
This study proved that there was a statistically significant correlation (p <0.05) with olfac-
tory dysfunction between the number of sticks per day and the number of years smoking. 
A case-control comparison, the inclusion of older age groups, and a larger study population 
can further strengthen the understanding of the association between smoking and olfactory 
dysfunction.
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ABSTRACT: Diabetes Mellitus (DM) is a disease for which treatment is expensive, therefore 
many researchers are looking for a cheap and effective treatment. The aim of this study is to 
evaluate the effect of andaliman fruit extract to blood glucose level of mice with type 1 diabe-
tes. The study was conducted on 25 male mice. The mice were divided into five groups. Every 
group was injected with alloxan intraperitoneally and treated with aquades, andaliman extract 
and metformin for 15 consecutive days. The results showed that administration of andaliman 
extract with doses of 100, 200 and 300 mg/kg decreased the blood glucose levels significantly 
compared to the negative control group (p ≤ 0,05). Andaliman extract of 100 and 200 mg/kg 
were not significantly different from the positive control group (p ≥ 0,05). Blood glucose levels 
of mice with DM type 1 were decreased after andaliman extract was administered.
Keywords: andaliman fruit, type 1 diabetes mellitus, blood glucose level, alloxan
1 INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic diseases characterised by hyperglycaemia 
which is caused by the disability of insulin secretion, insulin performance or both. Insulin 
is a hormone produced by beta cells in the pancreas which are needed to use glucose from 
digested food as a source of energy. Chronic hyperglycaemia in diabetes is associated with 
long-term damage, dysfunction or failure of several different organs, especially the eyes, kid-
neys, nerves, heart and blood vessels (American Diabetes Association, 2012).
The prevalence of DM is increasing rapidly worldwide and the World Health Organization 
has predicted that by 2030 the number of adults who suffer from diabetes will have increased 
twofold throughout the world, from 117 million people in 2000 to 370 million people. The 
experts observed that the incidence of diabetes will soar 65% by 2025, which means that 
53.1 million people will be affected by this disease (Ozougwu et al., 2013).
The ability of developing countries to treat DM is doubtful because patent medicines for 
patients with DM are increasingly diverse. The cost for the treatment of diabetes is also more 
expensive and thus not affordable so funding and management that is cheap and effective 
are needed (Subroto, 2006, p. 16). The prevalence of the use of herbal medicines in conjunc-
tion with synthetic drugs is influenced by the relationship between demographic and socio-
economic characteristics of the community. This is a powerful reason to examine the use of 
herbal medicines in health, including for people with DM (Adibe, 2009).
Andaliman fruit (Zanthoxylum acanthopodium DC) derived from the rutaceae family is 
a typical plant found in North Sumatra, Indonesia. The fruit is commonly used as a spice in 
traditional cooking of the Batak tribe (Siregar, 2002).
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From the phytochemical test conducted by Tensiska (2001), it was found that andali-
man fruit contains flavonoids and polyphenols that have antioxidant activity of  through 
an antioxidant test with ransimat method. Flavonoids are also reported to have inhibi-
tory activity against α-glucosidase enzymes. The activity of  α-glucosidase inhibitors and 
antioxidants are the two things that affect DM (Suarsana et al., 2010). The seeds of  most 
andaliman fruit are rich in oil that contains alkaloids in large quantities as well as unsatu-
rated fatty acids which have antioxidant activity (Gupta and Mandi, 2013).
Therefore, andaliman fruit as a medicinal herb to treat DM will be examined.
2 METHOD
Twenty-five male mice weighing 20–35 g had fasted and weighed, fasting blood glucose level 
are measured, each mice induced by alloxan dose of 125 mg/kg bw intravenously. The mice 
were fed as usual, and their behaviour and body weight observed; they were considered dia-
betic when their fasting blood glucose levels ≥200 mg/dL (Ozougwu, 2013). The mice can be 
used for examination.
The rats were randomly divided into five groups. The negative control group was given 
aquades, the next group was given andaliman extract in quantities of 100, 200, 300 mg/kg bw 
and the positive control group was given 65 mg/kg bw of metformin. Each group consists of five 
rats. Every group was injected with alloxan intraperitoneally and treated for 15 consecutive days. 
The blood glucose level was observed with a glucometer on the 3rd, 6th, 9th, 12th and 15th days.
3 RESULTS AND DISCUSSION
The results of data analysis showed that there were significant differences between blood 
glucose level before and after induction of alloxan 125 mg/kg bw in all test groups (p ≤ 0,05).
From the test results, the test group dose of 100, 200 mg/kg bw and positive controls show a 
decrease in blood glucose level from the third day and a decrease in the average blood glucose 
level to normal on day 15. The test group dose of 300 mg/kg bw and control negative did not 
show a decrease in blood glucose level on the third day; the blood glucose level in the test group 
dose of 300 mg/kg bw began to be seen on the 6th day and showed a decrease to the normal 
range on the 15th day. The negative control group showed an increase of blood glucose level on 
the 3rd, 6th and 9th days and a decline in blood glucose level on the 12th and 15th days.
The metformin dose of 65  mg/kg bw showed a decline of blood glucose level on the 
third day and a decrease in the average blood glucose level to normal on the 15th day. 
Provision of distilled water as a control group also decreased, but is still in the category of 
Table 1. Comparison of blood glucose level before and after induction of alloxan 125 mg/kg bw.
No Test group n
Blood glucose level before 
induction of alloxan 
Mean ± SD (mg/dL)
Blood glucose level after 
induction of alloxan 
Mean ± SD (mg/dL) P Value
1 K(−)  5 112,6 ± 12,64 258 ± 44,74 0,001*
2 D1  5 69,6 ± 15,85 348,8 ± 115,28 0,003*
3 D2  5 67,4 ± 21,65 379,8 ± 132,59 0,006*
4 D3  5 94 ± 26,96 304,4 ± 67,60 0,003*
5 K(+)  5 114,6 ± 25,58 396,4 ± 121,88 0,009*
Total 25
*K(−)  =  Negative control group (aquades), D1  =  andaliman fruit extract dose 100  mg/kg bw, 
D2 =  andaliman fruit extract dose 200 mg/kg bw, D3 =  andaliman fruit extract dose 300 mg/kg bb, 
K(+) = Positive control group (metformin dose 65 mg/kg bw).
*Significant (p ≤ 0,05).
ISCOC17_Book.indb   96 3/21/2018   2:04:14 PM
97
diabetes (≥200 mg/dL). A decrease in blood glucose levels in the negative control group was 
supported by the regeneration of beta cells of Langerhans of the pancreas that are not bro-
ken down entirely so that they can secrete insulin (Diandra, 2011).
It is known that a dose of 100 mg/kg bw has the highest reduction percentage compared 
to the 200 and 300 mg/kg bw dose test group. Blood glucose level decreased at doses of 100 
and 200 mg/kg bw and the positive control group did not differ much. On the 6th day, the 
dose of 300 mg/kg bw had the lowest reduction percentage compared to doses of 100 and 
200 mg/kg bw.
Although blood glucose level reduction effects should strengthen with an increase in dose, 
the results of the analysis showed that increased doses of andaliman fruit extract were not fol-
lowed by increased blood glucose level reduction effects in mice. This is presumably because 
it has saturated the receptors that it binds to in the interaction with bioactive chemical com-
pounds contained in fruit andaliman. If  the receptor has been saturated, the increased dose 
will not reach the maximum effect (Katzung, 2002).
Reduction of blood glucose level with andaliman fruit extracts can be caused by the pres-
ence of terpenoids, steroids and phenolic as well as their antioxidant activity. The result of 
identification with IR and UV-Vis showed that the main active compounds in the andaliman 
fruit are α-glucosidase inhibitors, antioxidants and flavonoids (class Auron) and flavanones 
(Gultom, 2011).
4 CONCLUSIONS
The results showed that andaliman fruit extract can lower blood glucose levels of mice mod-
els of DM type 1 induced by alloxan 125 mg/kg bw; and the andaliman fruit extracts dose of 
100 mg/kg bw has the highest percentage reduction of blood glucose level.
Based on the results obtained from the studies that were conducted, further research is 
advised using larger samples and a variation of a larger dose and longer duration of admin-
istration to establish the optimal dose of andaliman fruit extracts that is antidiabetic. In 
addition, there should be further research to investigate the side effects of andaliman fruit 
extracts on the organs of mice in order to ascertain whether the andaliman fruit extract is 
safe for use as an herbal medicine.
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Association of birth weight and body mass index with cognitive 
function at Singkuang
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ABSTRACT: Children with Low Birth Weight (LBW) have a generally increased incidence 
of neurological deficits or cognitive impairment during childhood compared with normal birth 
weight. Otherwise, that can affect cognitive function is a Body Mass Index (BMI). The purpose 
of this study was to determine the relationship between birth weight and BMI and cognitive 
function in children in primary school at Singkuang. A cross-sectional study was conducted in 
a primary school at Singkuang. The assessment of a child’s cognitive function with the Mini 
Mental State Examination (MMSE). The results of this study indicate a significant association 
between birth weight and cognitive function (P = 0.0001). There is no relationship between 
BMI and cognitive function in children in primary school at Singkuang (P = 0.356).
There was a significant association between birth weight and cognitive function, and no 
association between BMI and cognitive function in children.
Keywords: body mass index, birth weight children, cognitive function
1 INTRODUCTION
Birth weight is considered to be one of the most important determinants of a child’s health 
and survival and is seen as a good indicator of birth and lifelong health (Ayu, 2013). At 
present, one in ten infants in Indonesia are born with a low birth weight (LBW) of less than 
2,500 grams. Previous research has shown that 35.6% of infants are born with a birth weight 
of less than 3,000 grams and 9.3% of infants with a birth weight of less than 2,500 grams 
(Karima, 2012).
Low birth weight babies (LBW) are still a problem in almost all countries. The World 
Health Organization (WHO) recorded that about 15% of live births in the world are LBW, 
with 6% of LBW incidence occurring in developed countries and 30% in developing coun-
tries (Simbolon, 2013). Based on the data of the number of babies born with LBW in 2007, 
LBW infants accounted for 295 out of 25,185 babies born. The incidence of LBW in hos-
pitals in Indonesia is around 20%. In West Java regional referral centres each year record 
between 20–25% birth of LBW, while in rural areas the figure is 10.5%. In rural areas, most 
LBW die in the neonatal period (Risnah, 2009). Birth weight is considered to be one of the 
most important determinants of child health and survival and is seen as a good indicator 
of birth and lifelong health (Ayu, 2013). At present, one in ten infants in Indonesia is born 
under low birth weight (BBLR) is less than 2,500 grams. Previous research has shown that 
35.6% of infants born with birth weight are less than 3,000 grams and 9.3% of infants born 
with birth weight less than 2,500 grams (Karima, 2012).
Low birth weight babies (LBW) are still a problem in almost all countries. WHO recorded 
about 15% of live births in the world are BBLR, 6% of LBW incidence in developed coun-
tries and 30% in developing countries (Simbolon, 2013). Based on the data of the number of 
babies born with BBLR in 2007, LBW infants accounted for 295 out of 25,185 babies born. 
The incidence of LBW in hospitals in Indonesia is around 20%. In West Java regional referral 
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centres each year between 20–25% birth of LBW, while in rural areas 10.5%. In rural areas, 
most LBWs die in the neonatal period (Risnah, 2009).
According to WHO, LBW is closely related to neonatal mortality and morbidity, stunted 
growth and cognitive development, and chronic later disease (Setyo, 3013). Cognitive devel-
opment consists of aspects of development including language and motor visual components 
(Dharmayanti, 2009). Cognitive function—often called cognition—is defined as a broad 
understanding of thinking and observing. In addition, cognitive function is also seen as a 
broad and inclusive concept that refers to the mental activities involved in the acquisition, 
processing, organisation and use of knowledge (Sayodi, 2016). Children with LBW exhibit 
lower academic scores than normal birth weight children, whose value is significant at the age 
of one year (Sherman, 2016).
Another factor which can affect cognitive function is body mass index (BMI). Measure-
ments and assessments using BMI are associated with deficiency and excess of nutritional 
status (Adithya, 2016). Children with a low BMI for more than three years’ experience an 
impairment of the development of cognitive function (Sherman, 2016). Referring from the 
results of the above research then conducted research on the relationship between birth weight 
and BMI with cognitive function in elementary schoolchildren in the Singkuang district.
2 MATERIALS AND METHOD
2.1 Population and sample
The study population is elementary schoolchildren in the village of Singkuang. The sample 
in this study is part of an affordable population that complies with the inclusion and exclu-
sion criteria selected by consecutive sampling.
2.2 Data analysis
Data analysis was conducted by Chi-square to determine the relationship between categori-
cal variables, with a significance level at p < 0,05. Data processing was through the use of a 
computer program.
3 RESULTS
The study was conducted in Singkuang village, Mandailing Natal Regency, North Sumatera. 
The total sample included in this study was 98 children who were in accordance with the 
inclusion and exclusion criteria. The female sex slightly dominated with a proportion of 
33.3%.
The study also found that the majority of children have an underweight BMI. This study 
shows the association of birth weight with cognitive function in elementary schoolchildren in 
Singkuang village. The result of statistical test with a Chi-square test was a P value = 0.0001 
which shows there is a significant correlation between birth weight with cognitive function 
in elementary schoolchildren in Singkuang village. In this study also showed relationship of 
Table 1. Birth weight with cognitive function.
Birth weight
Cognitive function screening
Total P ValueNormal Disturbance
Normal 48  5 53 0,0001
Low 25 20 45
Total 73 25 98
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BMI with cognitive function in elementary schoolchildren in Singkuang village. The result 
of statistical test with a Chi-square test was a P value = 0,356 where there is no correlation 
between BMI and cognitive function in elementary schoolchildren in Singkuang village.
4 DISCUSSION
This study showed that the percentage of LBW was higher than normal birth weight in 
elementary schoolchildren in Singkuang village. Previous research in Nepal has a relatively 
high prevalence of LBW, ranging from 14% to 32% (Maleqpour, 2004). The Ministry of 
Health of the Republic of Indonesia states that from 2005 to 2006 there was an increase in 
the prevalence of LBW by 24.3 per 1,000 live births to 25.9 per 1,000 live births. One of the 
main causes of high infant mortality is LBW (<2,500 grams). One of the efforts to try and 
tackle the problem of LBW is to assess the condition of the mother and various factors that 
affect her condition when pregnant. In general, level of education is a factor that affects birth 
weight, because the level of education can describe a person’s level of knowledge about a 
matter related to health maintenance (Adi et al., 2015).
The study also found that the majority of children have an underweight BMI. In 2010, 
3.7 million elementary schoolchildren had an underweight body mass. The majority of BMT 
underweight can be caused by risk factors from the development of body mass, one of which 
is that the problem of malnutrition is also higher in low income communities than people who 
have higher incomes. The nutritional deficiencies found in primary schoolchildren are lack 
of protein and less nutritional problems can not be overcome, especially in primary schools 
in poor and underdeveloped areas. A person’s nutritional knowledge level affects attitudes 
and behaviours in choosing foods, which determine whether or not a person understands the 
nutritional benefits of the food consumed (Yudesti & Prayitno, 2013).
This study shows the association of birth weight with cognitive function in elementary 
schoolchildren in Singkuang village. The result of statistical test with Chi-square test was a 
P value = 0.0001 which shows there is a significant correlation between birth weight to cognitive 
function in elementary schoolchildren in Singkuang village. One of the effects of LBW is the 
slow growth of children seen in weight gain that does not reach normal levels when they are one 
year old. In addition, LBW is very susceptible to deficiencies and disturbances in the balance 
of various nutrients, making the child susceptible to permanent damage in physical and mental 
growth (Abadi et al., 2013). Many children who start life with a very LBW have problems when 
they start school. Other impacts of LBW include inability to focus on learning, visual-motor 
disturbance, answering skills of lower questions, and poor motor skills (Malekpour, 2004).
This study also showed the relationship of BMI to cognitive function in elementary 
schoolchildren in Singkuang village. The result of statistical test with Chi-square test was a 
P value = 0,356 where there is no correlation between BMI and cognitive function in elemen-
tary schoolchildren in Singkuang village. Lower BMI (underweight) and obesity tend to have 
lower cognitive scores (Julia et al., 2009). The results of this study may possibly be because 
the condition of cognitive function of children is influenced by environmental factors, includ-
ing education in schools and community culture. This causes the child to be less motivated 
to learn new information and the potential of the child does not develop to the maximum, 
so not only the condition of cognitive function is influenced by the mass weight of the child.
Table 2. Body mass index with cognitive function.
Body mass index
Cognitive function screening
Total P ValueNormal Disturbance
Underweight 38 16 54 0,356
Normal 35  9 44
Total 73 25 98
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5 CONCLUSION
From the results of this study it can be concluded that the initial screening of cognitive 
impairment with its relation to LBW and nutritional status is that there is a relationship 
between birth weight and cognitive function in elementary schoolchildren in Singkuang vil-
lage with a P value 0.01; and no relationship between BMI and cognitive function in elemen-
tary school children in Singkuang village, with a P value 0.356.
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Herbal medicine induces circulation and proliferation of 
Endothelial Progenitor Cell (EPC)
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ABSTRACT: Endothelial Progenitor Cells (EPC) can differentiate into mature endothelial 
cells as well as play a crucial role in the protection and improvement of vascular endothe-
lium. Based on multivariate regression analysis, there was a strong correlation between the 
number of circulating EPC and the subjects’ combined Framingham risk factor score. In 
hyperglycaemia, endothelial damage could occur over time, which may cause both micro- 
and macro-angiopathic complications. The number of EPC was reduced and was inversely 
related to levels of glycated haemoglobin (HbA1c) and type 2 diabetes mellitus. Additionally, 
hypercholesterolemic patients had lower EPC score compared to control subjects.
Keywords: endothelial progenitor cell, herbal medicine, proliferation
1 INTRODUCTION
Endothelial Progenitor Cell (EPC) is a type of stem cell with more limited ability in prolif-
eration and differentiation. This cell is unipotent, which can differentiate into the mature 
endothelial cell. EPC has an important role in the formation of blood vessels and the remod-
elisation of endothelial cells on damaged blood vessels (Frisca, Sardjono & Sandra, 2008; 
Nababan et  al., 2007). EPC is defined as a part of Mononuclear Cells that has molecule 
haematopoietic stem cell markers. The markers are: Cluster of Differentiation (CD)34, a 
glycoprotein mediating stem cell adhesion at bone marrow extracellular matrix; CD133, a 
molecule marker for more primitive stem cells; and Kinase Insert Domain Receptor (KDR), 
a protein that plays a crucial role in stimulating proliferation, formation of new blood vessels 
and angiogenesis (Frisca et al., 2008, 2010; Nababan et al., 2007; Sandra et al., 2010).
EPCs can be isolated from multiple sources, with the number of EPCs <1% in total in 
bone marrow and <0.01% in peripheral blood (PB) circulation (Frisca et al., 2008, Nababan 
et al., 2007). While the amount of EPC needed for use in human adult therapy is quite large 
in number, it is reported that it takes approximately 3–6 × 108 EPCs (Frisca et al., 2008). 
Therefore, it is necessary to increase the number of EPC. Expansion methods that have been 
developed are adherence assay using fibronectin, preplating or serial discarding with different 
induction of cytokines (Nababan et al., 2007).
Herbal medicine has been known to have potential in treating cardiovascular disease. For 
example, digoxin and digitoxin, derived from Digitalis lanata and Digitalis purpurea; reser-
pine, derived from Rauwolfia serpentina; and acetylsalicylic acid, derived from the willow bark 
(Liperoti et al., 2017). In cellular experiments, the herbal medicine was shown to have effects 
related to EPCs (Cai et al., 2013, Chen, Zhu & Zhang, 2013; Gao et al., 2010; Iijima et al., 2013; 
Lizandi et al., 2010; Lu et al., 2009; Tam et al., 2015; Widowati et al., 2012, 2014, 2016; Zhao, 
Li & Kong, 2014). In this article, various herbal medicines with their properties in EPC will be 
disclosed.
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2 EPC IN CARDIOVASCULAR DISEASE (CVD)
Circulating EPC (CEPC) which is derived from bone marrow, can differentiate into mature 
endothelial cells as well as play a crucial role in the protection and improvement of vascular 
endothelium. The number of CPEC has been correlated with various factors. Based on mul-
tivariate regression analysis, there was a strong correlation between the number of CEPC and 
the subjects’ combined Framingham risk factor score (Aragona et al., 2016; Hill et al., 2003). 
In smokers, the EPC count was correlated with a total number of risk factors and based on 
the individual risk factors analysis; smoking determined the numbers of CEPC (Aragona 
et al., 2016; Vasa et al., 2001). CEPC were significantly lower in smokers with coronary artery 
disease (CAD) compared to controls and non-smokers with CAD (Aragona et al., 2016; Yue 
et al., 2010).
Hyperglycaemia-induced endothelial damage over time may cause both micro- and 
macro-angiopathic complications (Aragona et al., 2016; Brownlee, 2005). The number of cul-
tured EPC was reduced and was inversely related to levels of glycated haemoglobin (HbA1c) 
(Aragona et al., 2016; Loomans et al., 2004) and Type 2 Diabetes Mellitus (T2DM) (Aragona 
et al., 2016; Egan et al., 2008). EPC levels are low in diabetic populations both with/with-
out vascular complications, therefore the EPC maturation/commitment process could be the 
cause, and not due to the EPC production/mobilisation failure from bone marrow (Aragona 
et al., 2016; Lombardo et al., 2012).
The EPC score was significantly lower in hypercholesterolemic patients when compared to 
control subjects (Aragona et al., 2016; Zhu et al., 2004). In an in vitro study, the exposure of 
cultured EPC to oxidised LDL induced a dose-dependent impairment of EPC activity. The 
impairment accelerated the rate of cell senescence and could be associated with a significant 
reduction in EPC numbers in vivo (Aragona et al., 2016; Imanishi et al., 2004).
3 HERBAL MEDICINE INCREASES NUMBER OF CEPC
There are experiments that show herbal medicine can increase the amount of CEPC and 
improve the function of CEPC which accelerates neovascularisation and re-endothelialsation 
in injured vessels. Among them, Xuezhikang, an extract of cholestin, was shown to increase 
CEPC. In a clinical study, after the treatment, CEPC in the Xuezhikang group (114.40 ± 6.55) 
was significantly higher than that in the antihypertensive drug treatment group (88.00 ± 6.32, 
p < 0.01) (Lu et al., 2009). Besides Xuezhikang, Tongguan capsule, a Chinese herbal prepara-
tion for supplementing qi and activating blood circulation showed an increase of CEPC as 
well. The number of EPC in the PB increased in the treatment group in comparison to the 
control group who were treated with placebos (p < 0.05). Also, the left Ventricular Ejection 
Fraction (LVEF) and Wall Motion Score Index (WMSI) was better in the Tongguan capsule-
treated group than in the control group (p < 0.05) (Chen et al., 2013).
There are other herbal medicines that can induce the number of CEPC. Salvianic acid A, 
salvianolic acid B, and tanshinone IIA all increased the number of CEPC in the PB as well 
(Zhao et al., 2014). NF3, a Chinese 2-herb formula could significantly enhance the circulat-
ing CD34+/Vascular Endothelial Growth Factor (VEGFR)2+/CD45− EPC levels in diabetic 
foot ulcer rats by 60% (p < 0.05) through the partial elevation of Stromal Cell-Derived Factor 
1 alpha (SDF-1α) (Tam et al., 2015).
4 HERBAL MEDICINE INCREASES PROLIFERATION OF EPC
Lycopene also significantly accelerates EPC proliferation in a time- and dose-dependent 
manner (Zhao et  al., 2014). Regarding Xuezhikang, EPC proliferation capability in the 
Xuezhikang group (0.415 ± 0.018) was superior to those in the antihypertensive drug treat-
ment group (0.333 ± 0.021, p < 0.01) (Lu et al., 2009). Studies on cultured EPC showed that 
ligustrazine, 3,4-dihydroxyacetophenone, breviscapine, and puerarin significantly stimulated 
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the number of Clonal Formation Units (CFU) in a time- and dose-dependent manner (Zhao 
et  al., 2014). Treatment with Saiko-Ka-Ryukotsu-Borei-To (SKRBT), a traditional herbal 
medicine that has been applied to treat stress-related neuropsychiatric disorders, increased 
EPC colony numbers significantly (p < 0.05) (Iijima et al., 2013).
A study in Curcuma longa L. and (-)-Epigallo Catechin-3-Gallate (EGCG) has shown 
that both these antioxidants, C. longa and EGCG, could enhance proliferation of Adipose-
derived Mesenchymal Stem Cell (AD-MSC)-derived EPC. The highest proliferation rates 
were achieved by induction of C. longa in concentrations of 1 μg/mL, while induction of 
EGCG in a concentration of 0.25 μg/mL (Widowati et  al., 2012). Meanwhile, β-carotene 
in the concentration of 20 μg/mL can also induce a proliferation of AD-MSC-derived EPC 
(Widowati et al., 2014). Another antioxidant, tea flavonoid, can induce proliferation of PB-
derived EPC. Treatment of Epigallo Catechin Gallate (EGCG), Epicatechin Gallate (ECG), 
Epigallocatechin (EGC) and Catechin (C) of tea flavonoids increased the percentages of 
EPC marked by CD34, CD133, VEGFR-2 expressions (Widowati et al., 2016).
5  SIGNALLING TRANSDUCTION AND CELLULAR 
REPROGRAMMING OF EPC
Some signal transduction in mediating the proliferation of EPC has been reported. Among 
them, Phosphatidylinositol-4,5-bisphosphate3-Kinase (PI3K)/Akt signalling pathway has 
been widely reported. The PI3K/Akt signalling then led to some downstream signals such 
as Nuclear Factor (NF)κB/survivin (Li et  al., 2012), Endothelial Nitric Oxide Synthases 
(eNOS) (Yu et al., 2014) or Forkhead Homeobox type O transcription factor (FOXO)3A 
(Huang et al., 2015). Besides PI3K/Akt, the Mitogen-Activated Protein Kinase (MAPK) sig-
nalling pathway has been shown as well (Xu et al., 2012; Oktaviono et al., 2014, 2016; Sandra 
et al., 2015). And among the MAPK family, p38 and p44/42 were shown to be correlated with 
the proliferation of EPC (Xu et al., 2012; Oktaviono et al., 2014, 2016; Sandra et al., 2015).
Cellular reprogramming as an approach has been proposed and shown in various cells, 
including EPC (Thal et  al., 2012; Tendenan et al., 2017; Yoo et al., 2013). Intramyocard 
transplantation of  reprogrammed EPC in acute myocardial infarction mouse models 
showed significant improvement in ventricular function, which is histologically supported 
by de novo cardiomyocyte differentiation and increased capillary density and fibrosis reduc-
tion (Thal et al., 2012). Interestingly, Human Dental Pulp Cells Induced Pluripotent Stem 
Cells (hDPC-iPSC) was shown capable of  differentiating into the functional endothelial cell 
(Yoo et al., 2013).
6 SUMMARY
Herbal medicine can potentially increase the number of CEPC and induce proliferation of 
EPC so that optimal number of EPC for treatment can be achieved. The mechanism of EPC 
proliferation has been well disclosed, however, there is still a lack of information on how 
herbal medicine induces proliferation of EPC. EPC reprogramming to gain a more potent 
EPC in higher EPC number is a novel promising approach. There will be exciting further 
experiments in this research field.
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Relationship between Procalcitonin (PCT) and High-Density 
Lipoprotein (HDL) in bacterial sepsis
D. Tarigan, T. Kembaren & A. Rahimi
Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, 
North Sumatera, Indonesia
ABSTRACT: Sepsis can decrease the anti-inflammatory and immunomodulator effects of 
High-Density Lipoprotein (HDL). Low HDL levels inversely correlate with the severity of 
sepsis and associate with an exaggerated systemic inflammatory response. Bacterial infection 
is a strong stimulus for PCT. To determine the correlation between PCT and HDL levels in 
bacterial sepsis an observational study with a case control design was conducted on 30 sepsis 
and 30 non-sepsis infection patients. Data was collected to fill out PCT and HDL level on 
the 1st, 3rd and 5th day and then analysed to assess their relationship. Statistically, a signifi-
cant difference shows in the PCT and HDL levels between the sepsis and non-sepsis groups. 
There was a negative correlation between HDL and PCT, and a negative correlation between 
HDL level and the severity of sepsis, which show a medium strength correlation. Sepsis can 
be estimated when the HDL value less than 17,50 mg/dl. There was a significant relationship 
between PCT and HDL level in bacterial sepsis.
Keywords: sepsis, high-density lipoprotein, procalcitonin
1 INTRODUCTION
Sepsis is defined as an infection (whether a suspicion or evidence) accompanied by a systemic 
inflammatory response/SIRS (Systemic Inflammatory Response Syndrome). This condition 
originates from the interaction between pathogenic microorganisms and the immune sys-
tem that triggers an excessive and irregular inflammatory response that is destructive. The 
new marker of sepsis, procalcitonin (PCT), has better accuracy values than previous markers 
(Wyllie et al., 2005), but is limited by relatively high prices and not all health facilities can 
afford it. Therefore it is necessary to find a marker that can predict sepsis and is also simple, 
cheap and easy to use in everyday practice without any additional cost (Wyllie et al., 2005; 
Christ dan Muller, 2005).
Low HDL levels are inversely related to the severity of  sepsis and also associated with 
excessive systemic inflammatory responses. HDL can bind and neutralise lipopolysaccha-
ride (LPS) of  gram-negative bacteria and Lipoteichoic Acid (LTA) of  gram-positive bac-
teria, thus supporting the clearance of  this product (Badellino et al., 2008). This study was 
conducted to assess the association of  HDL and PCT in patients with bacterial sepsis.
2 METHODS
The study design is case control. The study was conducted in the inpatient ward and Inten-
sive Care Unit (ICU) of H. Adam Malik General Hospital from January to March 2017. 
Inclusion criteria were sepsis patients >17 years old. Exclusion criteria were sepsis patients 
with lipid-lowering drug use, sepsis patients with chronic kidney or liver disease, thyroid 
dysfunction, diabetes or malignancy; sepsis patients with chronic inflammatory diseases such 
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as HIV, systemic lupus erythematosus or rheumatoid arthritis; and sepsis patients who died 
within 48 hours or were referred to another hospital.
There were 60 patients divided into two groups. The first group (30 people) were bacte-
rial sepsis patients as the sample and the second group (30 people) were non-sepsis bacterial 
infection patients (30 people) as the control. Each patient was treated according to clinical 
conditions, and blood sampling was taken on the 1st, 3rd and 5th day for PCT and HDL 
checking, then the results processed and analysed using a computer program, with p < 0.05 
significance. Ethical clearance was obtained from the Research Committee of the Medical 
Field Faculty of Medicine, North Sumatera University.
3 RESULTS
The study involved 30 subjects of sepsis and 30 non-sepsis patients, where no significant dif-
ferences in baseline characteristics were found between the two groups (Table 1).
The results also explained that the PCT level in the sepsis group was higher than that in the 
non-sepsis group, whereas the HDL level in the sepsis group was lower than the HDL level 
in the non-sepsis group. Based on the Mann-Whitney test (because no normal distribution 
were data obtained), p < 0.05 for all HDL and PCT levels, meaning there was a significant 
difference between the sepsis and non-sepsis groups for both HDL and PCT levels (Table 2).
Spearman correlation test results obtained a significant negative correlation between HDL 
and the severity of sepsis with the correlation strength r = −0.586 showing moderate correla-
tion. This indicates that the increase of the sepsis severity will decrease the value of HDL 
serum. The cut-off value of non-sepsis HDL was 17.50 mg/dl at baseline with a sensitivity of 
80% and a specificity of 73%. So it can be estimated sepsis when the HDL levels lower than 
17.50 mg/dl.
Table 1. The basic characteristics of research subjects.
Characteristics
Group
Total P valueSepsis Non-Sepsis
Age group (years)
 25–35  3 (10,0%)  3 (10,0%)  6 (10,0%) 0,987*
 36–45  7 (23,3%)  6 (20,0%) 13 (21,7%)
 46–55  7 (23,3%)  9 (30,0%) 16 (26,7%)
 56–65  9 (30,0%)  8 (26,7%) 17 (28,3%)
 >65  4 (13,3%)  4 (13,3%)  8 (13,3%)
Sex
 Male 14 (46,7%) 19 (63,3%) 33 (55%) 0,194**
 Female 16 (53,3%) 11 (36,7%) 27 (45%)
 Total 30 (100%) 30 (100%) 60 (100%)
Bacteria type
 Gram-positive  2 (6,7%)  3 (10%)  5 (8,3%) 0,146*
 Gram-negative 15 (50%) 18 (60%) 33 (55%)
 Polymicrobial  5 (16,7)  0 (0%)  5 (8,3%)
 No microbes  8 (26,7%)  9 (30%) 15 (25%)
Source of infection
 Lung 14 (46,7%) 16 (53,3%) 30 (50%) 0,791*
 Abdomen 10 (33,3%)  7 (23,3%) 17 (28,3%)
 Urinary tract  5 (16,7%)  5 (16,7%) 10 (16,7%)
 Etc.  1 (3,3%)  2 (6,7%)  3 (5%)
Fisher exact test*, Chi-square test**.
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Table 2. The mean and median values of Procalcitonin (PCT) and HDL of the study subjects.
Laboratory characteristics N Mean Std. Deviation Median P value*
1st day PCT
 Sepsis 30 20,02 20,51 18,12 0,0001
 Non-sepsis 30  0,74  1,24  0,25
3rd day PCT
 Sepsis 30 15,97 18,03  8,64 0,0001
 Non-sepsis 30  0,48  0,81  0,17
5th day PCT
 Sepsis 30 16,82 20,73  8,85 0,0001
 Non-sepsis 30  0,36  0,84  0,04
1st day HDL
 Sepsis 30 18,67 14,03 15 0,0001
 Non-sepsis 30 31,63 13,99 31
3rd day HDL
 Sepsis 30 15,67  7,45 14,50 0,0001
 Non-sepsis 30 31,93 14,50 30,50
5th day HDL
 Sepsis 30 15,10  7,67 14 0,0001
 Non-sepsis 30 35,40 16,37 34,50
Table 3. Correlation of HDL levels with PCT in the sepsis group.
Variable N R-value P value
1st day HDL and 1st day PCT 30 –0,422 0,02
3rd day HDL and 3rd day PCT 30 –0,567 0,001
5th day HDL and 5th day PCT 30 –0,700 0,001
This study also found a significant negative correlation between HDL and PCT with a 
correlation strength of r = –0.422 which shows moderate correlation on the first day, then cor-
relation strength increased on the third day r = –0.567 and became stronger on the fifth day 
r = –0.7 (Table 3). This suggests that in the presence of sepsis with elevated PCT the serum 
HDL level will decrease.
4 DISCUSSION
The results of this study found that the HDL level in the sepsis group was 18.67 ± 14.03, 
lower than the HDL level in the non-sepsis group of 31.63 ± 13.99. Statistically, there was 
a significant difference in HDL levels between the sepsis and non-sepsis groups (p < 0.05).
In the sepsis group, the mean PCT level at baseline was 20.02 ± 20.51 which decreased 
from the third day of treatment and increased again on the fifth day of treatment. The mean 
HDL level at baseline examination was 18.67 ± 14, 03 and decreased on third and fifth day 
of treatments to 15.10 ± 7.67.
Another study conducted by Naresh et al. (2015) using a total of 111 study subjects found 
that the HDL level on day five increased compared to HDL level at baseline, but among non-
survivors, the HDL level was lower than in the initial days.
This study also obtained gram-negative bacteria as the cause of most sepsis. In contrast 
to conditions that occur in developed countries as well as in the United States where the 
most gram-positive bacteria are detected, although gram-negative remains high. About half  
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of cases of diagnosed sepsis, unidentified organisms. Gram-positive bacteria continues to 
increase in incidents associated with increased invasive action and the incidence of nosoco-
mial infections (Artero et al., 2012).
Based on the literature, low levels of  HDL in sepsis cases can be explained that during 
the infection process, significant changes in lipid metabolism and lipoprotein composition 
occur. Triglycerides (TG) and Very Low-Density Lipoprotein (VLDL) increased concern-
ing several mechanisms, including reduction of  hydrolysis of  TG. Lipopolysaccharides 
(LPS) and pro-inflammatory cytokines induce free fatty acid production and TG synthe-
sis in the liver and decrease lipoprotein lipase activity resulting in VLDL clearance and 
elevated TG levels. Other significant changes are the presence of  significant changes in 
lipoprotein composition and increased levels of  acute phase proteins including serum amy-
loid A (SAA) and secretory phospholipase A (sPLA2), which may contribute to decreased 
levels of  HDL by replacing some of  the structural components and functions of  HDL 
(Von, 2007; Pirillo et al., 2013).
Khovidhunkit et al. (2014) found a change in other protein content associated with HDL 
(Serum paraoxonase (PON1), Platelet-activating Factor Acetylhydrolase (PAF-AH)), result-
ing in a decrease in antioxidant properties from HDL and enhanced pro-atherogenic lipid 
content (Cao et al., 1998). Endotoxemia also induces enhancement of some enzymes involved 
in HDL remodelling, including endothelial lipase [10] and secretory phospholipase A2 and 
other decreases such as Cholesteryl Protein Transfer Ester (CETP) and Lecithin-Cholesterol 
Acyltransferase (LCAT) which will eventually decrease the functional properties of HDL 
(Delaliera et al., 2012).
Low HDL levels are inversely related to the severity of sepsis and are associated with 
excessive systemic inflammatory responses. As with other plasma lipoproteins, HDL can 
bind and neutralise gram-negative Lipopolysaccharides (LPS) and gram-positive lipoteichoic 
acid (LTA), thereby supporting clearance of this product. HDL has several biological func-
tions, but the role of HDL regarding innate immunity emerged in 1970 with the first obser-
vation looking for a link between HDL cholesterol (HDL-C) plasma values for protection 
against sepsis. In the context of infection, HDL and its components have been associated 
with protection against gram-negative, gram-positive and parasitic bacteria. Furthermore, 
HDL affects the innate humoral immunity by regulating the activation of the complement 
and expression systems of Pentraxin 3 (PTX3). HDL is essential not only during sepsis but 
also in bacterial, parasitic and other viral infections (Von, 2007).
Shor et al. (2008) in their retrospective study in patients at Edith Wolfson Medical Center, 
Israel, with a total of 204 study subjects, found that very low HDL levels (≤20 mg/dl) were 
associated with sepsis, death and malignant risk. This result is consistent with that obtained 
by Chien et al. (2005) who found that low HDL levels on day one were significantly associ-
ated with increased mortality and poor outcomes.
Van Leeuwen et al. (2003) reported a rapid change that decreased by 50% in lipoprotein 
levels, especially HDL, which occurred during sepsis. As the HDL sepsis state changes into 
an acute phase HDL that contains more SAA and less Apo A-I.
Al-Zaidawi et  al. (2014) reported low HDL levels in burn patients treated in the ICU 
room, whose value continued to decrease to <15  mg/dl when sepsis occurred. HDL and 
triglycerides then begin to rise again when sepsis resolves until it reaches its normal value. 
Meanwhile, from this study it can be estimated that sepsis occurs when HDL levels are 
below 17.50 mg/dl.
The differences in these cut-off  values may also be attributed to the HDL baseline in each 
race or demographic and lifestyle. Although the data on HDL values are racially/ethically 
limited, it is found that people in eastern Asia tend to have low HDL and high TG, whereas 
those in southern Asia tend to have lower HDL, LDL and TG levels than non-Asians 
(Morris & Ferdinand, 2009).
The findings also support low HDL levels as a risk factor for sepsis, and it seems that tar-
geting HDL levels can provide efficient and effective sepsis treatment.
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5 CONCLUSION
There was a significant negative correlation between HDL with PCT. This suggests that the 
presence of sepsis with elevated PCT will decrease the serum HDL level. This study also 
obtained a significant negative correlation between HDL and the severity of sepsis with a 
correlation strength of r  =  –0.586  showing moderate correlation. This indicates that the 
increase of the sepsis severity will decrease the value of HDL serum. The cut-off value of 
non-sepsis HDL was 17.50 mg/dl at baseline with a sensitivity of 80% and a specificity of 73%.
This study also supports the result that HDL value can be used as an assessment to deter-
mine the severity of sepsis.
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Relation of ferritin and nutrition to pulmonary dysfunction in 
thalassemia major
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ABSTRACT: Thalassemia major is a chronic disease requiring regular transfusions that 
may result in iron loading, iron excess complications—such as in heart, liver, endocrine 
organs, and lung diseases. Restrictive pulmonary dysfunction is known as the dominantly 
observed. A pulmonary function test was conducted in 50 children aged 6–18 years with TM 
with no history of chronic respiratory disease. Assessment of nutritional status was based on 
the anthropometric examination (BW/H and MUAC/A). Among the 50 children, 18 (36%) 
had restrictive lung function. The mean ferritin levels of the restrictive pulmonary dysfunc-
tion group (2096.6 ug/L) was lower than the normal pulmonary function group (2209.6 ug/L). 
Nine of 18 children were mildly malnourished in the restrictive pulmonary dysfunction group 
(OR = 6.890; CI95% = 1.152–41.340). There is no significant correlation between serum fer-
ritin level and restrictive pulmonary dysfunction in children with TM. Mild malnutrition 
increases the risk of restrictive pulmonary dysfunction occurrence in pediatric TM.
Keywords: children, restrictive pulmonary dysfunction, ferritin, malnutrition, thalassemia major
1 INTRODUCTION
Thalassemia is a common genetic blood disorder that is clinically characterised by various 
degrees of chronic haemolysis anaemia (Permono & Ugraseno, 2010). Chronic anaemia that 
occurs as a result of ineffective erythropoiesis, haemolysis and reduction of haemoglobin 
synthesis causes thalassemia patients to require lifelong blood transfusions (Galanello & 
Origa, 2010; Viprakasit et al., 2014).
Repeated blood transfusions may prolong the life expectancy of major thalassemia patients, 
but also negatively impact the occurrence of iron overload which can cause damage to various 
organs, including the lungs (Porter & Garbowski, 2014; Hershko, 2010). Different types of 
pulmonary function abnormalities have been described in TM patients (Inselman, 2008). How-
ever, the precise aetiology of the pulmonary dysfunction remains unknown. Several pathologic 
mechanisms for the pulmonary dysfunction in thalassemia have been investigated, including 
iron overload, allergy and correlation with transfusion, but none of these has provided a sat-
isfactory explanation (Prakash, 2005). Examination of serum ferritin levels is the most com-
monly used method to measure the amount of iron accumulation in the body (Wood, 2015). 
Malnutrition is thought to be one risk factor for lung problems in thalassemia major.
This study aims to analyse the relationship between serum ferritin levels and nutritional 
status with lung function impairment in patients with major thalassemia major in our centre.
2 METHODS
This cross-sectional study included 50 patients with TM receiving regular blood transfu-
sion without any history of chronic respiratory disease and had been followed up at Haji 
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Adam Malik Thalassemia Center. None of the patients had any clinical or echocardiographic 
evidence of heart failure within six months of the present study. Major thalassemia chil-
dren with infectious disease and clinical inflammation and a history of chronic lung disease 
were excluded from the study. Characteristics of the study subjects were also recorded, which 
included age, sex, weight and height. All subjects were interviewed, and a physical examina-
tion, anthropometry, and serum ferritin level and spirometry examinations were performed. 
A statistical analysis to analyse the variables based on lung function was done using univari-
ate test, Mann-Whitney test and a multivariate test with logistic regression test. The signifi-
cance is determined based on the value of p < 0.05. The ethical research was confirmed by the 
Research Ethic Committee, Medical Faculty, University of Sumatera Utara.
3 RESULT
A sample of 50 people consisting of 25 boys and 25 girls were recruited. Demographic char-
acteristics based on pulmonary function test results are presented in Table 1. Most of the 
samples showed normal pulmonary function test results and 18 children (36%) had impaired 
restrictive lung function. The sample age ranged from 6–18 years with a mean age of sample 
at 10.2 (SB 2.89) years in children with normal lung function and 12.0 (SB 3.73) years in 
children with restrictive lung function disorder.
Based on the assessment of nutritional status, 35 children had good nutrition while 15 
children had malnutrition, whereas in the group of children with restrictive lung function 
disorder, nine children (50%) with moderate malnutrition were found.
Of the total sample, 25 children (50%) were of short stature, and in the subgroup of chil-
dren with restrictive lung function disorder, there were nine children with short stature. Based 
on serum ferritin level, mean serum ferritin level in the group of children with restrictive lung 
function disorder was 2096.6 ng/mL, whereas in the group of children without impaired lung 
function the mean rate of ferritin was 2209.6 ng/mL.
In Table 2, based on the Mann-Whitney test, no difference was found between ferritin lev-
els with normal and restrictive lung function (P = 0.237) in children with thalassemia.
Based on logistic regression multivariate analysis, the risk factors that influence the restric-
tive lung function in the patient with thalassemia. The analysis showed that only nutri-




Normal (n = 32) Restrictive (n = 18)








Body weight, kg (SB) 25.6 (7.71) 29.2 (10.34)
Body height, cm (SB) 126.5 (15.40) 134.7 (17.91)














Ferritin, ng/mL (SD) 2209.6 (327.53) 2096.6 (482.50)
Transfusion amount (SD) 86.6 (40.95) 107.3 (59.14)
FVC, % (SD) 91.5 (8.42) 71.2 (6.64)
FEV1/FVC, % (SD) 89.3 (6.82) 79.6 (3.36)
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tional status had an effect on restrictive lung function disorder in children with thalassemia 
major with a P-value <0.035. Children with thalassemia patients with less nutritional risk 
6.89 (CI95% = 1.151–41.340) times higher lung function impairment than patients with tha-
lassemia with normal nutrition.
4 DISCUSSION
Most researchers conclude that restrictive lung function disorder is a major lung function 
disorder in children with thalassemia major. They believe that early and aggressive use of 
iron chelation can prevent the impairment of lung function (Sohn et al., 2011; Bourli et al., 
2012; Noori et al., 2012). Our results also show that restrictive pulmonary function disorder 
is a dominant finding based on a lung function test using spirometry, with a result of about 
18 (36%) of patients with restrictive lung function disorders and the rest normal. In this 
study, patients had no complaints of respiratory problems, and all had normal pulmonary 
patterns based on chest x-rays. It can be concluded that routine lung function tests may be 
necessary, even in asymptomatic patients.
The study involved 50 children with thalassemia major, in which the proportion of male 
and female sex was balanced, and the age range was 6–18 years; the mean of children with 
restrictive lung function disorder is 12 years compared to the mean of children with normal 
lung function of around 10.2 years. Most of the boys – 11 children (61.1%) were found to 
have restrictive lung function disorder. Previous studies (Abu Ekhteish et al., 2007; Ozyoruk 
and Misirlioglu, 2015) found an association between increased age and serum ferritin levels 
and restrictive lung function disorder, but in this study, age was not associated with restric-
tion lung function disorder.
Assessment of nutritional status based on clinical findings and anthropometry (based on 
BW/H and MUAC/A) was performed in all patients, and it was found that some children 
with restrictive lung function had poor nutrition. This moderate malnutrition condition is a 
risk factor for major thalassemia children who have restrictive pulmonary function compared 
with thalassemia children with good nutrition, with OR 6.89 (CI95% = 1.151 to 41.340).
Growth disorders are one of the complications of thalassemia that can cause a dispro-
portionate chest cavity (Galanello & Origa, 2010). A disproportionate chest cavity can cause 
pulmonary volume disturbance resulting in impaired restrictive lung function (Bourli et al., 
2012). On anthropometric examination, 25 children (50%) have short stature, while only nine 
children (36%) have restrictive lung function. Statistical analysis of lung function disorder 
showed no significant results. The results were consistent with previous studies that per-
formed the logistic regression analysis of factors suspected to cause lung function impair-
ment, in which there was no BH/A relationship to restrictive pulmonary function impairment 
(Bourli et al., 2012). The outcome may be due to growth disorders not occurring in the chest 
cavity, other bones. This is indicated by more growth disorders occurring in subjects with 
normal lung function.
Although the measurement of serum ferritin levels was not the best quantitative estimate 
of body iron storage (Wood, 2015), thalassemia major patients with serum ferritin serum 
concentrations ≥3000 ng/dL have been reported to have high lung injury probabilities. Serum 
ferritin levels >2500  ng/dL have been associated with a mortality risk four times higher 
(Ozyoruk & Misirlioglu, 2015). The restrictive lung disorder group had a mean serum fer-
ritin level of 2096.60  μg/L, lower than the normal lung function group, with a mean of 
2209.60  μg/L. Statistical analysis of serum ferritin levels with lung function impairment 
Table 2. Relation of ferritin levels with impaired lung function.
Pulmonary function Mean serum ferritin level SD Z CI95% P
Normal 2209.6 327.53 −1.196 0.228–0.245 0.237
Restrictive 2096.6 482.50
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showed no significant results. This is in keeping with previous studies which show no 
association between elevated serum ferritin levels and restrictive lung function disorder in 
major thalassemia (Parakh et al., 2007; Boddu et al., 2015).
This study has strengths and limitations. The advantages of this research are the first study 
in North Sumatra. Some limitations of this study are that this study assessed lung function 
by cross-sectional. An ideal quantitative assessment of iron overload is to measure the liver 
iron content by biopsy, but this invasive action is not feasible, so it was not performed.
5 CONCLUSION
There is no significant correlation between serum ferritin level and restrictive pulmonary dys-
function in children with TM. Mild malnutrition increases the risk of restrictive pulmonary 
dysfunction occurrence in paediatric TM.
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The difference of MMSE and MoCA-Ina scores in brain tumors
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ABSTRACT: The Mini Mental State Examination (MMSE) is the most commonly used 
screening test for Brain Tumor (BT) patients but relatively insensitive compared to Montreal 
Cognitive Assessment (MoCA). The aim of this study was to compare the proportion of the 
MMSE and MoCA-Ina scores in BT patients. A cross sectional study was conducted in 33 
patients with BT. All of the subjects were assessed with MMSE and MoCA-Ina. To assess 
the difference in the proportion of brain tumor patients was used chi-square test or Fisher 
exact test. In BT patients with group of education 7–9 years presented a significantly higher 
percentage of abnormal MMSE and MoCA-Ina score than other group. We noticed that 
over 90.9% was impairment of attention and calculation using MMSE, while delayed recall 
have been affected on more than 90.9% using MoCA-Ina.
Keywords: Mini Mental State Examination, Montreal Cognitive Assessment, Cognitive 
Function, Brain Tumor
1 INTRODUCTION
Primary brain tumors are among the top 10 causes of cancer-related deaths in the United 
States, accounting for approximately 1.4% of all cancers and 2.4% of all cancer related 
deaths. About 14 per 100,000 people in the United States are diagnosed with a primary brain 
tumor each year, and 6 to 8 per 100,000 are diagnosed with a primary malignant brain tumor 
(Berger, M.S. 2005).
In evolution, most patients diagnosed with brain tumors have cognitive decline, but the 
mechanisms by which these neoplasms may compromise brain function are varied in different 
patients. It is well known that cognitive tests performances are influenced by patient-related 
variables (age, level of education) and disease-related variables (the location of the tumor, its 
growth rate, tumor’s size), but was not yet fully explained the nature of interactions between 
these variables. Cognitive dysfunction is a consequence of neoplastic process but it may be, 
also, secondary to associated intracranial hypertension or cerebral edema, being evident, at 
the time of diagnosis, on more than half  of patients (Stanca, D, 2011).
There are few studies about cognitive functions at the time of diagnosis in patients with 
brain tumors. Most of them were conducted to assess post-surgical cognitive function or as 
a measure for evaluating the effectiveness or adverse effects of treatment (chemo or radio-
therapy) (Tucha, O, 2000).
The Mini Mental State Examination (MMSE) was develop by Folstein et  al in 1975 
(Folstein, M.F., Folstein, S.E., McHugh, P.R. 1975). It has currently been widely used as a 
standard scoring tools in many countries and translated into various languages, including the 
Indonesia language (Ong, P.A., 2015).
The MMSE is the most commonly used screening test for patients with brain tumor patients, 
despite limited validation in this setting. The Montreal Cognitive Assessment (MoCA) has 
superior sensitivity in part because it does not have a ceiling test effect, likely because it more 
extensively tests executive functioning, delayed recall, and abstraction (Olson, R.A., 2011; 
Nasreddine, Z.S., 2005).
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The MMSE is best suited to detecting gross cognitive impairment, such as Alzheimer’s 
disease, and has been shown to be relatively insensitive to the cognitive changes that occur 
in brain tumor patients, especially in detecting impairments in abstract reasoning, executive 
functioning, and visual perception (Olson, R.A., 2008).
The purpose of our study was to compare two brief  and widely used tests (MMSE and 
MoCA-Ina) for detection of Mild Cognitive Impairment in brain tumor patients. Indonesian 
version of MoCA test has been validated (Husein, N. 2010).
2 METHOD
The study-group consisted of patients diagnosed with brain tumors in the Haji Adam Malik 
General Hospital between November 2015 and May 2017. The exclusion criteria of the study 
were the following:
• Patients with brain tumors that are not confirmed by neuroimaging examination
• Aphasic language disorders
• Previous psychiatric diseases
• Patients who have undergone radiotherapy, chemotherapy, or brain tumor surgery
• Patients with other condition that could influence cognitive function
The location of brain tumors was assessed on the radiological examinations of cranial 
computed tomography scans with contrast and or Magnetic Resonance Imaging (MRI). The 
location of the tumor is divided into supratentorial, infratentorial, and both sites. The size of 
the tumor was assessed on the basis of a radiological examination of head Computed Tom-
ography (CT) scans with contrast and/or MRI. The size of the tumor is divided into large 
sizes (≥30 mm, there is a mass effect) and small size (<30 mm, no mass effect). The mass effect 
is midline shift >3 mm and there is minimal cerebral edema to the extent, or the presence of 
ventricular compression or compression in the basal cisterna.
Cognitive function was assessed using MMSE and MoCA-Ina. A score less than 26 is 
considered optimal cutoff  point for diagnosis of cognitive impairment. This evaluation of 
cognitive performances was realized at the time of diagnosis.
We compared descriptive data using Chi-square or Fisher exact test. P-value < 0.05 consid-
ered statistically significant. All statistical analysis was performed using Statistical Package 
for the Social Sciences (SPSS).
3 RESULT
The study-group consisted of 33 patients diagnosed with brain tumors. In the distribution by 
gender, we found a predominance of males (20 cases), representing 60.6% of the total number 
of cases. the average age of occurrence of brain tumors was 46.48 (SD = 10.78) and mostly, 
the group of age was 51–60 years. As shown in Table 1, the average score on the MMSE was 
23.76 (SD = 4.08), while the average score on the MoCA-Ina was 21.79 (SD = 4.93).
4 DISCUSSION
In this study, we evaluated cognitive function in patients newly diagnosed with brain tumors. 
Our study demonstrated patients with group of education 7–9 years presented a significantly 
higher percentage of abnormal MMSE and MoCA-Ina score than other group. The data 
obtained by us are similar to data obtained by Maharani, patients with brain tumor that 
education <9 years also more cognitive impairment.
On the other hand, in our study suggest that most patients with tumor located in supraten-
torial and large tumor was abnormal MMSE and MoCA-Ina score. The Liouta et al show 
that patients in the large meningioma had poorer performance on language and fine motor 
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 5.94 ± 7.14
MMSE score, Mean ± SD 23.76 ± 4.08
MoCA-Ina score, Mean ± SD 21.79 ± 4.93
testing than patients with small meningioma. According to our results, that either primary 
and metastatic tumors located more than 1 lobe suffer more cognitive impairment than those 
located on only 1 lobe. It also explains that the more areas of the brain affected, the impact 
of cognitive impairment that appears also more real. Cognitive dysfunction may be a direct 
Table 2. Comparison of MMSE and MoCA-Ina score by sex, age, edu-
cation, and disease duration.
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Table 4. The percentage of MMSE in brain 
tumor patients impaired in domain-specific 
cognitive tests.





Attention and calculation 30 (90.9%)
Recall 26 (78.8%)
Language 27 (81.8%)
Table 5. The percentage of MoCA-Ina in brain 
tumor patients impaired in domain-sepesific cog-
nitive tests.
Domain MoCA-Ina n (%)
Visuospatial/Executive function 24 (72.7%)
Naming  4 (12.1%)
Attention 27 (81.8%)
Language  5 (15.2%)
Abstraction 28 (84.8%)
Delayed Recall 30 (90.9%)
Orientation 21 (63.6%)
Table  3. Comparison of MMSE and MoCA-Ina score by type, loca-
tion, and size of tumor.
MMSE MoCA-Ina
Normal Abnormal Normal Abnormal
Type of tumor (%)
 Primary 69.2 55.0 55.6 62.5
 Secondary 30.8 45.0 44.4 37.5
 p Value  0.485  0.509
Location tumor 76.9 70.0 77.8 70.8
15.4 10.0 11.1 12.5
Supratentorial  7.7 20.0 11.1 16.7
 0.598  0.91
Infratentorial
 Both lesion 84.6 85.0 77.8 87.5
 p Value 15.4 15.0 22.2 12.5




consequence of the neoplasm growth process or is a secondary outcome such as increased 
intracranial pressureor cerebral edema found at the time of diagnosis.
We noticed that over 90,9% of patients impairment of attention and calculation using 
MMSE, while delayed recall have been affected on more than 90.9% of patients using MoCA-
Ina. The Stanca et al showed that patients in group A (patients with meninges tumor) most 
commonly affected cognitive area was attention (66% of patients with meningiomas show-
ing the decline in this area), and in group B (patients with neuroepithelial tumors) over 60% 
of patients had impaired executive function, memory or attention. A possible hypothesis 
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could be that memory and attention are based on the integrity of widely distributed neural 
networks and are therefore prone to be affected by nearly any tumor location and histology 
(Olson, R.A., 2008).
We have some limitations: First, most of patient did not undergo a biopsy so the diagnosis 
would be difficult to determine. Second, patient with brain tumor were administered the 
MoCA-Ina and MMSE in the time on the same day, so influence of patient fatigue on test 
results.
5 CONCLUSION
Our study demonstrated a statistically significant abnormal MMSE and MoCA-Ina score in 
BT patients with the group of education 7–9 years. The present findings suggest that most 
patients with tumor located in supratentorial and large size of brain brain tumor demon-
strate abnormal MMSE and MoCA-Ina score. Finally, we recommend clinician to evaluate 
cognitive function in patients newly diagnosed with brain tumors.
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Pattern of fungal infections in Chronic Suppurative 
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ABSTRACT: Organisms that can be found in CSOM can be either aerobic or anaerobic 
fungi or a combination of both. Chronic secretions and the use of irrational and excessive otic 
topical antibiotics encourage the growth of fungal infections in CSOM. Aspergillus and Can-
dida sp are fungi which are commonly found in CSOM. To understand the pattern of fungal 
infections of patients with CSOM at the ORL-HNS Department, Faculty of Medicine, Uni-
versitas Sumatera Utara/Haji Adam Malik General Hospital Medan, a descriptive study with 
case series approach was conducted. Positive fungal cultures with as many as four specimens 
(13.33%) were found from 30 aural discharges. The types of fungi were Aspergillus sp. (75%) 
and Candida sp. (25%). From the results conducted a positive fungal culture, so the fungal infec-
tion is still considered on CSOM especially from the patients who do not respond to treatment.
Keywords: CSOM, fungal infections, fungal culture
1 INTRODUCTION
Chronic Suppurative Otitis Media (CSOM) is a chronic inflammation of the middle ear with 
perforation of the tympanic membrane and a history of secretion from the ear (otorrhoea) 
over three months, either continuous or disappearing. Secretions may be watery or thick, 
clear or pus (Helmi, 2005; Chole & Nason 2009).
CSOM can cause extracranial and intracranial complications in order to increase high 
morbidity. In developing countries the problem of poverty, little knowledge, lack of specialist 
personnel and limited access to health services exacerbate the course of illness and complica-
tions of CSOM (Geeta, 2014; Orji, 2013).
Otomycosis is a fungal infection of the ear that is usually an infection of the outer ear 
canal; in some cases this fungal infection may affect the middle ear in the case of perforation 
of the tympanic membrane (Chao et al., 2011). Chronicity of the discharge plays an impor-
tant role in the causation of fungal otitis media as it causes humid conditions in the ear and 
alters the pH of the media to alkaline epithelial debris. Both these factors help in the growth 
of fungus (Dhingra et al., 2014). However, the disease is still a challenge and can even lead to 
frustration in both patients and ENT specialists because of prolonged treatment due to high 
recurrence (Chao et al., 2011; Ozturkcan, 2014).
The use of irrational topical antibiotics and excessive ear drops encourages the growth 
of fungal infections in CSOM (Mittal, 1997; Mungia, 2008; Wolk, 2016). Common fungi in 
CSOM are Aspergillus and Candida Sp. Fungi spores are easily found in the middle ear as it 
has a warm and humid environment (Ashok, 1997). Organisms that can be found in CSOM 
can be aerobic, anaerobic or a combination of both fungi. However, many cases of CSOM in 
the administration of medication that do not use proper antibiotics could lead to therapeu-
tic failure, other hazards that can arise are the occurrence of resistance to microorganisms, 
sustained infection and ultimately complications that cause suffering to patients and require 
large medical expenses (Mungia & Daniel, 2008; Saraswati et al., 2013; Lubis, 2010).
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According to Lubis’ study (2010) from 75 secretion samples of CSOM patients who went 
to H. Adam Malik General Hospital Medan found that positive fungal culture were 54.7% 
and negative fungal culture were 45.3% with the most commonly results were Aspergillus sp. 
(Lubis, 2010).
Research on the pattern of these fungal infections is still to be renewed again, consider-
ing many cases of CSOM with chronic aural discharge and irrational uses of antibiotic so it 
needs to examined changes in the pattern of fungal infections in CSOM patients in H. Adam 
Malik General Hospital Medan. Therefore it is important to know how the role of fungal 
infections to CSOM patients especially in Department of ORL-HNS Faculty of Medicine 
USU/H. Adam Malik General Hospital Medan.
2 METHOD
The type of research is descriptive using a case series approach. The research was conducted 
in the Department of ORL-HNS Faculty of Medicine USU/H. Adam Malik General Hospi-
tal Medan. Specimens from the middle ear were collected from December 2014 to September 
2015. Examination of fungal patterns was conducted at the Department of Microbiology 
Faculty of Medicine USU/Haji Adam Malik General Hospital Medan.
The population of this study consists of CSOM patients who went to the Department of 
ORL-HNS Faculty of Medicine USU/H. Adam Malik General Hospital Medan during the 
period December 2014–September 2015. Diagnosis of CSOM is established based on history, 
physical examination and investigation.
The sample in this study is the entire population that meets the inclusion and exclusion 
criteria. Inclusion criteria: New/old CSOM patients with active aural discharge, willing to 
participate in research, subtotal and total tympanic membrane perforation, the not adminis-
tered any ear drops for the last seven days. Exclusion criteria: The anatomic conditions of the 
ear canal and the tympanic membrane cause specimen could not be taken.
The sample of the study that fulfilled both inclusion and exclusion criteria comprised 26 
people. The research sampling approach used is non-probability. The samples were taken 
purposively, that is from all patients who came to Department of ORL-HNS Faculty of 
Medicine USU/H. Adam Malik General Hospital Medan who met the inclusion and exclu-
sion criteria.
3 RESULTS
This research is descriptive conducted in Department of ORL-HNS Faculty of Medicine 
USU/H. Adam Malik General Hospital Medan in the period December 2014–September 
2015. From 26 patients collected 30 samples from unilateral ears both right and left were 
22 samples while bilateral were four samples.
From Figure 1 it can be seen that from 30 secretions from middle ear, four (13.33%) are 
positive for fungal culture, while the negative culture was 26 (86.67%).
Figure 1. Distribution of the results of the secretions culture of CSOM patients (in percent).
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Based on Table 1 it can be seen that from fungal culture result obtained four fungal infec-
tion. The most common fungi are Aspergillus fumigatus with three (75%) followed by Candida 
sp. as the remainder (25%).
4 DISCUSSION
This study was conducted on 26 CSOM patients in H. Adam Malik General Hospital Medan 
over the period December 2014–September 2015, and the results found that from 30 samples 
of secretions from middle ear were positive fungus culture as many as four (13.33%), whereas 
negative culture was 26 (86.67%) where Aspergillus fumigatus was obtained by 75% followed 
by Candida sp. as many as 25%.
The results of this research are similar to those of Prakash (2003) which obtained 12.25% 
of the fungal culture from 204 CSOM patients, where Aspergillus sp. obtained the highest of 
70.83%, while Candida sp. amounted to 29.17%. Vishwanath (2012) out of the 115 fungal 
cultures obtained found only 11 (9.6%) where Aspergillus sp. was obtained by 22.7% while 
Candida sp. was 27.27%. Aquino (2009) in 160 CSOM patients obtained fungi by 15.6% 
(Vishwanatha et al., 2012; Prakash et al., 2013; Aquino et al., 2009).
The results of Kumar and Seth’s (2011) study obtained from 100 cases of CSOM found 
Candida albicans to be the most common fungus with as many as nine (60%), followed by 
Aspergillus fumigatus with as many as three (20%), Aspergillus niger as many as two (13.3%) 
and Aspergillus flavus as many as one (6.7%) (Kumar, 2013).
This is slightly different from Geeta’s research (2014) which obtained a positive fungal 
culture of 25.6% where Aspergillus sp. is 16% while Candida sp. is 4% (Geeta, 2014).
A previous study conducted at the H. Adam Malik General Hospital Medan by Lubis in 
2010 found a positive culture result of fungi in 41 of 75 samples or 54.7%. The most common 
types of fungi are Aspergillus sp., which consists of Aspergillus niger with as many as 14 sam-
ples (43.9%), Aspergillus fumigatus with as many as five samples (8.7%) and Aspergillus flavus 
with as many as three samples. This is followed by Candida sp. with as many as 18 samples 
(43.9%), consisting of Candida albicans, as many as nine samples (21.9%), Candida tropicalis 
six samples (14.6%), Candida parapsilosis as many as two samples (4.8%), Candida krusei 
as many as one sample (1.3%) and Penicillium sp. as many as one sample (1.3%). From this 
it can be seen that the frequency of fungal infections in CSOM at H. Adam Malik General 
Hospital Medan has decreased from 54.7% in 2010 (Lubis, 2010) to 13.33% in this study 
(December 2014–September 2015). Specimen collection methods and inclusion criteria in 
both studies are relatively similar, but in our study we did not include the patients that have 
previously used ear drops. The use of irrational topical antibiotics and excessive use of ear 
drops encourage the growth of fungal infections in CSOM (Mittal et al., 1997).
Fungal infections of the middle ear generally develop well in moist and otorrhoea (Sauders 
et  al., 2011). Chronic secretions play an important role as a cause of fungal infections in 
CSOM because they cause a moist condition in the ear and alter the middle ear pH to a base 
(Dhingra et al., 2014). The most common fungi found in CSOM are the Candida and Aspergil-
lus species. In this study 75% Aspergillus fumigatus and 25% Candida sp. were found.
The likelihood of this is due to the type of fungus that often grows in the ear, when condi-
tions that support the influence of fungal infection become opportunistic. One theory states 
that Aspergillus and Candida are the opportunistic fungi. Pradhan’s (2003) findings in his 
Table 1. Distribution of the type of fungus on CSOM patients.
Fungal Number (n) %
Aspergillus fumigatus 3  75
Candida sp 1  25
Total 4 100
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study in India suggest the most common types of Aspergillus sp. were Aspergillus flavus, 
Aspergillus niger and Aspergillus fumigatus. Candida albicans is another fungal cause of ear 
infections that are endogenous microorganisms that often interfere with the gastrointestinal 
tract and urinary tract (Levinson, 2008; Pradhan et al., 2003).
5 CONCLUSION
There were positive fungal cultures in as many as four specimens (13.33%) from 30 ear secre-
tions, which consist of Aspergillus fumigatus and Candida sp.
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ABSTRACT: Nasopharyngeal Carcinoma (NPC) is one of the most common malignan-
cies in Indonesia with over 13,000 new cases reported yearly, especially in males. TNF-α 
serum is reported as a new biomarker to predict bone invasion, post-therapy distant metas-
tasis and poor life sustainability in NPC. To identify the expression of TNF-α in regard to 
clinical stage of NPC. This is an analytic study with 126 NPC samples of patients in Haji 
Adam Malik General Hospital. NPC was mostly found in the age group 41–60 years (57.1%), 
males (71.4%), non-keratinising SCC (79.4%), and stage IV group (54.8%). In immunohisto-
chemistry evaluation, most TNF-α is overexpressed in non-keratinising SCC (68.0%), T3-T4 
(50.8%), N2-N3 (62.7%) and clinical stage III–IV (69.9%). Spearman’s test for categorical 
correlation yields a p value of <0,001. Conclusion: There is a significant correlation between 
TNF-α expression and the stage of NPC.
Keywords: Nasopharyngeal carcinoma, TNF-α, overexpression
1 INTRODUCTION
Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma that grows on the lateral 
wall surface of nasopharynx (Adham et  al., 2012; Tualalamba, 2012). In Asia, especially 
China, NPC is the 11th most common malignancy with an average incidence of nearly 25 
cases per 100,000 (Patel et al., 2017; Chan et al., 2012). In Indonesia, more than 13,000 new 
cases are reported yearly, especially in men, and this is associated with a high mortality rate 
(Cao et al., 2011; Dhingra, 2014; Fles et al., 2017).
Cytokines play an important role in the pathogenesis and maintenance of cancer with 
different ways which include TNF-α, TRAIL, IL-6, IL-10, IL-12, IL-17 dan IL-23 (Kabel, 
2014). TNF-α as a main pro-inflammatory cytokine is capable as an endogenous tumour 
promoter in bridging inflammation and carcinogenesis. New studies have shown the role of 
TNF-α in all carcinogenesis aspects such as cellular transformation, proliferation, invasion, 
angiogenesis and metastasis (Wang & Lin, 2008).
TNF-α serum is reported as a new biomarker to predict bone invasion, post-therapy dis-
tant metastasis and poor life sustainability in NPC, which shows that TNF-α has biological 
significance in NPC (Song et al., 2013; Lu et al., 2011; Lu et al., 2012).
Signal pathway and the transcription factor activated by TNF-α are considered important in 
invasion and metastasis of cancer cells. Cancer cells are more dependent on transcription factors 
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compared to normal cells. The development of cancer cells is inhibited and apoptosis is promoted 
through the inhibition of the transcription factor and targeted signal pathway (Tang et al., 2017).
Considering the importance of TNF-α, the correlation of TNF-α expression to clinical 
stadium of NPC patients is studied.
2 METHODS
Research was conducted over the period July–October 2017  in the Adam Malik General 
Hospital, Medan, recruiting 126 samples of patients diagnosed with NPC based on history 
taking, physical examination and histopathological biopsy during the period 2015–2016.
The inclusion criteria includes patients diagnosed with NPC based on histopathological 
reports and who have not received radiotherapy, chemotherapy or a combination of both. 
Figure 1. Frequency of Age, Sex, Histopathology, Primary Tumour (T), Nodes (S) and Clinical Stag-
ing results based on TNF-α expression.
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By using the sampling formula, a minimal of 68 patients was required for the research. The 
samples were collected using non-probability consecutive sampling.
The tissues were examined using immunohistochemistry under a fluorescent microscope 
evaluating the immunoreaction of the TNF-α antibody. The results were evaluated based on 
the immunoreactivity score (≥ 4 is considered positive or overexpressed TNF-α) (Fedchenko & 
Reifenrath, 2014). All data is presented in the figure.
3 RESULTS
This study involved 126 samples with the highest frequency of  patients found in the age 
group 41–60 years (57.1%). With regard to gender, males are the largest population of 
NPC patients with 90  samples (71.4%). The non-keratinising squamous cell carcinoma 
(79.4%), and stage IV group (54.8%) is the most frequent regarding the histopathology 
characteristic. In immunohistochemistry evaluation, most TNF-α overexpressed in non-
keratinising squamous cell carcinoma (64.3%), T3-T4 primary tumour size (50.8%), neck 
nodes enlargement in the N2–N3  group (62.7%) and clinical stage in the III–IV group 
(69.9%).
Correlation analysis using Spearman’s test for categorical correlation yielded a p value of 
< 0,001, which indicates that there is a statistically significance correlation of clinical staging 
and the expression of TNF-α.
4 DISCUSSION
In this study, the largest age group in nasopharyngeal carcinoma is in the age group of 
41–60 years (57.1%). Similar to Adham’s (2012) study, the peak of most NPC patients was 
found to be 40–49 years old. This has happened because the DNA repair mechanism func-
tion and immune system have decreased as they undergo mutation after the age of 40 years. 
(Soehartono et al., 2007).
In our study, we found a similar predominance, with 71.4% male and 28.6% female cases 
yielding a 2.5:1 ratio. The male:female ratio was relatively stable over the years. Cao’s study 
(2011) also found the incidence rate of NPC in men to be higher than in women, with a 
ratio of 2–3:1. The exposure to environmental pollution from occupation and lifestyle caused 
males to have a higher ratio than females diagnosed with NPC (Lara, 2016).
In our study, non-keratinising squamous cell carcinoma (79.4%) was the most common 
form of NPC, consistent with studies conducted in other high-risk countries. More than 90% 
of NPC in endemic area is non-keratinising squamous cell carcinoma (Cao, 2011).
Tumour Necrosis Factor Alpha (TNF-α) is a kind of  pro-inflammatory cytokine 
mainly secreted by tumour cells and macrophages. TNF-α can not only take part in the 
mechanisms of  apoptosis induction, but also accelerates tumour growth in the process of 
tumour progression. And increasing evidence shows that TNF-α participates in many key 
processes of  tumour progression including activation of  the cancer gene, DNA damage 
and tumour metastasis. High expression of  TNF-α is closely related to tumour recurrence 
and lymph node metastasis (Wang & Lin, 2008). In this study, we found TNF-α overex-
pression is most common in T3 primary tumours (30.2%). In regional metastasis, TNF-α 
overexpression was found most frequently in the N3 lymph node (45.3%), and the lowest 
in N0 (7.1%). Elevated TNF-α expression was most common in stage IV (70%) and the 
highest TNF-α expression was found in non-keratinising squamous cell carcinoma type 
(64.3%).
The result of this study showed that there is a significant correlation of NPC clinical stage 
and the expression of TNF-α. Jin et al. (2017) reported a significant reduction of TNF-α 
expression after treatment of NPC, indicating that TNF-α expression may be used for clini-
cal staging of NPC. Andersson et al. (2014) also found that the upregulation of CRP and 
TNF-α in the NPC patient plasma was significantly related to shorter patient survival.
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5 CONCLUSION
Our study suggests that there is a significant relationship between TNF-α expression and 
NPC clinical stage. Therefore, a further study with larger samples is warranted, which could 
contribute to fully understanding the association of TNF-α and NPC, and to establish a new 
approach in screening and surveillance of NPC using TNF-α.
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ABSTRACT: To determine the expression of microvessel density in primary tumour size 
(T), lymph node (N) and clinical stage in nasopharyngeal carcinoma this descriptive study 
involved 30  samples in Haji Adam Malik General Hospital Medan. Nasopharyngeal car-
cinoma was mostly found in males (73.3%); 41–60 years old (60%); T4 primary tumour 
(36.7%), N3 lymph node (43.3%), and non-keratinising squamous cell carcinoma (53.3%). 
High microvessel density (>45 MV/LP) was found in 56.7%; non-keratinising squamous 
cell carcinoma (58.8%), T4 primary tumour (35.3%), N3 lymph node (47.1%); and stage 4 
(76.4%). Microvessel density mostly overexpressed in non-keratinising squamous cell carci-
noma, primary tumour size (T4), lymph node size (N3) and clinical stage 4.
Keywords: Nasopharyngeal carcinoma, microvessel density, immunohistochemistry
1 INTRODUCTION
Nasopharyngeal Carcinoma (NPC) is the most common malignancy in Asia, with a men to 
women ratio of 2:1. In Indonesia, the incidence of NPC is 3.9 cases per 100,000 people. In 
2006–2010 there were 335 new cases of NPC who came to the oncology division of the ENT 
department (Cho, 2007; Fachiroh et al., 2004; Puspitasari, 2011).
The process of formation of new blood vessels or angiogenesis plays an important role 
in the proliferation of cancer cells that are highly dependent on oxygen and nutrients. In 
addition, angiogenesis plays an important role in the spread of cancer cells. Cancer cells are 
able to penetrate into the blood vessels or lymph, circulate through the intravascular flow, 
and then proliferate elsewhere, known as metastases, as well as induce angiogenesis. There-
fore, the increased density of newly formed blood vessels in a tumour is closely related to an 
increase in the number of tumour cells (Nishida et al., 2006; Poon et al., 2002). The patho-
logical approach to estimating an angiogenesis is through microscopic estimation of blood 
vessel density or Microvessel Density (MVD) through immunohistochemical examination. 
Increased MVD was also associated with survival rates and metastatic spread in patients with 
NPC (Choi et al., 2005; Roychowdhury et al., 1996).
2 MATERIALS AND METHOD
This descriptive study was conducted at Haji Adam Malik General Hospital and Pathol-
ogy Anatomy Department Medan, Indonesia. The study sample was NPC patients diag-
nosed with histopathologic examination (WHO, 2012) who came to the oncology division 
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of ENT department during the period December 2011–May 2012. A total of 30  samples 
were included in this study and grouped according to histopathology type, primary tumour 
size (T), size of enlarged lymph node (KGB), and clinical stage. This study has obtained 
approval from the ethics commission Medical Faculty of Universitas Sumatera Utara. His-
topathologic preparations are examined under in pathology anatomy of the Medical Faculty 
of Universitas Sumatera Utara for immunohistochemical staining in order to demonstrate 
MVD expression.
Immunohistochemical MVD was examined using a Monoclonal Mouse anti-Human 
CD31 Endothelial cell with a low (< 45 MV / LP) or high (> 45 MV/LP) measurement. His-
topathologic examination was performed by three pathologists without knowing the clinical 
data of the sample. All data were collected and presented in tabulation form.
3 RESULTS
Thirty samples with various histopathologic types were then examined with CD31 immuno-
histochemical immersion to assess MVD expression. In this study high MVD expression as 
much as 58.8% was found in NPC-type non-keratinising squamous cell carcinoma. Along 
with increasing tumour size (T), high expression of MVD was more common, T4 as much as 
35.3%. High MVD expression was most prevalent in clinical stage 4, at 76.4%. On the size of 
node grade 3 is the highest group with high MVD (47.1%).
Table 1. Frequency distribution of MVD expression with histopathological type, primary tumour size 
(T), lymph neck enlargement (N) and clinical stage in nasopharyngeal carcinoma.
Microvessel density (MV/LP)
Overexpression Negative
N % N %
Histopathological Type
Keratinising squamous cell carcinoma
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4 DISCUSSION
In this study, high MVD values  were mostly found in non-keratinising squamous cell carci-
noma (58.8%). NPC, especially non-keratinising squamous cell carcinoma, is often associ-
ated with Epstein-Barr virus (Lutzky et al., 2008). In addition, an increase of MVD is often 
encountered simultaneously with Latent Membrane Protein-1 (LMP-1). LMP-1 is the main 
oncoprotein of the Epstein-Barr virus. Therefore, it causes a high MVD expression tendency 
to be found in certain types of NPC non-keratinising squamous cell carcinoma (Hardianti 
et al., 2010). Choi (2005) found a significant association between histopathologic type and 
MVD expression in breast cancer (p < 0.01) by using the cytometry method.
High MVD expression was found in T4 (35.3%). Sari et al. (2004) found a high MVD 
expression in all primary tumour sizes T3 and T4, while 76.75% of samples with T1 and 
T2 showed a low MVD expression (Sari, 2004). Increased tumour size (about 106 cells), the 
expansion of tumour cell populations requires vascular induction new capillaries (Weidner 
et al, 1991). Mohanad and Mohammed (2010) found significant increases in MVD in color-
ectal adenocarcinoma with a size > 3 mm3 compared with the size <3 mm3.
A total of eight samples (47.1%) with N3  KGB neck size had high MVD expression, 
whereas only 1 sample (7.7%) was present with low MVD expression at N0. Angiogenesis 
of tumours quantified by MVD measurement is currently believed to be one of the most 
important factors in tumour growth and metastasis (Zhao et al, 2006). The increased density 
of the newly formed microvessel is related to the number of cells entering the blood ves-
sels (Weidner, 1995). This explains the increase in MVD expression in groups of N1, N2, 
N3 compared to N0. The highest MVD expression which was 13 samples (76.7%) was also 
found in clinical stage 4. No NPC with clinical stage 1 samples were found because generally 
patients with KNF came at an advanced stage (Taweevisit et al., 2010).
5 CONCLUSIONS
Microvessel high density (> 45 MV/LP) was encountered in 17 tissues of tissues through-
out the entire tissue (56.7%). Overexpression of MVD was mostly found in non-keratinising 
squamous cell carcinoma, primary tumour T4, lymph neck enlargement N3 and clinical stage 
4. In this study, there was an increasing trend of MVD proportional to the increase in tumour 
size, lymph nodes and clinical stage. These three indicators influence the management and 
prognosis of NPC. Therefore, further research is needed on the role of MVD in the manage-
ment and prognosis of patients.
Figure 1. Examination of MVD expression using immunohistochemical CD 31 staining on NPC tis-
sue; Left: low MVD, Right: High MVD expression (200x magnification).
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ABSTRACT: Nasopharyngeal Carcinoma (NPC) is one of the most dominant cancers in 
Southern China and Southeast Asia. The prevalence of NPC in Indonesia is 3.9 per 100,000 
population every year. Cyclooxygenase (COX) is an enzyme in biosynthetic pathways of 
Prostaglandins (PG), thromboxane and prostacyclin of arachidonic acid. Expression of 
COX-2 increases in the early stages of carcinogenesis, and during the development and inva-
sive growth of tumours. To find out the expression of COX-2 in nasopharyngeal carcinoma 
patients this descriptive study was undertaken with 30 NPC samples of patients in Haji Adam 
Malik General Hospital Medan. NPC was mostly found in the group 41–60 years (60%), males 
(73.3%), and non-keratinising squamous cell carcinoma (53.3%). Positive COX-2 expression in 
non-keratinising squamous cell carcinoma (54.5%), T3-T4 primary tumour size (68.2%), neck 
enlargement of N2-N3 (68.3%) and clinical stage of III–IV (90.9%). There is an increase of 
COX-2 expression in the advanced stages of nasopharyngeal carcinoma.
Keywords: Nasopharyngeal carcinoma, COX-2, immunohistochemistry
1 INTRODUCTION
The main therapy for nasopharyngeal carcinoma (NPC) is radiotherapy. Considerations of 
radiotherapy selection are based on the fact that histopathologically most NPCs are undif-
ferentiated carcinoma (75–95%) and radiosensitive non-keratinised carcinomas (Wei, 2006; 
Jeyakumar, 2006). Recent meta-analysis studies suggest the need for additional chemother-
apy to radiotherapy. Concomitant chemoradiotherapy is considered better than single radio-
therapy and in 2006 it was started as standard therapy in patients at an advanced stage (T2B 
or more and/or N+) (Guigay et al., 2006; NCCN, 2010).
Cyclooxygenase (COX) is an enzyme in the biosynthetic pathway of Prostaglandin (PG), 
thromboxane and prostacyclin from arachidonic acid. There are two forms of COX, namely 
COX-1 and COX-2. Cellular expression of COX-2 increases in early stages of carcinogenesis, 
and during the development and invasive growth of the tumour (Murono et al., 2001; Gallo 
et al., 2001; Choi & Milas, 2003). COX-2 expressed on several tumours and in its develop-
ment proved to be a cause of carcinogenesis (Murono et al., 2001; Levita et al., 2009).
2 METHOD
This is a descriptive study conducted at RSUP Haji Adam Malik and Anatomy Pathol-
ogy Department of FK USU. The sample of the study was NPC patients who had been 
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diagnosed by anamnesis, physical examination, radiology examination and histopathology 
examination. Exclusion criteria in this study were patients who had received treatment with 
radiotherapy, chemotherapy or both. Samples were grouped according to gender, age, his-
topathology type and clinical stage. COX-2 expression was assessed using histopathologic 
tests based on immunoreactivity (negative = 0–3, positive/overexpression = 4–9). All data is 
presented in table.
3 RESULTS
This study involved 30 samples with the most being aged 41–60 years (60.0%), while in the 
gender category it was found that the male group is the largest population of NPC patients 
with as many as 22 samples (73.3%). In the histopathologic group, the non-keratinising squa-
mous cell carcinoma (53.3%), and stage in stage IV group (70%) were the highest categories. 
In immunohistochemistry evaluation, most COX-2 overexpressed in non-keratinising squa-
mous cell carcinoma (54.5%), T3–T4 primary tumour size (68.2%), neck enlargement in the 
N2–N3 group (68.3%) and clinical stage in the III–IV group (90.9%).
Table 1. Frequency of Histopathology, Primary Tumour (T), Nodes (S) and Clinical Staging results 
based on COX-2 expression.
Characteristic
COX-2 Expression
Over-reactive % Negative %
Age (y)
≤ 20  0  0,0 1 12,5
21–40  6 27,3 0  0,0
41–60 12 54,5 6 75
> 60  4 18,2 1 12,5
Sex
Male 16 72,7 6 75
Female  6 27,3 2 25
Primary Tumour (T)
T1  5 22,7 2 25,0
T2  2  9,1 3 37,5
T3  6 27,3 1 12,5
T4  9 40,9 2 25,0
Nodes (N)
N0  1  4,5 0  0,0
N1  6 27,3 2 25,0
N2  5 22,7 3 37,5
N3 10 45,6 3 37,5
Clinical Staging
I  0  0,0 0  0,0
II  2  9,1 1 12,5
III  3 13,6 3 37,5
IV 17 77,3 4 50,0
Histopathology
Keratinising SCC  1  4,5 0  0
Non-keratinising SCC 12 54,5 4 50
Undifferentiated carcinoma  9 41,0 4 50
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4 DISCUSSION
In this study, we found the largest group in nasopharyngeal carcinoma were aged 41–60 years 
(60.0%). Chew (1997) in his study found that most NPC patients were aged over 20 years, 
with the biggest group between 50–70 years. In China, NPC started to appear from 15–19 
years old, most often found at 15–34 years with peak age 35–64 years after which there is a 
decline (Chew, 1997).
This study found the gender of patients with nasopharyngeal carcinoma is mostly men 
with as many as 22 people with a ratio to women of 2.7: 1. This is allegedly as a result of the 
work and life habits of men who are often exposed to carcinogenic substances such as expo-
sure to steam, dust smoke, chemical gases, and exposure to formaldehyde and wood vapour 
in the workplace (Chang & Adami, 2006).
The histopathological type found in patients in this study is non-keratinising squamous 
cell carcinoma of 16 tissues (53.3%), followed by WHO type 3 (undifferentiated carcinoma, 
43.4%) and WHO type 1 (keratinising squamous cell carcinoma, 3.3%). This result is con-
sistent with the Harahap (2009) study which found the most histopathologic type in NPC 
patients was WHO type 2 (non-keratinising squamous cell carcinoma) by 50.0%. Non-
keratinising squamous cell carcinoma and undifferentiated carcinoma are the most common 
in NPC endemic areas, such as South China, Southeast Asia and North Africa, while the NPC 
type keratinising squamous cell carcinoma is more common in Europe (Guigay et al., 2006).
Increased COX-2 expression has been reported in various types of cancer in humans, 
including at least 80% of breast, colon, oesophageal, liver, lung, pancreatic, prostate, cervical 
and head and neck cancers (Choy & Milas, 2003). COX-2 overexpression is most common 
in T4 primary tumours (40.9%). The difference in the rate of proliferation with apoptosis 
rate when the greater the value, the greater the growth. Decreasing levels of COX-2 expres-
sion also reduce the rate of proliferation and apoptosis, which means lower tumour growth 
rates (Wu et al., 2003; Irianiwati, 2006). This is seen in the use of selective COX-2 inhibitors 
(Gandamihardja, 2010). High COX-2 expression will also increase proliferative markup 
expression such as Ki-67. In addition, the larger the size of the tumour the lower the expres-
sion of kaspase-3. This explains that COX-2 is involved in maintaining proliferation and 
inhibiting apoptosis thus accelerating tumour growth. Appropriate results were also proposed 
by Gandamihardja (2010) that selective COX-2 inhibitors resulted in a significant decrease 
in COX-2 expression, specifically 10% in the control group and 42% in the treatment group.
In regional metastasis, COX-2 overexpression was found most frequently in N3 lymph 
node (45.6%), with the lowest in N0 (4.5%). Kardinan (2003) in his study in colon carcinoma 
suspected COX-2 involvement in lymph node metastasis.
Figure  1. Immunohistochemical COX-2  staining (100x magnification) Left: weak intensity; Right: 
strong intensity.
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Elevated COX-2 expression was most common in stage 4 of 21 tissues (70%), and the low-
est was found in stage 2, in three tissues of nasopharyngeal carcinoma (10.0%). Tan and Putti 
(2005) conducted a study to assess COX-2 expression in NPC. Their research shows that 
there is a high proportion (60 out of 85 cases of NPC, 71%) expressing COX-2. Soo (2005) 
found an increase in COX-2 expression in 33 of 42 cases of NPC (79%) using immunohisto-
chemical methods. Although in the last two decades progress has been made in the methods 
of health screening and education, only a few changes have been made in establishing early 
diagnosis of NPC. Stage I still ranges from less than 10% of all cases (Chew, 1997).
The highest COX-2 expression was found in non-keratinising squamous cell carcinoma 
type of 12 samples (54.5%). Tan (2008) in his study found the same result. Another study 
found that COX-2 is associated with inflammatory responses, cell differentiation, cell cycle 
resting phases, apoptosis, cytokine production and RNA-related separation settings associ-
ated with EBV infection. Non-keratinising squamous cell carcinoma and undifferentiated 
carcinoma are most associated with EBV infection (Yenita & Asri, 2012).
5 CONCLUSION
In this study, we found an elevated of COX-2 expression in non-keratinising squamous cell 
carcinoma type, primary tumour T3-T4, nodes N2–N3 and clinical staging III–IV. Further 
research is required to understand the role of Cyclooxygenase-2 in the progression and prog-
nosis of disease in nasopharyngeal carcinoma patients that can be used to provide optimal 
therapy.
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ABSTRACT: Parotid glands Squamous Cell Carcinoma (SCC) are extremely uncommon. 
Most of the parotid SCC are metastases from the skin squamous cell carcinomas. Diagnosis 
of primary SCC of the parotid gland can be made by excluding the high-grade mucoepider-
moid carcinoma or metastatic SCC to the parotid gland. Combined modality treatment with 
surgery, facial nerve sparing and adjunctive radiotherapy is the treatment recommended by 
most of the researchers.
Keywords: squamous cell carcinoma, parotid gland.
1 INTRODUCTION
Parotid glands carcinoma are considered uncommon with an overall incidence of 3–5% of all 
head and neck cancers (DeVita et al., 2011; Edge, 2010). Mucoepidermoid carcinoma is the 
most common salivary malignancy, of which 50–70% arise in the parotid gland. On the other 
hand, most of the squamous cell carcinomas (PSCC) of the parotid glands are metastases 
from the skin squamous cell carcinomas. Occasionally, the primary site cannot be found. Pri-
mary parotid gland SCC is an aggressive tumour with an incidence 0.1–3, 4% of all parotid 
malignancy (Flynn et al., 1999). It is unknown whether or not such cases represent true pri-
mary parotid squamous cell carcinoma. We are reporting here a case of primary squamous 
cell carcinoma of the left parotid gland that means squamous cell carcinoma of parotid may 
not be metastases from another site.
2 CASE REPORT
A 74-year-old Malay female was presented to our otorhinolaryngology clinic at Univer-
sity Malaya Medical Center one and half  years ago with painless left side facial swelling. 
The mass gradually increased in size with no facial asymmetry. The overlying skin and oral 
mucosa were found to be normal in colour and not swollen. Fine needle aspiration was done 
which reported that neoplastic squamous epithelium was present; and the patient refused 
surgical intervention.
After a few months she returned back to the clinic with worsening facial swelling of about 
5 × 5 cm. It was firm, non-tender and extended from the annular area to retro mandibular area 
with a raised pinna lobule. No remarkable change was noted either on the surface of the buccal 
mucosa or on the skin of the cheek. A repeated FNAC resulted in SCC of the parotid gland. 
A whole body scanning and a Computed Tomography (CT) scan revealed a solid mass measuring 
3.3 × 4.5 × 5.9 cm with area of rim enhancing hypo density seen within the gland as in Figure 1.
The patient underwent a preservative total parotidectomy. Intraoperative frozen section 
showed SCC of parotid gland. The tumour was extensive and the facial nerve ran through the 
tumour itself  as in Figure 2. To excise the whole tumour we had to sacrifice the facial nerve. 
The histopathology report came out as moderately differentiated SCC and she was referred 
to oncology for post-operative radiation.
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3 DISCUSSION
Primary parotid gland SCC is an uncommon and highly malignant potential tumour that 
occasionally occurs in the major salivary glands (Ellis & Auclair, 1996; Wenig, 1993). Among 
various pathologic subtypes of parotid gland malignancy, the primary parotid gland SCC 
accounts for approximately 0.3–9.8% of all parotid gland malignant tumours (Bataskis et al., 
1976; Shemen et al., 1987). The frequency of PSCC is about nine times greater in the parotid 
gland than in the submandibular gland (Ellis & Auclair, 1996). Diagnosis of primary SCC of 
the parotid gland can be made by excluding the high-grade mucoepidermoid carcinoma or 
metastatic SCC to the parotid gland (Bataskis et al., 1976; Shemen et al., 1987) and it has been 
reported that the incidence of primary SCC of parotid is lower than that of metastatic SCC 
to the parotid glands (Bataskis et al., 1976; Shemen et al., 1987). It is proved that in parotid 
malignancy that histology is an important factor in survival. But because of the rarity of this 
disease and it usually being categorised under parotid malignancies (Friedman et al., 1986), 
Figure 1. Shows left parotid gland enlargement and heterogeneously enhancing.
Figure 2. Shows intraoperative facial nerve runs through parotid tumour.
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clinical features and modality of treatment for primary SCC of the parotid gland are not yet 
fully understood (Friedman et al., 1986).
Primary SCC of the parotid gland has been accepted in case the high-grade mucoepider-
moid or metastatic carcinoma are excluded. The incidence of primary SCC is much lower 
than that of SCC metastatic to the parotid glands (Bataskis et al., 1976; Shemen et al., 1987).
Marks et al. (1987) stated that “of 30 patients with parotid gland SCC, majority 24 patients 
had experienced intra-parotid nodal metastasis from other areas of cancer, three patients had 
direct invasion into the gland from skin cancer overlying the parotid gland, whereas only 
three patients were diagnosed as a primary SCC of the parotid gland”.
In literature it has been established that the surgical resection is the major treatment modal-
ity for primary parotid gland malignancies. However several factors such as such as tumour 
size, extent of tumour, presence of metastasis and facial nerve involvement have an influence 
in management decision (Woods et al., 1975; Zbaren et al., 2005).
The clinically negative (N0) neck management is still challenging. It’s well established that 
presence of regional metastasis is an indication for therapeutic neck dissection; however most 
experts strongly recommend elective neck dissection (END) in the management of clinically 
negative (N0) neck (Armstrong et al., 1992) although the effectiveness of the elective neck 
treatment (radiotherapy or neck dissection) are limited on survival rate (Zbaren et al., 2005; 
Armstrong et al., 1992).
Zbaren et al. report that “routine END should be performed to all primary SCC of parotid 
gland” [12], whereas Kelley and Spiro state that “END is an appropriate management for 
patient with facial nerve paralysis, extra parotid tumour extension, old age, perilymphatic 
invasion and the high tumour grade” (Kelley & Spiro, 1996).
In term of  5-year survival rate the parotid gland SCC has a poor prognosis being less 
than 50% (Woods et al., 1975; Armstrong et al., 1992). While Lee et al. (2001) put forth that 
“a 5-year DSS of  31.3% for primary parotid SCC” and Michael J et al. (2014) found out 
that a 5-year DSS of  54.4% for primary parotid SCC.
Michael J. P. Fisterer et al. conducted a population-based analysis of 2,545 cases and dis-
covered that parotid SCC was predominant in males (79.8%), whites (92.9%), and age group 
≥ 75 years. The poor prognostic factors were black race, age ≥ 75 years and clinical stages T3 
or greater. Patients with negative neck (N0) who underwent elective neck dissection (END) 
were associated with higher DSS (78.3% versus 51.1%, p <  0.0001) (Michael et al., 2014) 
whereas patients who did not receive END had a DSS of 51.1%. In terms of the histological 
grades they claim that “parotid gland SCC with histologic grade III has a 1.4-fold greater 
hazard of death than relative to grade I”. Patients with positive neck disease and did not 
undergo a neck dissection had poor prognosis with a 2.8-fold hazard of death compared to 
patients who received a TND.
4 CONCLUSION
Primary parotid gland SCC is a rare entity, and it is concluded that SSC of the parotid glands 
are mostly metastatic rather than primary tumours. The objective of reporting this case is 
to provide information in the field of primary parotid gland SCC management to deal with 
reporting the tumour’s behaviour and its management. Most authors recommend that com-
bined modality treatment with surgery, facial nerve sparing, and adjunctive radiotherapy is the 
treatment.
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ABSTRACT: The Singh index is the classification of trabecular patterns on the proximal 
femur, which can be seen with the use of X-rays. Since 1976, smoking has been linked to a 
decrease in bone density. This cross-sectional study was performed at the Haji Adam Malik 
Medan Hospital, Medan, Indonesia. Samples were divided into two groups of smokers and 
non-smokers, with 43 persons in each group. The Singh index value was evaluated from pelvic 
X-rays undertaken within both samples. There was a significant correlation between smoking 
and the Singh index value (p = 0.002). The duration of smoking directly affected the Singh 
index (p = 0.001), but there was no correlation between the cigarette type (p = 0.932) and the 
frequency of smoking (p = 0.259) with the Singh index. It was found that smoking has a sig-
nificant correlation with the Singh index value, where the smoking group had a lower Singh 
index value compared to the non-smoking group.
Keywords: osteoporosis, Singh index, smoking
1 INTRODUCTION
Osteoporosis is now viewed as a metabolic disease of the bone that is quite often found 
daily (World Health Organisation, 2004). In 2005, it was noted by the Center for Research 
and Development of Nutrition and Maintenance that as many as 10.3% of the entire Indo-
nesian population suffered with osteoporosis. According to PEROSI data in 2006, of the 
total number of patients who came for bone mineral density examination in Makmal inte-
grated FK UI, as much as 14.7% had osteoporosis. This amount will certainly increase every 
year, which will bring high morbidity with the occurrence of fractures. The more obvious 
problems in the Indonesian population are the low level of awareness and the high ‘undiag-
nosed’ rate in patients, due to the lack of both material and expert facilities needed to detect 
osteoporosis (Roeshadi, 2008).
The most feared and often occurs Battery process osteoporosis is a fracture. Fractures 
will greatly increase the morbidity and mortality of patients with osteoporosis, and the most 
common incidence of fractures is in the spine and wrist (Lucas et al., 1993). Therefore the 
examination detects.
Osteoporosis within the pelvic bone (proximal femur), spine (lumbar spine) and wrist 
(distal radius) was focused on within this study.
The Singh index is a trabecular image of the proximal femur that can be assessed using 
X-rays. This method has long been used in the screening as well as grading of the presence of 
osteoporosis in a patient. Much research has been done to assess the reliability of the Singh 
index, especially its comparison with the DEXA scan method, that has been determined 
as the ‘gold standard’ for diagnosing osteoporosis. But there are still some modern-day 
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advantages of the Singh index method, especially regarding cost-effectiveness when compared 
with other methods (Greenspan, 2004; Jergas, 2000). A meta-analysis study has attempted 
to find a direct link between smoking behaviour and bone health. It has been shown that 
there is a significantly proportional and significant effect of smoking behaviour on the risk 
of fracture, especially in the pelvis, spine and heel bone. For the smoking population, there is 
an increased risk in the occurrence of osteoporosis fractures; as much as 25% increasing to 
40–80% in the hip bone. The risk of an osteoporosis related fracture reaches 90% in smoking 
populations aged over 85 years.
2 METHOD
This research used a descriptive-analytic (cross-sectional) method. The population in this 
study were Indonesian men aged 60 years or older who came to Haji Adam Malik Hospital in 
Medan. The inclusion criteria was defined as: 1) male; 2) aged 50 years or more; 3) an X-ray 
taken in the Department of Radiology at the Haji Adam Malik Hospital; and 4) the patient 
was willing to participate in the study. The exclusion criteria was defined as: 1) a history of 
trauma to the pelvic bone or pelvis for longer than two weeks; 2) a history of taking corticos-
teroid drugs and anti-osteoporosis medications; 3) a history of intestinal surgery or thyroid 
surgery; 4) a history of cancer; and 5) a history of mumps.
3 RESULTS
In this research, the study population came from the patient population of Haji Adam Malik 
Hospital. As many as 86 people fulfilled the inclusion and exclusion criteria, and consisted 
of 43 people who smoked and 43 people who did not smoke.
Figure 1 shows most of the sample population (46) had a Singh index of 4–3 which is 
categorised as light osteoporosis (59.3%).
From Figure 2, it can be seen that the non-smoking population mostly had a Singh index 
of 6–5 (in 18 samples), which is classified as normal and corresponds to 20.9% of the total 
sample population. While the smoking population, mostly had a Singh index of 4–3 (in 
35 samples) which equates to mild osteoporosis in 40.6% of the total sample population.
4 DISCUSSION
Since it was first publicised in 1976 that there is a relationship between smoking and the 
occurrence of osteoporosis, more research has been done, including those seeking a link 
between smoking and the incidence of pathologic fracture in the pelvis. A meta-analysis 
Figure 1. Distribution of Singh index value in 
the total population.
Figure 2. Distribution of Singh index 
value in each proportion.
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study published by Vestergaard et al., stated that smoking significantly increases the risk of 
osteoporotic fractures in each region of the body, especially in the lumbar and proximal bone 
of the femur (Hoidrup, et al., 2000).
In the population who smoked, 35 samples (40.6%) were categorised as having mild osteo-
porosis (Singh index of 4–3) and four samples (6%) were categorised as having severe osteo-
porosis (Singh index of 2–1).
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ABSTRACT: Malnutrition is still a health problem that affects a child’s development and 
survival rate in developing countries. Malnutrition may cause lower serum zinc levels than 
normal children. Albumin is an important protein transport for zinc because 80% of zinc is 
bound to the albumin. A cross-sectional study was conducted in H. Adam Malik Hospital, 
Pirngadi Hospital and the University of Sumatera Utara Hospital, Indonesia, between July 
and November 2016. The study sample was children aged six months to five years old who had 
no liver function disturbances, kidney disease, were not obese or overweight, and did not take 
any zinc supplements. Anthropometric, serum zinc, and albumin level measurements were 
taken along with demographic information. Fifty-one samples were obtained and divided into 
normal nutrition status, moderate malnutrition, and severe malnutrition groups, equally. Sig-
nificant associations between malnutrition and serum zinc, and also malnutrition and albumin 
were found. There was a significant correlation between serum zinc and albumin level.
Keywords: albumin, children, malnutrition, zinc
1 INTRODUCTION
Malnutrition is still a health problem that affects a child’s development and survival in devel-
oping countries (Nolla, 2014). Data from the World Health Organization shows that for 
under-fives, approximately 150 million suffer with low weight and around 182 million have 
short stature (World Health Organization, 2007). Riset (2013), reported that work completed 
by Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan of Indonesia 
between 2007 and 2010, found that 18.4% of under-fives had mild to moderate malnutrition. 
This number increased to 19.6% in 2013.
Zinc is one of the trace elements which plays an important role in nutritional require-
ments. A case-control study amongst children with marasmus, kwashiorkor and marasmic-
kwashiorkor, stated that zinc serum levels in malnutritioned children was lower than that of 
healthy ones (Khubchandani, 2003). In a prospective study, the prevalence of zinc deficiency 
was found to be 50% (Gatto, 2015).
2 METHOD
This cross-sectional study was conducted at Haji Adam Malik Hospital, Pirngadi Hospital 
and the University of Sumatera Utara Hospital, Indonesia, between July and November 
2016. Study samples were hospitalised children aged six months to 5 years old who had no 
liver function disturbances and kidney disease. Samples were also not overweight or obese and 
did not consume zinc supplements two weeks prior to the study. Samples were obtained by 
using a consecutive sampling method. Demographic and anthropometric data were obtained 
by questionnaire and physical examination. Blood samples were collected and analysed for 
zinc and albumin serum levels. Data analysis was undertaken using statistical software, and 
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the results are presented in Tables 1–4. Informed parental consent was obtained before the 
child was enrolled onto the study. This study was approved by the Health Research Ethical 
Committee at the Medical School of the University of Sumatera Utara.
Normality tests were conducted using the Kolmogorov-Smirnov test. A Kruskal-Wallis 
test was performed in order to determine the association between nutritional status, and 













































Mean of body weight, kg (SD) 10,2 (2,80) 9,4 (2,46) 6,9 (2,33)
Mean of height, cm (SD) 80,6 (12,38) 82,6 (15,00) 79,0 (12,58)
Mean of age, months (SD) 22,7 (14,16) 24,3 (16,98) 20,6 (14,13)
Table 2. Association between nutritional status and mean serum zinc level.
Nutritional status




Normoweight 40,0 3,03 0,026
Mild to moderate 
malnutrition
29,9 2,10
Severe malnutrition  6,9 0,56
*Kruskal-Wallis test.







Normoweight 3,7 0,12 0,007
Mild to moderate 
malnutrition
3,4 0,06
Severe malnutrition 3,0 0,19
*Kruskal-Wallis test.
Table 4. Correlation between serum albumin and serum zinc level.
Variable Mean
Standard 
deviation (SD) R p*
Zinc 33,3 1,48 0,371 0,007
Albumin  3,4 0,08
*Spearman test.
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serum albumin and zinc levels. To determine the correlation between serum albumin and zinc 
levels, the Spearman test was used. A 95% confidence interval was chosen and p < 0.05 was 
considered significant.
3 RESULTS
A total of 51 children were enrolled onto this study and divided into three groups which were 
equally based on nutritional status. Of 51 children, 23 were from North Sumatera province, 
and the rest were from other provinces. Table 1 shows sample characteristics distribution. It 
was found that the mean sample weight for ‘normoweight’ (normal weight), ‘mild to mod-
erate malnutrition’, and ‘severe malnutrition’ was 10.2 kg (SD = 2.80), 9.4 kg (SD = 2.46), 
and 6.9 kg (SD = 2.33), respectively. Mean sample stature was 80.6 cm (SD = 12.38) for the 
normoweight group, 82.6 cm (SD = 15.00) for the mild to moderate malnutrition group, and 
79.0 cm (SD = 12.58) for the severe malnutrition group.
The results of the serum zinc levels were obtained two weeks after blood processing, while 
serum albumin level were obtained one day after blood processing. Based on the Kruskal-
Wallis test, there was a statistically significant relationship between nutritional status and 
serum zinc levels in this study (p =  0.026). Children with the worst nutritional status had 
lower serum zinc levels (Table 2).
Table 3 shows the association between nutritional status and mean serum albumin level. 
Based on the statistical analysis, there was a significant relationship between nutritional sta-
tus and mean serum albumin level (p = 0.007). Children with better nutritional status had a 
higher serum albumin level.
The correlation between serum albumin and serum zinc level was also statistically analysed 
by using the Spearman test. The results showed that there was a significant positive correla-
tion between mean serum albumin and mean serum zinc level (r = 0.371; p = 0.007).
4 DISCUSSION
Malnutrition is still a common health problem globally, but is mainly found in developing 
countries. Malnutrition in children will affect a population because it disturbs children’s growth 
and development, cognitive function later in life, and hampers the economic development of a 
country. Besides this, malnutrition in children will also increase morbidity and mortality from 
several diseases after the children reach adulthood (Nolla, 2014; Marasinghe, 2015).
The number of samples studied was 51 children, which were divided into three groups 
based on nutritional status. Their nutritional status was determined using a weight to height 
percentage ratio. Samples in this study were aged between six months and five years old and 
were from an urban area.
In this study, a statistically significant relationship between malnutrition and serum zinc 
levels was found. Statistical analysis showed that children with the worst nutrition status 
had lower serum zinc levels. This result is confirmed by several other studies. A research 
study in 2016 looked at 56 children with malnutrition in the teaching hospital of  Hanyang 
University, South Korea; the children were aged 1 to 15 years old and had their serum and 
hair zinc levels evaluated. There was a statistically significant association between hair zinc 
levels and malnutrition, where 55% of children with malnutrition also had zinc deficiency 
(Han et al., 2016).
Several other studies show the same results of this study. A study in Cameroon in 2014, 
reported no association between serum zinc level and nutritional status (Nolla, 2014). 
Another study from Bangladesh in 2009 reported the same result; an association between 
malnutrition, serum vitamin D level and haemoglobin was found, but not with serum zinc 
levels (Marasinghe, 2015). A study in South Africa in 2015 also confirmed the results above 
and stated that there was no association between serum zinc levels and malnutrition; it was 
thought that a helminth infestation was a confounder (Amara, 2012).
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In this research study, a statistical analysis to determine the correlation between serum 
albumin and serum zinc levels was conducted. The results show that there was a significant 
correlation between serum albumin and serum zinc levels (r = 0.371; p = 0.007). These results 
are supported by a 2013 study in the United States, where a significant correlation between 
serum albumin and serum zinc levels amongst 691 children aged between six and eleven years 
old was found. However, the correlation was weak, and the researchers decided that serum 
albumin levels were not a sensitive predictor of zinc deficiency in children with malnutrition 
(Bui, 2013). A study from South Korea in 2016 also reported that there was no significant 
correlation between serum zinc and albumin levels (Han, 2016).
Despite the results above, this study still has several weaknesses. First, the confounders for 
serum zinc and albumin levels, such as infection, diet pattern and knowledge about nutrition, 
had not been investigated in each sample, and that caused bias in the results of this study. 
Infection was the main confounder because samples in this study were hospitalised patients 
and thus were susceptible to infection. Infection can trigger inflammation and lower serum 
albumin levels, as well as malnutrition itself. A study from Japan in 2014 showed that serum 
albumin levels decreased in concomitant with increased C-reactive protein levels (the latter 
is a marker of inflammation) (Ishida et al., 2014). Inflammation will also affect serum zinc 
levels because zinc plays the role of a cofactor for enzymes in the immune system. The pres-
ence of infection and inflammation will therefore, increase zinc utilisation. It should be noted 
that zinc is not deposited in the human body and must be obtained from food intake (Walker 
& Black, 2004).
5 CONCLUSIONS
This study shows that there is a statistically significant association between malnutrition, and 
serum zinc and albumin levels. There is also a significant correlation between serum zinc and 
albumin levels.
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ABSTRACT: Domestic violence is a social problem associated with an increased risk of 
mental illness in women. This study investigated the association between education level, 
length of exposure and economic level with the level of depression amongst woman expe-
riencing domestic violence. This study was an observational study with a cross-sectional 
approach. Participants were women (82 in total) who were experiencing domestic violence, 
and were seeking support from PPT Bhayangkara Hospital and the psychiatry clinic of Pirn-
gadi Hospital, Medan, Indonesia. An association was found between education level and 
level of depression (p = 0.01), length of exposure and level of depression (p = 0.01), and eco-
nomic level and level of depression (p = 0.01). Factors significantly associated with a higher 
level of depression amongst women experiencing domestic violence were low educational 
level (OR = 3,754, p = 0.022), economic level (OR = 4,436, p = 0.01) and length of exposure 
(OR = 4,939, p = 0.018). Awareness needs to be raised through the mental health services 
and the government in the prevention of depression through psychosocial interventions for 
women experiencing domestic violence.
Keywords: domestic violence, depression, economic level, education level, length of exposure
1 INTRODUCTION
Women being abused over a long period may result in significant mental distress (Wong et al., 
2012). In studies examining violence, women who report abuse have higher rates of depression 
(Lawrence et al., 2004). Domestic violence is associated with depression, including depres-
sive symptoms, depressive disorders and suicide. Risk factors associated with depression in 
female survivors of domestic violence include age, education level, socio-economic status, 
and a long experience of violence (Ferrari et al., 2014).
Wong et al.’s (2012) study in Hong Kong amongst 200 women experiencing violence from 
their intimate partner in the Chinese community, used a Chinese version of the Beck Depres-
sion Inventory-Version II (C-BDI-II). They reported levels of depressive symptoms of: ‘mini-
mal level’ (9%, n = 18); ‘mild level’ (9.5%, n = 19); ‘moderate level’ (7%, n = 14); and ‘severe 
level’ (74.5%, n = 149) (Wong et al., 2011).
A study by Hegarty et  al. (2004) in Australia amongst abused women, reported 18% 
(218/1213) as currently ‘probably depressed’ and 24.1% (277/1147) had experienced some 
form of abuse in an adult intimate relationship (Hegarty & Gunn, 2004).
Abused women that experience depression are more likely to have experienced severe com-
bined abuse and violence, greater poverty, differing social rules and sex discrimination, more 
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negative life events abuse as a child and a poor education. They are also likely to be not mar-
ried, on a low income, unemployed or receiving a pension or pregnant.
The Beck Depression Inventory-II (BDI-II) is one of the most frequently used measures 
of the severity of depression in adolescents and adults, by both researchers and clinicians. 
BDI-II consists of 21 items that assess the symptoms of depression experienced over the 
previous two weeks. Each item contains four statements that reflect on the varying degrees 
of symptom severity. Respondents are instructed to circle the number (ranging from zero to 
three, indicating increasing severity) that corresponds with the statement that best describes 
their mental state. Rating is summed to calculate a total BDI-II score, which can range from 
0 to 63. BDI scores of 0–13 indicate a ‘minimal level of depression’, scores 14–19 indicate 
‘mild depression’, scores 20–28  indicate ‘moderate level’ and scores 29–63  indicate ‘severe 
depression’ (Grothe et al., 2006).
2 METHOD
This study is an observational study with an analytic comparative design and uses a cross-
sectional approach. Participants were 82 women seeking help from the Domestic Violence 
and Abuse Service in Medan, North Sumatera, Indonesia.
Eligible participants were women who were experiencing domestic violence or abuse which 
led them to seek support from Pusat Pelayanan Terpadu Bhayangkara Hospital and the psy-
chiatry clinic of Pirngadi Hospital, Medan, between August 2015 and March 2016. The par-
ticipants were women who had experienced domestic violence or abuse (emotional, physical, 
sexual or neglect) from adult family members, were aged between 18 and 60 years old, and 
were able to communicate in the language of Bahasa Indonesia. Women who suffered with 
other mental illnesses, had a history of medical illness, drug or alcohol problems, were cur-
rently receiving counselling, cognitive behavioural therapy or other psychological treatments, 
and were currently taking antidepressants or other psychopharmacologies, were excluded 
from this study (Ferrari et al., 2014).
Depression was assessed using the BDI-II rating scale. The results of the BDI-II was inter-
preted when all the data collection was complete. A bivariate analyses was used to examine 
the association between education level (high school and higher), length of abuse exposure 
greater, less than or for one year) and economic level (mild, moderate and high), with level 
of depression (mild, moderate and severe). Multivariate logistic regression was used to inves-
tigate the association between the independent variables and depression. The study was 
approved by the Medical Faculty of the Universitas Sumatera Utara Health Research Ethi-
cal Committee. Statistical tests were performed using SPSS software.
3 RESULTS AND DISCUSSION
A total of 82 women experiencing domestic violence and abuse were enrolled onto the study. 
The majority (93.9%) were married and aged between 31 and 40 years old (37%). Of this sam-
ple, 50% of them were in paid employment. The study revealed that 74.4% (61/82) had been 
experiencing abuse for more than one year, 9.8% (8/82) were experiencing physical abuse, and 
8.5% (7/82) were experiencing emotional abuse. It was also found that 19.5% (16/82) were suf-
fering a combination of physical and emotional abuse, 40.2% (33/82) neglect and emotional 
abuse, 18.3% (15/82) neglect, physical and emotional abuse, and 3.7% (3/82) neglect, physical, 
emotional and sexual abuse.
Out of 54 participants, 34 (63%) with a high school education suffered with severe depres-
sion, and for participants with education higher than high school, 25% (7/28) suffered with 
severe depression. Chi-square analysis showed there was significant association between edu-
cation level and level of depression (p = 0.01). It was also found that 61 participants had 
been experiencing abuse for more than one year, and 37 of them (37/61, 60.7%) suffered with 
severe depression.
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Of participants who were experiencing less than one year of abuse, 19% (4/21) suffered 
with severe depression. It was found that the length of exposure has a significant association 
with level of depression (p = 0.001).
Analysis of the results also revealed that 28 participants had a low economic level, 34 par-
ticipants had a middle economic level and 20 participants had a high economic level. Amongst 
low economic level participants, 71.4% (20/28) suffered with severe depression whereas 
amongst middle economic level participants, 50% (17/34) suffered with severe depression, and 
amongst the high economic level participants, 20% (4/20) suffered with severe depression. 
Therefore, economic level has a significant association with level of depression (p = 0.001).
Using structured multiphase logistic regression with the enter method, it was found that 
all of the independent variables had a significant association with the level of depression 




 18–30 21 25,6
 31–40 37 45,1
 41–50 17 20,7
 >50  7  8,5
Marital Status
 Married 77 93,9
 Single or separated  5  6,1
Employment status
 Paid employment 41 50
 Not employed 41 50
Education
 ≤Grade 12 54 65,9
 >Grade 12 28 34,1
Economic level
 Low 28 34,1
 Middle 34 41,5
 High 20 24,4
Length of exposure
 ≤1 year 21 25,6
 >1 year 61 74,4
Table 2. Level of depression amongst women experiencing domestic violence.
Level of depression BDI-II score n %
Mild 14–19 17 20,7
Moderate 20–28 24 29,3
Severe 29–63 41 50
Total 82 100
Table  3. Analysis of multivariate risk factors for 
depression in women experiencing domestic violence.
p OR 95% IK
Education level 0,022 3,754 1,205–11,692
Economic level 0,01 4,436 1,428–13,784
Length of exposure 0,018 4,939 1,309–18,632
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(p = 0.01, OR = 4,436, 95% CI = 1,428–13,784) and length of exposure (p = 0.018, OR = 4,939, 
95% CI = 1,309–18,632).
4 CONCLUSION
The main finding of this study is that there is a significant association between education 
level, length of exposure and economic level, with the level of depression suffered amongst 
women experiencing domestic violence. Awareness needs to be raised through the mental 
health services and the government, in the prevention of depression through psychosocial 
interventions for women experiencing domestic violence.
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Correlation of irritant exposure with nasal mucociliary 
transportation time for gas station workers in Medan
J. Tobing, A.Y.M. Rambe, F. Sofyan & T. Ashar
Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, 
Universitas Sumatera Utara, Medan, North Sumatera, Indonesia
ABSTRACT: The exposure of irritant substances, such as benzene, toluene, xylene, and 
ethylbenzene in the air can cause a disruption in transportation time of nasal mucociliary. The 
aim of this study was to find out the correlation between exposure to irritant substances and 
their effect on nasal mucociliary transportation time for workers at a gas station in Medan 
city, Indonesia. The type of research was analytical with a cross-sectional study design. There 
are 42 samples of subjects according to the inclusion and exclusion criteria where 31 subjects 
went through a deceleration of nasal mucociliary transport time. The location of exposure 
has a significant correlation between the nasal mucociliary transport time disorder that is 
as many as 31 people (100%) on direct exposure. The nasal mucociliary transport time was 
found to slow in the gas station workers who were exposed to a direct irritant.
Keywords: benzene, general nasal mucociliary, general refuelling station, toluene, xylene
1 INTRODUCTION
Exposure to recurrent air pollution in the environment will lead to many disruptions to 
the human body, such as heart and lung function disorders, brain disorders, cognitive and 
behavioural disorders and airway problems. One source of air pollution is fuel oil which is 
the world’s largest volume of fuel that has a complex content, with varying composition, 
depending on the source of its basic material (crude oil), the filtration process and other 
factors (Grebic et al., 2007). The aim of this study was to determine the correlation between 
exposure of irritant substance and disruption to transportation time of nasal mucociliary for 
gas station workers in Medan city.
2 METHOD
This research was analytic with a cross-sectional approach. The sample studied within this 
research was the gas station officer who fulfilled the inclusion criteria. The sampling formula 
of proportion produced at least 34 samples. This study obtained 42 samples/people.
3 RESULTS
3.1 The characteristics of the subject’s demography research
The results of the nasal mucociliary transport examination towards the officers showed that 
there were 31 subjects (73.8%) who had nasal mucociliary transport disruption (nasal muco-
ciliary transport time greater than 17  minutes). The number of subjects directly exposed 
to fuel at the gas station was 31 people (73.8%) while 11 people (26.2%) were not directly 
exposed.
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3.2 Statistical analysis results
3.2.1  The correlation between location exposure with transportation time of nasal 
mucociliary
Table 1. The correlation between location of exposure with trans-
portation time of nasal mucociliary.
Location of 
exposure
Transportation time of 
nasal mucociliary
p-value>17 minutes ≤17 minutes
Direct 31 (100) 0 <0.001
Indirect 0 11 (100)
3.2.2 The correlation between age and transportation time of nasal mucociliary
In the direct exposure group, significant correlation between age and transportation time of 
nasal mucociliary (p = 0.001), within the correlation value of r = 0.560, was found. The cor-
relation value indicated that there was moderate correlation with the positive value, which 
means that increasing age of the officer would be followed by an increasing transportation 
time of nose mucociliary. Meanwhile, for the group of officers who were not directly exposed, 
there was also a positive correlation between age and transportation time of nasal mucocili-
ary, with a strong correlation value of r = 0.771.
3.2.3 The correlation between sex and transportation time of nasal mucociliary
Transportation time of nasal mucociliary for the male officers in both groups was found to be 
longer in comparison to the female officers. In the direct exposure group, transportation time 
of nasal mucociliary for male officers was 22 minutes (SD = 1.97 minutes), while for female 
officers it was 19.33 minutes (SD = 1.54 minutes). The analysis used the Mann-Whitney test. 
It showed that there was a significant correlation (p < 0.001) between the sexes and trans-
portation time of nasal mucociliary for the group of officers which were exposed directly. In 
contrast, for the group of officers who were not directly exposed, no significant correlation 
was found (p = 0.104) after being analysed by the independent t-test, even though the trans-
portation time of nasal mucociliary in male officers was longer than the transportation time 
for female officers.
3.2.4  The correlation between the length of work and transportation time of nasal 
mucociliary
Analysis using the Spearman correlation test showed there was no significant relationship 
between duration of work and transportation time of nasal mucociliary (p = 0.084), in all 
research subjects.
3.2.5  The correlation between length of work and transportation time of nasal mucociliary 
on exposed subjects
Analysis by using the Spearman correlation test on exposed subjects in gas stations concluded 
that there was a significant correlation between the length of work and transportation time 
of nasal mucociliary (p < 0.001), with a correlation value of r = 0.717. The correlation value 
indicates that there was a strong and positive correlation between the length of work with the 
transportation time of nasal mucociliary; this means that the longer subjects are exposed (to 
fuel working in gas stations), the greater the transportation time of nasal mucociliary.
3.2.6 The correlation between smoking habits with transportation time of nasal mucociliary
The average transportation time of nasal mucociliary in officers who were exposed directly 
and smoked was 22.13 minutes (SD = 1.96 minutes), while the non-smoking officers had a 
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lower average of 19.38 minutes (SD = 1.5 minutes). The analysis by using the Mann-Whitney 
test showed that there was a significant correlation (p < 0.001) between smoking and trans-
portation time of nasal mucociliary in officers exposed directly. The officers that were not 
directly exposed and who smoked, had a longer transportation time of nasal mucociliary 
with an average of 15.6 minutes (SD = 1.52 minutes) compared to non-smokers who had an 
average transportation time of 14 minutes (SD = 1.41 minutes). However, analysis by using 
the independent t-test, showed that there was no significant correlation between smoking 
habits and transportation time of nasal mucociliary in the workers that were not directly 
exposed (p = 0.104).
4 DISCUSSION
From the 31 subjects which were directly exposed, all had undergone the disruption of trans-
portation time of nasal mucociliary, whereas from 11 subjects who were not exposed directly 
did not disruption of nasal mucociliary transport. Analysis by using the Fisher’s Exact test 
showed that there was a significant correlation between the exposure location and trans-
portation time of nasal mucociliary disruption (p < 0.001). This result was similar to previ-
ous research on the correlation between silver dust exposure with transportation time of 
nasal mucociliary conducted by Suherman (2013) in Kota Gede, Yogyakarta, Indonesia. The 
results showed a positive and very strong correlation between workers exposed directly to sil-
ver dust with those who were not exposed directly to silver dust; where workers were directly 
exposed, transportation time of nasal mucociliary any longer.
In the direct exposure group, significant correlation was found between age and trans-
portation time of nasal mucociliary (p = 0.001), with a correlation value of r = 0.560. The 
correlation value indicates that there is a moderate correlation with the positive value, which 
means that the increasing age of the officer will be followed by increasing transportation time 
of nasal mucociliary. The results of this study supported a theory that states that one of the 
factors that affect transportation time of nasal mucociliary is age. The transportation time 
of nasal mucociliary increased with the increase of age, and transportation time of nasal 
mucociliary slowed with the degradation of age. The slowing of transportation time of nasal 
mucociliary was very significant for persons over the age of 60 (Valia, 2007).
The transportation time of  nasal mucociliary in male officers in both groups was longer 
in comparison to female officers. This finding was not compatible with the study by Yadaf 
et  al. (2011) which stated that there was no statistically significant correlation between 
males  and females with regards to the disruption of  transportation time of  mucociliary 
(p = 0.005).
Analysis by using the Spearman correlation test showed that there was a strong cor-
relation and positive value between the length of  work with transportation time of  nasal 
mucociliary. This means that the longer the subjects are exposed to fuel (working in 
gas stations), the greater the transportation time of  nasal mucociliary. The research of 
Yudhanto (2015) found that there was a correlation between the length of  work with the 
transportation time of  mucociliary. There was a significant correlation between smoking 
habits in officers who were exposed directly, and the disruption to transportation time of 
nasal mucociliary, with a value of  p < 0.001 (using the Mann-Whitney test). This was in 
accordance with other studies that suggested that smoking may lead to the disruption of 
the transportation time of  nasal mucociliary. Philanthropists (2010) reported that there 
was a significant difference between transportation time of  nasal mucociliary of  smokers 
and those of  non-smokers.
5 CONCLUSION
There was significant correlation between the exposure location and transportation time of 
nasal mucociliary disruption (using the Fisher’s exact test with a score p < 0.001).
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SUGGESTION
It is necessary to control the exposure of irritant substances towards the officers in each gas 
station, by advising officers to use personal protective equipment such as masks, especially 
for those exposed directly to the irritant substances. This is to minimise the slowing of the 
transportation time of nasal mucociliary.
It is necessary to do further research to determine the specific types of irritant substances 
that can disrupt the transportation time of nasal mucociliary for gas station officers.
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Collection of stem cells in (autologous) donors by apheresis
H. Vrielink
Sanquin Blood Supply, Amsterdam, The Netherlands
ABSTRACT: Leukapheresis procedures are performed to collect Hematopoietic Progeni-
tor Cells (HPCs) from autologous and allogeneic donors for stem cell therapies. To collect 
sufficient HPCs, the cells must be mobilized from the bone marrow into the peripheral circu-
lation with G-CSF, chemotherapy, and or plerixafor. Transfusion of the specific number of 
HPCs is needed to guarantee sufficiently fast and reliable recovery of the bone marrow func-
tion after the myelosuppressive or myeloablative treatment in the patient. To assure safety 
for the donor as well as patient in this kind of therapy, solid quality in the complete chain is 
needed. Therefore, in many countries, by law, JACIE/FACT accreditation is required.
Keywords: stem cells, autologous, HPCs
1 INTRODUCTION
White blood cells (WBCs) can be collected with apheresis techniques. This is named leuka-
pheresis or leukocytapheresis. Apheresis is a method of obtaining one or more blood compo-
nents by machine processing of whole blood in which the residual components are returned 
to the donor or patient during or at the end of the process. The majority of the leukapheresis 
procedures are performed to collect cells for cellular therapies, of which the collections of 
autologous or allogeneic hematopoietic stem/progenitor cells (HPCs) are most frequent per-
formed. HPCs are found in the bone marrow and are identified by the presence of the CD34 
antigen on their surface, and therefore these cells are often named CD34 positive cells. HPCs 
are multipotent stem cells that can develop into all the blood cell types constituting from 
the myeloid (monocytes and macrophages, neutrophils, basophils, eosinophils, erythrocytes, 
megakaryocytes/platelets, dendritic cells), and lymphoid lineages (T-cells, B-cells, NK-cells).
In patients with haemato-oncologic malignancies such as non-Hodgkin lymphoma (NHL), 
multiple myeloma (MM) and Hodgkin lymphoma (HL), high-dose chemotherapy, with or 
without total body irradiation, is used as treatment. Because of the myelosuppressive or 
even myeloablative character of these treatments, subsequent stem cell transplant, in fact, 
administration of HPCs collected from previous cryopreserved autologous HPCs or an HLA 
compatible donor, is essential. Only this will guarantee sufficiently fast and reliable recovery 
of the bone marrow function.
2 COLLECTION STEM CELL
As said HPCs are found in the bone marrow. The cells are fixed to stroma cells. In recent 
history, the “bone marrow” was aspirated under general anesthesia. With the availability of 
hematopoietic growth factors as mobilizing agents, the connecting receptor between stroma 
cells and stem cells will be disrupted, the migration of HPCs into the circulating can be 
enhanced and therefore collected by leukapheresis techniques. In general two important drugs 
are in use. Subcutaneous administration of recombinant “granulocyte-colony-stimulating 
factor” (G-CSF) or plerixafor, in autologous situations usually in conjunction with chem-
otherapy, is used in this respect. Subsequent harvesting of these growth factor-mobilized 
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HPCs by leukapheresis techniques has almost replaced the use of bone marrow aspirate. 
Collection of HPCs by apheresis has some advantages over bone marrow harvesting, e.g., it 
is less invasive than harvesting bone marrow under general anesthesia with overnight hospi-
talization. Moreover, the number of HPCs that can be collected is far better than that can 
be obtained with marrow aspiration under anesthesia. Secondly, mobilized hematopoietic 
stem cell transplants usually induce a more rapidly hematological recovery due to the re-
infusion of the higher number of HPCs. This, together with the so-called non-myeloablative 
conditioning made hematopoietic stem cell transplant (HSCT) also available for the elderly 
patient. In these HSCTs, the G-CSF method is the one to be used. Mobilization and one 
or more apheresis procedures are usually well tolerated and are performed in an outpatient 
setting. Side effects of G-CSF and plerixafor are usually relatively mild and consist of pain 
from muscles and bones, and headache. Rare complications such as splenic rupture, aller-
gic reactions, reactivation of autoimmune disorders and vascular thrombosis, however, have 
been reported.
As discussed, in the bone cavity, HPCs are bound to stromal cells and various extracellular 
proteins. Administration of G-CSF leads to the release of a variety of serine proteases from 
granulocytes. This takes days. These proteases disrupt the binding between stromal cells and 
stem cells and with it the release of the HPCs in the peripheral circulation. Unfortunately, 
G-CSF mobilization has a 5–30% failure rate among healthy donors and patients. Risk fac-
tors for a sub-optimal HPC mobilization are ages above 60 years, disease status, duration of 
the previous chemo- and radiotherapy. Mobilization in patients is preferably achieved with 
chemotherapy followed with G-CSF (“chemo mobilization”). Usually, a higher number of 
stem cells are available in the peripheral blood stream for harvesting than after G-CSF only. 
Since some years, plerixafor became available for autologous HPC mobilization. Plerixafor 
leads direct antibody mediated interference with the CXCR4 receptor binding leading to 
peak levels of CD34-positive cells in the peripheral circulation 6–9 hours after administra-
tion. Plerixafor is used in combination with G-CSF when G-CSF mobilization shows to be 
insufficient.
Administration of G-CSF in healthy donors is typically started four days before the sched-
uled apheresis procedure and continues until the day of the last apheresis. On the 5th day of 
treatment, usually the number of circulating CD34-positive cells is maximized, and subse-
quent harvesting of these growth factor-mobilized HPCs by leukapheresis techniques begins. 
G-CSF mobilization schemes in patients are usually in conjunction with chemotherapy. In 
general, the leukapheresis procedure is started when the concentration of circulating CD34-
positive cells is above approximately 15–20/μl. The use of G-CSF or plerixafor, together 
with the pre-apheresis concentration of CD34-positive cells in the de peripheral blood of the 
patient/donor enables prediction of the number of HPCs that can be obtained with one or 
two apheresis procedures. The number of CD34-positive cells to be collected in the apher-
esis procedure is amongst others depending on the type of transplant and the weight of the 
recipient. The accepted minimum dose of CD34-positive cells for hematological recovery 
is 2 or more × 106 CD34-positive cells/kg of patients’ body weight. Re-infusion of a higher 
number of CD34-positive cells such as 4–5 × 106/kg leads primarily to a faster recovery of 
platelets and granulocytes. A higher number of CD34-positive cells then 4–5 × 106/kg has 
almost no additive effects.
In donor apheresis programs, usually, all standardized processes are according to guide-
lines and specification to assure that a process has been proven to yield safe, potent and pure 
products with optimal safety for the recipient, but also to assure safe processes for the donor. 
In a stem cell transplant program, clinic, collection facility, and processing facility are work-
ing together, and we should be aware that quality is the responsibility of all those involved in 
the processes. To assure quality and therefore safety for donor and patient, in many countries, 
governments decree that all units (clinic, collection facility, and processing facility) working 
in one stem cell transplant program are working together in one quality program. The Joint 
accreditation committee of ICST and EBMT (JACIE) and the Foundation for the Accredi-
tation of Cellular Therapy (FACT) composed together international standards for cellular 
therapy product collection, processing, and administration accreditation [1]. More and more 
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governments do require a JACIE/FACT accreditation or an intention to work according to 
these standards with an accreditation before a specific date. Otherwise, by law, no permission 
is given to work in this specific field of interest.
JACIE/FACT standards are designed to provide minimum guidelines for programs, facili-
ties and individuals performing cell transplantation and therapy or providing support serv-
ices for such procedures. Therefore, JACIE/FACT standards contain standards concerning 
hematopoietic cellular therapy applying to quality in the clinic (part B with standards for pre-
and post-transplants), the collection facility (part C) and in the processing facility (part D). 
Audits according to JACIE/FACT are also pointed at the interaction between the three dif-
ferent units. Accreditation according to the JACIE/FACT standards can solely be achieved 
for the complete hematopoietic cellular therapy program.
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Transfusion of blood components in a stem cell transplant 
programme
H. Vrielink
Sanquin Blood Supply, Amsterdam, The Netherlands
ABSTRACT: Heavily treated oncology patients need transfusions of cellular blood com-
ponents on a regular basis. Platelets, as well as units of erythrocytes, need to be ABO blood 
system compatible to the recipient. In platelet transfusions, rhesus D (RhD) compatibility 
needs to be discussed. It is preferred that all cellular blood components are leukoreduced, 
and for patients in a stem cell transplant programmes, gamma irradiated to prevent transfu-
sion associated graft versus host disease.
Keywords: stem cell, platelets, gamma irradiated
1 INTRODUCTION
Patients with malignancies are usually heavily treated with cytotoxic drugs, and in some cases, 
also with total body irradiation. Because of this treatment, besides the malignant cells, normal 
cells are also damaged in many cases leading to temporary suppression, or in other situations, 
the complete destruction of the haemopoietic progenitor cells giving rise to severe thrombo-
cytopenia and possibly anaemia. Usually the transfusion of a number of units of donor plate-
lets, and in some cases units of red blood cells as well, are needed when an haemopoietic stem 
cell transplant programme is started. What is important is the right choice of ABO and rhesus 
D (RhD) blood type, and if  needed, further preparations of the cellular blood component. 
This method is discussed further in this paper by the use of a theoretical/real-life?
2 PLATELET TRANSFUSIONS
A newly diagnosed male patient of 70 years old with multiple myeloma is being treated. During 
the first cycle of treatments, the platelet count decreases to 4.000 cells/μL. Since he is typed as 
AB RhD negative, and the number of available AB RhD negative donors is very low, discus-
sions concerning the choice of the blood type of the component is needed. Although platelets 
do not express RhD antigens, RhD immunisation is possible due to erythrocytes presenting as 
contamination in the platelet units. It is suggested that a presence of 0.03 mL (approximately 
1 × 1010 red blood cells/mL) of erythrocytes are capable of causing primary RhD immunisation 
(Cid & Lozano, 2005; Mollison et al., 1997). If the platelet suspension is pink in colour, it con-
tains more than 0.3 mL of erythrocytes. The risk of RhD immunisation in leukopenic patients 
who are immune suppressed is between 0 and 19% (Atoyebi et al., 2000; Goldfinger & McGin-
niss, 1971; Lozano & Cid, 2007). In many guidelines for avoiding RhD antibody problems dur-
ing pregnancy, it is recommended that platelet transfusions to female RhD negative patients of 
child bearing age (under 45 years old) should preferably be RhD compatible. Going back to the 
multiple myeloma patient case study, there is no direct need to use RhD negative donor plate-
lets since the development of anti-D is not of any direct clinical relevance (Valsami et al., 2015).
As the patient in the case study was typed as having an AB blood group, it has been dem-
onstrated that the transfusion of ABO blood system compatible platelets has a higher profit 
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in the patient and are therefore of first choice. In the case of major ABO incompatibility, the 
patient’s anti-A and/or anti-B antibodies have negative effects on the survival of the donor 
platelets with an impaired haemostasis of ABO compatible platelets compared to incompat-
ible (Blumberg et al., 2012). Major ABO incompatibility in platelet transfusions can also pos-
sibly lead to a higher refractoriness. Following minor ABO incompatible platelet transfusions, 
a positive direct antiglobulin test can be the result of a transfusion of incompatible plasma. 
This is usually associated with slight haemolysis and rarely severe—even fatal—haemolysis 
and renal failure. Usually, an anti-A and/or anti-B titre lower than 128 is not a problem and 
is recommended for patients who receive multiple transfusions (Lozano & Cid, 2003; Valsami 
et al., 2015). Taking all this into account, the choices shown in Table 1 can be followed.
Another issue to be considered in the patient case study, is the possibility of transfusion 
associated graft versus host disease (TA-GvHD), caused by the presence of immunocompe-
tent lymphocytes in the donor blood system of immune-compromised patients. This can be 
prevented by gamma irradiation (25 Gy) of the cellular blood component. Gamma irradia-
tion damages the blood cells that are capable of cell division (monocytes and lymphocytes) to 
such an extent that they can no longer multiply, and as a result, the mixed lymphocyte culture 
response disappears. Although it is not known how many immunocompetent lymphocytes 
are required to elicit TA-GvHD, it has been shown that transfusion of leukocyte reduced 
components decreases the incidence, but does not protect against TA-GvHD. Therefore, irra-
diation of cellular blood components are (amongst others):
• acquired immunodeficiency, as is the case with allogeneic stem cell transplantation (for 
at least six months after transplantation), if  total body irradiation formed part of the 
conditioning;
• autologous stem cell transplantation (for at least three months after reinfusion), after use 
of donor lymphocyte infusion or infusion of cytotoxic T lymphocytes for one year after 
transfusion;
• transfusion between first and up to, and including, third degree relatives of cell-containing 
blood components;
• leukaemia treatments, where this is required in the protocol (see other considerations);
• peripheral blood stem cell apheresis from mobilisation until after collection;
• bone marrow collection from six weeks prior to collection and until after collection;
• HLA compatible platelet concentrates;
• use of purine/pyrimidine antagonists and related medication (e.g. Fludarabine, Pentosta-
tin and Cladribine) for a year after cessation of the therapy;
• in the case of anti-T cell treatment (ATG, anti-CD52 and other T cell monoclonals) for 
aplastic anaemia or leukaemia from the start of administration through to half  a year after 
completion of the treatment;
• Hodgkin’s lymphoma—some advocate for all stages, others only for stages 3 and 4;
• non-Hodgkin’s lymphoma.
As described, the results of a transfusion of a unit of platelets can vary based on compat-
ibility issues between donor and patient. Therefore, the effects of a platelet transfusion need 
to be monitored. The easiest way to do this is a patient platelet count 1 and 24 hours after the 
transfusion, taking into account the number of platelets in the product and the body surface 
Table  1. ABO blood type of choice of donor platelets based on 
blood type of the recipient.
Recipient
ABO Type for donor platelets
1st choice 2nd choice 3rd choice 4th choice
O O B or A
A A O
B B O
AB AB A B O
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area of the patient (corrected count index (CCI)). One important issue in refractoriness is the 
HLA antibodies of the patient. The one-hour CCI will be very low, in other words, there is no 
increment in the platelet count of the patient. Platelets derived from an HLA compatible donor 
(taken from a database of HLA typed donors or first and second-degree relatives) can bring a 
solution. Gamma irradiation of these platelets prior to the transfusion is a requirement.
3 ERYTHROCYTE TRANSFUSIONS
Looking back at the case study within this paper, besides the thrombocytopenia, the patient 
also has anaemia, with a haemoglobin level of 4.0 g/dL. It is known that in an adult patient, 
one unit of erythrocytes results in an increase in haemoglobin of 0.8 to 1.0 g/dL therefore, 
three units of red blood cells are required. The choice of ABO RhD donor type for the AB 
RhD negative patient is more difficult. The risk of anti-RhD formation in patients who have 
received RhD incompatible transfusions is rather high and therefore, a blood donor that is 
RhD negative should be chosen. Minor ABO incompatibility is in the buffy coat, and plasma 
removed units of erythrocytes are not a major issue since only 15–20 mL of plasma is left in 
the unit, and antibody titres are usually lowered due to dilution by erythrocyte storage solu-
tions for the unit of red blood cells. Taking these considerations into account, the preferential 
choice when selecting ABO RhD compatible units is shown in Table 2.
Of course, for the units of red blood cells, it should be decided whether gamma irradiation 
for the patient is needed or not.
A different issue to consider is whether leukoreduction is an option, or not. With leu-
koreduction, the white blood cell count will be below one million cells per unit of platelets 
and erythrocytes. Leukoreduction decreases the likelihood of FNHTR and potentially sub-
sequent antibody (e.g. anti-HLA) formation. Leukoreduction cannot be achieved by washing 
the component.
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B pos B pos B neg O pos O neg
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AB neg AB neg A neg B neg O neg
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ABSTRACT: Tumour Necrosis Factor Alpha (TNFα) is one of the pro-inflammatory 
cytokines that play an important role in the pathogenesis of nasal polyps. Fluticasone furoate 
is the most potent inhibitor of NF-kB activation and TNF release. The aim of this study was 
to determine the effect of nasal spray fluticasone furoate  on TNFα expression of nasal pol-
yps. This study was analytic with an experimental quasi-study design, performed on 16 cases 
of nasal polyps obtained with non-probability consecutive sampling. 16  samples, TNFα 
expression in nasal polyps before treatment with fluticasone furoate was mostly overexpres-
sion (87.5%) while post-treatment was found to be negative (81.3%). Data analysis showed a 
significant decrease in TNFα expression after therapy (p = 0.001). There was no significant 
correlation between nasal polyp decline and decreased expression of TNFα in nasal polyps 
after fluticasone furoate therapy (p = 0.136). Fluticasone furoate has been shown to decrease 
TNFα expression in nasal polyps and significantly reduce polyp stages.
Keywords: nasal polyps, fluticasone furoate, TNFα expression
1 INTRODUCTION
Nasal polyps are chronic inflammatory diseases of the nasal mucosa characterised by oede-
matous masses stemming from the inflamed mucosa (Kirtsreesakul, 2005). Tumour Necrosis 
Factor Alpha (TNFα) is a pro-inflammatory cytokine produced by several cell types, includ-
ing epithelial cells and macrophages, which induce chronic inflammation. They play a role in 
the eosinophil recruitment process by increasing the adhesion of eosinophils to nasal polyps. 
In a study conducted by Otto and Wenzel (2008), it was found that TNFα mRNA increased 
significantly in nasal polyps compared to the inferior concha. TNFα has an important role in 
the pathogenesis of nasal polyps. This pro-inflammatory cytokine plays a role in the inflam-
matory process of nasal polyps by promoting the synthesis of immunoglobulin. Synthesised 
inflammatory mediators in fibroblasts such as metalloproteinase-1, COX-2 and IL-6 matrix 
are also stimulated by TNFα (Shun et al., 2005).
Nasal polyps are a manifestation of the inflammatory process, so corticosteroids are an effec-
tive therapy (Ferguson & Orlandi, 2006). Corticosteroids have extensive anti-inflammatory 
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effects. Apoptosis is an important process in reducing the number of inflammatory cells. 
Corticosteroids induce the process of apoptosis of inflammatory cells in nasal polyps (Assanasen 
& Naclerio, 2001). Intranasal or systemic corticosteroids work by reducing the concentration of 
inflammatory mediators and inflammatory cells by inhibiting cell proliferation and inducing 
apoptosis (Jankowski et al., 2002).
Intranasal steroids have non-specific anti-inflammatory properties that can improve symp-
toms of nasal obstruction and drainage (Aouad & Chiu, 2011). Intranasal corticosteroids 
are lipophilic and can easily enter the target cell cytoplasm, binding to the glucocorticoid 
receptors which are common in the airway mucosa. Fluticasone furoate significantly inhib-
its translocation of NF-kB in fibroblasts and suppresses pro-inflammatory TNFα cytokine 
activity. In contrast to methylprednisolone which reduces eosinophil inflammation and albu-
min retention so that the size of the polyp is reduced (Sastre & Mosges, 2012).
The purpose of this study was to determine the effect of fluticasone furoate on the TNFα 
expression of nasal polyps.
2 METHOD
This study was analytic with an experimental quasi-study design, conducted at the ENT 
department of H. Adam Malik Medan Hospital, from December 2015 until July 2016. 
The sampling technique involved non-probability consecutive sampling. Sampling tissue 
obtained from the biopsy which performed in patients with suspected nasal polyps who came 
to the outpatient clinic ENT department of H. Adam Malik Medan Hospital. An immune-
histochemical examination was conducted in the Anatomy Pathology Laboratory of FK 
USU to assess TNFα expression in the nasal polyps.
The sample in this study is a portion of the population that met the inclusion and exclu-
sion criteria. The inclusion criteria included patients diagnosed with nasal polyps, males and 
females (≥ 18 years), who were willing to be included in the study by signing informed consent 
and willing to use fluticasone furoate nasal spray every morning for four weeks. Exclusion 
criteria included histopathological examination results of malignancy, pregnancy and lacta-
tion, people with diabetes mellitus, patients with liver function disorder, patients with kidney 
function disorder and patients with a history of nasal surgery.
3 RESULTS
Based on TNFα expression it appears that pre-therapy the majority of the sample, as many 
as 14 people (87.5%), had a positive expression. Post-therapy, the number of samples with a 
positive expression decreased to three people (18.7%). The results of the analysis using the 
McNemar test showed significant differences in TNFα expression between pre- and post-
therapy (p = 0.001).
The results of the study showed that of 13 samples with decreased expression of TNFα, 
there were 11 samples (84.6%) which showed reduced polyp stages. Meanwhile, of three sam-
ples with a TNFα expression that persisted, only one sample (33.3%) demonstrated decreased 
polyp stages. The results of the analysis using Fisher’s exact test showed no significant rela-
tionship between TNFα expression and polyp stages (p = 0.136).
4 DISCUSSION
In this study, of 16  samples, before fluticasone furoate therapy, the highest group was 
obtained by overexpression of TNFα on nasal polyps, 14  samples (87.5%) while negative 
expression of two samples (12.5%). From the result of the bivariate data analysis, shown in 
Table 1, the difference table of TNFα expression on nasal polyps before and after receiving 
fluticasone furoate therapy, with McNemar test obtained a p value = 0.001, which showed a 
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significant decrease of TNFα expression on nasal polyps, after administration of intranasal 
fluticasone furoate.
Corticosteroids induce apoptotic processes, which are important in reducing the number 
of inflammatory cells. The work of nasal spray corticosteroids or systemic corticosteroids is 
to reduce the concentration of inflammatory cells and inflammatory mediators by inhibiting 
cell proliferation, inducing apoptosis and inhibiting cell proliferation. The anti-inflammatory 
effect of corticosteroids not only affects inflammatory cells such as lymphocytes, eosinophils, 
neutrophils and plasma cells, but also epithelial cells and fibroblasts. Corticosteroids inhibit the 
release of vasoactive mediators thereby reducing fluid extravasation, vasodilation and deposit 
mediators. Corticosteroids also play a role in reducing the binding of inflammatory cells and 
inhibit the proliferation of fibroblasts and the synthesis of the extracellular protein matrix so 
that the inflammatory reactions that occur can be reduced. This will lead to reduced cytokines 
and inflammatory cells. TNFα which is one of the pro-inflammatory cytokines also decreases 
its expression with the role of corticosteroids, which is illustrated by the results of this study. 
Fluticasone furoate, in small doses, is effective in inhibiting pro-inflammatory cytokines, spe-
cifically TNFα and IL-5 (Zhang et al., 2014; Tan & Putti, 2005; Yariktas et al., 2005).
Relation of TNFα expression on nasal polyps with decreased nasal polyp stage, showing 
from 13 samples with decreased expression of TNFα, found 11 samples (84.6%) indicating 
polyp stages also decreased (Table 2). While from three samples with the TNFα expression 
that settled only one sample (33.3%) whose polyps stage also decreased. The result of analysis 
using Fisher’s exact test obtained a p value = 0.136 which shows that there is no significant 
relationship between a decreased expression of TNFα and a decrease of polyp stage. It has 
been suggested that eosinophils are the dominant population of inflammatory cells found 
in nasal polyps and are thought to be the central effector cells responsible for the occur-
rence and survival of inflammatory processes in nasal polyps. The mechanisms underlying 
the activation, recruitment and survival of eosinophils involve complex interactions of some 
pro-inflammatory cells and some pathways. The increased synthesis and expression of the 
widely encountered cytokines (IL-1, IL-3, IL-5, IL-6, IFN-γ) and chemokines (IL-8, eotoxin 






n % n % n %
Pre-therapy 14 87.5  2 12.5 16 100
0.001Post-therapy  3 18.7 13 81.3 16 100
*McNemar test.







n % n % n %
Declining 11 84.6 2 15.4 13 100 0.136
Fixed  1 33.3 2 66.7  3 100
Total 12 75 4 25 16 100
*Fisher’s exact test.
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and RANTES) play an important role in the activation and survival of eosinophils, which 
mediates the occurrence of inflammatory processes in nasal polyps. There are many studies 
that focus on cytokines that are responsible for the function of eosinophils, such as IL-1, 
IL-3, IL-4, IL-5, IL-10, GM-CSF, TNFα, although each involves different mechanisms. The 
ones with the greatest role are IL-3, IL-5 and GM-CSF which induce the effector function 
and survival of eosinophils and also stimulate eosinophils in expressing various receptors for 
cytokines (Anolik, 2010; Rui et al., 2002; Duda, 2015).
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ABSTRACT: Sinonasal squamous cell carcinomas are malignant tumours occurring in the 
nasal cavity and paranasal sinuses. The p53 protein is a tumour suppressor gene, functioning 
in processes of cellular apoptosis, differentiation, ageing and angiogenesis. The purpose of 
this study was to observe the expression of the p53 mutant protein in sinonasal squamous cell 
carcinoma. This was an observational study in Haji Adam Malik General Hospital where we 
performed the immunohistochemical examination on paraffin blocks from 30 patients with 
sinonasal carcinoma who had undergone surgery. Out of 30 samples of sinonasal carcinoma 
blocks, we found 16 samples with an overexpression of the p53 mutant protein (53.3%).
Keywords: p53 mutant protein, sinonasal squamous cell carcinoma
1 INTRODUCTION
Sinonasal squamous cell carcinomas are malignant tumours occurring in the nasal cavity 
and paranasal sinuses (Thompson, 2006). They occur in 3% of head and neck tumours and 
1% of tumours in general. They can be hard to evaluate in the early stages due to mislead-
ing symptoms which are very similar to rhinitis or sinusitis. Diagnosis of this disease can be 
acquired from careful history taking and physical examination including endoscopic find-
ings. Radiologic examination is most helpful for gathering information about conditions 
inside the sinus cavities, while in some cases pre-operative histopathologic examination is 
possible where a tissue sample can be acquired nasally or via sinuscopy; in such cases diag-
nosis is absolute. However, many practitioners believe that radiologic imaging is enough to 
diagnose malignancy in the paranasal sinuses. Maxillary sinuses are the most common site of 
occurrence (60%–80%), followed by the nasal cavity (20%–30%) and ethmoid sinuses (around 
15%). Male patients are more common than females (2:1). Therapy for sinonasal carcinoma 
includes surgery, chemotherapy, radiotherapy or a combination of the three regimes (Roezin, 
2007; Carlson et al., 2012).
The mechanism of malignancy formation is multifactorial. However, theories are revolv-
ing around cell cycle disturbance and their system regulation (Handayani et al., 2011). The 
p53 protein is a tumour suppressor gene, functioning in processes of cellular apoptosis, dif-
ferentiation, ageing and angiogenesis (Shahib, 2012). The p53 gene is known to be the most 
mutated gene in malignancies (>50% of cancer cases). Wild-type p53 is an unstable protein 
with unstructured regions. Their half-life is less than 30 minutes. The p53 mutant, however, 
has a longer half-life and can be detected with immunohistochemical examination (McDon-
ald et al., 2004; Irish, 2003).
The aim of this study was to observe the expression of the p53 mutant in cases of sinonasal 
squamous cell carcinoma.
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2 METHOD
This study was an observational study conducted in Haji Adam Malik General Hospital 
where we performed the immunohistochemical examination on paraffin blocks processed 
from tumours from patients with sinonasal squamous cell carcinoma who had undergone 
surgery. Paraffin blocks were smeared with eematoksilin eosin and damaged blocks were 
excluded. We acquired 30 blocks for the study.
3 RESULTS
Table  1  shows that sinonasal squamous cell carcinoma patients were mostly male (19 
patients/63.3%). Age distribution peaked in the 41–60 years old group (63.3%) with one 
case occurring in the under 20 years of age group. Out of 30 samples, 21 were determined 
as non-keratinising squamous cell type (70%), and nine were keratinising squamous cell 
type (30%). Most patients attended at the stage IV tumour stage (11 cases/36.7%).
Table  1. Distribution of age, gender, histopathology type and 
tumour stage of patients with sinonasal squamous cell carcinoma.
Sinonasal carcinoma n %
Gender
 Male 19 63.3
 Female 11 36.7
Age
 <20  1  3.3
 21–40  2  6.7
 41–60 19 63.3
 >60  8 26.7
Histopathology type
 Keratinising squamous cell carcinoma  9 30
 Non-keratinising squamous cell carcinoma 21 70
Tumour stage
 Stage I  7 23.3
 Stage II  5 16.7
 Stage III  7 23.3
 Stage IV 11 36.7
Table 2. Distribution of area score, intensity score and the immunoreactive score 
of p53 mutant expression in sinonasal squamous cell carcinoma.
Scores n %
Area score
 0  0 0
 1 12 40.0
 2 10 33.3
 3  8 26.7
Intensity score
 0  0 0
 1 12 40.0
 2 10 33.3
 3  8 26.7
Immunoreactive score
 Negative 14 46.7
 Overexpression 16 53.3
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Table  2  shows the immunoreactive score of the p53  mutant (area score times intensity 
score). In total, 16 samples exhibit overexpression (53.3%) and 14 samples exhibit negative 
expression (46.7%).
Table 3 shows that sinonasal carcinoma of the non-keratinising type had the most over-
expression of the p53 mutant (10 samples/62.5%) while the keratinising type had six sam-
ples with p53 overexpression (37.5%). Stage IV tumours had the most overexpression of 
p53 mutant (9 samples/81.8%).
4 DISCUSSION
Our study showed that the occurrence of sinonasal carcinoma is more frequent in male 
patients (19 patients) than their female counterparts (11 patients). This is similar to a study 
by Roezin (2007) at Cipto Mangunkusumo General Hospital, Jakarta where they reported a 
ratio of sinonasal carcinoma in males:females of 2:1.
Distribution by age showed that most cases occurred in the 41–60 years age group 
(19 cases). This again shows similarity to a study by Thompson (2006) in the US where 
they  reported the average age for sinonasal carcinoma as being in the 55–65 years age 
group.
The histopathology findings in our study showed that most cases were non-keratinising 
squamous cell type (21 samples). Results of histopathologic examination are varied in many 
studies. Salim (2010), also in Medan, reported that most cases of sinonasal carcinoma were 
of the keratinising squamous cell type (56.9%).
Tumour stage distribution shows us just how poorly our patients understand their ail-
ments. Eleven patients (36.7%) came seeking treatment at stage IV. This is in tune with a 
report from Salim (2010) of 56.9% of cases in their study being at stage IV. A report from 
Turkey by Cengiz (2013) shows different results, where most cases (15 out of 36) attended at 
stage III.
Our study showed overexpression of the p53  mutant protein in 16  samples out of 30. 
Holmila (2010), from Finland, also reported a high rate of overexpression of the p53 protein 
(77%). Oncel (2011), from India, reported that three out of nine cases of sinonasal carcinoma 
showed an overexpression of the p53 protein.
5 CONCLUSION
In our study, 16 out of 30 samples of sinonasal carcinoma showed an overexpression of the 
p53 mutant protein (53.3%).
Table 3. Distribution of p53 mutant expression based on histopathology type and tumour stage.




n % n %
Keratising squamous cell carcinoma  6 37.5  3 21.4  9
Non-keratising squamous cell carcinoma 10 62.5 11 78.6 21
Tumour stage
 Stage I  2 28.6  5 71.4  7
 Stage II  2 40.0  3 60.0  5
 Stage III  3 42.9  4 57.1  7
 Stage IV  9 81.8  2 18.2 11
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ABSTRACT: Physical activity and sedentary behaviour play an important role in prevent-
ing the progression of obesity in adolescence to adulthood. This study was conducted to 
determine the association between physical activity, sitting time (sedentary behaviour) and 
Body Mass Index (BMI) in students at the Faculty of Medicine, University of Sumatera 
Utara. One hundred and thirty students were respondents in this study, selected based on 
inclusion and exclusion criteria and completion of the International Physical Activity Ques-
tionnaire (IPAQ). BMI was determined using a digital weighing scales and microtoise. All 
data were analysed using SPSS. Based on one-way ANOVA test analysis revealed that there 
was a significant association (p = 0.007) of physical activity toward the mean of BMI but no 
relationship the sedentary behaviour with BMI (p = 0.546). The results suggest that BMI is 
related to physical activity but not to sedentary behaviour.
1 INTRODUCTION
Technological developments and advancements in this modern age have positive and negative 
impacts on (human) life. Many activities can be done easily and quickly if  they are viewed 
from their positive impact; however, from their negative impact, they tend to make people 
reluctant to move. For example, the use of an escalator can make people reluctant to climb 
the stairs (Booth et al., 2012).
Physical activity constitutes every movement produced by the skeletal muscles which 
requires energy above the acceptable resting threshold. Physical activity in daily life can be 
categorised as involving sport, cycling, walking, recreational activities, housework, gardening 
and other activities (Booth et al., 2012).
Physical inactivity occurs when body movements are minimal and can also be referred to as 
sedentary behaviour (behaviour that is bound to one place). Included in sedentary behaviour 
is watching television, reading, working in front of a computer or talking to friends on the 
phone or learning. Physical inactivity is counted as sitting time. Lack of physical activity and 
the duration of time spent in sedentary behaviour can be a risk factor for obesity (Heinonen 
et al., 2013; Brodersen et al., 2007). According to research Jayamani et al. (2013) comparison 
of women with moderate physical activity who are overweight/obese as much as 3,87 times 
than women with high physical activity. Previous research has shown that sedentary behav-
iours such as watching television and videos, using computers and playing video games are 
linked to obesity (Stamatakis et al., 2008).
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In 2014, 11% of men and 15% of women worldwide were obese. Thus, over half  a billion 
adults worldwide are classified as obese. This data also showed that about 3.4 million people 
die each year as a result of being overweight or obese. According to the Centers for Disease 
Control and Prevention (CDC), in 2012 the incidence of obesity reached more than 72 mil-
lion people and included 20.5% of the adolescent population (World Health Organization, 
2014). Adolescence is a period that is susceptible to the development of obesity as it is char-
acterised by slowing growth and a decline in the value of physical activity. There is a risk a 
teenager with obesity or being overweight would be an obese or overweight adult compared 
to a person of normal weight (Ogden et al., 2012).
Obesity can be determined by anthropometric measurements. Anthropometric measure-
ments exist in many forms, with one of the most widely used in nutrition surveys being the 
measurement of body mass index (BMI). BMI is the ratio of body weight (in kilograms) to 
squares of height (in metres). BMI is associated with body fat (Alaska Division of Public 
Health, 2011).
One group that demonstrate low physical activity are medical students (Resende et  al., 
2010). The age range of students can be classified as adolescence. Based on the above descrip-
tion, this study aimed to determine the association between physical activity, sitting time 
(sedentary behaviour) and BMI among students in the Faculty of Medicine, University of 
Sumatera Utara.
2 MATERIALS AND METHODS
This study was conducted after getting permission from the ethical committee of the Faculty 
of Medicine of the University of Sumatera Utara. The subjects who agreed to participate in 
the study were asked to fill out and sign informed consent after being given an explanation 
about the purpose and benefits of the research. This research involved an analytical study 
with a cross sectional design which searched for the relationship between the independent 
variables (physical activity and sedentary behaviour) and the dependent variable (BMI). It 
was conducted at the Faculty of Medicine, University of Sumatera Utara from March until 
November, 2016.
Inclusion criteria for this research included being students of  the Faculty of  Medi-
cine, University of  Sumatera Utara, aged between 16 to 23 years old. Exclusion criteria 
for this research included being students who smoked and suffered from chronic disease. 
An unpaired categorical analytical formula was used to determine the assumption of  the 
number of  samples. Primary data were gathered directly from the research subjects (ques-
tionnaires and BMI). Body height and weight were measured using a digital scale with a 
maximum capacity of  150 kg, a microtoise with a maximum length of  200 cm and an accu-
racy of  0.1 cm. The BMI was calculated by dividing weight and square of  height. The data 
for physical activity and sedentary behaviour were obtained from the International Physical 
Activity Questionnaire (IPAQ) which had been completed by the respondents (Hagstromer 
et al., 2005).
Respondents’ data were included and analysed using SPSS (Statistical Product and Service 
Solution). A one-way ANOVA was used to determine the mean value of BMI in groups cat-
egories physical activities and sedentary behaviour (sitting time).
3 RESULTS
There were 130 students who participated in this research. Table 1 shows the characteristics 
of the participants. The mean value for age was 20.21 ± 1.65. It was found that there were 
more female respondents (74 respondents or 56.9%), while there were 56 male respondents 
(43.1%). The mean value of body height, body weight, BMI, physical activity and sedentary 
behaviour were: 162.20 ± 9.10; 68.93 ± 18.90; 26.25 ± 5.83; 2.020 ± 1.665.3 and 6.6 ± 3.03, 
respectively.
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The categories of physical activity of subjects is shown in Table 2. The respondents were 
divided into three physical activity categories: low activity, moderate activity and high activ-
ity. Based on MET-minute/week, the mean value of low physical activity was 423 MET-
minute/week, the mean value of moderate physical activity was 1546 MET-minute/week 
and the mean value of high physical activity was 6.468 MET-minute/week. There were 45 
respondents (34%) involved in low activity, 34 respondents (30%) involved in moderate activ-
ity and 48 respondents (36%) involved in high activity. It was found that the mean BMI for 
low activity was 27.69 kg/m2, for moderate activity was 26.47 kg/m2 and for high activity was 
24.05 kg/m2.
The result of the one-way ANOVA test showed that there was a significant difference 
(p = 0.007) in physical activity with BMI. As Table 3 shows, after multiple comparative analy-
sis using the post hoc Bonferroni test, it was found that there was a significant difference 
(p = 0.006) in the mean BMI between respondents involved in low activity and respondents 
involved in high activity, but a significant difference was not found (p = 0.99) in the respond-
ents involved in low activity and in the respondents involved in high activity. There was also 
no significant difference (p = 0.127) in the mean BMI between the respondents involved in 
moderate activity and the respondents involved in high activity.
It was also found that for the sitting time (sedentary behaviour) divided in three categories 
(shown in Table 4). The mean value of the sedentary behaviour in less than four hours was 
2.7 hours/day, the sedentary behaviour four to eight hours was 5.5 hours/day, and sedentary 
behaviour more than eight hours was10.3 hours/day. The mean value of BMI in sedentary 
Table 1. Characteristics of study population.
Variables N (Mean, SD) Min, Max
Age (year) 20.21 ± 1.65 16.00, 23.00
Sex
 Male n (%) 56 (43.10)
 Female n (%) 74 (56.90)
Anthropometry
 Body height (cm) 162.20 ± 9.10 186.50, 146.50
 Body weight (kg) 68.93 ± 18.90 133.00, 40.00
 BMI (kg/m2) 26.25 ± 5.83 44.27, 16.21
Physical activity (MET-minute/week) 2.020 ± 1.665.3 126.00, 6102
Sedentary behaviour (hours/day) 6.6 ± 3.03 1.30, 15.00







MET (MET-minute/week) 423 1546 6468 0.007
BMI±SD (kg/m2) 27.68 ± 6.1 26.47 ± 5.5 24.05 ± 5.3
*One-way ANOVA test.
Table 3. Multiple comparison analysis of physical activity and BMI.
Variable Physical activity p*
BMI Low activity Moderate activity 0.99
High activity 0.006
Moderate activity High activity 0.127
*Post hoc Bonferroni test.
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behaviour less than four hours was 25.12 kg/m2; the mean value of BMI in sedentary behav-
iour four to eight hours was 25.50 kg/m2; and the mean value of BMI in sedentary behaviour 
more than eight hours was 26.18 kg/m2.
4 DISCUSSION
In this research, the mean value of  the respondents’ BMI was 26.25 kg/m2. This high mean 
value of  BMI was caused by the large number of  obese students who participated in this 
research. The rate of  one of  the respondents’ weight even reached 133 kg. Students tend 
to lack a healthy lifestyle, such as not sleeping until late at night and a lack of  exercise. 
Students do not have time to exercise or undertake recommended physical activity. This 
was because their study schedule was from 8.00 a.m. to 5.00 p.m. The curriculum and 
examination pattern of  the students at the Faculty of  Medicine was tight so that they 
had less time to concentrate on extracurricular activities. They only had spare time in 
the evening (Wattanapisit et al., 2016). These are risk factors for obesity (World Health 
Organization, 2014).
In this research categories physical activity of the students: the mean value of low physical 
activity was 423 MET-minute/week, the mean value of moderate physical activity was 1546 
MET-minute/week and the mean value of high physical activity was 6.468 MET-minute/
week. The result of a one-way ANOVA test showed that there was a significant difference 
(p = 0.007) in the mean BMI of the respondents involved in low activity (27.68 ± 6.1), moder-
ate activity (26.47 ± 5.5) and high activity (24.05 ± 5.3), respectively.
Research conducted by Labban (2014) revealed that there was a correlation between physi-
cal activity and weight, height and obesity status. This indicates that physical activity plays 
an important role in body metabolism through fatty acid oxidation, gluconeogenesis proc-
esses and burning calories to hamper fatty adiposity (Sugondo, 2014). A previous study in 
the Faculty of Medicine, University of Sumatera Utara shows the effect of nutrients cause 
obesity (Sari & Sari, 2017).
Based on the research conducted by Kaplan, it was found that a person with higher IMT 
group was inclined to have a risk of being affected by diabetes, hypertension and cardiovas-
cular disease. A high mortality rate occurred in IMT ≥ 25 kg/m2 and ≥ 30 kg/m2 (Kaplan 
et al., 2014).
Adolescents with good physical activity will mostly not be affected by obesity, compared 
with inactive adolescents. An adolescent with obesity or who is overweight will be an obese 
adult, compared with an adolescent of normal weight (Rauner et al., 2013).
Physical inactivity occurs when body movements are minimal and can also be referred to as 
sedentary behaviour (behaviour that is bound to one place). Sedentary behaviour is assessed 
by measuring sitting time using the IPAQ (Resende et al., 2010). Most of the respondents 
tended to engage in sedentary behaviour from four to eight hours with the mean value being 
6.6 hours/day. This may happen because most of the students of the Faculty of Medicine 
had to follow the curriculum of the Faculty of Medicine such as courses of lectures, practical 
work, laboratory skills and tutorials, which enabled them to sit down in the same position for 
a prolonged period of time.
Table 4. Sedentary behaviour categories in relation to BMI.
Less than 4 Hours 
(N = 19)
4 to 8 Hours 
(N = 67)




2.7 5.5 10.3 0.546
BMI±SD (kg/m2) 25.12 ± 6.5 25.5 ± 6.5 26.18 ± 5.4
*One-way ANOVA test.
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The research conducted by Krishnakumar et al. (2013) found similar results to those of 
the present study. In that research, it was found that the average sitting time for students 
of the Faculty of Medicine in Bangalore, India, reached six to seven hours per day. Students 
of the Faculty of Medicine in Casablanca, Morocco, also had a similar average sitting time of 
six hours per day (Otmani, 2016).
The results of this research showed that there was no difference in the mean value of sed-
entary behaviour between BMI. Different results from Labban, (2014) suggest that longer sit-
ting times will result in higher BMI values. The existence of a trend that refers to the decrease 
in physical activity due to work activities that cause more sitting and transportation activities.
5 CONCLUSION
There was a significant difference in the mean value of BMI between low, moderate and 
high physical activity levels in students at the Faculty of Medicine, University of Sumatera 
Utara, but no difference in the mean value of BMI between sedentary behaviour. These find-
ings indicate that physical activity modulates obesity in students at the Faculty of Medicine, 
University of Sumatera Utara because most of the students had to follow the curriculum 
including courses of lectures, practical work, laboratory skills and tutorials which involved 
prolonged periods of sitting.
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ABSTRACT: Fibrinolytics are one of the modalities of treatment for STEMI patients. Suc-
cessful fibrinolytics have been associated with better clinical outcomes. We sought to explore 
whether the Simplified Selvester Score could predict successful fibrinolytic therapy electrocar-
diographically. Fifty-three STEMI patients who received fibrinolytic therapy with streptokinase 
were enrolled in this retrospective study. The Simplified Selvester Score was estimated on the 
first admission by ECG. STEMI patients were divided into two categories: successful or failed 
fibrinolytic therapy, based on ECG. The optimal cut-off Simplified Selvester Score was ana-
lysed. Patients with successful fibrinolytics have a lower Simplified Selvester Score (2.3 ± 1.6 vs 
5.1 ± 1.7; p = 0.001). In multivariate analysis, a Simplified Selvester Score ≤ 3.5 remained signifi-
cantly associated with successful fibrinolytic therapy and appeared to be a strong predictor for 
successful fibrinolytic therapy (p = 0.004: OR = 6.8; 95% CI [1.55, 37.05]). A Simplified Selvester 
Score ≤ 3.5 can be used as a predictor of successful fibrinolytic therapy in STEMI patients.
Keywords: fibrinolytics, Selvester Score, STEMI
1 INTRODUCTION
STEMI is a leading cause of cardiovascular disease worldwide. The immediate therapeutic 
goal of reperfusion therapy is to restore full antegrade flow in the infarct-related epicardial 
coronary artery, as well as to achieve adequate myocardial perfusion at the tissue level. Fibri-
nolytic therapy is one reperfusion modality. It is well established that early and complete 
resolution of ST segment elevation is a powerfull predictor of successful fibrinolytic therapy. 
Successful ST segment resolution as an electrocardiographic sign of restored myocardial per-
fusion may vary according to how far the infarction process has progressed (Al-Daydamony, 
2014; Ghaffari, 2013; Gusto Investigators, 1993; Steg, 2012).
During the evolution of acute STEMI, pathologic Q waves evolve and R-wave regression 
develops. Measurements of these ECG parameters at presentation may reflect the progres-
sion of the infarct process and predict the extent of myocardial salvage to be gained from 
successful fibrinolytic therapy (Granger, 1992; Grines, 2003).
The Simplified Selvester Score was initially developed to estimate electrocardiogaphically 
the size of myocardial infarction and scars. It has been validated with high sensitivity and 
specificity and high intra and inter-observer agreement (Selvester, 1985). We choose to study 
the ability of the Simplified Selvester Score as a pre-fibrinolytic predictor of successful man-
agement of STEMI because the electrocardiogram (ECG) remains a simple yet powerful tool 
and is easily available in the assessment of reperfusion efficacy.
2 METHODS
This was a single centre study in which a total of  53 STEMI patients received fibrinolytic 
therapy in the form of  streptokinase by intravenous infusion, at a dose of  1,500,000 U 
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over 30–60  minutes from January 2015 until December 2016. Standard anti-ischaemic 
medications were allowed and remained unchanged during the study period. All patients 
underwent resting high-quality 12-lead ECG recordings, from which the following was 
estimated:
1. QRS score calculated according to the simplified form of the Selvester scoring system 
based on 37 criteria capable of generating 29 points.
2. ST segment elevation measured 20 ms after the J point. The height (in mm) of ST segment 
elevations was measured in leads I, aVL and V1 through V6 for anterior infarctions, and 
in leads II, III, aVF, V5 and V6 for inferior infarctions.
The ST segment was measured in the single lead with the highest elevations. The resting 
ECG was analysed for all patients 90 minutes following the initiation of fibrinolytic therapy, 
the sum of ST segment resolution was measured, classified into two groups: successful fibri-
nolytic therapy with a sum of ST segment resolution ≥ 50%, and failed thrombolytic therapy 
if  a sum of ST segment resolution < 50%.
All statistical analyses were performed using statistical software, and a p value  <  0.05 
was considered significant. A receiver operating characteristic curve analysis was used to 
determine the optimum cut-off  values of the Simplified Selvester Score to predict successful 
fibrinolytic therapy. Clinical, laboratory and procedural data were compared with the use 
of Student’s t-test or Mann-Whitney U test for continuous variables and the Chi-square or 
Fisher’s exact test for categorical variables (expressed as counts and percentages). The cor-
relation of the Simplified Selvester Score and troponin T was analysed by a correlation test. 
Continuous variables were analysed for normal distribution using the Kolmogorov–Smirnov 
test. To address concerns over confounding variables affecting successful fibrinolytics, we 
also performed a multivariate logistic regression analysis which significant variables in bivari-
ate analysis before were included. The study protocol was reviewed and approved by our local 
institutional human research committee.
3 RESULTS
From a total of  53 STEMI patients, 33 patients (62%) had successful fibrinolytic therapy 
and 20 patients (38%) had failed fibrinolytic therapy. The mean age of  our study popula-
tion was 52 ± 7.8 years, and the mean Simplified Selvester Score was 3.5 ± 2.6. The baseline 
characteristics of  the overall cohort, as well as the two individual study groups, are shown 
in Table 1. The median time from symptom onset to reperfusion was four hours. Compared 
to the successful fibrinolytic group, patients in the failed fibrinolytic group had a longer 
onset to reperfusion 4.5(1–10) vs 3(0.5–8) hours respectively, p < 0.05, were more likely to 
be diabetic [10 (50%) vs 7 (21.2%) respectively, p < 0.05], with a higher troponin level [0.25 
(0–2.39) vs 0.03 (0–7.8)  μg/l respectively, p  <  0.05]. The Simplified Selvester Score was 
higher in the failed than the successful fibrinolytic group [5.1 ± 2.1 vs 2.3 ± 1.6 respectively, 
p < 0.05].
There was a good significant positive correlation between the Simplified Selvester Score 
and troponin level with a correlation coefficient r = 0.53.
The receiver operating characteristic (ROC) curve identified a cut-off  value of ≤ 3.5 as 
the optimal cut-off  value of the Simplified Selvester Score, with a sensitivity of 75% and 
specificity of 64%.
On bivariate analysis, some variables are significant: Diabetes mellitus (odds ratio [OR] 
0.27; p = 0.019); Dislipidaemia (odds ratio [OR] 2.8; p = 0.082); chest pain onset ≤ three 
hours (odds ratio [OR] 4.8; p  =  0.013); Diastolic BP  ≥  70  mmHg (odds ratio [OR] 3.0; 
p = 0.092); Troponin level ≤ 0.11 (odds ratio [OR] 6; p = 0.03) and the Simplified Selvester 
Score ≤ 3.5 (odds ratio [OR] 5.3; p = 0.006. From the multivariate analysis, a Simplified 
Selvester Score of  ≤ 3.5 was an independent predictor for successful fibrinolytic therapy 
in STEMI patients who received fibrinolytic treatment (p = 0.004: OR = 6.8; 95% CI [1.51, 
37.06]) (Table 2).
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4 DISCUSSION
The present study demonstrated that a Simplified Selvester Score of ≤ 3.5 was independently 
associated with successful fibrinolytic therapy in STEMI patients.
It seems appealing to identify those who are more likely to benefit from fibrinolysis in this 
patient category. Evaluation of the Simplified Selvester Score on admission ECG recordings 
would simply and readily offer the chance for this stratification. In this way, one would avoid 
giving fibrinolytic therapy (with its notorious risk of bleeding) to patients who are less likely 
to get its benefit and restrict it only to those who are more likely to improve (Schroder, 1995; 
Selvester, 1985).
The extent of myocardial damage in STEMI patients suggested a worse prognosis. Tro-
ponin T prone to describe this. Our study showed a good correlation with troponin level 
and also the Simplified Selvester Score. An advantage of the QRS scoring system is that it 
requires only an adequately obtained 12-lead ECG, which is univer sally available, inexpen-
sive, safe and noninvasive.
In our study, the optimum cut-off  point of the Simplified Selvester Score of ≤ 3.5 predicted 








(n = 20) Sig (p)
Age (year) 53 ± 7.6 51 ± 8.3 0.78
Male (%) 32 (97%) 19 (95%) 0.67
Smoking 28 (84.8%) 18 (90%) 0.59
Hypertension 12 (36.4%) 7 (35.0%) 0.92
Dyslipidaemia 18 (54.5%) 6 (30.0%) 0.08
Diabetes mellitus 7 (21.2%) 10 (50%) 0.03
Chest pain onset (hour) 3 (0.5–8) 4.5 (1–10) 0.016
Systolic BP (mmHg) 129 ± 23.7 126 ± 26.1 0.62
Diastolic BP (mmHg) 84 ± 12.5 80 ± 17.5 0.35
Hear rate (times/i) 7 (20–107) 62 (46–94) 0.30









Hb (g/dL) 14.7 ± 1.2 14.8 ± 1.9 0.09
Ht 42 ± 4 43 ± 4 0.44










Table  2. Multivariate model analysis of inde-
pendent factors of successful fibrinolytic therapy.
Variable p OR
95% CI for OR
Lower Upper
Selvester Score 0.004 6.842 1.511 37.065
Diastolic BP 0.031 4.245 1.594 40.186
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found a cut-off  point of ≥  3.5  in failed fibrinolytic therapy. In bivariate and multivariate 
analysis, the Simplified Selvester Score is associated with predicting successful fibrinolytic 
therapy, but this finding must be tested in a larger sample involving multicentres.
The main practical result of our study is that the Simplified Selvester Score can be used to 
predict incomplete ST segment resolution in those patients presenting with a high calculated 
Simplified Selvester Score and avoid administrating fibrinolytic therapy in a subset of these 
patients who arrive late to the emergency department with some ongoing chest discomfort, 
where the benefit of fibrinolytic therapy might be negligi ble or those deemed to be at high risk 
of thrombolytic (TLT)-related complications (e.g. elderly). It can also help in more accurate 
selection of STEMI patients for primary PCI in those centres with PCI facilities available.
This study has some limitations. First, our study was a single centre study. Second, using 
the complete version of the scoring system (54 criteria for a total of 32 points) might have 
changed the results. The simplified version may underestimate infarct size because it excludes 
posterior extension of inferior infarcts. Third, we studied patients with their first STEMI, 
where this scoring system performs best, so the results are not applicable to patients with pre-
vious MI. We also excluded patients with left bundle branch block, left anterior or posterior 
fascicular block, left ventricular hypertrophy or right ventricular hypertrophy. Fourth, we 
used only SK for TLT which has a lower reperfusion, patency and TIMI-3 flow rate than the 
newer generation of thrombolytics (e.g. alteplase, reteplase or TNK-t-PA).
5 CONCLUSION
The Simplified Selvester Score can reliably predict the occurrence of adequate successful 
fibrinolytics in patients with first acute STEMI receiving fibrinolytic therapy. Using the cut-
off  value of ≤ 3.5, the Simplified Selvester Score can predict adequate ST segment resolution 
with a high sensitivity and specificity.
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ABSTRACT: Cryptosporidium sp. is a common intestinal parasite infecting immunocom-
promised patients. This organism causes chronic diarrhoea. Infection is related to the inges-
tion of oocyst-contaminated drinking water or food. For immunocompromised individuals, 
this infection could have a higher mortality and vary in clinical manifestation. We report on 
three patients, aged 33–40 years, suffering from chronic diarrhoea caused by Cryptosporid-
ium sp. These patients were diagnosed with AIDS and a very low CD4 count (< 5%). The 
inadequacy of antiretroviral cause progressively decrease CD4 count according to host fac-
tors, it explains Cryptosporidium sp. is still a burden for AIDS patient, especially with very 
low CD4 count. There was no medication given to these patients including paromomycin or 
nitazoxanide, continuing antiretroviral therapy was the only medication given to patients. 
Diarrhoea frequency decreased after 8–10 days adminstration to hospital and discharge was 
done to these patients.
Keywords: cryptosporidium, AIDS, HIV, diarrhoea
1 INTRODUCTION
Cryptosporidium is an apicomplexan protozoa causing infections in the gastrointestinal tract 
and lungs (Leitch & He, 2011). There are two species associated with human infection, Crypt-
osporidium parvum and Cryptosporidium hominis (Widerstrom et al., 2014). In the early 1980s, 
several cases were confirmed as related to HIV infection. In the 1990s, cryptosporidium was 
also linked to waterborne outbreaks of diarrhoea, with approximately 403,000 people being 
infected by this organism in Wisconsin (White, 2015; MacKenzie et al., 1994).
Although this organism is a protozoa, it has a complex life cycle, with infection occurring 
when a fully sporulated oocyst is ingested by a human through contaminated water or food 
(Levinson, 2014). Excystation occurs in the upper part of the small intestine and penetra-
tion by the enterocyte will ensue, producing watery diarrhoea. Unfortunately, oocysts of this 
organism are thick-walled, which explains their resistance to chlorination or other disinfect-
ing agents (Fritsche & Pritt, 2017).
Most studies have shown that self-limiting diarrhoea is the main clinical manifestation in 
immunocompetent hosts worldwide, but chronic diarrhoea will ensue if  the host is immu-
nocompromised. The focus of treatment for this infection is supportive care, especially fluid 
replacement therapy (Flynn, 2016). Comparison studies using nitazoxanide and a placebo 
showed no difference, particularly in the HIV-infected population (Agnamey, 2010).
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2 CASE REPORT
The first patient, a 40-year old female was admitted to Adam Malik General Hospital for 
diarrhoea lasting for more than three days. She tested positive for HIV infection five years 
previously and underwent antiretroviral therapy. Unfortunately, her CD4 count progressively 
decreased, until now her absolute CD4 count was 17 cell/μL. This woman did not have any 
special condition or family history of systemic disease. She was negative for the Hepatitis B 
virus and Hepatitis C virus antibodies. For prophylaxis of Pneumocystis carinii pneumonia, 
co-trimoxazole was given to this patient.
The second patient, a 33-year old woman with chronic diarrhoea lasting for more than 
seven days was admitted to the same hospital. She was diagnosed with HIV eight years previ-
ously. This woman presented to hospital with fever and profuse watery diarrhoea. She also 
reported abdominal cramp. She also received co-trimoxazole as prophylactic medication. Her 
absolute CD4 count was just 2 cell/μL.
The third patient, a 35-year old man became debilitated with watery diarrhoea and fatigue. 
He experienced that for more than five days, and first line antiretroviral therapy was given to 
this patient. This man was a stage IV HIV-infected individual with pulmonary tuberculosis. 
This patient was also positive for HIV infection for eight years. Because of the high-burden of 
infection, this patient was also malnourished. The medication history of this patient included 
first category for pulmonary tuberculosis (isoniazid, pyrazinamide, rifampicin and ethambu-
tol), antiretroviral therapy and co-trimoxazole. His absolute CD4 count was 8 cell/μL.
All patients underwent further examination, especially microbiological and parasitological 
examination. Nevertheless, faecal smear under microscope examination revealed only Crypt-
osporidium sp. in all samples. We do not use any anti-parasitic medication for cryptospori-
diasis due to opportunistic infection in immunocompromised patients, especially those with 
AIDS. Using anti-parasitic medication is only considered for the paediatric population, not 
the HIV-infected population. Maintaining the fluid and nutritional status were the goals of 
therapy for this infection. Thus, continuing antiretroviral treatment was the only option here. 
After 8–10 days hospitalisation, diarrhoea frequency had decreased and resolved several days 
afterward.
3 DISCUSSION
Cryptosporidiidae are named based on the host they infect and approximately five common 
cryptosporidium species usually infect humans. However, more than 90% of human infec-
tions are caused by Cryptosporidium parvum (C. parvum) and Cryptosporidium hominis (C. 
hominis) (Rossle & Latif, 2013). Sporulated oocysts are an infective stage for this organism 
and have been found in 87% of water samples sourced from the United States and Canada 
(Yoder & Beach, 2010). Hardy, chlorine-resistant oocysts can spread by direct person-to-
Figure 1. Cryptosporidium sp. under microscopic examination. (1000x magnification field).
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person contact and survive for up to 12 months in cold water (Chalmers & Katzer, 2013). 
After oocyst ingestion, excystation in the upper small bowel will occur, with each oocyst 
consisting of four sporozoites and the sporozoites penetrate the enterocyte. Sporozoites will 
develop into their mature form in the enterocyte (Xiao & Griffiths, 2013).
Diarrhoea caused by this organism presents in four different populations: childhood 
diarrhoea in developing regions; travellers’ to developing regions diarrhoea; diarrhoea in 
immunocompromised patients; and outbreaks in developed countries (Lima & Guerrant, 
2016).
Clinical manifestation similarities are found in giardiasis, isosporiasis and cyclosporiasis. 
After a 3–12 day incubation period, clinical manifestation will be present. Watery diarrhoea 
is the main symptom, which may be associated with other symptoms, such as: abdominal 
cramps (96% of patients); anorexia, malaise, flatulence, nausea, vomiting (65%); and mildly 
elevated temperature (59%) (Davies & Chalmers, 2009). Cryptosporidiosis is associated with 
a higher mortality rate and more severe symptoms when an immunocompromised host is 
infected. Moreover, the CD4 count can be a predictor for this infection. There is no effective 
therapy for this infection because of its resistance to many antiprotozoal drugs, particularly 
for immunocompromised patients. Vaccine is also unavailable, however, ongoing research is 
still trying to find a vaccine using microRNAs (Checkley et al., 2015).
After excystation from the oocyst, sporozoites will invade mucosal epithelium and Pey-
er’s patch M cells. Intestinal Epithelial Cells (IECs), as a part of the innate immune system, 
have their own Toll-Like Receptors (TLRs) and intracellular Nod-Like Receptors (NLRs) 
which finally detect cryptosporidium. Presentation to CD4+ will ensue using IECs via 
MHC-II (Leitch & He, 2011). After recognition, CD4+ will be activated and play a major 
role in the acquired immune response (Checkley et al., 2015). Several studies have shown 
that two chemokines, CXCL-10 and CXCL-8, were attracting immune cells while infection 
developed (Rescigno, 2011). However, cell-mediated immunity is severely affected by HIV, 
which explains the inadequate clearance of this organism. Nevertheless, many observations 
have shown that the humoral immune response to cryptosporidium is quite strong in AIDS 
patients, even greater than those in immunocompetent patients. Unfortunately, the humoral 
immune response and antibody production, are not associated with clearance of this infec-
tion. IFN-ϒ is still required for an effective immune response to eradicate cryptosporidium. 
As noted, IFN-ϒ is produced by the Th1 (a subset of CD4 lymphocytes) (Santarlasci et al., 
2013). IFN-ϒ can accelerate the immune response, as it inhibits proliferation of cryptosporid-
ium in cultured enterocytes and it increases transcription factor for TNFα and NF-kB, which 
also increases the amount of TNFα. In addition, patients with a low CD4 count will suffer 
from a severe form of this infection. Meanwhile, CD8+ does not have several roles in crypt-
osporidiosis but requires further study to prove its function (Reijasse et al., 2001). In vitro 
studies have shown that peripheral blood mononuclear cells (PBMCs) of AIDS patients do 
not have normal respones to the cryptosporidium antigen (Leitch & He, 2011).
Borad and Ward summarised their studies using mice and humans, confirming that the 
severity of cryptosporidiosis is related to the CD4+ count. Those with a CD4+ of  less than 
50 cell/mm3 are susceptible to a severe form of the disease, otherwise those with a CD4+ 
count more than 180 cells/mm3 are not susceptible to severe disease or self-limiting disease 
(Rossle & Latif, 2013). Cryptosporidium sp. can also induce inflammation without tissue inva-
sion. Several studies tried to prove the toxin related to boost the inflammation but it remains 
elusive (Bouzid et al., 2013).
Nutritional support and replacement of fluid therapy are vital in immunocompromised 
hosts infected by this organism. Anti-motility drugs, such as loperamide or diphenoxylate/
atropine, can be used to relieve symptoms related to abdominal cramp and diarrhoea (Spark 
et al., 2015). Nitazoxanide has been approved by the FDA for treatment of cryptosporidium. 
However, clinical studies have shown that nitazoxanide has failed to eradicate this organism 
in the immunocompromised population and malnourished children (Checkley et al., 2015). 
Azithromycin, spiramycin and bovine anti-cryptosporidium immunoglobulin were consid-
ered as treatment for cryptosporidiosis, unfortunately, all were not superior to a placebo in 
AIDS patients (Cabada & White, 2010).
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4 CONCLUSIONS
Chronic diarrhoea caused by Cryptosporidium sp. is a common infection in those with a very 
low CD4 count or AIDS patients. The use of anti-parasitic drugs is still debatable because 
of the lack of effectiveness. The main goals of therapy for those suffering from opportunis-
tic infection, particularly Cryptosporidium sp. are fluid replacement therapy and nutritional 
support. Continuing antiretroviral drugs are the major mainstay for this infection to restore 
immune function over a period of time.
REFERENCES
Agnamey, P., Djeddi, D., Vanrenterghem, A,. et al. (2010). Childhood cryptosporidiosis: A case report. 
Journal of Parasitology Research.
Bouzid, M., Hunter, P.R., Chalmers, R.M. & Tyler, K..M. (2013). Cryptosporidium pathogenicity and 
virulence. Clinical Microbiology Reviews, 26(1), 115–134.
Cabada, M.M. & White, A.C. Jr. (2010). Treatment of cryptosporidiosis: Do we know what we think we 
know? Current Opinion in Infectious Diseases, 23(5), 49.
Chalmers, R.M. & Katzer, F. (2013). Looking for cryptosporidium: The application of advances in 
detection and diagnosis. Trends in Parasitology, 29(5), 237–248.
Checkley, W., White, A.C., Jaganath, D., et al. (2015). A review of the global burden, novel diagnostics, 
therapeutics, and vaccine targets for cryptosporidium. The Lancet Infectious Diseases, 15, 85–94.
Davies, A.P. & Chalmers, R.M. (2009). Cryptosporidiosis. BMJ, 339, 963–966.
Flynn, P.M. (2016). Cryptosporidium, isospora, cyclospora, and microsporidia. In Nelson textbook of 
pediatrics. New York: Elsevier.
Fritsche, T.R. & Pritt, B.S. (2017). Medical parasitology. In Henry’s clinical diagnosis and management. 
New York: Elsevier.
Leitch, G.J. & He, Qing. (2011). Cryptosporidiosis-an overview. Journal of Biomedical Research, 25(1), 
1–16.
Levinson, W. (2014). Intestinal & urogenital protozoa. In Review of medical microbiology and 
immunology. New York: McGraw-Hill.
Lima, A.A.M. & Guerrant, R.L. (2016). Cryptosporidiosis. In Goldman-Cecil medicine. New York: 
Elsevier.
MacKenzie, W.R., Hoxie, N.J., Proctor, M.E., et al. (1994). A massive outbreak of Cryptosporidium 
infection transmitted through the public water supply. The New England Journal of Medicine, 331, 
161–167.
Reijasse D., Canioni D., de Serre, N.P.M., Canioni, D., et al. (2001). Cytotoxic T cells in AIDS colonic 
cryptosporidiosis. Journal of Clinical Pathology, 54, 298–303.
Rescigno, M. (2011). The intestinal epithelial barrier in the control of homeostasis and immunity. Trends 
in Immunology, 32(6), 256–258.
Rossle, N.F. & Latif, B. (2013). Cryptosporidiosis as threatening health problem: A review. Asian Pacific 
Journal of Tropical Biomedicine, 3(11), 916–924.
Santarlasci, V., Cosmi, L., Maggi, L., et al. (2013). IL-1 and T helper immune responses. Frontiers in 
Immunology, 4, 1–5.
Spark, H., Nair, G., Castellanos-Gonzalez, A. & White, A.C. (2015). Treatment of cryptosporidium: 
What we know, gaps, and the way forward. Current Tropical Medicine Reports, 2(3), 181–187.
White, A.C. (2015). Cryptosporidiosis (Cryptosporidium Species). In Mandell, Douglas, and Bennett’s 
principles and practices of infectious diseases. USA: Elsevier.
Widerstrom, M., Schonning, C., Lilja M., et al. (2014). Large outbreak of Cryptosporidium hominis infec-
tion transmitted through the public water supply, Sweden. Emerging Infectious Disease, 20(4), 581.
Xiao, L. & Griffiths, J.K. (2013). Cryptosporidiosis. In Hunter’s tropical medicine and emerging infec-
tious diseases (9th edition). New York: Elsevier.
Yoder, J.S. & Beach, M.J. (2010). Cryptosporidium surveillance and risk factors in the United States. 
Experimental Parasitology, 124, 31–39.
ISCOC17_Book.indb   192 3/21/2018   2:04:22 PM
Stem Cell Oncology – Adella (Ed.)
© 2018 Taylor & Francis Group, London, ISBN 978-0-8153-9272-9
193
Endoscopic approach in maxillary tumours
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ABSTRACT: With the advent of dynamic and better resolution camera systems, an endo-
scopic approach is more popularly acceptable than conventional methods. Thus, surgical 
intervention in maxillary pathology has shifted into less invasive procedures with lower mor-
bidity and better disease surveillance.
Keywords: endoscopic, maxillary tumours
1 INTRODUCTION
Maxillary tumours are traditionally excised via an open approach even at early disease stages. 
However, with current advanced video technology and better resolution of camera systems, 
the tumours can be removed endoscopically, promising better outcomes.
2 CASE PRESENTATION
A 49-year-old man presented to our centre with a persistent unilateral nose blockage with a 
protruding mass in the left nostril. He was then further assessed using computer tomography. 
The mass was noted to occupy his entire unilateral sinuses; however, there was no evidence 
of orbital and intracranial involvement. He was then scheduled for endoscopic excision of 
the tumour.
A complete excision was successfully performed with a microdebrider. He has been under 
clinical surveillance at our centre. To date, no recurrence has been noted. His histopathology 
reported inverted papilloma.
3 DISCUSSION
Tumours in the maxillary sinus originate either from the apical point or medial wall of the 
sinus. In some cases, they extends into the nasal cavity and with further involvement of other 
sinuses, such as the ethmoidal and frontal sinuses. These tumours distort the natural anatomy 
of the region, providing a technical challenge to head and neck surgeons.
Traditionally, the tumours are removed using an open approach in which a facial incision 
is made along the lower lid of the eyes and continuously parallel to the nasal area and down 
to the philtrum. This is called a Weber-Ferguson incision.
However, the approach has become less popular since the 1980s, when the endoscope 
became evolutionised with better resolution and also became more easily available on the 
market. Currently, endoscopic training and technique has been markedly improved with bet-
ter camera systems so that early maxillary tumours can be removed endoscopically. This min-
imally invasive approach promises better outcomes and improved monitoring for patients.
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4 CONCLUSION
Currently, an endoscopic approach for maxillary tumours is widely acceptable. However, 
intensive training for endoscopic surgeons and delicate instruments are required.
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ABSTRACT: Urine culture is the gold standard in the diagnosis of a Urinary Tract 
Infection (UTI). More simple tests are often used instead of urine cultures. To compare the 
sensitivity and specificity of the urine nitrite test and gram staining with urine culture, a 
cross-sectional study was conducted at RSUP H Adam Malik, from February to July 2017, 
with participants recruited by consecutive sampling. The data collected were sample charac-
teristics, clinical manifestations, causal organisms, nitrite test, gram staining and urine culture 
results. The data were analysed using Fisher’s exact test with p < 0.05. A total of 60 samples 
were included. The organism encountered was Escherichia coli. The most frequent clinical 
manifestation was fever, exhibited by 37 children with UTIs. The sensitivity and specificity 
of the nitrate test were 64.8% and 86.9%, respectively, while the sensitivity and specificity of 
gram staining were 94.5% and 100%, respectively. Gram staining is a good alternative test for 
diagnosing UTIs, but nitrite testing still needs further research.
Keywords: nitrite test, gram staining, urine culture, urinary tract infection
1 INTRODUCTION
Early detection of urinary tract infection (UTI), such as urine dipstick test, microscopic 
examination and urine culture, is necessary because of the incidence of UTI misdiagnosis 
(Najeeb, 2015). Urinalysis was conducted in children aged over three years old who exhib-
ited dysuria, frequency, haematuria, abdominal pain and urinate incontinence (Robinson, 
2014). The urine dipstick test is a method for detecting leucocyte esterase and nitrite (White, 
2011). Gram staining and the urine dipstick test are considered as useful, simple, practical 
and effective methods for early diagnosis of UTIs (Zorc, 2005; Whiting, 2005). Urine culture 
is unavailable in some health care facilities. The nitrite test is an alternative, but its accuracy 
compared to urine culture is controversial. Gram staining is a simple test with high accuracy 
(Zorc, 2005).
A meta-analysis study from the American Academy of Pediatrics (AAP) in 2011 revealed 
that sensitivity and specificity of gram staining were 81% and 83%, respectively, while the sen-
sitivity and specificity of the urine nitrite test were 53% and 98%, respectively (Subcommittee, 
2011). A meta-analysis study in 2010 by William et al. indicated that the sensitivity of the 
urine nitrite test was 49%, while gram staining was 91% (Cantey, 2015). A study in Indonesia 
noted that the sensitivity and specificity of gram staining were 88% and 100%, respectively 
(Putri, 2013).
All of those studies pictured a controversy of sensitivity and specificity of urine nitrite 
test, however, they revealed a high sensitivity and specificity for gram staining. Therefore, it is 
necessary to determine the sensitivity and specificity of the urine nitrite test and gram stain-
ing so that clinicians can choose the best, quickest, most accurate and reliable examination 
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at all levels of health care facilities. Thus, the diagnosis and management of UTIs in children 
could be well performed, leading to a satisfactory outcome.
2 METHOD
The study protocol and the informed consent process were approved by the Research Eth-
ics Committee of the Universitas Sumatera Utara Medical School, Indonesia. This was a 
descriptive study with a cross-sectional approach.
The 60 participants were recruited by consecutive sampling. We enrolled children aged 
from 13 to 18 years old with suspected UTIs based on symptoms, urine dipstick test, gram 
staining and urine culture. The samples were children who could do midstream urine col-
lection, agreed to participate and filled the informed consent form. UTI was suspected in 
patients who had symptoms such as dysuria, frequency, urgency, vomiting, abdominal and 
flank area pain, decreased appetite and costovertebral angle tenderness, including children 
with unexplained fever which can occur in all age groups, and children with congenital anom-
aly of the urinary tract (Bou, 2017; Saheed, 2016). The study was conducted from February 
to July 2017 in H Adam Malik General Hospital, Department of Child Health. The exclu-
sion criteria were children who received antibiotic therapy one week before the examination, 
corticosteroid therapy or who used a urine catheter. All urine specimens were collected using 
clean-catch midstream urine collection.
The urine specimens were transported to the Microbiology Laboratory of H Adam Malik 
General Hospital within the hour. MacConkey agar was used for the urine culture. UTI was 
diagnosed with bacteriuria of ≥ 105 CFU/ml. The gram staining was performed by one physi-
cian. The urine dipstick test (Verify Urinalysis) procedure was conducted.
We used SPSS version 15.0 to examine the data. The data were tabulated and presented in 
a frequency distribution 2 × 2 table. The relation between the nitrite test and the urine culture 
was analysed using a Chi-square test with Fisher’s exact test.
3 RESULTS
Sixty children aged 3 to 18 years old were included in this study. Twenty-nine samples (48.3%) 
had gram-negative staining. Twenty-seven samples (45%) had a positive nitrite test. The 
median age of participants was ten years old, and from the Kolmogorov-Smirnov test, there 







Median age, year (minimum–maximum) 10 (3–18)

















ISCOC17_Book.indb   196 3/21/2018   2:04:23 PM
197
was significant result, p < 0.05 (Table 1). A positive result with UTI mostly was found in girls 
21 (56.8%) and boys 16 (43.2%).
There were 31 gram-negative samples (83.7%). The most common types of bacteria caus-
ing UTIs were Escherichia coli eight (21.6%), Klebsiella pneumoniae five (13.5%) and Entero-
bacter faecalis four (10.8%) (Table 2).
The clinical manifestations of UTIs in children attending the Adam Malik General Hos-
pital are described in Table 3. The most common symptom found with a UTI in this study 
was fever 21 (56.8%).
The other common clinical symptoms were dysuria and abdominal pain; both had a pro-
portion of 24.3%.
Table 4 shows the ratio of nitrite test to urine culture, with the sensitivity and specificity 
of the nitrite test being 64.8% and 86.9%, respectively. Table 5 shows that the sensitivity and 
specificity of gram staining were 94.5% and 100%, respectively.
Based on Fisher’s exact text, the association between the nitrite test and the organisms 
resulting from the urine culture was significant, with p  =  0.014 and PR (95% CI) 14.375 
(Table 6).
Table 2. Distribution of organisms causing UTIs.



































Table 3. Distribution of clinical manifestations of UTIs in children.
Clinical manifestation Frequency, n (%)
Fever 21 (56.8)
Dysuria  9 (24.3)
Abdominal pain  9 (24.3)
Frequency  5 (13.5)
Dysfunctional voiding  4 (10.8)
Urgency  3 (8.1)
Flank pain  3 (8.1)
Decreased appetite  3 (8.1)
Vomiting  2 (5.4)
Costovertebral angle tenderness  1 (2.7)
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4 DISCUSSION
Acute UTIs are relatively common in children. School-aged children may have symptoms 
similar to adults, including dysuria, frequency or urgency. Females have a high risk of UTI 
infection (White, 2011).
Common uropathogens include Escherichia coli (accounting for approximately 85% of 
UTIs in children). Gram-negative bacteria are the most common (White, 2011; Bou, 2017). 
In this study, in accordance with the results of previous studies, the most common organism-
causing encounter is Escherichia coli followed by Klebsiella pneumoniae. Furthermore, UTIs 
are caused by coliform and Enterococcus spp. This is due to their presence in high numbers 
on the perineum (Saheed, 2016).
UTIs are more common in girls than boys. According to the AAP, in 2011 the incidence 
of UTIs in girls was 8% and in boys was 2%. UTI rates are largely unchanged from 6 to 16 
years of age (Chang, 2006; Trapote, 2011). In Indonesia, the risk of UTIs in prepuberty is 
3%–5% in girls and 1%–2% in boys (Pardede, 2001). UTI prevalence in children ranges from 
3%–73%, with a median of 20% found in some studies (Whiting, 2005). In this study, the 
number of a girls suffering from UTIs is 56.8% of all proven UTI samples.
Usually, in children over two years of age, midstream urine can be taken. Research in 
France concluded that direct urine sampling is better than through a urine catheter 















Positive 24 (88.9) 3 (11.1) 64.8 86.9 88.8 60.6 4.9 0.4 73.3
Negative 13 (39.4) 20 (60.6)
*Sn: sensitivity, Sp: specificity, PPV: positive predictive value, NPV: negative predictive value, PLR: 
positive likelihood ratio, NLR: negative likelihood ratio, A: accuracy.















Positive 24 (88.9) 3 (11.1) 64.8 86.9 88.8 60.6 4.9 0.4 73.3
Negative 13 (39.4) 20 (60.6)
*Sn: sensitivity, Sp: specificity, PPV: positive predictive value, NPV: negative predictive value, PLR: 
positive likelihood ratio, NLR: negative likelihood ratio, A: accuracy.










Positive 23 (95.8) 1 (4.2) 0.014 14.375
Negative  8 (61.5) 5 (38.5)
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(Mori, 2007). A study in New York concluded that the midstream urine sample is less likely 
to be contaminated with bacteria (Dayan, 2000). Research in Spain, in 2012, introduced the 
concept of urine collection by the midstream method (Bou, 2017). Some studies concluded 
a sensitivity of clean-catch midstream urine sampling of 98% to 100%, whereas a specificity 
of 71% to 97% was reported (Holm, 2016). Midstream urine collection has decent sensitivity 
and specificity besides its superiority in patient comfort, reduced trauma and ease of sam-
pling compared to other urine sampling methods.
Urinalysis and the dipstick urine test cannot replace urine culture as the gold standard for 
investigating UTIs. Research in Nigeria showed a sensitivity and specificity of urine nitrite 
testing of 66.2% and 93.5%, respectively (Maya, 2011). A study in Iran revealed the sensitiv-
ity of the nitrite test as being 79% (Ayazi, 2007). In the present study, the sensitivity of the 
nitrite test was 64.8% and the specificity was 86.9%. The sensitivity of gram staining was 
94.5% and the specificity was 100%.
The relationship between the nitrite test and gram of bacteria using Fisher’s exact test 
showed p = 0.014, indicating a statistically significant relationship with a PR value of 14.375 
(95% CI [1.452, 142.351]). The change of nitrate to nitrite in urine by gram-positive bacteria 
is unclear. In positive gram, the change was found in staphylococcus with a negative coagu-
lase, with some of the nitrite yields positive (Sato, 2005). A study in Riyadh, in 2010, showed 
a sensitivity of urine nitrite to gram-negative organisms of 45%–60%, while for specificity the 
range was 85%–98%%. Overall, positive nitrite found in gram-positive ranged from 5.5% (0% 
to 50% and to gram-negative 49.7% (21.4% to 55.2%) (Majid, 2010).
5 CONCLUSION
This study showed that the sensitivity and specificity of gram staining are high. The nitrite test 
showed high specificity. The nitrite test and gram urine staining are good alternative diagnos-
tic and screening tests for UTIs in children in areas with limited facilities and health workers.
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ABSTRACT: The World Health Organization (WHO) have recommended albendazole 
400 mg for the eradication ascariasis. Despite effective treatment options, reinfection follow-
ing treatment alone is inevitable. A case-control study was conducted to investigate the differ-
ence in incidence of ascariasis in children who received education on sanitation and personal 
hygiene once with recurrent in Singkuang village, South Tapanuli, North Sumatera from 
April to October 2016. The subjects were elementary school children selected using a cluster 
sampling technique. Statistical analysis was performed by Chi-square and Fisher’s exact test. 
One hundred and seventy elementary school children were divided into two groups, with 
85 subjects in the control group. The incidence of ascariasis was found to be 24% in the con-
trol group and 3% in the case group. Children who received recurrent education tended to be 
8.4 times more likely not to succumb to ascariasis. There were significant differences in the 
incidence in both groups (p = 0.001).
Keywords: ascariasis, children, educational lecture, parasitic worm
1 INTRODUCTION
The incidence of soil-transmitted helminths (STH) in developing countries remains high. 
The main cause of intestinal parasitic infections is Ascaris lumbricoides (Clarke et al., 2017; 
Yap et al., 2016). The groups most vulnerable to this infection are school-age children, with 
an intensity peaking in the 5–14 year-age group (Yap et al., 2016). Among STH, ascariasis 
is the most common worm infection, with an estimated worldwide incidence of 25% (0.8 to 
1.22 billion people) (Bethony et al., 2006).
The World Health Organization’s (WHO) policy for control of ascariasis centres on three 
groups, preschool-aged children (pre-SAC), school-aged children (SAC) and women of child 
bearing age, on the basis that heavy infection in these groups will have a detrimental impact 
on anaemia, child growth and development. The current WHO guidelines focus on school-
aged children, both for monitoring infection and as a target for treatment, although treat-
ment of pre-SAC and women of childbearing age is also recommended where sustainable 
delivery mechanisms exist, especially in areas of intense transmission. The guidelines recom-
mend treating SAC annually where any STH prevalence falls between 20% and 50% and twice 
a year where it exceeds 50% (Anderson et al., 2015). At present, the control strategy for STH 
infection promoted by the WHO is based solely on the eradication of periodic worms or 
deworming in high-risk communities (Clarke et al., 2017). By treating the highest risk group, 
environmental contamination is reduced and consequently, infection in the wider commu-
nity decreases. School-based deworming programmes have been shown to contribute towards 
achieving several of the Millennium Development Goals (MDG).
Despite effective treatment options for STH infections, reinfection following treatment 
alone is inevitable (Jia et al., 2012). One strategy that has been identified to reduce reinfec-
tion following deworming treatment is health education, focussing on teaching hygienic and 
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sanitary behaviours. The simplest and cheapest strategy is handwashing. Previous studies 
have assessed the effectiveness of handwashing in reducing the prevalence of ascariasis (Mah-
mud et al., 2015). Regular education in schools can be a way of conveying the right method 
of handwashing to a child. A school-based health hygiene education intervention was effec-
tive in increasing STH knowledge and in reducing ascariasis (Gyorkos et al., 2013). Educa-
tion on health, especially prevention of ascariasis disease, for both parents and children is 
an important factor in breaking the chain of transmission as well as the incidence rate of 
ascariasis disease (Schmidlin et al., 2013; Corneiro et al., 2002).
2 METHOD
This study took place in Singkuang village, Mandailing Natal, North Sumatera from April 
2016 until October 2016. The subjects were elementary school children selected using a clus-
ter sampling technique. The exclusion criteria were students who refused to take worm medi-
cines and incomplete follow the execution. All children who fulfilled the inclusion criteria 
were enrolled in the study. Primary school data collection in Singkuang village, the selection 
of elementary school will be conducted randomly. Elementary schools that were selected 
were randomised for one or three-time extension interventions. Basic baseline data on par-
ents’ and children’s knowledge of helminth infection and its prevention were collected based 
on the available questionnaires. Examination of faeces by the parasitology officer of the 
Faculty of Medicine, the University of North Sumatra was conducted using the Kato Katz 
method. All participants who suffered and did not suffer from a worm infection were given 
the anthelmintic medication, albendazole 400 mg, in a single dose. The participants were 
randomly grouped into case and control groups. Single education was performed in the con-
trol group and repeated three times in the case group. We tested the validity of the education 
lecture instrument by using Pearson’s correlation test and obtained a result for Cronbach’s 
alpha coefficient of 0.86. Repeat examination of faeces was conducted three months after 
and assessed the incidence rate of ascariasis in both new and reinfected children. Data were 
analysed using the Statistical Package for Social Sciences (SPSS) for Windows, version 19 
(2010), with a 95% confidence interval and a p value <0.05 was considered as significant. 
Randomisation was used Microsoft Excel Randomisation. The analysis was performed using 
a Chi-square and Fisher’s exact test. Ethical approval was granted by the Research Ethics 
Committee, Medical Faculty, University of North Sumatera.
3 RESULTS
One hundred and seventy elementary school children from Singkuang village, Mandailing 
Natal, North Sumatra, were enrolled and divided into two groups, with 85 subjects in the 
control group.
The study population characteristics showed that the mean age of children in the control 
group was 10.1 (SD 1.97) years and in the case group 8.8 (SD 2.04) years. Both groups were 
dominated by males. Based on the class, children in the control group were mostly in fifth 
class (23.5%), while in the case group they were mostly in first grade (28.2%). The number of 
siblings and the order in the family of children in each group was almost the same. Children 
in both groups mostly had short stature and normal nutritional status. Parents of children in 
both groups have incomes ranging from 500,000 to 1,000,000 Rupiah, with most occupations 
being either fishermen or farmers. More than 80% of children’s parent’s education is up to 
elementary school. From the total sample, 50 students suffered from ascariasis. This shows 
that the prevalence of ascariasis in this study was 29.4%.
This study reported that after six months follow-up, we found 96.5% (82/85 samples) and 
76.5% (65/85) samples in the uninfected state, the remaining was 3.5% and 23.5% samples 
in reinfection state, respectively for intervention and control group. The relative risk ratio 
for both groups was 8.410. The findings from the six months follow-up assessment showed 
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that there were differences in the incidence in both groups (p = 0.001). Children who received 
recurrent education tended to be 8.4 times more likely not to succumb to ascariasis (Table 1).
This study also looked for factors related to the success of the education programme. The 
results of the logistic regression test on factors related to the success of education in this 
study showed that the parent’s occupation is the only factor affecting the success of educa-
tion, where the success of education will increase 184 times in children of parents with civil 
service employees compared with children of parents with other jobs (Table 2).
4 DISCUSSION
In Indonesia, the prevalence of ascariasis remains high, especially in children aged one to 
ten years. Research conducted by Rahmad in Sibolga, North Sumatra, showed a preva-
lence of ascariasis of 55.8% and in Karo of 18.3% (Rahmad, 2008). Meanwhile, research by 
Ginting (2009) in Samosir reported a higher figure of 55.8%. Another study in the area of 
North Sumatra, Deli Serdang by Rahma reported a prevalence of 84.4% (Rahma, 2011). The 
present research was conducted in the North Sumatera province, Mandailing Natal Regency. 
This region consists of coastal and tropical lowlands. The results showed a prevalence of 
ascariasis of 29.4%. This figure is lower than the prevalence in the Sibolga and Deli Serdang 
areas which are both coastal and lowland areas. This may be due to a lack of STH infection 
screening conducted in the study area.
Ascaris infection is more common in children aged 6–12 years (Mahmud et al., 2015). This 
is because children still have a lack of knowledge or consciousness about personal hygiene 
and health. The presence of Intestinal Parasitic Infections (IPIs) have a statistically signifi-
cant association with the educational status of the household heads, the absence of washing 
facilities, home cleanness conditions and type of toilet used (p < 0.05) (Abbosie & Seid, 2014). 
The economic and educational level of parents also affects the incidence of ascariasis in 
children (Nematian et al., 2004). Parents with low economic levels tend to use health facili-
ties more often associated with prevention of health or ascariasis. Low-educated parents will 
have less knowledge, including in the health field. One of the things they often ignore is 
personal hygiene and the environment. Also, poorly educated parents will find it difficult to 
provide good health education to their children, including the prevention of worms.
Table 2. Factors related to the success of education.









































Table  1. Educational relationship of sanitation and 
hygiene with the occurrence of ascariasis.
Education
Ascariasis
RR 95% CI p*No Yes
Multiple 82  3 8.410 [2.394, 29.543] 0.001
Single 65 20
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STHs are easily treated with one of  four drugs: albendazole and mebendazole, and to 
a lesser extent, levamisole and pyrantel pamoate (Anderson et al., 2015). In line with the 
WHO strategy for controlling STH infections in endemic countries, a national school-
based deworming programme currently provides annual delivery of  albendazole to school 
children (Kepha, 2017). However, reinfection commonly occurs due to the inability of 
the human host to mount protective immunity to reinfection by intestinal helminths (Jia 
et al., 2012). The impacts on both prevalence and intensity of  infection were significantly 
higher among children receiving four-monthly treatments of  albendazole compared to 
those who received a single annual treatment (Kepha, 2017). But if  treatment combined 
with inadequate hygiene and sanitation. Ziegelbauer et al. (2012) to restrict or eliminate 
re-exposure in environments continuously contaminated with the egg or larval free-living 
transmission stages of  these parasitic worms (Gabrie et al., 2014; Seid et al., 2015; Walker 
et al., 2011).
The major strengths of this study include the large sample size, the randomised design, 
the high response and follow-up rates, appropriate statistical adjustment for clustering by 
schools, the matched-paired design and potential confounders. One limitation of this study 
is related to the open-label design. Although difficult to assess, it may be possible that stu-
dents’ knowledge of their exposure status (i.e. whether they received the intervention or not) 
may have biased their self-reported responses to the behaviour questions, leading to poten-
tial measurement error. Another limitation is that we only had one follow-up period (i.e. 
four months) and we cannot conclude if  knowledge of STH transmission and the protective 
effects on the intensity of Ascaris lumbricoides infection can be maintained over longer time 
periods.
5 CONCLUSION
There is a significant difference in the incidence of ascariasis between children receiving edu-
cation on sanitation and recurrent hygiene with those who only receive a once off  educational 
lecture.
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ABSTRACT: Fentanyl has a potency ratio 100 times stronger than morphine. Oxycodone 
is a receptor agonist of mu and kappa opioids, structurally similar to codeine, but pharma-
codynamically similar to morphine. The aim of this study was to determine the comparison 
of time achievement of VAS ≤ 3 on oxycodone. This study used a double-blind, randomised 
clinical trial, collecting 48 samples from participants aged 21–60 years, PS ASA I-II. Oxyco-
done (A): fentanyl (B) (initial bolus 5 mg than continuous infusion dose of 1 mg/hour: initial 
bolus 5 cc of NaCl 0.9% than continuous infusion dose of 0.5 mcg/hour) with significance 
level 95% (p < 0.05). Average length of surgery fentanyl: oxycodone (218.96 ± 53.38 minutes: 
191.87 ± 80.10, p > 0.05). Oxycodone is faster in achieving VAS ≤ 3 compared with fentanyl 
intravenous infusion.
Keywords: effectiveness, fentanyl, opiates, oxycodone, visual analogue score
1 INTRODUCTION
Fentanyl has a potential ratio 100 times stronger than morphine (Barash, 2013). According 
to the South African Anesthesiologist’s Guide, the average fentanyl dose for post-operative 
pain is 1–5 mcg/kg/day (SASA, 2009).
Opioid drugs are most commonly used in the first 24 hours post-operatively. Patients who 
have frequently received previous opioid administration may become resistant to commonly 
used opioid doses (Fabregat, 2011).
Kloub in 2015 examined the efficacy of oxycodone for the treatment of short-term pain in 
post-operative patients. This study involved 263 patients undergoing various surgical proce-
dures. It was reported that 220 patients (83.7%) had no pain and 20 patients (7.6%) reported 
pain with a score of five more than those concluded. Oxycodone is effective in the treatment 
of short-term pain in most types of surgery (Kloub, 2015).
Park in 2015 studied 74 patients undergoing elective laparoscopic hysterectomy or laparo-
scopic myomectomy with a random choice to obtain fentanyl or oxycodone using IV-PCA 
(potential ratio 1:60). Patients were also examined for post-operative pain, side effects and 
patient satisfaction. There was a significant difference in patient satisfaction with analgesics 
observed during the post-operative period. Patients in the oxycodone group showed a low 
intake of opioids (10.1 ± 8.5 ml vs. 16.6 ± 12.0 ml, p = 0.013). It was found that oxycodone 
and fentanyl showed similar effects (Park, 2015), differences in VAS values  and adverse events 
after the administration of oxycodone is 1 mg/hour and fentanyl dose 0.5 mcg/kgbb/hour 
intravenously continuously in overcoming post-surgical pain of long bone surgery under gen-
eral anaesthesia on the grounds of finding alternatives to opioid analgesic drugs that have 
an effect the same for post-operative pain management with general anaesthesia techniques 
without side effects that could harm the patient.
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2 METHODS
The design of this study involved a double-blind, randomised controlled clinical trial. The 
aim was to determine the differences in VAS values and adverse events after oxycodone doses 
of 1  mg/hour and fentanyl doses of 0.5  mcg/kgbb/hr of intravenous continuous pain in 
post-surgical pain with general anaesthesia. This research was conducted at RSUP.H. Adam 
Malik. The research was conducted after ethical clearance was published until the number 
of samples was met.
The study population involved elective patients scheduled to undergo long bone surgery 
under general anaesthesia techniques using ETT. The study sample fulfilled the inclusion and 
exclusion criteria. Once calculated statistically, all samples were divided into:
a. Group A received an oxycodone bolus of 5 cc and continued with an intravenous continu-
ous 1 cc/hour continuous maintenance dose.
b. Group B received fentanyl doses of 0.5 mcg kg bw continuous intravenously.
Inclusion criteria: aged 21–60 years; undergoing long bone surgery; physical status of ASA 
1 and 2; with ideal body weight according to BMI; patients agreed to participate in the study. 
Exclusion criteria: patients who received opioid analgesics before surgery. Criteria of Discon-
nect Test (Drop Out): Occurred emergency heart and lung, allergic reactions occur after the 
use of drugs studied.
The patients received an explanation about the procedure to be followed and provided 
informed consent. Both groups of patients were given preloading fluid Ringer Lactate 
10 ml/kg BW. Both groups were prepared for general anaesthesia. Premedication with fen-
tanyl 2 mcg/kg, midazolam 0.05 mg/kg, awaited onset 5 minutes. Patients were induced with 
propofol 2 mg/kg, rocuronium muscle paralytic 1 mg/kg, after the onset of 1 min, a direct 
laryngoscopy was performed with a laryngoscope and the trachea was intubated with an 
appropriate size endotracheal tube. Surgery begins, the maintenance of sedation using Iso-
flurane, maintenance of analgesia with fentanyl according to hemodynamic response, and 
maintenance of muscle paralysis using rocuronium.
After surgery, having fulfilled the extubation criteria, the patient was extubated and the 
time was recorded as T0 and the VAS was assessed using the VAS drawing table, by asking 
the patient to indicate on the scale the point corresponding to their perception of pain expe-
rienced. This assessment was conducted directly by researchers who are not involved in the 
administration of drugs to these patients. The time of initiation of the study in which group A 
received an oxycodone bolus 5 mg was followed by intravenous 1 mg/hour continuous main-
tenance for 24 hours, while group B received fentanyl with the initial bolus using 0.9% NaCl 
0.5 doses of 0.5 mcg/kgbw/hour intravenously for 24 hours. If, during the study, the patient 
was still in pain (VAS > 3) then oxycodone was increased by 1 mg per hour until VAS < 3 is 
reached. Fentanyl was increased by 0.5 mcg to VAS < 3.
The patient was observed in the recovery room and transferred to the ward when the 
Aldrette Score was 10. The VAS assessment and the side effects of the drug were performed 
directly by the researchers at 0 (T0), 1 (T1), 2 (T2), 3 (T3), 4 (T4), 6 (T5), 12 (T6) and 24 (T7) 
after surgery ends. T0 begins after the patient is extubated and fully awake. The results of 
observational data in both groups were statistically comparable.
3 RESULTS
No statistically significant differences in age, sex and ASA between the two study groups was 
demonstrated (p > 0.05).
Statistically, there was no significant difference in pre-operative VAS between the two 
study groups (p > 0.05).
Based on the above table, it can be seen that the average duration of group operation 
given fentanyl was 218.96 ± 53.38 minutes and the mean duration of group operation given 
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Table 1. Distribution of research subjects by age, sex and ASA.
Characteristics
Drugs given
Total p valueMorphine Oxycodone
 Age (year)
 19–29 11 (45.8%)  7 (29.2%) 18 (37.5%)
0.604 30–39  3 (12.5%)  2 (8.3%)  5 (10.4%) 40–49  4 (16.7%)  6 (25.0%) 10 (20.8%)
 50–59  6 (25%)  9 (37.5%) 15 (31.3%)
Total 24 (100%) 24 (100%) 48 (100%)
 Sex
 Male 13 (54.2%) 15 (62.5%) 28 (58.3%) 0.558 Female 11 (45.8%)  9 (37.5%) 20 (41.7%)
Total 24 (100%) 24 (100%) 48 (100%)
 ASA
 ASA 1 10 (41.7%)  8 (33.3%) 19 (39.6%) 0.551 ASA 2 14 (58.3%) 16 (66.7%) 29 (60.4%)
Total 24 (100%) 24 (100%) 48 (100%)
*Fisher’s exact test.
Table 2. Distribution of research subjects based on pre-operative VAS values.
VAS Pre-Op
Drugs
Total p value*Fentanyl Oxycodone
4 15 (62.5%) 11 (45.8%) 26 (54.2%) 0.247
5  9 (37.5%) 13 (54.2%) 22 (45.8%)
Total 24 (100%) 24 (100%) 48 (100%)
*Chi-square tests.
Table 3. The average difference in surgery duration based on the drugs given.
Drugs given n
Duration of operation (Minutes)
Value of p*Mean Std. Deviation Median Minimum Maximum
Fentanyl 24 218.96 53.38 217.5 50 310 0.185
Oxycodone 24 191.87 80.997 200 65 365
*Mann-Whitney test.
Table 4. The average time difference to achieve VAS ≤ 3 based on the drugs given.
Drugs given n
Time to reach VAS 3 (Hours)
Value of p*Mean Std. Deviation Median Minimum Maximum
Fentanyl 24 2.58 0.50 3 2 3 0.001
Oxycodone 24 1.46 0.509 1 1 2
*Mann-Whitney test.
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oxycodone was 191.87 ± 80.10 minutes. Based on statistical tests with Mann-Whitney test 
showed no difference in the duration of surgery between the two study subjects (p > 0.05).
Based on statistical tests with Mann-Whitney test showed no time difference to achieve 
VAS ≤ 3 between the two study subjects (p < 0.05).
From the graph above, the oxycodone group has a lower average VAS value compared to 
the fentanyl group from T1–T7. At T0, both groups have the same VAS. This is because there 
are still effects of analgesic drugs used during surgery.
4 DISCUSSION
This study assessed the effectiveness of oxycodone analgesics and continuous infusion fenta-
nyl in monitoring post-operative pain in long bones. From the sample characteristic data, it 
can be seen that the age between the two sample groups did not have a statistically significant 
difference. Thus, the samples taken were relatively homogeneous (p > 0.05). Similarly, sex, 
ASA physical status, VAS pre-op and duration of operation between the two groups of sam-
ples were not statistically significant (p > 0.05).
Based on the statistical test of the average dose used to achieve VAS ≤ 3 it was found that 
the mean dose of fentanyl group drug group was 0.4058 ± 0.054 mcg more than the group 
given oxycodone by as much as 1.46 ± 0.51 mg. The Mann-Whitney test showed significant 
differences between the two groups (p < 0.05).
The results of the clinical trial showed that the oxycodone group required a faster time to 
achieve VAS ≤ 3 with a mean time of 1.46 hours compared with the fentanyl group with an 
average time of 2.58 hours. The Mann-Whitney test results in this study also showed that the 
average dose of drugs produced in the oxycodone group had a smaller dose range of 1.46 ± 
0.51 mg compared with fentanyl of 0.4058 ± 0.054 mcg.
A study conducted by Kim et al. in 2014 found that oxycodone IV-PCA was more favour-
able than IV-PCA fentanyl for laparoscopic hysterectomy surgery regarding oxycodone con-
sumption accumulation, pain control and favourable effects related to price. This is in line 
with this study, where the use of oxycodone by continuous infusion is more effective in reduc-
ing VAS ≤ 3 compared with fentanyl use.
This study did not assess the incidence of adverse events occurring from both drugs. 
In further studies, an assessment of possible side effects due to the use of this drug may be 
possible.
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ABSTRACT: It is common to believe that depression can lead to more severe disease. 
Breast cancer is the most studied cancer in terms of its psychosocial effects and not surpris-
ingly, many studies of the prevalence of depression in cancer are studies of women with 
breast cancer. Aim: To determine the level of depressive syndrome in breast cancer patients 
by using the BDI questionnaire. Method: The respondents amounted to 66 breast cancer 
patients who come to the Clinic of Surgical Oncology and General Surgery at Adam Malik 
Hospital, and Hospital Haji Medan. Results: It was found that moderate depressive syn-
drome was most prevalent in patients with breast cancer (42.4%), followed by severe (25.8%), 
mild (19.7%) and minimal (12.1%) depression severity.
Keywords: depression, BDI, breast cancer
1 INTRODUCTION
In psychiatry, depression points to a clinical syndrome composed of diminished mood (pain-
ful feelings and sadness), difficulty in thinking and psychomotor retardation (Campbell, 
1981). A survey by the Indonesian Psychiatry Association reported that 94% of Indonesians 
had depressive symptoms ranging from mild to severe (Sadock et al., 2007).
The age of onset for severe depressive disorder was about 40 years, with 50% of all patients 
having an onset between the ages of 20 and 50 years. Severe depressive disorders could also 
occur in childhood or old age. Maguire reported that up to 80% of the psychological and 
psychiatric problems of cancer patients were under detected. The barriers identifying depres-
sion in cancer patients included the following: no reports by cancer patients; the inability of 
doctors to recognise depression in cancer; patients consider depression to be ‘appropriate’; 
difficulties distinguishing depression from other psychological conditions; signs and symp-
toms that accompany cancer; and fear of psychiatric disorder stigma (Wah, 2004).
There were few reasons why depression and anxiety were not diagnosed in cancer patients; 
for example, lack of time during office visits, misinterpretation of depression and anxiety as 
‘normal’ reactions, depression-related symptoms and anxiety-related cancer, focusing only 
on medical issues and therapeutic absence. Some risk factors for the occurrence of anxiety 
and depression in cancer patients are organic mental disorders, less controlled physical symp-
toms, lack of communication between staff  and patients, previous history of mood disorders 
and lack of support from family and friends (Jones, 2011). Depressive symptoms in cancer 
patients may be from psychiatric comorbidity, symptoms of a medical disorder or psycholog-
ical reaction. Moreover, the overlapping symptoms between depression and physical illnesses, 
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for example vegetative symptoms, result in complexity in making a diagnosis of depression. 
Few approaches were used in previous epidemiological studies of depression in patients with 
physical illnesses, including inclusive and exclusive approaches (Gross et al., 2007).
Depression develops in those who have had cancer in relation to the medical illness itself, 
to factors related to management and the nature of a person. The frequency of depression 
is associated with the type of cancer. The severity of the disease is also a predictive factor, 
with metastatic disease leading to higher rates of depression than cancer detected at an early 
stage. The presence or absence of social support and a person’s ability to overcome problems 
also contributed to the development of depression in cancer patients (Gross et al., 2007).
2 METHODS
This study was an analytic study with a cross-sectional design to assess whether there was a 
depressive syndrome in patients with breast cancer and whether the depressive syndrome in 
breast cancer patients was different based on age, education, marital status, tribe, occupation, 
income and stage of cancer.
Subjects in the study were patients diagnosed with histopathologic breast cancer, as well 
as all stages administered by RSUP H. Adam Malik, Medan and Haji Hospital, Medan, 
with the following inclusion criteria: (1) Breast cancer patients diagnosed on histopathologic 
examination; (2) Age ≥  30 years; (3) First contact with investigator; (4) Cooperative and 
willing to fill out the questionnaire; (5) Never received therapy for breast cancer. Exclusion 
criteria included: (1) Having psychiatric disorders before taking the study; (2) Having other 
general medical conditions.
3 RESULTS
The respondents amounted to 66 breast cancer patients who came to the Clinic of Surgical 
Oncology and General Surgery at Adam Malik Hospital and Haji Hospital, Medan within 
the four months of the study.
Table 1 shows that the sample was dominated by the age group 40–49 years old (63.6%), 
elementary education (65.2%), marital status (77.3%), Batak (39.4%), monthly income <Rp 
500,000.00 (75.8%) and stage IIIB (63.6%) for clinical stage of cancer disease.
Our findings show that medium depressive syndrome was most prevalent in patients with 
breast cancer (42.4%), followed by severe (25.8%), mild (19.7%) and minimal (12.1%) depres-
sive syndromes.
Table 3 shows that depressive syndrome in patients with breast cancer is most common 
in stage IIIB (76.5%) in the form of severe depressive syndrome. There was no significant 
difference in depressive syndrome in patients with breast cancer based on clinical stage of 
breast cancer.
Table 4 shows that age risk factors for the occurrence of depressive syndrome in patients 
with breast cancer were aged 30–39 years (PR = 6.180; 95% IK 1.518 to 34.139).
Table 1. Characteristics of age, education, marital status, tribe, 
employment, revenue and clinical stage of breast cancer.
Characteristics of respondents Total %
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Table 2. Depressive syndrome in breast cancer patients.
Depressive syndrome Total %
Minimal  8  12.1
Mild 13  19.7
Moderate 28  42.4
Severe 17  25.8
Total 66 100.0
Table  4. Risk factor age for occurrence of depressive syn-







50–59 yr 2.481 0.115 0.682 33.798
40–49 yr 3.170 0.075 0.878 15.242
30–39 yr 6.180 0.013 1.518 34.139
Table 1. (Continued).
Characteristics of respondents Total %
Mean = 50.4 yr (SD = 10.1)
Education No education 2 3.0
Primary 43 65.2
Lower secondary 8 12.1
Higher secondary 8 12.1
University 5   7,6
Marital Status Married 51 77.3
Not married 15 22.7





Occupation Employed 33 50.0
Unemployed 33 50.0
Income/Month <Rp 500,000 50 75.8
Rp 500,000–1,000,000 9 13.6
>Rp 1,000,000 7 10.6
Staging of 
 breast cancer
III A 9 13.6
III B 42 63.6
III C 8 12.1
IV 7 10.6
SD = Standard Deviation.






Minimal Mild Moderate Severe
n % n % n % n %
IIIA 0  0  3  23.1  4  14.3  2  11.8
IIIB 6  75.0  6  46.2  17  60.7 13  76.5 0.647*
IIIC 2  25.0  2  15.4  3  10.7  1  5.9
IV 0  0  2  15.4  4  14.3  1  5.9
Total 8 100 13  100 28  100 17  100
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4 DISCUSSION
Overall, this study showed that among 66 breast cancer patients, 58 of them had depressive 
syndrome (87.9%). However, in previous studies on depression in breast cancer patients, Ell 
et al. reported that from 250 breast cancer patients, 76 of them (67%) suffered severe depres-
sive disorders (Ell et al., 2007) and Burgess et al. (2005) reported that in 107 breast cancer suf-
ferers, 48% suffered depression after one year from breast cancer diagnosis, while 25%, 23%, 
22% and 15% of them developed depression after breast cancer diagnosis two, three, four and 
five years later, respectively. The differences encountered from the results of this study with 
those reported by Ell et al. were due to the use of different instruments, as this study used 
the BDI while Ell et al. used the Patient’s Health Questionnaire-9. Our findings are different 
compared to those reported by Burgess et al. because in our study, other than using the BDI 
which was assessed only once, Burgess et al. used the Structured Clinical Interview for DSM 
and assessed it over a period of five years after breast cancer diagnosis. Another point that 
should be considered is the bias of the use of the BDI in this study of women, low education 
and parents tending to have higher BDI values (Beck, 2000).
We also found that depressive syndrome in most breast cancer patients occurs in stage 
IIIB (76.5%) in the form of severe depressive syndrome. There was no significant differ-
ence in depressive syndrome in patients with breast cancer based on clinical stage of breast 
cancer. Similar results were obtained by Burgess et al. (2005) who conducted a study of 170 
breast cancer patients and reported that the number of axillary nodules present and the size 
and histology of the tumours were unrelated to depression and anxiety. The age risk factors 
for the occurrence of depressive syndrome in patients with breast cancer were 30–39 years 
(PR = 6.180; 95% IK 1.518 to 34.139). The results of this study are consistent with the results 
of the Ell et al. (2005) who found that those <50 years of age tended to be depressed and 
the theory that one risk factor for depression in the female population was being younger 
(Burgess et al., 2005).
5 CONCLUSION
Although depression as a psychiatric illness still has a stigma for those that experience it, 
depression can worsen the prognosis of cancer. Special attention should be made to women 
who have breast cancer and depressive syndrome concurrently, so that treatment for their 
condition can be made using a comprehensive approach by the physician.
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ABSTRACT: The incidence of anaemia in infants is still high and nutritional deficiency 
is suggested as the main factor due to inappropriate feeding practices. To evaluate the rela-
tionship between feeding practices and anaemia in 9-month-old infants, a cross-sectional 
study was conducted in 6 Puskesmas in Medan from August–October 2016. Chi-square tests 
and multivariate analyses were used in the statistical analysis. The incidence of anaemia was 
66.7%. No significant association between anaemia and exclusive breastfeeding (P = 0.214, 
95% CI) was found. The variables associated with anaemia were: starting complementary 
feeding at <6 months old (P = 0.032, PR = 2.830, CI 95%), using steamed rice as an initial 
Complementary Food (CF) (P = 0.021, PR = 12 318, 95% CI) and CF not containing animal 
protein (P = 0.013, PR = 14 160, 95% CI). Anaemia in 9-month-old infants was associated 
with the infant’s age when complementary feeding was first started, the type of CF first 
given, and the animal protein content in the CF.
Keywords: anaemia, infant feeding, 9-month-old infants
1 INTRODUCTION
Appropriate feeding practice is an important factor in ensuring optimal nutrition for infant 
growth and development (Luo et  al., 2014). Incorrect feeding practice could cause both 
macro- and micro-nutrient deficiency, especially protein and iron, progressing into nutri-
tional deficiency anaemia (Luo et al., 2014; Maguire et al., 2013). Anaemia has become a 
major health issue in Indonesia, as it has caused serious, irreversible impairment on infant 
and child growth and development (Maguire et al., 2013). When an infant reaches the age of 
nine months, it enters a critical phase of feeding practice, providing the nutritional require-
ment for rapid growth/development, while simultaneously stimulating its oral and motor 
skills. Therefore, the Centres for Disease Control and Prevention (CDC) recommends anae-
mia screening for infants aged 9–12 months by measuring blood haemoglobin (Hb) levels, 
with the test repeated six months later (McDonagh et al., 2015).
2 METHOD
2.1 Study design
This study used a cross-sectional design, conducted from August 2016 to October 2016 in 
6 community health centres (puskesmas) and 42  integrated health service posts (posyandu) 
in Medan, North Sumatera. Infants were brought to these puskesmas or posyandu by their 
parents to measure their body weight or to undergo routine vaccination.
2.2 Sample and subjects
Sample was recruited with consecutive sampling method. The inclusion criteria were infants aged 
nine months, full-term born with birth weight ranged from 2.500 grammes to 4.000 grammes. 
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The exclusion criteria were infants who had never been given breastmilk, or infants with chronic 
diseases, such as heart problems and congenital heart disease. Infants who had ever been diag-
nosed with blood disorders, or had ever been pale since birth without any known diagnosis, or 
had received a blood transfusion even once in their lifetime were also excluded from this study.
2.3 Data collection
The subjects of this study were 9-month-old infants brought to puskesmas or posyandu, as 
mentioned above. The subjects who met the inclusion criteria were recruited using the con-
secutive sampling method. Parents were interviewed to obtain a socio-economic character-
istic of the family along with infant feeding practices (e.g. breastfeeding exclusively, the age 
when complementary feeding started, when the first complementary food was given, the ani-
mal protein content, the preparation of complementary food and the frequency of giving 
one type of complementary food). The subjects’ body weight and length were measured, 
and blood haemoglobin levels measured using a HemoCue® Hb 201+ System device. This 
research received ethical approval from the Ethical Research Committee, Faculty of Medi-
cine, University of Sumatera Utara, and has also been approved by the local public health 
office, puskesmas and posyandu, in which this research took place.
2.4 Statistical analysis
The data sets were analysed using statistical software SPSS 17.0. The association between infant 
feeding practice and anaemia was analysed using the Chi-square test. The relationship between 
each variable of feeding practice and anaemia was examined using multivariate logistic regres-
sion analysis, generating a Prevalence Ratio (PR) value for each variable mentioned above.
3 RESULTS
Ninety-nine infants aged nine months were examined in this study, each of whom underwent 
body weight and length examinations, as well as a general physical examination and haemo-
globin level measurement. Demographic characteristics were also obtained from the parents 









 Male 19 (58) 38 (58)
 Female 14 (42) 28 (42)
Body weight, n(%)
 Normal 32 (97) 53 (80)
 Underweight  1 (3) 11 (17)
 Severely underweight   (0)  2 (3)
Body length, n(%)
 Normal 31 (94) 63 (95)
 Stunting  2 (6)  2 (3)
 Severe stunting   (0) 1 (2)
Nutritional status, n(%)
 Normal 31 (94) 53 (80)
 Malnutrition  2 (6) 11 (17)
 Severe malnutrition   (0)  2 (3)
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feeding at age < 6 months, and in infants given steamed rice as their first complementary food 
and there was no association between exclusive breastfeeding and anaemia in the infants. 
These results are displayed in Table 2.
This study also examined indicators of good infant feeding practice as recommended by 
WHO Global Strategy for Feeding Infant and Young Children 2003 and is displayed in Table 3. 
Multivariate regression logistic analysis showed that the lack of animal protein content in com-
plementary food was the strongest factor related to anaemia in 9-month-old infants (Table 3).
Table 3 association between anaemia and animal protein content in complementary food, 
preparation of complementary food and introduction of complementary food in 9-month-
old infants.
4 DISCUSSION
This study showed that anaemia prevalence in 9-month-old infants in Medan city was still 
high (67%). The main factors related to anaemia in Indonesia are feeding practices, using 
low-iron-content foods and a high prevalence of parasitic infections. The most common type 
of anaemia in the first 1000 days of life is nutritional deficiency anaemia, caused by iron 
deficiency (Lozoff et al., 2016).
In this study, the exclusive breastfeeding rate was still low (23%). Although not statisti-
cally significant, the prevalence of anaemia was lower in infants given exclusive breastfeed-
ing compared to those who were not. This result is similar to studies conducted in other 
countries, such as Brazil and China, which showed that infants given exclusive breastfeeding 
had a lower anaemia prevalence at the age of 6–12 months, albeit this was not statistically 
significant (Assis, 2004). A longitudinal study in Peru found that maternal Hb level and iron 
status while breastfeeding correlated with infant Hb level and iron status (Finkelstrein, 2013). 
A study in Cambodia examining 928 infants aged 3–24 months also revealed similar results, 
namely, 6- to 12-month-old infants who were exclusively breastfed by anaemic mothers were 
1.77 times more likely to develop anaemia (Reinbott, 2016). Low maternal Hb level and iron 
Table 3. Factors associated with anaemia in 9-month-old infants.
Variable P-value PR CI 95%
Complementary feeding started at <6 months old 0.032*  2.830 1.093 to 7.324
Steamed rice as the first complementary food 0.021* 12.318 1.472 to 103.068
Complementary food not containing animal protein 0.013* 14.160 1.749 to 114.614
Table  2. Association between anaemia and exclusive breastfeeding, 
starting age of complementary feeding, and type of first complementary 









 Yes 11(46) 13(54) 0.214
 No 22(29) 53(71)
Complementary feeding started at, n(%)
 6 months old 21(46) 25(54) 0.027*
 6 months old 12(23) 41(77)
First complementary food is given, n(%)
 Milk or fine porridge 32(39) 51(61) 0.026*
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status could be the reason why anaemia was more prevalent in exclusively breastfed infants. 
However, this study did not measure maternal nutritional status nor Hb level.
An inappropriate feeding practice when starting complementary food could be another 
reason why exclusively breastfed infants may develop anaemia because complementary feed-
ing practices greatly affected iron storage in the infant’s body (Assis, 2004).
This study has found that infants who were started on complementary feeding at 
<6 months old were more likely to develop anaemia than infants who were started at 
6 months old (PR = 2.83). This result is similar to a randomised controlled trial examining 
the iron level and growth pattern in 119 full-term infants in Iceland. It was found that infants 
given complementary feeding at 6 months old had a higher serum ferritin level compared to 
infants given this at 4 months old (Jonsdottir, 2013).
It was also found that infants who were given steamed rice or coarse porridge had a 12.318 
times higher risk of developing anaemia than infants who were given fine porridge or milk 
porridge as their first complementary food (P = 0.026). A similar result was also found in a 
study conducted in China, whereby, infants given coarse steamed rice as their first solid food 
had a higher risk of developing anaemia than infants who were given fine porridge or milk 
porridge (Luo et al., 2014).
Animal protein has the highest iron content and thus can be considered as the best source 
of iron; it includes red meat, duck meat, lamb meat, and liver (Grote et al., 2015). In this 
study, complementary food containing animal protein could prevent anaemia if  given daily 
to the infant (P = 0.006). Infants who were given complementary food without any animal 
protein content had a 14.160 times higher risk of developing anaemia.
This research had several limitations. Firstly, it was a cross-sectional study which could 
not evaluate a cause-effect mechanism between the variables of infant feeding practice and 
anaemia. Additionally, data about infant feeding practice was collected through interview, 
which could be influenced by recall-bias from the parents.
In conclusion, there was no association between exclusive breastfeeding and anaemia 
in 9-month-old infants. Factors associated with anaemia in 9-month-old infants were the 
infant’s age when complementary feeding was first started, the type of complementary food 
first given, and the animal protein content in the complementary food.
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Low survival rate in high-grade osteosarcoma: A retrospective 
study at a single institution in Indonesia
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ABSTRACT: Osteosarcoma is a very rare malignant bone tumour, it is an aggressive bone 
neoplasm. Combination of surgical removal and systemic multidrug chemotherapy is the 
current treatment strategy. This study aims to evaluate the prognostic factors influencing the 
survival rate in our centre. A retrospective cohort study of patients diagnosed with osteosar-
coma between January 2012 and December 2014 was carried out. A total of 58 osteosarcoma 
patients were included in this study, including 36 men (62%) and 22 women (38%), with a 
mean age at diagnosis of 15 years. The median survival of this group was 12 months. Patients 
with no pulmonary metastases after treatment had better survival rates of 18 and 90% at two 
years. The overall survival of osteosarcoma patients in this study is low. Patients who did not 
comply with treatment had a worse survival rate. Patients with pulmonary metastases have a 
significantly increased risk of death.
Keywords: amputation, osteosarcoma, prognosis, survival analysis
1 INTRODUCTION
Osteosarcoma is a very rare malignant bone tumour. It is an aggressive bone neoplasm aris-
ing from primitive transformed cells of mesenchymal origin (Ayerza et al., 2010). It is such a 
fatal disease that “months to metastasis”, rather than actual survival time, was used to meas-
ure the outcomes of treatment in studies of early stage. The combination of surgical removal 
of the tumour and systemic multidrug chemotherapy is the current treatment strategy for 
conventional osteosarcoma. Primary chemotherapy, surgery, and adjuvant chemotherapy are 
the most frequent approaches in osteosarcoma (Bacci et al., 2005; Bacci et al., 2006; Bielack 
et al., 2002).
It is now generally accepted that surgical amputation is adopted for high malignancy 
osteo sarcoma (Bispo et al., 2009). Some surgeons hold the view that immediate and aggres-
sive removal of the tumour will prevent the progression of the fracture-induced disease and, 
consequently, amputation is considered to be a better option for osteosarcoma patients with 
a pathologic fracture. Survival after amputation is no different from that after Limb Salvage 
Surgery (LSS) with neoadjuvant therapy in patients with osteosarcoma (Ayerza et al., 2010). 
The question of whether LSS correlates with higher local rates of recurrence remains a con-
troversial topic. Recent literature suggests that local recurrence has only a small influence on 
overall survival in patients with high-grade osteosarcoma. The other crucial factor determin-
ing the risk of local recurrence is the resection margins of a primary tumour. With LSS, the 
surgical margin obtained will always be narrower than with amputation (Bramwell et  al., 
1992; Chang et al., 2002; Cho et al., 2011).
Before the advent of neoadjuvant chemotherapy for osteosarcoma, there was a 5-year 
overall survival (OS) rate of only 10–20%. In the 1950s, there was no optional therapy that 
could significantly increase the survival rate, with a 5-year survival rate of 22%. However, 
with the aid of effective chemotherapeutic drugs, the survival rate of osteosarcoma has been 
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significantly improved since the late 1970s. The 5-year survival rate using a multidisciplinary 
approach varies from 60 to 70% (Enneking et  al., 1980; Huvos et  al., 1977; Kager et  al., 
2003).
The drugs currently used in the neoadjuvant treatment of osteosarcoma are doxorubicin 
(or adriamycin, ADM), cisplatin (CDDP), methotrexate (MTX), ifosfamide (IFO) and 
etoposide (ETO).
We conducted a retrospective study to assess the efficacy of four drug regimens with 
metho trexate, cisplatin, adriamycin, and ifosfamide (MTX-CDDP-ADM-IFO) chemother-
apy for high-grade osteosarcoma patients who underwent a limb amputation. We analysed 
the response and survival of the patients in a series of patients based on 2-survival rates.
2 METHOD
This was a retrospective cohort study of all patients diagnosed as having osteosarcoma 
between January 2012 and December 2014 within our centre, the Haji Adam Malik General 
Hospital. The patients with osteosarcoma were identified through a search of the compu-
terised databases. As a part of the staging process, routine haematological and biochemi-
cal investigations were performed using radiology. The final diagnosis was determined by 
pathologists after performing the biopsy. The patients were staged according to Enneking’s 
Staging System (1980) for musculoskeletal sarcoma.
The survival parameters were described using frequencies and percentages and the survival 
rate at two years was calculated. Differences in the survival functions between levels in pre-
dictors were tested using the log-rank test. We plotted the Kaplan–Meier survival curves to 
depict the survival function over time between levels of the predictor (Kaplan et al., 1958).
To identify the significant prognostic factors for the multivariable analysis, we used the 
Cox proportional hazard regression. The proportional hazard assumption was checked in 
Stata. In all of our analyses, P-values (two-sided) of less than 0.05 were deemed statistically 
significant.
3 RESULTS
A total of 58 osteosarcoma patients were included in this study, including 36 men (62%) 
and 22 women (38%), with a mean age at diagnosis of 15 years (3–43 years). Five (9%) 
patients had hand, proximal humerus, shoulder, and pelvic osteosarcoma. Thirty-three (57%) 
patients were diagnosed with osteosarcoma in the distal femur, 13 (39%) in the right thigh 
and 18 (55%) in the left thigh. Eighteen (31%) patients were diagnosed with osteosarcoma 
in the proximal tibia: 15 (83%) in the right cruris and 3 (16%) in the left cruris. The median 
follow-up was 32 months (ranging from 36 to 48 months).
The overall survival and disease-free survival analysis for all subjects are depicted in 
Table 1. The survival parameters for both groups are also shown in the table. The results 
from this study were variable. We found that 21 (36%) who didn’t undergo any chemotherapy 
protocol and 11 (52%) patients among are alive in 2 years survival rate, 2 (18%) of them 
survive non-chemotherapy group didn’t undergo limb salvage or amputation, and 10 (47%) 
patients die under 1 years after diagnosed, 3 (30%) of them survive with chemotherapy group 
didn’t underwent limb salvage or amputation. Thirty-seven (64%) patients who diagnosed 
as osteosarcoma and underwent chemotherapy protocol, which 10 (27%) patients were alive 
in 2 years survival rate and 27 (73%) patients died under one year after treatment, all of the 
patients in this group had undergone amputation.
For the 58 osteosarcoma patients in this study, 36 (62%) patients had been diagnosed 
with pulmonary metastases at presentation, 1 (3%) of whom survived after undergoing the 
chemotherapy protocol and amputation. Twenty-two (38%) patients had no pulmonary 
metastases at presentation, and at the end of treatment, 20 (91%) patients survived with 
18 (90%) of these having undergone chemotherapy and amputation, and 2 (10%) not receiv-
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ing any treatment at all. Pulmonary metastases at the time of diagnosis were associated with 
poor survival rates of 1 and 3% at two years. Patients with no pulmonary metastases after 
treatment had better survival rates of 18 and 90% at two years. Of the 21 (36%) patients who 
survived, 19 (90%) completed treatment and had a 90% survival rate for 2 years, and none 













Survival overall 58 39 19
Complete treatment
 No 21 18  3
 Yes 37 21 16
Gender
 Male 36 25 11 p = 0.52 Female 22 14  8
Age group
 <12 years 11  5  6 p = 0.41 ≥12 years 47 34 13
Age group
 0–10  7  2  5
p = 0.10
 10–20 36 23 11
 20–30 11  8  3
 30–40  2  2 –
 >40  2  2 –
Surgery (amputation)
 No  6  6 – p = 0.00 Yes 52 33 19
Lung Metastasis
 Yes 22 15 12
p = 0.83 No 36 24  7
Survival overall 37 21 16
Complete treatment
 No – – –
 Yes 37 21 16
Gender
 Male 20 12  8 p = 0.50 Female 17  9  8
Age group
 <12 years  9  4  5 p = 0.62 ≥12 years 28 17 11
Age group
 0–10  6  2  4
p = 0.75
 10–20 26 17  9
 20–30  3  1  2
 30–40  1  1  0
 >40  1  1  0
Surgery (amputation)
 No – – – p = 0.00 Yes 37 21 16
Lung Metastasis
 Yes 11  5  6
p = 0.59 No 26 16 10
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had a local recurrence, irrespective of the methods of surgical treatment and chemotherapy, 
and 2 and 10% survival rate at 2 years and none had a local recurrence, irrespective of the 
methods of surgical treatment and chemotherapy.
4 DISCUSSION
This study included all 58 consecutive patients managed in our institution over a period of 
3 years. This analysis will provide an additional perspective to discuss with patients, particu-
larly as the acceptance of treatment is still low in developing countries. The overall survival 
for all subjects in this study was slightly lower than in other studies (Chang et  al., 2002; 
Ogihara et al., 1991; Yip et al., 1996). The overall survival of patients who for all the patients 
was 33% above two years, whereas it was 43% above two years for the group of the patient 
that performed completed treatment (amputation and complete chemotherapy). The group 
of patients who did not comply with the treatment had poor survival, with a 14.3% survival 
rate at above two years.
In our study, we included patients who did not complete, or refused, treatment even as 
their disease progressed. These patients were either from a lower socioeconomic group or 
had a poor educational status. However, with the addition of chemotherapy, the survival rate 
had no significant improvement. The combination of chemotherapy and surgery should be 
the standard choice of treatment, including pre- and post-operative chemotherapy. Ablation 
was the only treatment in this study, while limb-sparing surgery couldn’t be applied due to 
the staging and condition of patients where the presentation was large and extensive systemic 
metastases (Bacci et al., 2005; Bacci et al., 2006; Lewis et al., 2007; Li et al., 2011).
Local recurrence was not found in this study, as compared to other studies. Amputation 
conferred only a marginal benefit against local recurrence; however, it was the treatment of 
choice for large tumours and patients with a worse perceived prognosis (Ayerza et al., 2010). 
This study showed that patients had a poor survival rate and this had been confirmed by 
other studies. Microscopic pulmonary metastasis spread was present in 62% of osteosar-
coma patients at the time of diagnosis. Pulmonary metastasis at initial diagnosis and multiple 
nodules were associated with poor prognosis (Kager et al., 2003; Pakos et al., 2009). From 
the patients who complied, this study found that in patients with pulmonary metastasis, the 
survival rate above two years was 38% compared to the patient with no pulmonary metastasis 
with a survival rate of 55% at two years.
This study also showed that the survival rate is still low because most of the patients came with 
pulmonary metastasis. The patients with pulmonary metastasis who did not comply had a sur-
vival rate above two years of almost 20% which is less than the group of patients who complied.
Table 2. Survival predictor in patients with high-grade osteosarcoma—multivariate analysis.
Predictor Hazard ratio Standard error 95% CI P-value
Female 1.00 0.26 0.4–1.5 0.57
Male 0.85
Complied 1.00
 Surgery + Chemotherapy  
Not Complied 3.31 1.7 1.6–6.6 0.00
 Surgery without chemotherapy
 No surgery + No chemotherapy
At or above 12 years old 0.90 0.33 0.4–1.8
Less than 12 years old 1.00 0.21 0.3–1.2
Had Lung Metastasis 0.70 0.78
No Lung Metastasis 1.00 0.23
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5 CONCLUSIONS
The overall survival of osteosarcoma patients in this study is low. Amputation is preferred and 
this study conferred only a marginal benefit against local recurrence and treatment of choice 
for those with large tumours and a worse perceived prognosis. Patients who do not comply 
with treatment have a worse survival rate. Within our centre, of those with osteosarcoma, older 
patients and patients with pulmonary metastases have a significantly increased risk of death.
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Relationship of depressive syndrome level with duration 
of detention and type of crime
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ABSTRACT: In the course of reform of the criminal justice system in Indonesia, deten-
tion is one problem that has not received serious attention. Loss of freedom for a person can 
cause a decrease in dignity and self-esteem allowing stress to manifest. Further, the changes 
that occur in the life of a prisoner who is full of pressure and loss can increase the likelihood 
of depression.
Keywords: Beck Depression Inventory-II (BDI-II), Detention, Depression
1 INTRODUCTION
People in detention are more likely to experience psychiatric disorders that may not be 
treated. Studies conducted in Australia noted that among prisoners treated in hospitals for 
12 months, the primary cause of hospitalisation were depressive disorders at a rate of 15.4% 
among women and 7.8% among men (Hughes, 2012). Roy Walmsley in the World Prison 
Population List (2010) stated that in Indonesia there are 117,863 detainees with an estimated 
total population of 232.5  million so, the average proportion of detainees per 100,000 of 
population is 51 (Walmsley, 2008).
The detention of a suspect is essentially a loss of liberty. In the Indonesian context, deten-
tion of a person has long been regarded as at the discretion of an official who has the author-
ity to detain without having to justify the validity of his/her unilateral decision. Therefore, for 
such a long period in state detention houses and without an adequate process of detention 
testing becomes one of the factors deteriorating the situation and conditions in places of 
detention in Indonesia (Eddyono, 2009).
In Indonesia, pre-trial detention is commonly termed as the arrest. However, such deten-
tion is a detention before the criminal justice process has begun. In other words, detention is 
carried out within the framework of investigation and the prosecution conducted by inves-
tigators and prosecutors. For the purpose of this research, the term used shall be ‘pre-trial 
detention’ (Semendawai et al., 2009).
Pre-trial detainees may lose their jobs, be forced to abandon their education and be dis-
placed from their homes. They are exposed to illness and suffer from physical and mental 
disorders that last long after their term of detention ends. Their families also suffer from 
loss of income and educational opportunities, including a multi-generational impact where 
children of detainees experience decreased educational attainment and reduced income for 
the rest of their lives (Berry, 2010).
Among the mental disorders that occur in custody, the most common is depression. 
Several studies have reported a significant association between the symptoms of depression 
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and antisocial behaviour. Although depression is associated with antisocial and criminal 
behaviour, there is also evidence to suggest that, once a person is arrested for criminal behav-
iour, he/she can suffer from depression due to social, economic, and family factors, as well as 
the punishment experienced. Galvan, Romero, Rodríguez, Durand, Colmenares & Saldivar 
reported that there was a relationship between the frequency of visits in prison and the symp-
toms of depression, especially in women. For example, women who had not had a visit for 
about a month or more displayed levels of depression. The most common type of crime com-
mitted by both men and women is persecution, then abduction and robbery in women as well 
as murder and immorality (rape) in men (Lanz & Díaz, 2013).
The history of previous psychiatric disorders and the presence of physical illness is a risk 
factor for the occurrence of depression while in custody. In young adult arrestees, economic/
occupational factors and length of stay in detention are risk factors for neurotic disorders. 
However, in respect of detention of elderly prisoners, Fazel et al. (2001) stated that there is no 
relationship between depression and work and length of stay in detention.
2 METHOD
2.1 Study design
This study is an analytical study with a cross-sectional study approach to prisoners in Medan 
Police prison in March 2015. Inclusion criteria are Medan Police prisoners, aged between 
18–60 years old, with a minimum junior high school education and willing to take part in the 
study. Exclusion criteria are having a history of previous psychiatric disorders such as anxi-
ety, depression, etc., not drug prisoner resistance and poor general medical conditions. The 
psychometric test used in this research is the Beck Depression Inventory-II (BDI-II), with the 
data analysed using the Chi-Square statistical technique.
2.2 Setting and sample
This study required 80 prisoners in Medan Police prison in March 2015 with Inclusion 
criteria are Medan Police prisoners, aged between 18–60 years old, minimum junior high 
school and willing to take part in the study. Exclusion criteria are having a history of  pre-
vious psychiatric disorders such as anxiety, depression, etc., not drug prisoner resistance 
and poor general medical conditions. The instrument used in this research is Beck Depres-
sion Inventory-II (BDI-II), then the data is analysed by using the Chi-Square statistical 
technique.
2.3 Ethical consideration
This research will be conducted after obtaining approval from the Research Ethics Commit-
tee at the Faculty of Medicine, Universitas Sumatera Utara. Subjects meeting the inclusion-
exclusion criteria, will be interviewed with Mini International Neuropsychiatric Interview 
(MINI) techniques, version ICD-10 (A1). If  the subjects who meet the criteria have a ten-
dency towards depression they will then be asked to complete an informed consent form. 
After obtaining a detailed and clear explanation on participation in this research, the sub-
jects were asked to give information regarding their identity and demographic characteristics. 
The research subjects were then asked to complete the Beck Depression Inventory-II (BDI-
II) questionnaire consisting of 21 questions. After completion, all the questionnaires were 
collected and the data analysis performed.
2.4 Data analysis
The processing and statistical analysis of the data obtained was computerised using the Sta-
tistical Package for Social Sciences (SPSS) programme.
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3 RESULTS
Table 1 shows that most of the participants are aged 31–40 years (38.75%), male (68.75%), 
unmarried (56.25%), in work (68.75%), have a high school education level (51.25%), a dura-
tion of detention <3 months (61.25%) and committed the crime of murder/persecution 
(43.75%).
Table 2 shows that the highest level of depressive syndrome is mild (43.75%), with moder-
ate at 31.25% and severe at 25.0%.
Table 3 shows that the level of severe depressive syndrome was highest in a duration of 
detention <3 months (24.5%), moderate in a duration of detention >3 months (35.5%) and 
mild in a duration of detention <3 months (46.9%). There was no significant difference 
between depressive syndrome level and the duration of detention (p = 0.742).
Table 4 shows that the level of severe depressive syndrome is highest in the immorality 




(n = 80) %
Age (years)
 18–30 20 25.0
 31–40 31 38.75
 41–50 19 23.75
 51–60 10 12.5
Gender
 Male 55 68.75
 Female 25 31.25
Marital status
 Unmarried 45 56.25
 Married 35 43.75
Job status
 Work 55 68.8
 No work 25 31.3
Education
 Junior High School 21 26.3
 Senior High School 41 51.3
 College 18 22.5
Duration of detention
 <3 months 49 61.25
 >3 months 31 38.75
Type of crime
 Murder/Persecution 35 43.75
 Robbery/Theft 21 26.25
 Immorality 24 30.0
Table  2. Depressive syndrome level 
in Medan Police prisoners.
Depressive 
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murder/persecution type of crime (48.6%). There was no significant difference between the 
level of depressive syndrome and the type of crime (p = 0.822).
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Murder/Persecution 17(48.6) 10(28.5) 8(22.9) 0.822
Robbery/Theft 10(47.6) 6(28.6) 5(23.8)
Immorality 8(33.3) 9(37.5) 7(29.2)
Total 35(43.75) 25(31.25) 20(25.0)










<3 months 23(46.9) 14(28.6) 12(24.5) 0.742
>3 months 12(38.7) 11(35.5) 8(25.8)
Total 35(43.75) 25(31.25) 20(25.0)
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Correlation of BDNF and cognitive function in smoking Batak 
male schizophrenic patients
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ABSTRACT: Schizophrenia is a complex neurodevelopmental disorder with impaired 
cognitive function as a major element. BDNF may be a marker of abnormal neuronal 
development and neurotransmission in schizophrenia. Cognitive function often correlates 
significantly with awareness of pain, social skills and the presence of a delayed return to nor-
mal life. The purpose of this study was to look at the association of serum levels of BDNF 
and cognitive function in Batak male, schizophrenic patients who smoke and have a history 
of using risperidone treatment. This study was a cross-sectional, correlative numerical study 
in order to assess cognitive function using the Montreal Assessment Cognitive Instrument 
Indonesia (MoCA-Ina) version. BDNF serum levels were analysed using the quantitative 
sandwich enzyme, immunoassay. There was a significant correlation between the MoCA-Ina 
score and BDNF serum levels with a correlation value of 0.441 showing a positive correlation 
with moderate correlation strength (r = 0.4 − <0.6).
Keywords: Schizophrenia, BDNF, Cognitive
1 INTRODUCTION
Schizophrenia is a complex neurodevelopmental disorder with impairment of cognitive func-
tion as a central feature. This confirmed by a number of studies performed on patients who 
suffer from schizophrenia where clinical symptoms and social functioning of patients are 
consequences of neurocognitive deficits. The cognitive deficit is a core aspect of the schizo-
phrenic condition (Fisekovic et al., 2012).
Over two decades of research has highlighted the relationship of cognitive performance 
with the neurotrophins system. Neurotrophins are a unique family of polypeptide growth 
factors with similar structures that are involved in the process of brain development, dif-
ferentiation and survival of neurons, synaptic plasticity, and connectivity. The neurotrophins 
comprise of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neu-
rotrophin-3 (NT-3), and neurotrophin-4 (NT-4) (Bath et  al., 2006). BDNF, a member of 
the neurotrophic family, is common in the mammalian brain and plays an important role in 
the development, regeneration, survival, maintenance, and function of the neuron (Zhang 
et al., 2015; Niitsu et al., 2011). BDNF is a protein highly involved in the development of 
the nervous system of all mammals, and in the regulation of synaptic transmission. During 
the period of development, BDNF has been involved in the survival of stem cells, neuro-
genesis, and neuronal differentiation along with polarisation and neuronal guidance. BNDF 
also regulates the plasticity aspect of the brain and is thus involved in cognitive function 
(Rowbotham et al., 2015).
The smoking rate in schizophrenics is estimated between 40–90%, higher than among 
the general population or individuals with severe mental illness. The reasons for smoking 
in schizophrenics are not well understood, but these patients may be trying to reduce the 
ISCOC17_Book.indb   231 3/21/2018   2:04:25 PM
232
side effects of treatment and the negative symptoms and/or cognitive deficits associated 
with schizophrenia, suggesting that they are smoking tobacco or nicotine as self-medication 
(Zhang et al., 2010).
A study conducted by Kim et al. found that serum levels of BDNF in smokers, as compared 
to non-smokers, supports the idea of a possible relationship between BDNF and smoking. 
They found that the smoking group had significantly lower levels of BDNF in baseline while 
the BDNF serum level after two months of quitting was significantly higher. A study by 
Zhang et al. found that the BDNF level was significantly higher in smokers (7.8 ± 3.2 ng/ml) 
than non-smokers (6.4 ± 2.1 ng/ml). Furthermore, higher BDNF levels are associated with a 
large number of smoked cigarettes (Zhang et al., 2010).
2 METHOD
2.1 Study design
This study design is a cross-sectional study that assessed differences in serum levels of BDNF 
and cognitive function in smoking Batak male, schizophrenia patients.
2.2 Setting and sample
Participants were recruited from the inpatient ward in a psychiatry facility in Professor. 
Muhammad Ildrem Mental Hospital, Medan, Indonesia with the following inclusion crite-
ria: (a) those who had been diagnosed with schizophrenia in a stable phase by a psychiatrist, 
(b) from the Batak clan, (c) smoker, (d) aged between 20–40 years old who understood the 
purpose of this study and agreed to participate with written consent, (e) and with their last 
education being in junior high school. Exclusion criteria: (a) suffering from other mental ill-
ness, (b) suffering from other neurologic disease.
This study required 22 participants and each participant who was suitable, with respect to 
the inclusion and exclusion criteria, had their body mass index (BMI) ratio measured (weight 
to height ratio). Blood samples were then taken to check the levels of BDNF. The serum level 
of BDNF was analysed using the quantitative sandwich enzyme, immunoassay. After the 
serum level of BDNF results had been accepted, the cognitive function was calculated using 
the Montreal Cognitive Assessment Indonesia version (MoCA-Ina).
2.3 Ethical consideration
The present study was conducted after receiving approval from the institutional review board 
at the Faculty of Medicine of the University of Sumatera Utara. The recruitment of research 
participants was conducted through individual interviews with schizophrenia inpatients that 
met the selection criteria. When the potential participants agreed to take part in the study, 
we asked them to sign the consent form. The purpose and the procedures of the study were 
explained, including voluntary participation and withdrawal.
2.4 Data analysis
The results were analysed using the statistical software package SPSS for Windows.
3 RESULTS
From the 22 participants took part in the study, the majority of participants were 31–40 
years old (86.4%), married participants (12, 54.5%), and the duration of illness number of 
participants was the same for 2–3 years and >3 years. Participants’ characteristics are pre-
sented in Table 1.
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The mean of MoCA-Ina score was found to be 20.64 ± 6.02. From the results, using the 
Shapiro-Wilk test, p = 0.362 (p > 0.05), so the data was normally distributed.
The mean of serum level of BDNF was found to be 26651 ± 6084. From the results, using 
the Shapiro-Wilk test, p = 0.715 (p > 0.05), so the data was normally distributed.
The Pearson correlation test of serum level of BDNF and the MoCA-Ina score obtained 
the result of p < 0.05 which showed a correlation between BDNF serum and the MoCA-Ina 
score. The correlation between MoCA-Ina score and BDNF serum was 0.441  showing a 
positive, moderate correlation (r = 0.4 − <0.6).
4 DISCUSSION
Zhang et al. (2012) state that the neuroprotective effects of BDNF where BDNF plays a key 
role in modulating synaptic and plasticity transmission and have important factors in long-





20–30 years  3 13.6





2–3 years 11 50
>3 years 11 50
Table 2. Mean of MoCA-Ina score.
Variable Mean SD p
MoCA-Ina 20.64 6.02 0.362*
*Shapiro-Wilk test.
Table 4. Correlation score of MoCA-Ina and 
serum level of BDNF.




Table 3. Mean of serum level of BDNF.
Variable Mean SD p
BDNF 26651 6084 0.715*
*Shapiro-Wilk test.
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Preclinical studies have shown that LTP is impaired in that the deficient genes BDNF and 
LTP can be recovered with adenovirus-mediated mutant transfection with the BDNF gene. 
Simultaneously, these results support a mechanism linking cognitive function and BDNF 
levels. BDNF may play a role in the pathogenesis of schizophrenia, but it also examines evi-
dence suggesting that it plays a role in the pathophysiology of cognitive deficits.
The results of the study by Zhang et al. in 2012 that examined a group of schizophrenic 
patients with recurrent episodes found an association between poor BDNF and visuospatial 
performance variants/construction and attention deficit in schizophrenic patients. They also 
found that there was a relationship between decreased serum BDNF levels and cognitive 
impairment in schizophrenic patients depending on BDNF polymorphisms having a signifi-
cant relationship of p = 0.023 i.e. <0.05.
There was a significant correlation between MoCA-Ina score and serum BDNF level with 
a correlation value of 0.441, showing a positive, moderate correlation (r = 0.4 − <0.6).
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ABSTRACT: Nasal irrigation is the treatment of choice to relieve symptoms in chronic 
rhinosinusitis (CRS). Adding a surfactant to the solution may increase its efficacy, but the 
effects on mucociliary function are unknown. To determine the effect of nasal irrigation with 
surfactant on the symptoms and Mucociliary Transport Time (MTT) in CRS, 40 patients 
in the hypertonic saline and the baby shampoo group were evaluated for symptoms and 
MTT, before and after nasal irrigation, for two weeks. The difference of the average Sino-
Nasal Outcome Test 20 (SNOT-20) score in the hypertonic group was statistically significant 
(p = 0.01), but not in the baby shampoo group. The average VAS score in both groups was 
significantly different (p = 0.01 and p = 0.05). Neither hypertonic nor baby shampoo solution 
affects MTT. Nasal irrigation with the baby shampoo solution has not affected the quality of 
life and MTT in CRS but may affect the severity of the disease.
Keywords: Baby shampoo, Chronic rhinosinusitis, Mucociliary transport time, Nasal irrigation
1 INTRODUCTION
Nasal irrigation using a hypertonic saline solution is the treatment of choice for patients with 
CRS. Inexpensive and easy to perform, nasal irrigation not only relieves symptoms, but can 
also decrease the medication required in CRS.
Recent studies reported that saline nasal irrigation given additives such as a surfactant, 
may increase its efficacy and prevent biofilm formation (Woodworth et al., 2005; Schlosser, 
2006; Harvey & Lund, 2007). The surfactant can reduce surface tension on the liquid and 
increase solubility, mobility, bioavailability and subsequent biodegradation of hydrophobic 
compounds and insoluble organic compounds (van Hamme et al. 2006).
Baby shampoo may be a useful and well-tolerated surfactant in the treatment of CRS. 
Chiu et al. (2008) showed that CRS patients experienced improved symptoms based on the 
SNOT-22 score and the University of Pennsylvania Smell Identification Test (UPSIT). Simi-
larly, Farag et al. (2013) reported improved symptoms based on the Rhinosinusitis Outcome 
Measure (RSOM-31) and the SNOT-22 questionnaire along with the phenyl ethyl alcohol 
(PEA) smell threshold test in patients who used baby shampoo solution as nasal irrigation.
Studies of the effects of baby shampoo solution on mucociliary function in CRS have not 
yet been found. This study aims to compare baby shampoo and hypertonic solutions with 
symptoms and MTT in CRS patients.
2 METHODS
This study has been approved by the Health Research Ethics Commission at the Faculty of 
Medicine, Universitas Sumatera Utara. A quasi experimental study was performed from 
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August 2015 until January 2016 where patients were recruited from the outpatient clinics of a 
teaching hospital and its satellites in Medan. Inclusion criteria included patients with CRS aged 
≥18 years, willing to participate and sign a consent form. The exclusion criteria were pregnant 
women and patients with hypersensitivity to hypertonic saline or baby shampoo solutions.
Forty patients with CRS were allocated into two groups, a hypertonic saline (H) and a 
baby shampoo (BS) irrigation group. Before the treatment, patients received an instruction 
leaflet and an explanation on how to irrigate the nose. Patients were asked to repeat the 
instructions and perform the nasal irrigation to make sure they understood the task.
Patients conducted nasal irrigation using a prepared irrigation formula. The formula con-
sisted of 1 teaspoon of non-iodised salt and ½ teaspoon of baking soda mixed with 500 cc of 
previously boiled water. This was given to the H-group while 1 teaspoon of baby shampoo 
was added to this solution for patients in the BS-group. Patients then irrigated each nostril 
twice with a 60 cc catheter tip syringe filled with their respective solution, two times a day for 
two weeks. Patients were also given an oral antibiotic, Ciprofloxacin 2 × 500 mg.
To assess the quality and severity of the nasal symptoms, patients completed SNOT-20 
and VAS questionnaires. A saccharin test was also performed.
Patient data was collected before and after the nasal irrigation treatment, but the assessment 
of the nasal irrigation was carried out every week. If a patient discontinued the use of nasal 
irrigation, no further data would be collected, and the patient was excluded from the study.
Statistical analysis was conducted to obtain the frequency distribution and mean value of 
each variable. The dependent t-test was used to compare the proportions. When data was 
not normally distributed, the Wilcoxon signed-rank test was used for analysis. P values lower 
than 0.05 were considered significant.
3 RESULTS
The results are presented for 21 patients who used the hypertonic saline solution and 19 
patients who used the baby shampoo solution, with a total of 40 patients.
The scores of SNOT-20 are presented in Table 1. The mean SNOT-20 scores in group H 
before (37.00 ± 20.69) and after (25.71 ± 19.68) treatment are significantly different (p = 0.01). 
As for group BS, the mean SNOT-20 scores decrease from 34.95 ± 25.00 to 28.16 ± 23.23 but 
it does not differ statistically.
Both groups showed significant difference in mean VAS scores (Table  2). Group BS 
(p = 0.05) showed slight decreases as compared to group H before treatment (p = 0.01).
There is a decrease of mean mucociliary transport time in group H and group BS, but it 
does not differ statistically.
The number of patients who discontinued with the baby shampoo nasal irrigation was 
higher than those who used the hypertonic saline solution (24% vs 9%). In the baby shampoo 
group, six patients did not finish the treatment, 5 of whom we could not contact to follow up 
and one who changed his mind due to nasal burning and headaches. In the hypertonic saline 
solution group, two patients did not finish the treatment. One felt he had been doing so well 
that he chose not to continue. The most common side effect complaint by patients in the baby 
shampoo group were nasal burning and headaches.
Table 1. Mean and standard deviation of SNOT-20 scores before and after treatment in groups H and BS.
SNOT-20
Pre Post
pMean SD Mean SD
Group H 37.00 20.69 25.71 19.68 0.01*
Group BS 34.95 25.00 28.16 23.23 0.07**
*Dependent t-test.
**Wilcoxon signed-rank test.
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4 DISCUSSION
There are many studies about hypertonic saline solution being used for nasal irrigation. Many 
have demonstrated the benefits of surfactant solutions to diseases that fulfil the biofilm bac-
terial profile (Desrosiers et al., 2007; Chiu, et al., 2008; Farag, et al., 2013). However, there 
are fewer studies when it comes to adding a surfactant into the nasal irrigation solution. Baby 
shampoo is a surfactant solution that is believed to decompose the bacterial layer of biofilm 
in the nasal mucosa of CRS.
Chiu et al. (2008), were the first to describe the use of baby shampoo in nasal irrigation for 
CRS patients. Farag et al. (2013) did a further research over a longer period. Our study, which 
was different from these two previous studies, was performed in CRS patients before nasal endo-
scopic surgery. Administration of nasal irrigation for postoperative patients requires recovery 
time from postsurgical mucosal changes. Moreover, the goal of nasal irrigation is to clear secre-
tion and relieve symptoms which can be done immediately after a diagnosis of CRS is confirmed.
In their study, Chiu et al. (2008) provided each patient with topical steroids, 10 of whom 
had an oral antibiotic for two weeks and two who used oral prednisone. For this study, we 
only gave antibiotics for two weeks as the main treatment.
Farag et al. (2013) studied their patients for four months during which they found decreased 
SNOT-22 scores both in the hypertonic saline and the baby shampoo groups in the first eight 
weeks. There was a slight increase of the SNOT-22 scores in the baby shampoo group at the 
end point, but the score continued to decrease in the hypertonic saline group. At the end of 
the study, there was an overall improvement over time with both forms of irrigation.
In our study, the average SNOT-20 score in the baby shampoo group began to decrease 
6.79 points. Thus, one could infer that the symptoms begin to improve 2 weeks after irriga-
tion. But, given such a short period, this small difference was not statistically significant.
Based on the VAS category, the hypertonic saline group showed better improvement compared 
to those in the baby shampoo group. This may be due to the side effects that arose after the baby 
shampoo irrigation. Thus, assessment of the severity of the disease became perplexing. Neverthe-
less, significant improvement in the VAS scores in the baby shampoo group showed that irrigation 
with the baby shampoo solution might help to reduce the severity of the disease in CRS patients.
Previous studies have shown variable results about the effects of the hypertonic saline solu-
tion on mucociliary transport time. Hauptman & Ryan (2007) and Ural et al. (2009) reported 
Table 2. Mean and standard deviation of VAS scores before and after treatment in groups H and BS.
VAS
Pre Post
pMean SD Mean SD
Group H 6.24 2.72 4.43 2.71 0.01*
Group BS 6.84 2.85 5.47 3.12 0.05**
*Dependent t-test.
**Wilcoxon signed-rank test.
Table 3. Mean and standard deviation of mucociliary transport time before and after treatment in 




pMean SD Mean SD
Group H 13.92 7.51 12.22 6.29 0.19**
Group BS 15.72 7.47 13.26 5.72 0.09*
*Dependent t-test.
**Wilcoxon signed-rank test.
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that the hypertonic saline solution improved the mucociliary transport time in CRS. How-
ever, Low et al. (2014) found no significant improvement in mucociliary transport time in 
patients who used either normal saline, Ringer’s lactate or hypertonic saline solutions.
Isaacs et al. (2011) provided a surfactant solution to 27 healthy volunteers and evaluated 
the mucociliary transport time before and after treatment. They found a significant improve-
ment (p = 0.031), but this study lacked controls and, thus, cannot specifically address the 
impact of surfactant on mucociliary transport time.
In our study, both hypertonic saline and baby shampoo solutions have little effect on the 
mucociliary transport time. Improvement in symptoms can be caused by the nasal irrigation 
properties which can dissolve the hydrophobic compounds of mucus, thereby reducing its 
surface tension and viscosity (Rosen et al. 2013). However, it does not seem to be able to fully 
improve the mucociliary transport time.
The results of this study were not able to prove that baby shampoo solution can be used in 
the routine management of CRS. However, because of its ability to reduce the severity of the 
disease, it may be considered as an adjunctive treatment when further research is done with 
more samples over a longer period of time. It is also necessary to modify the surfactant solu-
tion in order to reduce the side effects so that it can be widely used as a nasal irrigation.
5 CONCLUSION
Nasal irrigation with a baby shampoo solution does not affect the quality of life and MTT in 
CRS but it may affect the severity of the disease.
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ABSTRACT: The etiology of Non-Syndromic Cleft Lip and Palate (NSCLP) has not yet 
been defined. Some studies have investigated the involvement of genetic and environmental 
factors. Some genes involved in the folate metabolism have been recently examined to dis-
cover the genetic factors in the cleft lip etiology. This research intends to identify the involve-
ment of polymorphism in the Reduced Folate Carrier 1 (RFC1) A80G with NSCLP in the 
population of Sumatera Utara. In this case-control study, 62 NSCLP patients and 61 con-
trols underwent DNA isolation and genotyping process using PCR-RFLP. The distribution 
of genotype and allele variants between the case and control were not significantly different 
(p = 0.271, p = 0.809). In the subgroup analysis, the polymorphism of RFC1 A80G showed a 
significant relationship in the group of CLO + CPO. The data obtained through this research 
confirms that the RFC1 A80G mutant variant has a relationship with NSCLP.
Keywords: cleft lip, folic acid, NSCLP, polymorphism RFC1
1 INTRODUCTION
The case of cleft lip most frequently found is cleft lip with or without cleft palate, which may 
be experienced by one in 500 births in the population of Asia and Indian-North American 
(Wehby & Murray, 2011). The prevalence of cleft lip in the whole of Indonesia according to 
the data of RISKESDAS 2013 was 0.08%, and in Sumatera Utara, 0.07% (Badan Penelitian 
Dan Pengembangan Kesehatan Kementerian Kesehatan RI, 2013).
Non-syndromic cleft lip and palate (NSCLP) is a complex result of genetic and environmental 
factors. Several studies have found that low levels of folic acid are predisposing factors to NSCLP 
(Langer 2014; Wilcox et al., 2007). This is not only influenced by intake or supplementation of 
folic acid but also in the process of folic acid metabolism (Cai et al., 2016; De Vos et al., 2008).
Folate undergoes a metabolism consisting of absorption, modification, transport, and 
interconversion. One of the proteins that plays an important role in the process of folate 
metabolism is the Reduced Folate Carrier 1 (RFC1) protein that plays a two-way transport 
of 5-methyltetrahydrololate and thiamine monophosphate into intracellular and red blood 
cells and maintains folate homeostasis in the event of down-regulation in folate deficiency. 
The RFC1 protein is coded by the RFC1 gene mapped at the end of the long arm of chromo-
some 21 (21q22.2-q22.3) (Yee et al., 2010).
Polymorphisms in the RFC1  A80G (rs1051266) are non-synonymous polymorphisms 
in exon two, which induce histidine substitution into arginine at codon 27  in the protein 
sequence. In several studies of polymorphism of RFC1 A80G, folic acid levels found in indi-
viduals with AA genotype had higher plasma folate levels than individuals variant AG and 
GG (Wehby et al., 2013), but this relationship was not found in other studies. In another 
study conducted in India, it was found that children with G alleles were at higher risk of 
the non-syndromic cleft lip with or without palate compared with the children of A allele 
(OR = 1,4) (Lakkakula et al., 2015). The purpose of this study was to clarify the involvement 
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of polymorphism in the Reduced Folate Carrier 1 A80G with non-syndromic cleft lip and 
palate (NSCLP) in the population of Sumatera Utara.
2 MATERIAL AND METHOD
2.1 Subjects
This case-control study has earned the approval of the ethics committee. 62 case subjects 
were NSCLP patients treated for Labiaplasty at the Acuplast Hospital and RSUP Haji 
Adam Malik Medan from July to September 2017 and 61 control subjects obtained by using 
a consecutive sampling method who have signed an informed consent for the genotyping 
examination.
2.2 Genotyping
The DNA of the subject was extracted from a blood sample using the Wizard® Genomic 
DNA purification kit (Promega Corporation, USA) in accordance with the manufacturer’s 
instructions. Then the DNA was amplified by the PCR method following the procedure used 
by Lakkakula et al., (2015) with the forward and reverse primer sequences used as follows 
5: AGC GGT GA GGT-3 and 5-GGA GGT AGG GGG TGA AG-3. PCR products were 
cleaved with PCR-RFLP techniques using restriction enzyme HaeII for four hours at 30°C 
and electrophoresis on agarose gel 3% stained with ethidium bromide.
RFLP products were visualised under UV light to group genotype variants. The fragment 
140 bp showed allele A and allele G saw on fragments 76 bp and 64 bp.
2.3 Statistical analysis
Genotype frequencies in the control group and patients were compared using a chi-square 
test. Analysis of the distribution of genotype and allele varieties in NSCLP subgroups were 
CLP and CLO + CPO with the control group using chi-square and alternative tests if  not 
qualified.
The risk estimation was calculated by variant AA and allele An as reference category. 
P < 0.05 with two-way hypothesis is considered statistically significant.
3 RESULTS
3.1 Distribution of RFC1 polymorphism
The proportion of RFC1 exon 2 A80G gene polymorphism in case study and control subjects 
of this study can be seen in Table 1. In genotype distribution group AA 30.6%, AG 51.6%, GG 
17.7% compared to control group AA 36.1%, AG 37.7% and GG 26.2%. The genotype distri-
bution between the NSCLP and control cases was not significantly different (p = 0.271). The 
allele G frequency between the control group and the NSCLP cases was also not that different 
[45.1% (55/67) versus 43.5% (54/70); p = 0.809). However, there were significant differences in 
genotype distribution between a subgroup of NSCLP and control cases (p = 0.044).
To assess the effect of  variant genotype RFC1 A80G at risk of  NSCLP, an odd ratio 
(OR) was calculated and 95% confidence interval (Table 2). Genotype AG (OR 0.621; 95% 
CI: 0.275–1.402) and GG (OR 1.256 95% CI: 0.47–3.357) indicated an increased risk of 
NSCLP. In AG  +  GG versus AA model had OR: 1,188; 95% CI: 0,558–2,529 and GG 
versus AG + AA having OR 1,648; 95% CI 0,693–3,919 indicated that variant A80G did 
not increase susceptibility of  NSCLP because it was statistically insignificant >0.05. Allelic 
model having OR 1,064; 95% CI: 0.643–1.760  indicated no increased risk of  NSCLP in 
subjects with G allele. In subgroup analysis, variant A80G showed a significant association 
with CLP group susceptibility in AG + GG versus AA model and allelic model (Table 2). 
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The risk of  CLO + CPO increased in subjects AG + GG versus AA (OR: 5.658; 95% CI: 
1,203–26,614; P = 0.04) and in subjects with G allele compared to allele A (OR 4.629; 95% 
CI 1.081–19.816, P = 0.019).
4 DISCUSSION
Nowadays, researchers have investigated the association of Single Nucleotide Polymorphism 
(SnPs) with the occurrence of a disease or drug side effects due to amino acid substitution 
Table 1. Distribution of genotype and frequency of Allele RFC1 A80G in NSCLP.
Control % Overall clefts (%) CLP (%) CLO + CPO (%)
Genotype distribution
AA 22 (36,1) 19 (30,6) 14 (25,5)  5 (71,4)
AG 23 (37,7) 32 (51,6) 30 (54,5)  2 (28,6)
GG 16 (26,2) 11 (17,7) 11 (20,0)  0 (0,0)
P value 0,271* 0,701**
Alelle frequency
Aalelle 67 (54,9) 70 (56,5) 58 (52,7) 12 (85,7)
Galelle 55 (45,1) 54 (43,5) 52 (47,3)  2 (14,3)
P value 0,809* 0,044*
*Tested by chi-square.
**Tested by Mann-Whitney.
Table 2. Results of risk estimating polymorphism RFC1 A80G 
SNP in cleft lip and palate.
RFC 1 A80G OR (95% CI) p-value
Overall cleft
AA reference
AG 0,621 (0,275–1,402) 0,250*
GG 1,256 (0,47–3,357) 0,649*
AG + GG versus AA 1,188 (0,558–2,529) 0,654*
GG versus AG + AA 1,648 (0,693–3,919) 0,256*
A allele reference
G allele 1,064 (0,643–1,760) 0,809*
CLP
AA reference
AG 0,786 (0,592–1,043) 0,058**
GG 0,737 (0,563–0,964) 0,082**
AG + GG versus AA 0,773 (0,586–1,019) 0,024**
GG versus AG + AA 0,863 (0,773–0,963) 0,235**
A allele reference
G allele 0,860 (0,764–0,969) 0,019*
CLO + CPO
AA reference
AG 4,211 (0,904–19,610) 0,058*
GG –
AG + GG versus AA 5,658 (1,203–26,614) 0,024**
GG versus AG + AA – –
A allele reference
G allele 4,629 (1,081–19,816) 0,019*
*Tested by chi-square.
**Tested by Fisher.
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caused and affecting the activity of the protein produced (Mostowska et al., 2010; Hasni 
et al., 2016). This study analyses the relationship of polymorphism of the RFC1 gene on 
the long arm of chromosome 21 (21q22.2-q22.3) exon 2, which causes the amino acid sub-
stitution of histidine to arginine (H27R; rs1051266) due to the substitution of nucleotide 80 
adenine to guanine (A80G) (Wang et al., 2009; Yee et al., 2010). These RFC1 proteins play 
a role in regulating folate transport to red blood cells; in a previous study it was found that 
subjects with RFC1 alleles G experienced a decrease in plasma folic acid and increased levels 
of homocysteine due to negative regulation caused by the RFC1 protein in allele G patients 
(Cai et al., 2016).
Nowadays, researchers have investigated the association of single nucleotide polymorphism 
(SnPs) with the occurrence of a disease or drug side effects due to amino acid substitution 
caused and affecting the activity of the protein produced (Mostowska et al., 2010; Hasni et al., 
2016). This study analyses the relationship of polymorphism of RFC1 gene on the long arm of 
chromosome 21 (21q22.2-q22.3) exon two, which causes the amino acid substitution of histi-
dine to arginine (H27R; rs1051266) due to the substitution of nucleotide 80 adenine to guanine 
(A80G) (Wang et al., 2009; Yee et al., 2010). These RFC1 proteins play a role in regulating 
folate transport to red blood cells; in a previous study it was found that subjects with RFC1 
alleles G experienced a decrease in plasma folic acid and increased levels of homocysteine due 
to negative regulation caused by the RFC1 protein in allele G patients (Cai et al., 2016).
In this study, we found an association and increased susceptibility of NSCLP in subjects 
with RFC1 80G alleles. The results of this study support Viera et al.’s research in Brazil that 
aimed to find the variant association of MTHFR and RFC1 associated with cleft lip inci-
dence, with the results obtained by the variation of RFC-1 over-transmitted to children born 
with cleft lip. (p = 0.017) with the conclusions of Polymorphisms in RFC1 contributed to the 
incidence of Clef Lip Only (CLO) (Bufalino et al., 2010).
The findings of this study also resemble the results of Lakkakula et al.’s (2015) study in 
India that examined 142 non-syndromic cleft lip and 141 control subjects, which found a 
comparison of genotype variant distributions between case and control groups was not sta-
tistically different, but there was an increased risk of NSCLP in subjects with G allele (OR: 
1.40; 95% CI: 1.00–1.97; p = 0.005) (Lakkakula et al., 2015).
The possible role of RFC1 gene polymorphism in NSCLP susceptibility is supported by 
previous research that the protein encoded by this gene will affect the transport of folic acid 
to red blood cells and is associated with low levels of folate and elevated levels of homo-
cysteine (Cai et al., 2016; Biselli et al., 2008). In conclusion, in this case-control study, there 
was a relationship between RFC1 A80G polymorphism with an increased risk of NSCLP in 
the Population of Sumatra Utara.
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ABSTRACT: To determine an association between Matrix Metalloproteinase 2 (MMP 2) 
and Tissue Inhibitor Matrix Metalloproteinase 2 (TIMP 2) and bone destruction in atticoan-
tral type Chronic Suppurative Otitis Media (CSOM) in patients at Haji Adam Malik Gen-
eral Hospital. This analytical cross-sectional study included cholesteatoma from atticoantral 
type CSOM taken and made into paraffin blocks. These tissues were immunohistochemically 
examined by assessing MMP 2 and TIMP 2 immunoreactivity at the anatomical pathology 
installation. MMP 2 overexpression (36 sample, 90%), however, samples that overexpressed 
and did not overexpress TIMP 2 were relatively even, 21 (52.5%) and 19 (47.5%), respectively. 
MMP 2 expression was not significantly associated with TIMP 2 (p = 0.342). MMP 2 and 
TIMP 2 expressions were not significantly associated, and TIMP 2 with bone destruction 
were not significantly associated in atticoantral type CSOM.
Keywords: Chronic Suppurative Otitis Media (CSOM), bone destruction, Matrix Metal-
loproteinase 2 (MMP 2), Tissue Inhibitor Matrix Metalloproteinase 2 (TIMP 2)
1 INTRODUCTION
CSOM accompanied by cholesteatomas has been known to disturb the balance between 
bone formation and resorption. This condition is associated with damage to structures of 
the middle and inner ear, consequently resulting in conductive hearing loss, sensorineural 
hearing loss, facial nerve palsy, vestibular function disorder, or intracranial complications 
(Widyatama, 2014). The proteolytic erosion of the temporal bone is the key event in the 
pathognomonic course of cholesteatoma progression (Schonermark, 1996).
The balance between MMP and TIMP is essential in determining extracellular matrix 
integrity (Rezende, 2012).
Therefore, this study was conducted to determine the association between MMP 2 and 
TIMP 2 and bone destruction in atticoantral type CSOM in patients at Haji Adam Malik 
General Hospital, Medan.
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2 MATERIALS AND METHOD
This analytical cross-sectional study included cases of CSOM in which surgery was per-
formed and the cholesteatoma taken and made into paraffin blocks.
Immunohistochemical testing of the paraffin blocks was performed at the anatomical 
pathology installation of Haji Adam Malik General Hospital, Medan.
2.1 Study sample
Patients diagnosed with the atticoantral type CSOM. The cholesteatomas have been operated 
upon in these patients and made into paraffin blocks.
2.2 Inclusion criteria
Cholesteatoma samples obtained from a mastoidectomy surgery on patients diagnosed with 
atticoantral type CSOM.
2.3 Exclusion criteria
Cholesteatoma samples, on which an adequate histopathological or immunohistochemical exam-
ination could not be performed due to an unrepresentative or damaged paraffin block based on 
the assessment of the anatomical, pathological installation, were excluded from this study.
2.4 Operational definition
Cholesteatomas defined as cystic lesions extending to the temporal bone lined by stratified 
squamous epithelium containing desquamated keratin (Son, 2013).
MMP 2 is a nucleus cell induced protein which is associated with several characteristics 
such as tumour development consisting of growth, invasion, metastasis and angiogenesis 
(blood vessel growth), in accordance with Sun & Hemler (2001) who found MMP 2 extracel-
lular interactions. It is described as a proteolytic enzyme with the ability to decrease con-
nective tissue components (Morales, 2007). Furthermore, TIMP 2 was defined as a specific 
endogenous protein inhibitor that inhibits MMP, especially MMP 2 (Murphy, 2011).
The degree of bone destruction was assessed by observing the damage extent on tempo-
ral CT scan, and was classified according to Kuczkowski et al., (2011) with the following 
degrees; mild degree: scutum and ossicleerotion, moderate degree: tegmen and entire ossicle 
destruction, severe degree: destruction of the ossicle, labyrinth bone, facial canal, and outer 
ear (Kuczkowski et al., 2011).
Figure 1. Overexpression of MMP 2 and TIMP 2.
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2.5 Variables
Factors that were presumed to affect bone destruction due to cholesteatoma were set as 
independent variables. These dependent variables were MMP 2 and TIMP 2. Assessment of 
MMP 2/TIMP 2 immunoreactivity was also obtained by multiplying the extent score with the 
intensity score, resulting in the MMP 2/TIMP 2 immunoreactivity score.
2.6 Materials and instruments
Medical records of the patients from which the paraffin blocks were extracted and the immu-
nohistochemistry kit.
2.7 Procedure
Cholesteatoma was taken during a mastoidectomy surgery and then put into formalin 10%. 
Immunohistochemical images were then assessed using a fluorescence microscope by two 
anatomical pathology specialists.
2.8 Data management
In this study, the main data comprised secondary data which was paraffin blocks from chole-
steatoma tissues. Other secondary data were obtained from patients’ medical records.
3 RESULT
A total of 40 paraffin blocks were obtained, retrieved from 27 men and 13 women, during 
the study period.
The results displayed in Table 1 show that this study was dominated by samples with MMP 2 
overexpression (36  sample, 90%). However, samples that overexpressed and did not over-
express TIMP 2 were relatively even, 21 (52.5%) and 19 (47.5%), respectively. Furthermore, 
based on a degree of bone destruction, 19 samples (47.5%) categorised as moderate bone 
destruction dominated this study, with only three samples categorised as mild bone destruc-
tion (7.5%).
Results from Table 2 showed that MMP 2 expression was not significantly associated with 
TIMP 2, with p-value = 0.342. Of 36 samples with MMP 2 overexpression, 19 (52.8%) had 
TIMP 2 overexpression and 17 with no TIMP 2 overexpression.
Table 1. Distribution of atticoantral type CSOM 
based on the degree of MMP 2, TIMP 2 expres-
sion and bone destruction.
Characteristic (n = 40) %
Expression MMP2
Overexpression (Score 4–9) 36 90
No Overexpression (0–3)  4 10
Expression TIMP 2
Overexpression (Score 4–9) 21 52,5
No Overexpression (0–3) 19 47,5
Bone destruction
Mild  3  7.5
Moderate 19 47.5
Severe 18 45
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The proportion of  MMP 2 and TIMP 2 expression associated with the degree of  bone 
destruction is displayed in Table 3. Statistical analysis showed that expression of  TIMP 2 
was not significantly correlated with the degree of  bone destruction (p = 0.165, p > 0.05).
4 DISCUSSION
Inflammations that promote epithelial proliferation is associated with increased expression 
of lysis enzymes that could further stimulate osteoclast differentiation and maturation or 
react to bone matrix, therefore exposing the osteoclast.
This could cause bone extracellular matrix degradation resulting in bone erosion and 
destruction that could further complicate the atticoantral type of CSOM (Frickmann & 
Zautner, 2012). Matrix metalloproteinases and TIMPs have contradicting functions, there-
fore a sample that overexpresses MMP should at the same time not overexpress TIMP.
The contradictive results obtained in this study may be because of the different intensity 
and extent scores that were seen on immunohistochemically examining MMP 2 and TIMP 2, 
and then maybe we cannot know matrix of cholesteatoma because we used block paraffin of 
cholesteatoma retrospectively. Also, there are many other cytokines inflammation and inhibi-
tor influence bone destruction in CSOM patients.
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ABSTRACT: Children glioma is a life-threatening condition with a survival rate of less 
than one year. Nimotuzumab, a unique and affinity differentiated anti-EGFR antibody for 
the past ten years had been used in combination with radiotherapy or radiochemotherapy. 
The aim of these studies was to evaluate nimotuzumab in combination with radiotherapy or 
radiochemotherapy in newly diagnosed children with DIPG. Patients received i.v. infusions 
of 150  mg/m2 of nimotuzumab in combination with 54 Gy radiotherapy or radiochemo-
therapy for DIPG patients or 150 mg/m2 of nimotuzumab as monotherapy on high-grade 
glioma, weekly, for 6–8 weeks, and then every 2–3 weeks until disease progression or unac-
ceptable toxicity. A total of 87 newly diagnosed children with DIPG (35 male/52 female), 
median age 7.6 yr old were recruited. Use of nimotuzumab had been efficacious in newly 
diagnosis children with DIPG and recurrent or refractory children with high-grade glioma.
Keywords: anti-EGFR, nimotuzumab, DIPG
1 INTRODUCTION
Glioma is a rare but devastating cancer. Although temozolomide is currently the first-line 
standard of care for the treatment of glioma, temozolomide has shown minimal activity in 
high-grade glioma of childhood with no convincing evidence of its activity in diffuse intrinsic 
pontine glioma (DIPG) (Fangusaro, 2012). To date, there is no standard therapy to treat newly 
diagnosed DIPG or recurrent or relapse high-grade glioma in children and adolescents.
Nimotuzumab, formerly called h-R3, is a genetically engineered humanized mAb that rec-
ognizes an epitope located in the extracellular domain of human EGFR. It is an IgG1 isotype 
that was obtained by transplanting the complementary determining regions (CDR) of the 
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murine anti-EGFR mAb ior egf/r3 (IgG2a) to a human framework assisted by computer 
modeling (Mateo, 1997).
Nimotuzumab blocks EGF and TGFα binding to the EGFR receptor and inhibits its 
intrinsic tyrosine kinase activity. In preclinical studies, nimotuzumab showed antiprolif-
erative, proapoptotic, and antiangiogenic effects in tumors that overexpress EGFR, and 
enhanced radiosensitivity with reduction of tumor blood vessels and proliferation in the 
human GBM cell line U87MG (Diaz et al., 2009).
The aim of these studies was to evaluate nimotuzumab in combination with radiotherapy 
or radiochemotherapy in newly diagnosed children with DIPG or as monotherapy in recur-
rent or refractory children with high-grade glioma, as assessed by overall survival.
2 MATERIAL AND METHODS
2.1 Study objectives
a. Study OSAG 101-BSC-05: Multicentre phase III trial to explore the feasibility and effi-
cacy of the h-R3 monoclonal antibody (nimotuzumab) simultaneously to conventionally 
fractionated local radiotherapy in the treatment of children and adolescents with newly 
diagnosed DIPG.
b. Study IIC RD EC-097/EF-090: To evaluate the efficacy of nimotuzumab in children and 
adolescents with newly diagnosed brain stem gliomas.
c. Study BN-001 PED-04: To evaluate the effectiveness of a humanized EGFR antibody 
on the treatment of pediatric and adolescents with chemotherapy-resistant high-grade 
glioma.
d. Study YMB-1000-013: to determine the efficacy of the use of the EGF-R antibody nimo-
tuzumab monotherapy in the treatment of recurrent or refractory brain stem glioma.
e. Expanded Access Program: to evaluate the effectiveness of the monotherapy treatment 
of the anti-EGFR monoclonal antibody nimotuzumab in children and adolescents with 
recurrent or refractory high-grade glioma.
2.2 Inclusion/exclusion criteria
2.2.1 First line treatment on newly diagnosed DIPG patients
Inclusion criteria: pediatric patients with newly diagnosed DIPG which have been docu-
mented by conventional imagery methods (MRI, CAT), Age ≥3 years old ≤18 years old, life 
expectancy ≥12 weeks, laboratory parameters for hematological, liver and renal functions 
must be within the normal defined limits, and both parents or legal guardian(s) must express 
in writing the will to allow the patient to participate in the study by signing the informed 
consent within others.
Exclusion criteria: patients with low grade brain stem glioma (i.e. focal, cerebromedullary, 
tectal brain stem gliomas), patients previously treated with a monoclonal antibody, patients 
who previously received some type of cancer treatment including chemotherapy, immuno-
therapy or radiation therapy, concurrent cancer treatment which is not part of the study pro-
tocol, pregnant or nursing patients, patients with a chronic disease (i.e. cardiopathy, diabetes, 
high blood pressure) at the time of inclusion, patients with hypersensitivity to the drug or 
to a similar drug, febrile condition, severe septic condition and/or serious or acute allergic 
condition, patients participating in another clinical study with the intent to treat their tumor 
at the time of inclusion and presence of a second tumor.
2.2.2 Recurrent or refractory high-grade glioma
Inclusion criteria: histologically verified diagnosis of a high-grade glioma (WHO III and IV) 
(not applicable or necessary for intrinsic pontine glioma) who were in progression after sev-
eral lines of treatment, age ≥3 years to ≤20 years, adequate hematological, renal, and hepatic 
function (CTC grade ≤2), condition is measurable by X-ray in at least one dimension, life 
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expectancy ≥4 weeks and written consent from parents/legal guardian, and, if  possible, chil-
dren, after being informed.
Exclusion criteria: a history of prior use of EGFR-targeting agents (monoclonal antibod-
ies, tyrosine kinase inhibitors), recent introduction of an “alternative” curative treatment 
method after progressive diagnosis, and during this study, more than one line of treatment 
(i.e. more than one progression after initial therapy) for the disease, had radiation therapy 
completed within 12 weeks of enrollment, previous chemotherapy completed ≤2 weeks prior 
to enrollment, and pregnancy in females of childbearing age.
2.3 Treatment schedule
2.3.1 First line treatment on newly diagnosed DIPG patients
Eligible patients for studies OSAG 101-BSC-05 and IIC RD EC-097/EF-090 were adminis-
tered i.v. infusion of 150 mg/m2 of nimotuzumab once a week for 6 weeks and then if  patients 
had stable disease or better response additional 150 mg/m2 of nimotuzumab every two weeks 
until disease progression or unacceptable toxicity and radiotherapy 54 Gy based on 1.8 Gy 
daily for 5 days a week for 6 weeks.
2.3.2 Recurrent or refractory high-grade glioma
Eligible patients from studies BN-001 PED-04, YMB-1000-013, and Expanded Access Pro-
gram were administered i.v. infusion of 150  mg/m2 of nimotuzumab once a week for six 
weeks and them if  stable disease or better response additional 150 mg/m2 every two or three 
weeks until disease progression or unacceptable toxicity.
2.4 Statistical analysis
Analysis of demography, baseline characteristics, safety, and efficacy were performed on the 
data set of all treated patients.
Demographics and baseline characteristics: were summarized using descriptive statistics.
Primary efficacy analysis: The primary estimate of median overall survival (OS), progres-
sion-free-survival (PFS), overall response rate (ORR) and disease control rate (DCR) was 
estimated by Intent-To-Treat population.
The primary analysis of survival was conducted using a log-rank test using Kaplan-Meier 
curves. Median OS, PFS and their 95% confidence interval (CI) were calculated by each 
tumor localization using a Cox, regression model.
3 RESULT
3.1 Patients demographics
A total of 87 newly diagnosed children with DIPG (35 male/52 female), median age 7.6 yr old 
were recruited in 2 clinical studies in Brazil, Cuba, Germany, Italy and Russia and 113 recur-
rent or refractory children with high-grade glioma (60 male/53 female), median age 9.9 yr old 
were recruited in 2 clinical studies and 2 physician lead studies in Canada, Cuba, Germany 
and United States (Table 1).
3.2 Clinical response to the treatment
3.2.1 First line treatment on DIPG patients
In the study OSAG 101-BSC-05, there were four patients with partial remissions, 27 stable 
disease and eight patients progressed. The overall response rate (ORR) in this study was 
9.5%, and the disease control rate (DCR) was 73.8%, and in the study IIC RD EC-097/
EF-090, there were 20 patients with partial remission, 14 patients with stable disease and 11 
patients progressed. The ORR on this study was 44.4%, and the DCR was 75.5% (Table 2).
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3.2.2 Recurrent or refractory high-grade glioma
In the study BN-001 PED-04 on the DIPG tumors, there was one patient with partial remission, 
ten stable disease and 11 patients progressed. The ORR was 4.56%, and the DCR was 50.0%. On 
the GBM tumors, there were three stable diseases, and ten patients progressed. The DCR was 
23.1%, and on the AA tumors, there was one patient with partial remission, two stable disease 
and eight patients progressed. The ORR was 8.33%, and the DCR was 25.0% (Table 2).
On the Expanded Access 1 on the AA tumors, the patient did not receive the response to 
the treatment.
On the Expanded Access 2 on the DIPG tumors, there were two patients with complete 
remission, one patients with partial remission, two patients with stable disease and four 
patients progressed. The ORR was 33.3%, and the DCR was 55.6%.
On the GMB tumors, all five patients did not respond to the treatment, and on the AA 
tumors, there were one patients with complete remission, one stable disease and one patient 
who progressed. The ORR was 33.3%, and the DCR was 66.7% (Table 2).
3.3 Progression-Free Survival (PFS) and Overall Survival (OS)
3.3.1 First line treatment on DIPG patients
In the study OSAG 101-BSC-05, DIPG patients following treatment with radiotherapy and 
nimotuzumab had a median PFS [95% CI] of 5.6 months [5.04, 6.16] and a median OS [95% 
Table 2. Clinical response to the treatment.





OSAG 101-BSC-05 DIPG RT + nimotuzumab  9.52 73.8
IIC RD EC-097/EF-090 DIPG RT + nimotuzumab 44.4 75.6
BN-001 PED-04
DIPG nimotuzumab  4.56 50.0
GBM nimotuzumab  0 23.1
AA nimotuzumab  8.33 25.0
YMB-1000-013 DIPG nimotuzumab  4.4 19.6
Expanded Access 1 AA nimotuzumab  0  0
Expanded Access 2
DIPG nimotuzumab 33.3 55.6
GBM nimotuzumab  0  0
AA nimotuzumab 33.3 66.7
RT, radiotherapy, ORR, overall response rate, DCR, disease control rate.









OSAG 101-BSC-05 42 16 26  7.6 DIPG
IIC RD EC-097/EF-090 45 19 26  7.9 DIPG
BN-001 PED-04
22 17  5  8.9 DIPG
13  7  6 12.2 GBM
12  5  7 10.3 AA
YMB-1000-013 46 21 25  6.0 DIPG
Expanded Access 1  3  0  3 10.8 AA
Expanded Access 2
 9  5  4 10.0 DIPG
 5  3  2 10.2 GBM
 3  2  1  8.3 AA
DIPG, diffuse intrinsic pontine glioma, GBM, glioblastoma, AA, 
anaplastic astrocytoma.
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CI] of 9.2 months [7.55, 10.85]. The 1-year PFS and OS rate were 5.3% and 33.3% respec-
tively and in the study IIC RD EC-097/EF-090, DIPG patients following treatment with 
radiotherapy and nimotuzumab had a median PFS [95% CI] of 8.23 months [6.47, 9.99] and 
a median OS [95% CI] of 9.7 months [7.99, 11.41]. The 1-year PFS and OS rates were 33.3% 
and 42.2% respectively (Table 3).
3.3.2 Recurrent or refractory high-grade glioma
In the study BN-001 PED-04, the DIPG patients who at the time of the inclusion in the 
study were in progression and had a life-expectancy of at least 4 weeks following treatment 
of nimotuzumab monotherapy had a median PFS [95% CI] of 1.53 months [1.04, 2.02] and 
a median OS [95% CI] of 4.67 months [2.48, 6.85]. The 1-year PFS and OS rates were 4.5% 
and 9.1% respectively. The GBM patients had a median PFS [95% CI] of 1.67 months [1.61, 
1.72] and a median OS [95% CI] of 3.47 months [2.93, 4.00]. The 1-year PFS and OS rate 
were 0% respectively, and the AA patients had a median PFS [95% CI] of 1.67 months [1.29, 
2.04] and a median OS [95% CI] of 6.33  months [1.51, 11.0]. The 0.5-year PFS rate was 
16.7%, and the 1-year OS rate was 25.0%. In the study YMB-1000-01, the DIPG patients 
who at the time of the inclusion in the study were in progression and had a life-expectancy of 
at least 4 weeks following treatment of nimotuzumab monotherapy had a median PFS [95% 
CI] of 1.8 months [1.51, 2.10] and a median OS [95% CI] of 3.1 months [1.89, 4.31]. The 
0.5-year PFS rate was 4.8%, and the 1-year OS rate was 7.6%, and in the Expanded Access 
Program 2, patients after receiving nimotuzumab monotherapy had a median OS [95% CI] 
of 9.17 months [4.28, 14.1] and 1-yr OS rate of 35.3%.
3.4 Safety and tolerability of the treatment
3.4.1 First line treatment on DIPG
In the studies, OSAG 101-BSC-05 and IIC RD-EC-097/EF-090 patients received a median 
of 20.6 infusions of nimotuzumab (range 1–28). These patients experienced a total of 937 
adverse events (AEs) reported in 77 patients (88.5%). Out of 937 AEs, 118 AEs in 35 patients 
(40.2%) were reported to be possible, probable or definite related to the administration of 
nimotuzumab and radiotherapy. The most frequently reported related AEs (>5 patients, 
5.75%) were vomiting (11 subjects, 12.64%), headache (7 subjects, 8.05%), alopecia (6 sub-
jects, 6.90%), and constipation (5 subjects, 5.75) (Table 4).
3.4.2 Recurrent or refractory high-grade glioma
In the studies, BN-001 PED-04 and YMB-1000-013 these patients experienced a total of 645 
adverse events (AEs) reported in 86 patients (94.5%). Out of 645 AEs, 98 AEs in 46 patients 
(50.5%) were reported to be possible, probable or definite related to the administration of 
nimotuzumab. The most frequently reported related AEs (>5 patients, 5.49%) were nausea 
(7  subjects, 7.69%), leukopenia (6  subjects, 6.59%), vomiting (5  subjects, 5.49%), fatigue 
(5 subjects, 5.49%), and erythema (5 subjects, 5.49%) (Table 5).
Table 3. Progression free survival and overall survival.
Parameter OSAG 101-BSC-05 IIC RD EC-097/EF-090
Treatment RT + nimotuzumab RT + nimotuzumab
No of Patients 42 45
PFS (months) [95% CI] 5.60 8.23
[5.04–6.16] [6.47–9.99]
one yr PFS rate (%) 5.3 33.3
OS (months) [95% CI] 9.2 9.7
[7.55–10.85] [7.99–11.41]
1-yr OS rate (%) 33.3 42.2
ISCOC17_Book.indb   255 3/21/2018   2:04:27 PM
256
4 DISCUSSION
Brain tumors are a heterogeneous group of neoplasms, each with its biology, treatment, and 
prognosis. New therapies are needed, especially for the astrocytic gliomas. In particular brain 
stem gliomas (BSG) remain the most problematic childhood brain tumor to treat. BSG com-
prises 10–15% of all pediatric CNS tumors and is uncommon in the adult population. Peak 
incidence is between 5–9 years of age but may occur anytime in the childhood. These lesions 
tend to be located in the pons and are termed diffuse intrinsic pontine gliomas (DIPG), 
which constitute approximately 75–80% of all childhood brain stem gliomas. This DIPG will 
respond transiently to radiotherapy but have not yet been shown to benefit from the addition 
of chemotherapy (Paker et al., 1990). After radiotherapy, progressive disease and death will 
occur in approximately 90% of the patients within 8–10 months of diagnosis.
The treatment of radiotherapy in combination with the anti-EGFR monoclonal antibody 
nimotuzumab increased the progression-free survival and overall survival of newly diag-
nosed children and adolescents with DIPG. The addition of nimotuzumab to radiotherapy 
increased 1-yr OS rate to 38% in newly diagnosed children and adolescents with DIPG.
The use of nimotuzumab monotherapy in recurrent or refractory heavily pretreated chil-
dren and adolescents with high-grade glioma can achieve an overall response rate (ORR) of 
7.1%, and a disease control rate (DCR) of 29.2%.
Table 4. Percentage of subjects with all grades related AEs occurring 
in more than 5.0%.
System organ class
preferred term
RT (54 Gy) + nimotuzumab 
(150 mg/m2) (N = 87)
N1 (%)
Gastrointestinal disorders
 Constipation  5 (5.75%)
 Vomiting 11 (12.64%)
Nervous system disorder
 Headache  7 (8.1%)
Skin and subcutaneous tissue disorders
 Alopecia  6 (6.90%)
1Reported number and percentages based on number of patients.
Table 5. Percentage of subjects with all grades related AEs were occurring in more 
than 5.0%.




Blood and lymphatic system disorders
 Leukopenia 6 (6.59%)
Gastrointestinal disorders
 Nausea 7 (7.69%)
 Vomiting 5 (5.49%)
General disorders and administration site conditions
 Fatigue 5 (5.49%)
Skin and subcutaneous tissue disorders
 Erythema 5 (5.49%)
1Reported number and percentages based on number of patients.
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Nimotuzumab monotherapy in recurrent or refractory heavily pretreated children and 
adolescents with high-grade glioma increases median PFS to 1.83 months, median OS to 
3.90 months, 1-yr PFS rate to 7.1% and 1-yr OS rate to 12.6%.
Use of nimotuzumab had been efficacious in newly diagnosis children with DIPG and in 
recurrent or refractory children with high grade glioma.
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ABSTRACT: Transthoracic Needle Aspiration (TTNA) for diagnosing thoracic lesions are 
usually performed with image guidance, including thoracic computed tomography scan and 
thoracic ultrasound. The aim of this study is to describe the characteristics of samples, and 
diagnostic accuracy of TTNA using US guidance compare to CT guidance. Image-guided 
TTNA were performed in 91 consecutive patients suspected of lung cancer on clinically and 
radiological work-up. Image guidance was selected randomly. The final diagnosis was based 
on cytology analysis or clinical follow-up. For thoracic ultrasound guided TTNA, the accu-
racy, sensitivity, specificity, were 87.8%, 91.6%, and 77.7%, respectively. For thoracic CT-
guided TTNA the accuracy, sensitivity, specificity, were 86.84%, 78.3%, and 100%. Thoracic 
US-guided TTNA had a high sensitivity and specificity in lesions that abut the chest wall.
Keywords: diagnostic accuracy for transthoracic needle aspiration using an Ultrasound 
thoracic compared thoracic ct scan guided, lung cancer
1 INTRODUCTION
Transthoracic Needle Aspiration (TTNA) was first used for the diagnosis of pulmonary dis-
ease in 1883 when Leyden performed the procedure on three patients with pneumonia. In 
1886, Menetrier reported the use of TTNA in the diagnosis of lung carcinoma. Since that 
time, many published series have explained the method of TTNA for the diagnosis of a vari-
ety of benign and malignant thoracic lesions (Kern & McLennan, 2008).
The significant indications for TTNA include evaluation of solitary lung nodules and 
masses, mediastinal and hilar lesions, metastatic disease to the lung from a known extratho-
racic malignancy, chest wall invasion by lung carcinoma, and pulmonary consolidation or 
infiltrates that are likely to be of infectious origin (Kern & McLennan, 2008).
Transthoracic needle aspiration is performed with an image guidance, including Thoracic 
Computed Tomography (CT) and Thoracic Ultra Sound (US). Several previous published 
articles for a CT-guided TTNA (Schreiber & McCorry, 2003, ERS/ATS, 2002) and a US-
guided TTNA (Saito et al, 1988, Yang et al, 1992, Knudsen et al, 1996, Taviad et al, 2014) 
have illustrated their role as an active guidance modality for diagnosing intra thoracic lesions. 
In our facility, a tertiary referral hospital (Adam Malik general hospital, we usually per-
form TTNA using the CT guidance with good performance, but many other services in our 
area do not have this equipment, only US. In this paper, our purpose was to describe the 
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characteristics of samples and diagnostic accuracy for transthoracic needle aspiration using 
the US guidance compared to the CT guidance for diagnosing lung cancer.
2 METHOD
From 1st February 2015 to 29th February 2016, 91 consecutive patients underwent TTNA. 
All patients were suspected of lung cancer on clinical and radiological work-up. At the time 
of TTNA, all patients had standard or corrected coagulation parameters (prothrombin time 
and activated partial thromboplastin time) and platelet count. Written informed consent was 
obtained in all cases. The image guidance was selected randomly.
The technique for the CT-guided biopsies was as follows: preliminary 5-mm-collimated 
CT scans were obtained to localize the lesion and select the optimal approach. A CT scan 
Toshiba asteion slice 4, CXB-400C/1A was used. The skin entry site was marked by using 
the laser light from the CT gantry and a grid placed on the patient’s skin. Additional scans 
were obtained during a passage of the needle through the chest wall and into the lesion to 
allow adjustment of the needle direction and to record the position of the needle tip inside 
the target before sampling.
Our technique for the US-guided TTNA was as follows: preliminary localizing scans were 
obtained by using 3.5-MHz or 4-MHz multi-frequency sector transducers or a 5-MHz lin-
ear transducer (Sonix 01: Ultrasonix Medical Corporation S/N: SX1.1-0809.1841). When 
necessary, color Doppler was used to detecting potential vessels in the path of the needle. 
The scans were obtained with the patient in the supine, prone, or decubitus. Frequently, the 
aspiration was performed by using US transducer with a needle-guide attachment, but in our 
setting, we used a separate transducer and needle. We marked the location and inserted the 
needle separately. The transthoracic needle aspiration was performed by using a 25-gauge 
needle for both images guidance. The aspiration was performed either by one of our pulmo-
nologists with a subspecialty in thoracic oncology or pulmonology residents under the close 
supervision of the pulmonologist.
The specimens were handled similarly regardless of the guidance modality used: each fine-
needle aspirate was immediately smeared onto glass slides, air-dried, fixed by using alcohol 
96% and sent to the pathology department for further examination. The diagnostic catego-
ries used in cytology of TTNA were inadequate (C1), benign (C2), atypical (C3), suspicious 
of malignancy (C4), and malignant (C5) according to the National Cancer Institute (NCI) 
guidelines in 1996 (NCI, 1997).
At the completion of the procedure, all patients were monitored for the signs and symp-
toms of complication, such as hemoptysis and pneumothorax. The location and size of the 
lesion, the diagnostic accuracy, and any complications were also recorded.
The success of each procedure was established at a review of the final pathology report 
and cultures when appropriate. We attempted to obtain a clinical and imaging follow-up in 
cases where a diagnosis of malignancy was not established.
3 RESULT
During the study period, a total 91 TTNA were done, 46 (50.5%) were performed with the US 
guidance, and 45 (49.5%) were performed with the CT guidance.
There were no pneumothorax or hemoptysis associated with the US-guided or the CT-
guided TTNA.
For the US-guided TTNA, the accuracy, sensitivity, and specificity were 87.87%, 91.6%, 
and 77.7%, respectively. On the other hand, for the CT-guided TTNA, the accuracy, sensitiv-
ity, and specificity were 86.84%, 78.3%, and 100%, respectively.
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Table  1. Baseline characteristics of 91 patient underwent 
TTNA randomised to US guidance or CT guidance.
Characteristics
US-guided 
TTNA (n = 46)
CT-guided 
TTNA (n = 45)
Mean (SD) age (years) 54.76 (12.89) 50.46 (16.78)
Age (years)
 18–30  4 (8.7)  9 (20)
 31–40  1 (2.2)  1 (2.2)
 41–50 10 (21.7)  9 (20)
 51–60 15 (32.6) 11 (24.4)
 61–70 14 (30.4) 10 (22.2)
 71–80  2 (4.3)  5 (11.1)
Male 35 (76.1) 36 (80)
Final diagnosis
 Lung cancer 33 (71.7) 28 (62.2)
 Others 13 (28.3) 17 (37.8)
  Mediastinal tumor 12 (26.1) 15 (33.3)
  Chest wall tumor  1 (2.2)  0 (0)
  Aspergilloma  0 (0)  2 (4.4)
Smoking history
 Smoker 37 (80.4) 32 (71.1)
 Non-smoker  9 (19.6) 13 (28.9)
Table 2. Comparison of TTNA cytology using dif-




TTNA (n = 46)
CT-guided 
TTNA (n = 45)
C1  7 (15.2)  4 (8.9)
C2  6 (13) 12 (26.67)
C3  1 (2.2)  1 (2.2)
C4  2 (4.3)  0 (0)
C5 30 (65.2) 28 (62.23)
Table  3. Comparison of diameter of lesion, depth of needle insertion, 
and position of patients in both groups.
US-guided 
TTNA (n = 46)
CT-guided 
TTNA (n = 45)
Diameter of lesion (SD)
 Mean (SD) 9.81 cm (4.1) 6.12 cm (2.76)
 Median (min–max) 9.3 cm (3–19) 5.7 cm (3–16)
Depth of needle insertion
 Mean (SD) 3.58 cm (1.11) 5 cm (1.21)
 Median (min–max) 4 cm (1.4–6) 5 cm (2–8)
Position of patients (n, %)
 Supine 38 (82.6) 36 (80)
 Prone  3 (6.25)  9 (20)
 Left Lateral Decubitus (LLD)  2 (4.35)  0 (0)
 Right Lateral Decubitus (RLD)  3 (6.25)  0 (0)
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4 DISCUSSION
The imaging-guided transthoracic needle aspiration (TTNA) has achieved a great impor-
tance in the diagnosis of a variety of thoracic lesions. Due to simplicity, safety, and diagnostic 
accuracy, this procedure has become a widely used diagnostic technique in the manage-
ment of lung cancer. This process is performed under the US guidance or the CT guidance 
(Schreiber & McCorry, 2003, ERS/ATS, 2002).
The National Cancer Institute recommends five categories for a diagnosis of aspiration 
cytology to bring a degree of uniformity in the diagnostic reports. These types are unsatisfac-
tory (C1), benign lesion (C2), atypical, probably benign (C3), suspicious, probably malignant 
(C4), and malignant (C5) (NCI, 1997).
Our study found more inadequate smears for the US-guided TTNA compared with 
the CT-guided TTNA (7/46 [15.2%] versus 4/45 [8.9%]. We used the US with a separate 
transducer and needle, as we marked the location and inserted the needle separately, we 
could not evaluate the position of  the needle tip directly, inside the tumor or not. Mean-
while, we conducted TTNA under the CT guidance to locate the site of  needle insertion 
and made an additional scan to make sure that the tip of  the needle was properly inserted 
into the lesion.
In terms of position of the patient during the performance of the procedure, we found 
four different locations in the US-guided TTNA: 38 patients (82.6%) in a supine position, 
3 patients (6.25%) in a prone position, 2 patients (4.35%) in a RLD position, and 3 patients 
(6.25%) in a LLD position. On the other hand, patients under the CT guidance were per-
formed TTNA only in two positions, 36 patients (80%) in a supine position and nine patients 
(20%) in a prone position. The approach for the needle placement in the CT guidance is 
usually limited to the axial plane. Angled approaches are more difficult in the CT guidance, 
and it is an advantage of using the US guidance. The US-guided TTNA allows the use of an 
oblique, angled approach if  necessary (Liao et al., 2013).
In our study, the sensitivity of the US-guided TTNA was higher than the CT-guided 
(91.6% versus 78.3%). It can be explained by our findings that the average diameter of the 
lesion in the US group was larger than in the CT group (9.81 cm vs. 6.12 cm). The specificity 
of the US-guided TTNA was lower than the CT-guided (77.7% vs. 100%). This result can be 
explained by the fact that we did not use the US with a needle-guide attachment on the trans-
ducer to make a real-time visualization during the procedure. Meanwhile, on the CT-guided, 
the additional scan using the CT was performed to make a documentation of the needle tip’s 
position if  it was properly inserted into the mass.
Pneumothorax and minor bleeding are common complications of  TTNA. The reported 
frequency of  biopsy associated pneumothorax ranges from 20–35% (Hoffmann, Mauer, and 
Vokes, 2000). There were no pneumothorax or hemoptysis associated with the US-guided or 
the CT-guided TTNA in our study. All the lesions in this study were abutted the chest wall.
The limitation of this study was that we assessed complication by signs and symptoms. An 
immediate posteroanterior chest radiograph was obtained if  pneumothorax was suspected 
clinically.
5 CONCLUSION
The results from our study demonstrated that with proper triaging of patients, the US-guided 
TTNA might be an attractive and safe alternative compared to the CT-guided TTNA, with a 
high sensitivity and specificity in lesions that abut the chest wall.
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ABSTRACT: A common polymorphism, Arg257Cys of CYP2A13 gene, is associated with 
lung cancer in several populations. The aim of this study was to analyse the relationship between 
this polymorphism and lung cancer in several ethnics of the Indonesia population. Consecutive 
sampling and case-control study were applied. The PCR-RFLP assay was employed to geno-
type. The chi-square test with p < 0.05 considered as significant. Of all 50 subjects, 26 (13%) indi-
viduals were heterozygotes, and 37 (74%) were homozygote for the 257Cys allele. The frequency 
distributions among ethnics were Acehnese two (5.4%) homozygote, Malay two (5.4%) homozy-
gote, Chinese one (7.7%) heterozygote, 20 (54%) homozygote and six (46.1%) heterozygotes in 
Batak, 13 (35.1%) homozygote and six (46.1%) heterozygotes in Javanese. The CYP2A13 Arg-
257Cys variant represents a common polymorphism in Batak and Javanese ethnics. There is no 
association between Arg257Cys polymorphism of CYP2A13 and lung cancer.
Keywords: CYP2A13 gene, PCR-RFLP, lung cancer, Indonesia population
1 INTRODUCTION
Lung cancer is the most common cancer in the world, representing approximately 1.2 million 
lung cancer patient annually, which is leading cause of cancer death (Parkin et al., 2001). Lung 
cancer deaths contribute to more than 1 million deaths with the prediction of approximately 
1.4 million people (Globocan, 2012). Since 1950, tobacco smoke has been recognised as the 
main cause of lung cancer and smoking has also become a life style. Lung cancer will be the 
health problem in the future (Medical Research Council, 1957). In Indonesia, tobacco smoke 
and smokeless tobacco is used by approximately 67.4% of the male and 4.5% of the female 
population. It means Indonesia has the most common tobacco use, approximately 61.4 mil-
lion people (31.1% of the population), (Global Adult Tobacco Survey, 2011).
Cytochrome P450 2 A13 (CYP2A13) is expressed in the highest level in the human respiratory 
tract, in the nasal mucosa, lung, and trachea (Su et al., 2000). Several genetic polymorphisms 
of CYP2A13 Single Nucleotide Polymorphism (SNP) C3375T were identified. Polymorphism 
C3375T in exon 5 of CYP2A13 and changes in Arg257Cys are functionally important. The Arg-
257Cys polymorphism provides some protection against xenobiotic toxicity to individuals who 
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are homozygous for the Cys257 allele because the Cys257 variant had a > 2-fold less catalytic 
efficiency for Nicotine-derived Nitrosamine Ketone (NNK). However, this relationship is still 
controversial, and further study is needed in several ethnics (Cheng et al., 2004).
So far, there is still limited data regarding the Arg257Cys polymorphism of CYP2A13 in 
the Indonesia population. Therefore, the aim of this study is to identify this polymorphism 
and its relationship to lung cancer in the Indonesia population.
2 METHOD
2.1 Subjects
50 male subjects with a history of cigarette smoking were recruited in the study, 25 subjects 
with lung cancer compared with 25 healthy subjects. All subjects were patients in Adam Malik 
General Hospital. This study was approved by the Ethical Committee of Faculty of Medicine, 
Universitas Sumatera Utara, and obtained informed consent from each participant.
2.2 Blood acquisition and DNA isolation
3 ml of venous blood was collected from the mediana cubiti vein in a sterile tube containing 
EDTA and stored at 4°C in the refrigerator (Sambrook et al., 1989).
2.3 PCR-RFLP assay for genotyping
Exon 5 of the CYP2A13 gene was amplified using a forward primer 5’- CCTGGACAGAT-
GCCTTTAACTCCG-3’ paired with a reverse primer 5’- TGGCTTTGCACCTGCCT-
GCACT-3’. PCR amplification was performed in a Bio-Rad DNA Model T-100 thermal cycler 
in a total volume of 25 μl containing approximately 200 ng of genomic DNA, 2.5 μl × PCR 
buffer 2 mmol/l MgCl2, 0.2 mmol/l of each dNTP, 0.28 μmol/l of each primer, and 2 U of 
Taq DNA polymerase. The PCR conditions involved an initial denaturation at 95°C for three 
minutes, followed by 35  cycles of denaturation at 95°C for 30  seconds, annealing at 63°C 
for 45 seconds, and extension at 72°C for 30 seconds, with a final extension at 72°C for five 
minutes. After amplification, the PCR products (332 bp) were digested with HhaI restriction. 
Endonuclease at 37°C for at least four hours. Digested products were analysed by electro-
phoresis on a 2% agarose gel in the presence of ethidium bromide (Zhang et al., 2003).
2.4 Statistical analysis
The chi-square test was used to compare genotypic frequencies between the case and control. 
The OR and 95% CI were calculated to determine the association between variables and 
the risk of lung cancer regarding the Arg257Cys polymorphism in both cases and controls. 
Statistical analyses were conducted using statistical software SPSS 17.0 for PC A p-value of 
< 0.05 was required for statistical significance.
3 RESULT
The characteristic of subject is shown in Table 1. Of all 50 participants, the overall frequency of 
genotype CC, CT and TT was 72%, 26%, and 2% respectively. The frequency of allele homozy-
gote was 74%, while the heterozygote was 26%. Genotype distribution based on six groups of 
ethnicity revealed that Javanese and Batak had the highest frequency of CT genotype, 31.5%, 
and 23% respectively of Chinese participated in this study. The TT genotype was detected in 
one sample only (Table 2). The genotype distribution was in Hardy-Weinberg equilibrium.
This research failed to confirm the association between genetic polymorphism of 
CYP2A13 Arg257Cys and lung cancer susceptibility. Of all 25 cases and 25 controls, the 
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combined genotype frequency of CT and TT was found to be 32% and 24% respectively 
(Table  2). Chi-square analysis revealed that there was no significant association between 
genetic polymorphism CYP2A13 Arg257Cys and lung cancer susceptibility (OR 0.67; 95% 
CI 0.19–2.32; p = 0.52). Figure 1 shows that the Arg257Cys mutation eliminates an HhaI 
cleavage site (Cheng et al., 2004).
Figure  1. PCR-RFLP analysis of the CYP2A13 Arg257Cys polymorphism with Hha I. M: DNA 
Marker, lane 6 was genotype with Cys/Cys at 257; lanes 7 and 10 were genotype with Arg/Cys at 257; 
lanes 1–5, 8, 12–15 were genotype with Arg/Arg at 257.
Table 1. The characteristics of the subjects.
Subjects
Case Control
n % n %
Age 25–34 years old – – 19 76
35–44 years old  1   4  5 20
45–54 years old  3  12  1  4
55–64 years old 15  60 – –
> 65 years old  6  24 – –
Type of cigarette Kretek 14  56  1  4
Mild  8  32 22 88
Kretek Mild  3  12  2  8
Brinkman Index Mild  1   4 15 60
Moderate – –  9 36
Severe 24  96  1  4
Lung cancer Adenocarcinoma 19  76 – –
Squamous cell ca  5  20 – –
Large cell ca  1   4 – –
Ethnicity Batak 16  64 10 40
Javanese  4  16 15 60
Acehnese  2   8 – –
Malay  2   8 – –
China  1   4 – –
Total 25 100 25 10
Table 2. CYP2A13 polymorphism and lung cancer.
Case Control
p-value OR 95% CIn % n %
CC 17 34.0 19 38.0 0.529 0.671 0.193–2.329
CT&TT  8 16.0  6 12.0
Total 25 100 25 100
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Furthermore, we evaluated the association of genetic polymorphism CYP2A13  Arg-
257Cys and histologic type of lung cancer. Of the 25 lung cancer patients, the highest rate 
of type was adenocarcinoma, in which the frequency of CC, CT, and TT was 70%, 25% 
and 5% respectively (Table 3). There was no relationship between genetic polymorphism of 
CYP2A13 Arg257Cys and histologic type of lung cancer (p = 0.42).
4 DISCUSSION
We found that the most predominant ethnicity in this study was Batak (52%) compared with 
four other ethnics in Indonesia. There is a tradition in Batak culture to serve cigarettes in 
several traditional ceremonies, and smoking habits are very common among the Batak popu-
lation. Furthermore, Batak ethnics are well known to have a pure genetic heritance due to its 
culture in marriage and thus will provide a better model for genetic polymorphism to identify 
its effect on Tobacco-Specific Nitrosamine (TSNA) contained in cigarettes.
Each cigarette contains a mixture of carcinogen, including a small dose of Polycyclic Aro-
matic Hydrocarbons (PAH) and 4-(methylnitrosamino)-1-(3-pyridyl)-1 butanone (NNK/
Nicotine-derived Nitrosamine Ketone) among other lung carcinogens, tumour promoters 
and co-carcinogens. The metabolism of TSNA needs a CYP2A13 in phase 1 metabolism (Su 
et al., 2000, Wang et al., 2003).
Arg257Cys CYP2A13 variant has been detected at frequencies of 1.9%, 14.4% and 7.7% 
in the white, black and Asian population respectively. Functional analysis has shown that the 
Cys257 variant is some 37–56% less active than the wildtype Arg257 form of the CYP2A13 
protein in all subtracts tested. Heterozygosity and homozygosity for the Cys257 variant have 
been found to be associated with the Chinese population with the significantly reduced risk 
of lung adenocarcinoma (OR 0.41, 95% CI 0.23–0.71). On this basis, it might seem reason-
able to surmise that individuals possessing a significantly reduced level of CYP2A13 may 
manifest sensitivity reduction to xenobiotic toxicity resulting from the CYP2A13 mediated 
metabolic activation of procarcinogens in the respiratory tract (Zhang et al., 2003).
CYP2A13-catalysed metabolic activation in situ may play a critical role in human lung 
carcinogenesis related to cigarette smoking. It is reasonable to further speculate that func-
tional genetic polymorphisms of  CYP2A13 may have a significant impact on human sus-
ceptibility to lung cancers related to NNK. Single nucleotide polymorphism CYP2A13 in 
5 exons with the variant of  C/T had been identified with Arg257Cys amino acid alteration 
in this study. This study found wild-type Arg257 allele could be cut to yield two fragments 
of  99 and 233bp in length, whereas the variant Cys257 allele gave only a 332bp band, 
C/C about 36 persons (72%), C/T about 13 persons (26%) and T/T about one person 
(2%). Genetic polymorphism analysis of  CYP2A13 in lung cancer patients revealed C/T in 
about seven persons (58.8%), C/C in about 17 persons (47.2%) and T/T in about one per-
son (1%). In contrast to Zhang et al., (2003), statistical analysis of  this study showed that 
there was no significant relationship between CYP2A13 gene with lung cancer, OR = 0.67 
(95% CI = 0,193–2,329).
Table 3. CYP2A13 polymorphism and histologic type of lung cancer.
Adenocarcinoma Squamous cell carcinoma Large cell carcinoma
p-valuen % n % n %
CC 14  70 3  75 0 0
CT  5  25 1  25 1 100 0.471
TT  1   5 0   0 0 0
Total 20 100 4 100 1 100
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5 CONCLUSION
The CYP2A13  Arg257Cys variant represents a common polymorphism in the Indonesia 
population, particularly in Batak and Javanese ethnics. There is no association between Arg-
257Cys polymorphisms of CYP2A13 and lung cancer.
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ABSTRACT: The presence of EGFR mutation L858R conferring sensitivity to Tyrosine 
Kinase Inhibitor (TKI) in primary breast cancer has been unclear. An anti L858R EGFR 
mutant protein specific antibody was used to screen EGFR mutations in 174 Formalin Fixed 
Paraffin Embedded (FFPE) specimens. Immunohistochemistry revealed strong reactions to 
the L858R antibody in 16 out of 174 specimens. The proportion of positive staining was 
highest in HER2 (11 of 16), followed by the triple negative (2 of 55) and luminal (3 of 103) 
subtypes. However, upon DNA isolation and analyses, there were six L858R mutations, four 
L861Q mutations, and the remaining six had no mutations. HER2 had the highest propor-
tion of confirmed EGFR L858R and L861Q mutations (31%; n = 16), followed by the triple 
negative (3.6%; n = 55), and Luminal (1.9%; n = 103) cancer subtypes. While EGFR mutation 
was rare, HER2 subtype had the highest frequency of TKI sensitising EGFR mutations.
Keywords: EGFR, HER2 breast cancers, L858R
1 INTRODUCTION
Breast cancer has been categorised into three major types, namely Luminal or hormone recep-
tor positive (expressing estrogen and/or progesterone receptors, and HER2 negative), HER2 
(hormone receptors negative and HER2 positive), and Triple Negative Breast Cancer (TNBC, 
expressing neither hormone receptors nor HER2) subtypes (Allison, 2012). TNBC constitutes 
approximately 10–20% of all breast cancer and demonstrates the high histological grade of inva-
sive carcinoma with poor prognosis (Dent et al., 2007). Notably, TNBC patients are responsive 
to chemotherapy but succumb to rapid relapse as shown by having visceral metastases. Therefore, 
TNBC patients have poor overall survival and high mortality rates (Kumar & Aggarwal, 2016).
Lung adenocarcinoma patients bearing mutations in L858R in exon 21 of Epidermal 
Growth Factor Receptor (EGFR) gene have shown good responses to TKIs, such as gefit-
inib, erlotinib and afatinib treatments, and have reduced the hazard risk of Progression-Free 
Survival (PFS) (Petrelli et al, 2012; Morgenztern et al, 2015). Recently, some publications have 
described genetic alterations of the EGFR gene in breast cancer including TNBC. 30–50% of 
TNBC patients have overexpressed EGFR proteins (Masuda et al., 2012), which has been asso-
ciated with gene copy numbers caused by gene amplification (Shao et al., 2011). Also, there are 
contrasting reports describing either presence (Teng et al., 2011; Ly et al., 2011) or absence of 
EGFR mutations in Asian (Cao et al., 2015) and Caucasian (Secq et al., 2014) TNBC.
In this study, we wish to report the presence of TKI sensitive L858R EGFR mutant proteins 
in different subtypes of breast cancer, namely Luminal, HER2 and TNBC subtypes. We used the 
antibody against L858R EGFR mutant protein followed by direct DNA sequencing and Restric-
tion Fragment Length Polymorphism (RFLP) to confirm the presence of bona fide mutations.
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2 MATERIALS AND METHOD
2.1 Patients samples
174 FFPE breast cancer samples from Dharmanugraha Hospital were sent to Kalgen 
Laboratory between 2011 and 2015. Using a protocol approved by the Research Ethics 
Board at Stem Cell and Cancer Institute, we anonymised patient identity and categorised 
samples into three breast cancer subtypes, namely Luminal (Estrogen receptor (ER) and/or 
Progesterone Receptor (PR) positive), HER2 (positive for HER2 and negative for both ER 
and PR expression), and TNBC (ER/PR/HER2 negative). HER2 was positive when tumour 
cells scored 2+ and 3+ for the degree of membrane staining. Hormone ER and PR positive 
were defined as positive when at least 1% of tumour cells had expressed hormone (estrogen 
or progesterone) receptors.
2.2 Immunohistochemistry
Immunohistochemical staining was performed on 4 μm thick sections cut from FFPE blocks. 
Antigen epitopes were retrieved using heat method by boiling the tissues for 10 minutes in 
0.01 M Tris-EDTA pH9 using the microwave. Tissues were then incubated for 1.5h with 
EGFR mutation-specific antibody L858R (43B2, Cell Signaling Technology, Inc.) that were 
diluted at 1:100 at room temperate. The antibody was detected using Envision Detection 
Systems Peroxidase/DAB (Dako). Immunohistochemical staining results were scored as 
described previously (Fan et  al., 2012). We did not pursue screening of exon 19 deletion 
mutation of EGFR because we could not get consistent immunopositive staining in FFPE 
samples that had known status of exon 19 deletion mutation.
2.3 DNA extraction
Tumour areas were identified and marked by the pathologist. Tissues were then scraped, and 
DNA was extracted using High Pure PCR Template Preparation Kit (Roche) or QIAamp 
DNA Micro Kit (Qiagen) according to the manufacturer’s protocol. DNA yield and purity 
were quantified using Nanodrop (Thermo Fisher Scientific).
2.4 DNA sequencing
PCR was performed in 25  μl PCR reaction volume containing 1  ×  PCR buffer, 0.2  mM 
dNTP, 400 nM forward and reverse primers, and 1.25U Taq DNA polymerase. The PCR 
protocol was set as follows: one cycle of denaturation at 95°C for 15 minutes, then 40 cycles 
of 95°C for 40 seconds, 58°C for 40 seconds, and 72°C for 40 seconds (Y. Nagai et al., 2005). 
PCR products were purified using High Pure PCR Product Purification Kit (Roche) and 
cycle sequencing reaction performed using BigDye Terminator v.3.1 (Applied Biosystems). 
The cycle sequencing reactions were then purified with ethanol precipitation methods and 
then sequenced using ABI 3500 Genetic Analyzer (Applied Biosystems).
2.5 Restriction Fragment Length Polymorphism (RFLP)
We had used this method as routine lung cancer genotyping and had passed routine pro-
ficiency examination of EGFR mutation testing organised by the European Molecular 
Genetic Quality Network (EMQN). Briefly, restriction enzymes MscI and PvuII were used 
to differentiate between L858R and L861Q point mutation in exon 21 of EGFR gene as 
described. MscI enzyme digested TGGCCA sequence within wild-type allele of PCR ampli-
cons. The mutant allele (L858R) was not digested due to the base substitution of T to G at 
the first base of TGGCCA. On the other hand, PvuII enzyme digested mutant allele in the 
CAGCTG sequence. We then ran the RFLP method on 4 μl of  PCR products and analysed 
on 2.5% agarose gel (Kawada et al., 2008).
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3 RESULT
174 breast cancer samples categorised as Luminal A (n = 103), HER2 (n = 16), and triple 
negative (n = 55) breast cancer subtypes were screened for EGFR mutant proteins using the 
L858R mutant specific antibody as shown in the following diagnostic algorithm (Figure 1). 
Samples that showed positive results were then followed up by sequencing and RFLP method 
to confirm DNA mutations.
Expressions of L858R EGFR mutant proteins were found in 11 of 16 HER2 (68.8%), 3 
of 103 Luminal A (2.9%), and 2 of 55 triple negatives (3.6%) breast cancer subtypes. Rep-
resentative results of immunohistochemistry staining with anti L858R EGFR mutant anti-
body were shown in Figure 2.
Samples showing L858R positive staining results were then submitted for independent 
DNA mutation analyses using direct DNA sequencing (examples are shown in Figure 3) and 
RFLP (data not shown). In HER2 breast cancer subtypes, DNA mutations were found in 
5 out of 11 L858R immunohistochemistry positive samples. Three samples had consistent 
L858R mutations, while one sample had L861Q and one sample had the complex mutation 
(L858R and L861Q). In Luminal subtype, L858R DNA mutation was not found in spite 
of positive L858R immunohistochemistry in two samples. Instead of L858R, we detected 
L861Q mutations in those two samples.
Lastly, within TNBC subtype, two samples that were L858R immunohistochemistry posi-
tive was associated with one sample showing DNA mutation of L858R, and the other sample 
showed L861Q mutation. The false positive rate was also not seen in TNBC, while both lumi-
nal and HER2 demonstrated a high false positive rate. Therefore, using stepwise screening of 
L858R mutation with immunohistochemistry followed by a sequencing method, we observed 
L858R EGFR mutation frequency is 25%, 1.8% and 0% in HER2, triple negative and lumi-
nal breast cancer subtypes, respectively.
Figure 1. Diagnostic algorithm.
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4 DISCUSSION
EGFR mutation L858R is an important predictive genetic marker of sensitivity to TKIs, 
such as gefitinib, erlotinib, and afatinib in lung cancer. The prevalence of TKI sensitive 
EGFR mutation tends to be higher in Asian (30–55%) than Caucasian lung cancer patients 
(5–15%). In contrast to lung cancer, several EGFR TKI clinical trials in breast cancer have 
shown minimal efficacy or disappointing result [15–17]. The relatively rare frequency of TKI 
sensitising mutations in breast cancer (Y.H.-F. Teng et  al., 2011; N. Ly et  al., 2011) may 
explain poor response to TKI in trials that enrolled largely Caucasian and unselected breast 
cancer. Interestingly, few Caucasian patients had been shown to harbour T790M EGFR 
mutation that is known to confer TKI resistance (Bemanian et al., 2015).
Our study showed that EGFR mutation, specifically TKI sensitising L858R in exon 21 of 
EGFR gene was found in certain breast cancer subtypes such as HER2 (25%) and TNBC 
(1.8%) using combined immunohistochemistry and direct DNA sequencing. However, there 
are two caveats when using immunohistochemistry to genotype EGFR mutations in breast 
Figure 2. A representative of positive (B) and negative (D) expressions of EGFR L858R proteins. 
A&C were corresponding tissues stained with Hematoxylin/Eosin.
Figure 3. Sanger sequencing to detect EGFR mutations.
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cancer. The first caveat was the issue of cross-reactivity. While anti-mutant EGFR antibod-
ies have shown excellent sensitivity in lung cancer specimens, there are studies including ours 
in which these antibodies have shown high cross-reactivity in HER2 overexpressing breast 
cancer samples (Verdu et al., 2015). It is thought that amplification of HER2 genes causes 
cross-reactivity between HER2-epitope and EGFR L858R mutant-specific antibody. The 
mutation site of EGFR exon 21 was located near the C-terminus as well as the position of 
HER2-epitope, making the high chance of cross-reactivity between them (Verdu et al., 2015). 
A previous study using highly sensitive ARMS PCR was not able to demonstrate L858R 
mutations in HER2 breast cancer showing strong immunostaining to anti L858R (Verdu 
et al., 2015). Although the cause of discrepancy was not clear, we speculate that differences 
may be due to different ethnic and geographical location as shown in lung cancer.
The second caveat was the issue of non-specific binding to EGFR mutations other than 
L858R. We showed that anti L858R antibodies apparently showed non-specific binding to 
antigens that were coded by L861Q mutation instead of L858R of EGFR gene especially 
in the luminal subtype of breast cancer. In lung cancer, L861Q mutations are rare, yet sev-
eral groups have shown some sensitivity of L861Q patients to TKI (Peng et al., 2014). In 
spite of these two caveats, we had confirmed EGFR mutations in HER2 and TNBC when 
both immunohistochemistry and DNA sequencing were used in stepwise manners. Consist-
ent mutations of L858R that were in agreement with positive immunohistochemistry results 
were 25% in HER2 (N = 16) and 1.8% in TNBC samples (N = 55).
Teng et al. (2011) reported that the frequency of EGFR mutation was 11.4% upon screening 
four exons of EGFR gene (18, 19, 20 and 21) in TNBC population in Singapore using sequenc-
ing method (Teng et al., 2011). Mutation prevalence of L858R was 1.5% in TNBC (n = 70) 
population in Singapore (Teng et al., 2011), which is similar to our cohort (1.8%, N = 55).
Contrary to our study, Chao et al. (2015) reported that there was no mutation found in 
EGFR gene in 50 frozen specimens of TNBC patients in China. They screened for 25 EGFR-
activating mutations (G719S, G719A, G719C, S768I, L858R and L861Q and 19 mutations 
of exon 19-Del) using Amplification Refractory Mutation Systems (ARMS) and sequencing 
assay. The study of EGFR in TNBC was also carried out on Japanese patients. There was 
no mutation found in 108 of primary breast cancer patients that were analysed with mutant-
allele specific amplification assay (Uramoto et al., 2010). Jacot et al. (2011) also reported 
there was no mutation in 229 frozen tumours of European TNBC patients that were analysed 
with High-Resolution Melting (HRM) and sequencing method.
Variations in the frequency of EGFR mutations in breast cancer, particularly in TNBC, 
potentially were caused by geographic and ethnic variations. Specific environmental carci-
nogenic factors were seen to play a role in NSCLC and TNBC in East Asian patients (Broet 
et  al., 2011). It is necessary to do the specificity and sensitivity analysis in breast cancer 
patients according to IHC methods as detection assay of EGFR mutation and also to have 
genomic profiles related to ascertaining the geographic and ethnic variations, as was done in 
lung adenocarcinoma and NSCLC cases (Brevet et al., 2010).
To summarise, the anti-EGFR L858R mutation antibody may be prone to false positive in 
HER2 breast cancer and requires the additional genotyping method to confirm. However, the 
rate of false positive was low in TNBC and luminal subtypes making immunohistochemistry 
a cost-effective method to screen low prevalence rates of EGFR mutation in breast cancer 
patients. A future clinical trial involving EGFR TKI is warranted to assess the impact of 
EGFR L858R mutations in breast cancer. Moreover, immunohistochemistry may be useful to 
select Asian breast cancer patients for future clinical trials to test the efficacy of EGFR TKI.
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ABSTRACT: To analyse the association of p53 and muscle invasiveness in bladder cancer. 
The samples of this study are patients with bladder cancer. The samples were then classified 
into Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer 
(MIBC). All samples then underwent immunohistochemistry assay for p53, and then group 
analysed. p53 was expressed in 29 (96.7%) patients with MIBC and 23 (76.7%) patients with 
NMIBC. There was a significant difference in the expression of p53 between both groups 
(OR 8.8; 95% CI: 1.012- 76.96). The expression of p53 was significantly associated with 
muscle invasiveness of bladder cancer. Prospective study is needed to determine its potential 
in predicting muscle invasiveness of bladder cancer.
Keywords: Bladder cancer, predictive factors, p53
1 INTRODUCTION
Bladder cancer is the ninth most common malignancy in the world, with more than 380,000 
cases and 150,000 deaths annually (Witjes et al., 2014). More than 90% of bladder cancers 
are Urothelial Cell Carcinoma (UCC). Most of all new cases (75–80%) from UCC are classi-
fied as non-muscle-invasive or superficial. This tumour has a recurrence rate of 50–70% and 
10–15% progress to muscle invasion over a five year period (Shariat et al., 2008).
The high incidence causes special attention became necessary after the initial manage-
ment. Progression and metastasis are the main problems after initial therapy (Cheng et al., 
2009). Staging, grading, size, and multifocality, which are conventional prognostic factors, 
could not predict clinical outcome in the majority of patients with bladder cancer. Marking 
could predict recurrence, progression, therapeutic response, and survival (Malats et al., 2005; 
Schrier et al., 2004).
UCC has various biological and functional characteristics. Recurrence, progression into 
a higher grade and stage tumours and metastasis are the most common risks in patients 
with clinically diagnosed UCC. Bladder cancer prognostic could not be predicted by current 
available prognostic markers that to newly discovered molecular markers. Molecular changes 
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caused phenotype alterations, thus immunohistochemistry could be used as an early detec-
tion tool for bladder cancer.
2 METHODS
The expression of p53, which indicates the muscle invasion in bladder cancer, were analysed 
in this case-control study, which included patients with muscle-invasive bladder cancer while 
patients with non-muscle invasive bladder cancer were used as controls. The study was con-
ducted in Haji Adam Malik Hospital – Faculty of Medicine, Sumatera Utara University in 
conjunction with the Pathology Department, Haji Adam Malik Hospital in Medan, Indone-
sia from January 2012 to December 2015. Histopathologically diagnosed bladder cancer and 
good condition of paraffin block. Meanwhile, the exclusion criteria patients with bladder 
cancer who chemotherapy or radiotherapy and other malignancy.
Changes in brownish colour in epithelial cell cytoplasm or stroma for p53, which is seen 
the light microscope and will be assessed as intensity positivity and classified into four levels: 
Negative = 0; Weak = +1, Moderate = +2, Strong = +3. The positive value of p53 immunohis-
tochemistry is defined as a quantitative value in the brown intensity distribution percentage 
per one field of view of the light microscope with a magnitude of 400 times. Positivity of value 
is classified into three levels: Negative (0): IHC negative; Focal (1): coloured cells < 50%; Dif-
fuse (2): coloured cells > 50%. These two positivity value combined nH-score value. H-score 
value is determined based on McCarty criteria, which are: intensity positivity value with 
the addition of 1 multiplied with the quantity positivity value; [HS = (i+1) x k] (McCarty, 
1986) thus the cut-off  point is determined at 3. Therefore, the samples were divided into two 
groups, with H-score 3 or greater, and below 3.
The negative value is acquired by determining the cut-off  point involving cases with colour 
intensity and negative control, cases with weak, moderate, and strong positive colour, with 
focal quantity positivity. Further analyses were done using SPSS version 20.0. Any statistical 
test which has p-value < 0.05 is considered statistically significant.
3 RESULT
A total of 60 subjects were involved. This study consisted of 30 cases and 30 controls. Char-
acteristics of the subjects are presented in Table 1.
The mean age in the cases and controls group were 57.07 years and 55.9 years respectively 
theten. ladder cancer occur in men. Both age and gender were not significantly correlated 
with muscle invasiveness of bladder cancer (p > 0.05). The example result of IHC of p53 is 
shown in Figure 1.
p53 was significantly correlated with muscle invasiveness of bladder cancer. The prob-
ability of positive expression of p53 was 8.8 times higher in MIBC (p = 0.026; OR 8.8; 95% 
CI: 1.012–76.96).
Table 1. Frequency of age and sex results based on p53 expression.
Variable
Group
p-valueCases n = 30 Controls n = 30
Age
0.687  Mean  5.9 ± 10.37 55.9 ± 11.91
Gender
  Male 26 (86.7%) 26 (86.7%) 0.647
  Female  4 (13.3%)  4 (13.3%)
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4 DISCUSSION
A total of 96.7% of MIBC patients in this study showed a positive p53 expression. To find 
the relationship between the expression of IHC p53 with the occurrence of muscle invasion 
in bladder cancer, we performed bivariate analysis using a chi-square test. The chance of IHC 
p53 positive appearing in MIBC is 8.8 times higher than the negative p53 IHC. This indicates 
that p53 contributes to muscle invasion in bladder cancer.
The result in this study is in accordance with some previous studies (Schrier et al., 2004; 
Esrig et al., 1994; Serdar et al., 2005), which also concluded that overexpression of p53 was 
higher in group invasive tumours. This study also discovered that overexpression of p53 with 
tumour progression does not depend on the grading, the presence or absence of vascular 
invasion, or the presence of carcinoma in situ (Sarkis et al., 1993).
Grosmann Barton et al. (1998) recommend allocating bladder cancer patients stratifica-
tion of pT1 based on the status of p53 and RB.10 as results suggest that patients whose 
normal expression of these two genes can be managed conservatively. However, if  there is a 
change in any of the two genes, aggressive management to prevent disease progression into 
invasive is recommended (Grossman et al., 1998; Van Rhijn et al., 2001).
A meta-analysis that was performed by Malats et al. (2005) in 117 studies had shown dif-
ferent results. Four showed that changes in p53 are a weak predictor factor of recurrence, 
progression, and mortality in bladder cancer. This result might be caused by the long period 
of patient recruitment, thus causing a heterogeneity, variability of immunohistochemistry, 
either in the antibody or the scoring system used, or the absence of a uniform definition 
to determine the limits of positive staining so that it can give different results due to dif-
ferences in the cut-off  (Malats et al., 2005). p53 has an important role for cell response to 
various stress and to maintain the stability of the gene. Because of its critical role in tissue 
homeostasis, p53 is the most commonly mutated gene in malignancy. p53 mutation causes 
the accumulation of p53 in the cell nucleus. Generally, overexpression in cell nuclei associates 
with p53  inactivation. In addition, overexpression can also be caused by the physiological 
response to DNA damage. The instability of these genes can also be caused by their bond 
Figure 1. A) Moderate intensity positivity; B) Diffuse quantity positivity > 50% coloured cells.
Table 2. Correlation of p53 expression with MIBC and NMIBC.
Variable p53
Group
p-Value OR 95%CIMIBC n = 30 NMIBC N = 30
Positive 29 (96.7%) 23 (76.7%) p = 0.026 8.8 1.012–76.96
Negative  1 (3.33%)  7 (23.3%)
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with other molecules, such as MDM2 oncogenes, and viral genes, or even mutations that 
cause damage to the protein due to the insertion of a stop codon prematurely.
5 CONCLUSION
Expression of p53 was significantly associated with muscle invasiveness of bladder cancer. 
Prospective study is needed to investigate further its potential in predicting muscle invasive-
ness of bladder cancer.
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ABSTRACT: This study seeks to determine the characteristics of the patient with benign 
ovarian cysts, the histopathologic distribution of benign ovarian cysts, Human Epididymis 
Protein 4 (HE4) expression in various benign ovarian cyst tissues and normal ovaries, and 
to determine an HE4 expression base from histopathologic type. This analytic observational 
study was performed with a case-controlled design. In this study, HE4 immunohistochem-
istry staining was performed for various benign ovarian cysts (n = 20), and normal ovaries 
(n = 20) and interpretation was performed by a pathologist using Allred scoring. There is a 
statistically significant relationship between benign ovarian cysts and HE4 expression. How-
ever, there is no significant difference between histopathologic subtype of the benign ovarian 
cyst and HE4 expression.
Keywords: benign ovarian cyst, normal ovaries, Human Epididymis Protein 4 (HE4)
1 INTRODUCTION
Ovarian cysts are sacs filled with fluid or semi-liquid material derived from ovarian tissue. 
Ovarian cysts often appear at reproductive age and are benign. Ovarian cysts may vary in 
size, and in most cases are harmless; there are even types of cysts that can disappear by 
themselves. Nevertheless, ovarian cyst findings can cause anxiety among women with poten-
tial malignancies (American College of Obstetricians and Gynecologists, 2015; Grabosch & 
Karjane, 2017).
The overall incidence of symptomatic ovarian cysts in premenopausal women which are 
malignant is 1:1000 and increases to 3:1000 at 50 years of age. About 7% of women world-
wide develop ovarian cysts during their lifetimes. A screening test carried out in Europe 
showed an incidence of 21.2% of ovarian cysts among healthy postmenopausal women. Data 
from the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program 
(SEER) (2003) indicated that the lifetime risk for the development of ovarian cancer was 1 in 
70. An estimated 22,430 new ovarian cancer cases occurred in the US that year. The SEER 
data also showed an increased incidence of ovarian cancer annually among women aged 
65 and under (Kaloo et al., 2011).
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Increased expression of HE4 tissue occurs in some malignant tumours, especially those 
from gynaecological or respiratory tracts. A large study has reported serum HE4 as a puta-
tive tumour marker which can be used to distinguish between benign gynaecologic tumours 
and ovarian cancer, suggesting that HE4 is as good as CA-125 as a tumour marker. So far 
there has been no comprehensive review of HE4-expressing tissues and conditions associated 
with elevated serum HE4 (Karlsen et al. 2014).
In addition to the mitogen-activated protein kinase (MAPK) pathway, the extracellular 
matrix (ECM) receptor interaction pathway is also involved in the regulation of the HE4 pro-
tein (Zhu et al. 2015; Jinping, 2013). Expression of HE4 protein, as in other ovarian markers, 
can be identified by gene expression analysis and related processes found in cortical inclusion 
cyst formation and Mullerian metaplasia. So far, the study of HE4 is still relatively limited, 
and the authors are therefore interested in research to increase the understanding of benign 
ovarian tumours by means of immunohistochemistry (IHC).
2 METHOD
This research is an observational analytic study with a case-controlled design. The IHC 
expression of HE4 in paraffin blocks of benign ovarian cysts is compared with normal ova-
ries. The study was conducted at the Department of Obstetrics and Gynecology, Faculty of 
Medicine Universitas of Sumatera Utara, and immunohistochemical examination was per-
formed at the Laboratory of Anatomy Pathology Department of the Universitas Sumatera 
Utara Medical School Medan during May and June 2017.
The case group comprises paraffin blocks of benign ovarian cyst tissue obtained from gynae-
cological surgery of benign ovarian cysts. The control group is composed of normal ovarian 
tissue paraffin blocks obtained from non-ovarian cyst gynaecological surgery.
The sample size of the groups is n1 = n2 = 18.63 rounded to 19 samples (the number of 
samples of each case and control), so the total sample size in this study is 38. However, in this 
study, HE4 IHC examination was carried out for 20 paraffin blocks each of benign ovarian 
cysts and normal ovarian tissue, giving a total sample size of 40.
Data analysis and statistical tests were computerised, and the results are presented in fre-
quency distribution tables. The relationship between variables was analysed by chi-square 
testing with 95% confidence interval and p <0.05 was considered significant. This research 
has received approval from the Ethics Committee of the Faculty of Medicine, Universitas 
Sumatera Utara.
3 RESULTS
Table 1 shows that in the benign ovarian cysts group the majority are in the age range 20–50 
years (14 people, 70%).
Table 2 shows the histopathologic distribution of benign ovarian cysts. The most common 
types are epithelial (85%), subtype cystadenoma mucinosum (40%).
Table  3  shows that the benign cyst ovarian group has predominantly positive HE4 
expression (12 people, 60%) with a negative result for eight people (40%). Statistically, 
there was a significant correlation between the group of  study subjects with HE4 expres-
sion with p < 0.05, with an odds ratio for the possibility of  negative HE4 expression of  0.4 
(CI 95% 0.23–0.68) which means the probability of  negative HE4 expression is approxi-
mately 0.4.
Table 4  shows that the highest positive HE4 expression was found in the cystadenoma 
mucinosum group (two samples, 66.7%) while negative HE4 expression was found most fre-
quently in the cystadenoma serosum and endometriotic cyst subtypes. Statistically, it was 
concluded that there was no correlation between the subtype of benign ovarian cyst in HE4 
immunohistochemical expression (p > 0.05).
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Table 2. Distribution of benign ovarian cyst histopathology.




 Cystadenoma mucinosum 8 40
 Cystadenoma serosum 7 35
 Endometriotic cyst 2 10
Non-epithelial
 Dermoid cyst 3 15
Table 3. Expression of immunohistochemistry HE4 in benign ovarian cysts and normal ovaries.
Research subject
HE4 expression (Allred score)
p* OR CI 95%Positive n (%) Negative n (%) Total n (%)
Benign ovarian cyst 12 (60)  8 (40) 20 (100) 0,001 0,4 0,23–0,68
Normal ovarium  0 (0) 20 (100) 20 (100)
*Chi-square test.





n % n %
Cystadenoma mucinosum 2 66.7 1 33.3 0.98
Cystadenoma serosum 5 62.5 3 37.5 0.77
Endometriotic cyst 4 57.1 3 42.9 0.89
Dermoid cyst 1 50.0 1 50.0 0.71
*Logistic regression test.
Table 1. Characteristics of research subjects by age, age of menarche, parity and body mass index.
Characteristics
Benign ovarian cyst Normal ovarium
n (%) n (%)
Age (years)
<20  3 (15)  0 (0)
20–50 14 (70)  8 (40)
>50  3 (15) 12 (60)
Age of menarche (years)
≤12 17 (85) 15 (75)
>12  3 (15)  5 (25)
Parity
Virgo  4 (20)  0 (0)
Nullipara  2 (10)  0 (0)
1 14 (70) 20 (100)
Body Mass Index (BMI)
Normoweight 14 (70) 15 (75)
Overweight  4 (20)  5 (25)
Obese  2 (10)  0 (0)
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4 DISCUSSION
The results show that the benign ovarian cyst group are mostly in the age range of 20 to 50 
years (14 people, 70%), with the remaining samples split equally between the 20 and under 
and the 50 and over age groups (3 people (15%) in each group). In the normal ovary group, 
12 people (60%) are over 50 and eight people (40%) are aged from 20 to 50 years.
The risk factors associated with ovarian cysts are increasing age, premature menarche and 
late menopause. The ageing process will allow an extended time to cause random genetic 
changes in the ovarian surface epithelium. Repeated stimulation of the ovarian surface epi-
thelium will cause changes. The pathogenesis theory of ovarian cysts is known as the ‘inces-
sant ovulation’ hypothesis. The process of repairing the epithelial tissue of the ovaries during 
repeated and cyclic periods of ovulation causes frequent cellular proliferation. This will lead 
to the mutation of the p53 gene in the DNA phase, and this occurrence is considered to con-
tribute to the process of ovarian cyst tumourigenesis (Kumar, 2010).
The majority of the benign ovarian cyst group presented with positive HE4 expression, (12 
people, 60%) with only eight people (40%) having negative HE4 expression. Meanwhile, the 
normal ovarian group all had negative HE4 expression (100%). Statistically, there was a sig-
nificant correlation between the group of study subjects with HE4 expression with p < 0.05. 
Expression of HE4 in cortical inclusion cysts with epithelial Mullerian and ovarian carci-
nomas showed that expression of HE4 could be raised in early-stage ovarian carcinomas. 
Immunofluorescence studies show that HE4 is distributed in the region of the cytoplasm 
with a perinuclear pattern of endoplasmic reticulum and Golgi apparatus. HE4 existence 
with positive findings in benign ovarian cysts is not in line with several previous research 
studies, such as that of Escudero et al. (2011), which show that HE4 is less affected by gender 
or menopausal status than CA-125. HE4 levels did not increase in benign conditions when 
compared with CA-125, including in benign gynaecological conditions.
From the results shown in Table 4 it was concluded that there was no correlation between 
subtypes of benign ovarian cysts with HE4 immunohistochemical expression (p  >  0.05). 
However, since HE4 expression increases in the benign ovarian cyst, this might show that 
HE4 plays a role in the process of benign ovarian cyst formation. The expression of HE4 in 
the progression of benign neoplasms is not fully understood. Findings at histopathological 
examination levels show that HE4 is not only expressed in malignant ovarian tumours, but 
also in various benign ovarian lesions. Previous findings have shown that HE4 shows strong 
expression in serous carcinomas and endometrioid tumours. Georgakopoulos et al. (2012) 
found strong HE4 expression in clear-cell carcinomas, borderline serous tumours, endome-
triosis and ovarian mucinous cystadenomas. In fallopian tubes, carcinomas showed elevated 
HE4 expression levels. HE4 was strongly expressed in primary carcinomas of the fallopian 
tubes, cortical inclusion cysts and in mesothelial cells.
5 CONCLUSION
There is a significant association between benign ovarian cysts and HE4 expression. But 
there is no significant association between histopathologic subtypes of benign ovarian cysts 
and HE4 expression. More studies are needed to determine the role of HE4 in the pathogen-
esis of benign ovarian cysts.
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The accuracy of the Paediatric Appendicitis Score (PAS) based 
on age group in cases of acute appendicitis
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ABSTRACT Acute appendicitis in children is one of the leading causes of abdominal 
emergencies that require immediate surgery. The authors conducted research to determine 
the accuracy of the Paediatric Appendicitis Score (PAS) based on age group in acute appen-
dicitis patients. Data were analysed by bivariate analysis with appropriate hypothesis testing. 
The results were then reanalysed by dividing the PAS value according to age group, and the 
sensitivity of the PAS to the histopathological outcomes found in the appendix tissue was 
then calculated to assess the accuracy of the PAS in each age group. There was no statistically 
significant relationship between PAS and outcomes in the <5 years age group. Overall, PAS 
accuracy was higher, at 77.6%, in the 13–18 age group. There is no statistically significant 
relationship between PAS value and appendicitis diagnosis in the under 5 age group.
Keywords: Appendicitis, child, Paediatric Appendicitis Score (PAS)
1 INTRODUCTION
Acute appendicitis in children is one of the causes of abdominal emergencies requiring 
immediate surgical action (Kong et  al., 2012; Ballester et  al., 2009; Huckins et  al., 2013). 
The world incidence of acute appendicitis in children ranges from 1% to 8% of all paediatric 
patients attending emergency departments with acute abdominal pain (Jangra et al., 2013). 
In 2006, acute appendicitis was ranked as the fourth most common reason (28,949 cases) for 
hospitalisation in Indonesia, after dyspepsia, duodenitis and other gastrointestinal diseases 
(Eylin, 2009). In the city of Medan, there is no data on the incidence of acute appendicitis in 
children. However, in 2009 there were 60 cases of acute appendicitis at Rumah Sakit Umum 
Pusat (RSUP) Haji Adam Malik Medan (Ivan, 2013).
Acute appendicitis is common in young adults: 40% of patients with acute appendicitis are 
between the ages of 10 and 30, while the condition is very rare in infants. Ratios of males to 
females are 3:2 in adolescence, becoming 1:1 after the age of 25 years. The incidence of appen-
dicitis in children and young people of one to two cases per 10,000 children aged one day to 
four years increases to 25 cases for every 10,000 children aged 10–17 years (Schwartz, 2009).
2 RESEARCH METHODS
This study comprises a diagnostic test with a cross-sectional design. The research was conducted 
at RSUP Haji Adam Malik Medan (RSUP HAM) from April to November 2016. The popula-
tion of this study was composed of paediatric patients who attended RSUP HAM with com-
plaints of abdominal pain and who were diagnosed with appendicitis, thus fulfilling the inclusion 
criteria. Sampling was consecutive. The collected data was presented descriptively in a frequency 
distribution table. Data for PAS components and histopathologic results were then analysed by 
bivariate analysis with appropriate hypothesis testing. The results were then reanalysed by divid-
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ing the PAS value according to age group and then calculating the sensitivity of the PAS in rela-
tion to the histopathological outcomes of the appendix tissue, to assess the accuracy of the PAS 
in each age group. The hypothesis testing performed on PAS (ordinal), and the histopathologi-
cal result (ordinal) was carried out using the Mann-Whitney test. The study included toddlers, 
children and adolescent patients as reference points for PAS groupings, which were then used to 
assess PAS accuracy in predicting the histopathological results of postoperative appendix tissue.
3 RESULTS
A total of 135 patients, including 70 males (51.9%), were included in the study after patients 
with a PAS that could not be assessed were excluded from the study. All patients had appen-
dectomies, with pathology results showing that 86 (63.7%) of them had complicated appendi-
citis. The mean ± SD age of the patients was 15.4 ± 1.73 years, with the most populated group 
being for children aged 6–12 years, numbering 62 patients (45.9%). Detailed data for patient 
characteristics are presented in Table 1.
Complete components of PAS are then presented by age group in Table 2. Most history-tak-
ing components (pain during coughing, nausea/vomiting, lower right abdominal pain and pain 
migration) were difficult to assess in the <6 years age group, thus giving small numbers for these 
components. Lower right abdominal pain was the most common component in all age groups.
The researchers then performed an analysis of PAS and its relationship to the diagnosis of 
appendicitis. The PAS was grouped into three ranges of values: ≤ 5, 6–8, and ≥ 9. The PAS did 
not have a statistically significant relationship in the < 5 years age group (Table 3).
Table 1. Subject characteristics.
Characteristic n %
Sex Male 70 51.9
Female 65 48.1
Appendicitis diagnosis Simple 49 36.3
Complicated 86 63.7
Age Mean ± SD (y/o)* 15.4 ± 1.73
Infant and toddler (<5 y/o) 15 11.1
Child (6–12 y/o) 62 45.9
Adolescent (13–18 y/o) 58 43.0




Table 2. PAS by age group.
Diagnostic indicator
Age group (y/o)
< 5 6–12 > 12
Pain during coughing/percussion/jumping  4 (26.7%) 44 (71%) 44 (75.9%)
Decreased appetite  9 (60%) 34 (54.8%) 22 (37.9%)
Increased body temperature 15 (100%) 46 (74.2%) 33 (56.9%)
Nausea/vomiting 11 (73.3%) 49 (79%) 38 (65.5%)
Lower right quadrant abdominal pain  5 (33.3%) 60 (96.8%) 57 (98.3%)
Leukocytosis (≥ 10,000/mm3) 13 (86.7%) 54 (87.1%) 39 (67.2%)
Neutrophilia (≥ 70/mm3) 12 (80%) 55 (88.7%) 39 (67.2%)
Migration of pain  1 (6.7%) 39 (62.9%) 40 (69%)
Total 15 (100%) 62 (100%) 58 (100%)
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The <5 age group was then excluded from the assessment as a diagnostic tool. The value of 
PAS and its relationship with the complications of appendicitis diagnosis was then assessed 
for sensitivity and specificity based on the value of PAS in the ≥ 9 range for complicated 
appendicitis. The diagnostic test values of PAS in both age groups are presented in Table 4.
4 DISCUSSION
Of all PAS components, the most frequently occurring was found to be the fever component 
which was present in all the children in the <5 years of age (n = 15; 100%). This was fol-
lowed by leukocytosis (≥ 10,000/mm3) as the second most common finding (n = 13; 86.7%). 
In the age groups 6–12 years and >12 years, the lower right quadrant abdominal pain com-
ponent was the most frequent finding, at 96.8% and 98.3% respectively. The second and 
third most common components in this group were leukocytosis (87.1%) and neutrophilia 
(88.7%). In the >12 group, pain migration and nausea/vomiting were jointly the second and 
third most frequent complaints (69% and 65.5%). Researchers suspect that this is a result of 
the improved communication skills of older children. Almost all children <6 years have PAS 
components that can hardly be assessed in terms of history-taking. In the 6–12 year group 
children begin to describe their perception of and the location of pain more accurately.
In previous studies, the authors found that the PAS in the <5 years age group always has 
a value of below 5. PAS values begin to vary in children aged 6 years and over. This results 
from older children indicating more severe appendicitis levels. PAS has a lower sensitivity in 
the younger age group (Rao & Galani, 2015).
The PAS value of 5 has a higher sensitivity value in detecting appendicitis in children 
younger than four years when compared with the use of 6 as the cut-off  point in PAS as a 
diagnosis of appendicitis. In the 2008study by Goldman et al. it is suggested that PAS scores 
of <2 had high validity in excluding appendicitis diagnosis, whereas a value of >7 was effec-
tively predictive in the diagnosis of appendicitis. Children with a PAS score of 3 to 6 should 
undergo further assessment, in the form of observation, ultrasonography or CT scanning, 
before a diagnosis of appendicitis can be established. In this study, all children were diag-
nosed with appendicitis by a ‘gold standard’ postoperative histopathologic examination.
Table 3. PAS and appendicitis diagnosis.
Age Group (y/o) PAS Simple Complicated p*
< 5 ≤ 5  2 (18.2%)  9 (81.8%) 0.382
6–8  0  2 (100%)
≥ 9  0  2 (100%)
6–12 ≤ 5  2 (100%)  0 (0) <0.0001
6–8 10 (27.8%) 26 (72.2%)
≥ 9  0 (0) 24 (100%)
13–18 ≤ 5  4 (80%)  1 (20%) <0.0001
6–8 31 (72.1%) 12 (27.9%)
≥ 9  0 (0) 10 (100%)
*Mann-Whitney Test.
Table 4. PAS sensitivity.
Child (6–12) Adolescent (13–18)
Sensitivity 52%  45.8%
Specificity 91.7% 100%
Accuracy 59.7%  77.6%
ISCOC17_Book.indb   291 3/21/2018   2:04:32 PM
292
In this study, the researchers used PAS 6 as the cut-off  point to establish the diagnosis of 
appendicitis and found a low sensitivity value, but a high specificity value. This means that 
the PAS value > 6 may include a child with complicated appendicitis, but values of <6 are not 
sufficient to exclude complicated appendicitis.
5 CONCLUSION
The study found that PAS sensitivity was higher in patients aged 6–12 years than in the 12–18 
age group (52% vs 45.8%), but the specificity of PAS was higher in the 12–18 age group (91.7% 
vs 100%). Overall, PAS accuracy was higher in the age 13–18 group, at 77.6%, compared with 
59.7% at age ≤ 12 years. This study also analysed PAS and appendicitis diagnosis in the <5 years 
age group and found no statistically significant relationship between PAS value and appendici-
tis diagnosis at that age. Thus, PAS should not be used at ages of ≤ five years.
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Proportion of ameloblastoma subtypes based on location, size 
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ABSTRACT: Ameloblastoma is the most common odontogenic tumour of odontogenic 
epithelial origin. The objective of this study is to investigate if  there is any dominant subtype 
at a specific location, size or radiological imaging appearance. This is a descriptive study with 
a cross-sectional approach. The samples for this study were determined by histopathological 
subtype and then correlated with location, size and radiological appearance from medical 
records. Based on data from 25 samples, this study showed that in the mandible the most fre-
quent subtype has the follicular pattern. In terms of tumour size, the smallest group (<5 cm) 
was dominated by the plexiform pattern while the largest size (>5 cm) was dominated by the 
follicular pattern. Tumours with multilocular appearance were dominated by the follicular 
pattern while those with unilocular appearance contained follicular and plexiform patterns 
in equal proportions. The follicular pattern was the most frequently found in the mandible, 
in large size tumours and in multilocular radiological appearance.
Keywords: ameloblastoma, histopathological subtype, location, tumour size, radiological 
imaging appearance
1 INTRODUCTION
Ameloblastomas are the most common odontogenic tumours of odontogenic epithelial ori-
gin. They are slow-growing but locally invasive (Neville et al., 2002; Soames & Southam, 2005; 
Slootweg, 2007; Sapp et al., 2004; Burciaga et al., 2015; Setiady, 2013; Singh, 2010; Gardner, 
2005). Global incidence is about 0.5/1,000,000 of the population per year, with occurrence in 
Indonesia of approximately 115 cases per year (Setiady, 2013; Rudiana et al., 2011). The treat-
ment of ameloblastomas consists of enucleation, curettage and resection (Dandrigal et al., 2011; 
Filizzola, 2014). Inadequate treatment results in high rates of recurrence, and some studies sug-
gest that this could be a factor in the malignant transformation of ameloblastomas (Slootweg, 
2007; Soames & Southam, 2005; McClary et al., 2005). The mapping of a proportion of the his-
tological subtypes of ameloblastomas based on their location, size and radiological appearance 
can assist pathologists and clinicians in diagnosis and in deciding on the optimal treatment for 
patients. Up to now, there has been no study of the proportion of histopathological subtypes of 
ameloblastomas in terms of their specific locations, tumour sizes and radiological appearance.
2 MATERIALS AND METHODS
2.1 Location
This study was carried out at Haji Adam Malik General Hospital in Medan, Indonesia.
2.2 Method
This study was a retrospective descriptive study with a cross-sectional approach. It was carried 
out over ten months, from December 2016 to September 2017, with consecutive sampling. 
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The medical records of ameloblastoma patients were selected using inclusion and exclusion 
criteria, and slides and paraffin blocks for the chosen cases were collected for review. Broken 
and inadequate slides from the paraffin blocks were reprocessed. These samples were then 
reviewed by the researchers and two pathologists without the identity of the patients being 
known. The sample slides were stained by haematoxylin-eosin, categorised according to his-
tological subtypes and then correlated to medical record data of location, size and radiologi-
cal imaging appearance. This study was approved by the Ethical Committee of the Medical 
Faculty of University of Sumatera Utara Medan.
3 RESULTS
In this study, 40 cases of ameloblastomas from Haji Adam Malik General Hospital from 
between 2012–2016 were identified, but only 25 of them met the inclusion criteria (i.e. had 
location, tumour size and radiological imaging records). The results of this study are pre-
sented in the following tables.
Of the samples, 12 (48%) were from female patients and 13 (52%) from males (Table 1).
It was found that ameloblastomas most frequently occurred in the 28–37 age range (eight 
cases; 32%), with fewer found in the 48–57 range (1 case; 4%). The mean age was 34.04 years 
with standard deviation of 13.23 years (Table 2).
Most of the ameloblastomas in this study were found in the mandible (18 cases; 72%) com-
pared to the maxilla (six cases; 28%). In the mandible, the most frequent histopathological 
subtype was follicular (66.67%) followed by plexiform (27.77%) and extraosseous (5.56%), 
while in the maxilla the most frequent histopathological subtype was plexiform (57.14%), 
followed by follicular (38.57%) and unicystic (14.29%) (Table 3).
Table 1. Distribution by sex of ameloblastoma cases.
Sex Sum (n) Percentage (%)
Male 13  52
Female 12  48
Total 25 100
Table 2. Distribution of ameloblastomas based on patient’s age.
Patient age (years) Sum (n) Percentage (%)
10–18  3  12
19–27  5  20
28–37  8  32
38–47  6  24
48–57  1   4
58–67  2   8
Total 25 100




Maxilla Percentage (%) Mandible Percentage (%)
Follicular 2  28.57 12  66.67
Plexiform 4  57.14  5  27.77
Extraosseous 0   0  1   5.56
Plexiform 1   0  0   0
Unicystic 7  14.29 18   0
Total 100 100
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Multilocular lesions were more frequent than unilocular ones (multilocular: 18 cases; uniloc-
ular: 7 cases). The most frequently found subtype in multilocular lesions was follicular, fol-
lowed by plexiform and extraosseous subtypes. In unilocular lesions it was found that follicular 
and plexiform subtypes were the most frequent, followed by the unicystic subtype (Table 4).
Ameloblastomas with follicular subtype was the most numerous tumour type in this study, 
with three cases measuring >10 cm and nine cases measuring 5–10 cm. Tumours of <5 cm in 
size were dominated by the plexiform subtype followed by the follicular, extraosseous and 
unicystic subtypes (Table 5).
4 DISCUSSION
In this study, 40 cases of ameloblastoma were found at Haji Adam Malik General Hospital 
between 2012 and 2016, of which 25 met the inclusion and exclusion criteria. Of these sam-
ples, males were slightly more frequent than females. This result is similar to studies by Singh 
et al, (2010), Setiady (2013) and Gardner et al. (2005). This can be correlated to information 
from the literature review identifying that ameloblastoma is closely related to tooth develop-
ment, which is not differentiated by sex (Neville et al., 2002). In this study, peak incidence 
occurred in the 28–37 age group. This reflects the results of studies by Setiady (2013) and 
Singh et al. (2010), although in the latter study the incidence began in a younger age group 
(the second decade). This can be correlated to the eruption of the third molars in the second 
to third decades of life that is often correlated to the formation of ameloblastomas (Gardner 
et al., 2005; Neville et al., 2002). Histologically, ameloblastomas present with four subtypes: 
solid (follicular and plexiform), unicystic, desmoplastic and extraosseous. The unicystic type 
has the cystic structure of the ameloblastomatous epithelium; the extraosseous type could 
present with follicular or plexiform patterns, while the follicular pattern shows islands of 
palisading columnar cells with displaced nuclei away from the basal membrane, and with 
reticulum stellate-like cells in the centre of the island. The plexiform pattern shows basal cells 
arranged in anastomosing strands. The desmoplastic type appears as islands that are pinched 
by the dominant fibrous stroma (Gardner et al., 2005; Neville et al., 2002; Cui et al., 2011).




 5 cm Percentage (%) 5–10 cm Percentage (%) >10 cm Percentage (%)
Follicular 2  8  9 36 3 12
Plexiform 4 16  4 16 1  4
Extraosseous 1  4  0  0 0  0
Desmoplastic 0  0  0  0 0  0
Unicystic 1  4  0  0 0  0
Total 8 32 13 52 4 16





Uni-locular Percentage (%) Multi-locular Percentage (%)
Follicular 3  42.86 11  61.11
Plexiform 3  42.86  6  33.33
Extraosseous 0   0  1   5.56
Desmoplastic 0   0  0   0
Unicystic 1  14.28  0   0
Total 7 100 18 100
ISCOC17_Book.indb   295 3/21/2018   2:04:32 PM
296
As is known, ameloblastoma can occur in the maxilla or mandible, but when found on other 
sites such tumours would be classified as adamantinomas. Ameloblastomas are mainly found in 
the mandible rather than the maxilla (Gardner et al., 2005; Slootweg, 2007; Neville et al., 2005). 
The radiographic appearance of ameloblastomas can be unilocular or multilocular, and the 
multilocular appearance can be further subdivided into honeycomb and soap-bubble patterns 
(Gumgum & Hosgoren, 2005; Figueiredo et al., 2014; Li et al., 2012; Neville et al., 2002). In this 
study, the ameloblastomas which were most commonly found in the mandible had the follicular 
pattern, and this pattern was also mostly found in larger tumours and in those with multilocular 
appearance. These results were similar to studies carried out be Singh et al. (2010) and Neville 
et al. (2002). This characteristic of this pattern would need further research if it had a higher pro-
liferation index. The result would be very useful for clinicians in deciding to resection this type 
of tumour. It is expected that adequate treatment of this tumour would reduce its recurrence.
5 CONCLUSION
Based on location, the most frequent histological subtype of ameloblastomas was follicular 
for those located in the mandible and plexiform for the maxilla. The follicular subtype domi-
nated the larger size tumours, while smaller tumours were dominated by the plexiform sub-
type. The type most frequently found in those with multilocular appearance was the follicular 
subtype, while in those with unilocular appearance both follicular and plexiform subtypes 
were found in the same proportion.
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Correlation of subjective global assessment with resting metabolic 
rate and fat free mass as measured by bioelectrical impedance 
analysis in non-Hodgkin lymphoma
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ABSTRACT: Subjective global assessment is used as a simple way to assess malnutrition 
without the use of complete body composition analysis. Increased metabolism, characterised 
by increased resting metabolic rate, is often found in patients with cancer. The aim of this 
research is to identify the correlation between subjective global assessment, resting metabolic 
rate and fat free mass in patients with Non-Hodgkin lymphoma. Correlation between rest-
ing metabolic rate and fat free mass are measured by bioelectrical impedance analysis and 
subjective global assessment and then assessed and analysed. A sample of 27 non-Hodgkin 
lymphoma patients was used, consisting of approximately 60% men and 40% women. Of 
the subjects, 7.4% were found to be well nourished, 63% were malnourished and 29.6% 
were severely malnourished. The mean resting metabolic rate and fat free mass were 1346.3 
± 145.7  kcal and 44.5 ± 6.8  kg respectively. Only 3% of the patients were found to have 
above-normal resting metabolic rates. No correlation was found between subjective global 
assessment and resting metabolic rate (p = 0.275) or fat free mass (p = 0.850). There was no 
correlation between subjective global assessment and resting metabolic rate or fat free mass 
as measured by bioelectrical impedance analysis in non-Hodgkin lymphoma patients.
Keywords: BIA, free fat mass, resting metabolic rate, SGA
1 INTRODUCTION
Non-Hodgkin Lymphoma (NHL) is the most commonly found haematopoietic neoplasm, 
ranking as the seventh most frequent of all cancers. NHL is found five times more frequently 
than Hodgkin lymphoma. The number of patients with NHL is increasing, and this may be 
related to early detection or to increased HIV infection (Sanjay, 2015; Lin & Guan, 2008).
Patients with haematologic malignancies and breast cancer rarely experience significant weight 
loss, unlike most patients with solid tumours, who frequently suffer from weight loss. It is esti-
mated that the incidence of malnutrition in cancer patients ranges from 40–80% (Filipovic et al., 
2010). When diagnosed, 80% of patients with upper gastrointestinal cancer and 60% of lung 
cancer patients have experienced obvious weight loss (Akio, 2002). In cancer patients, weight 
loss can be caused by increasing energy expenditure and reduced food intake. Some studies have 
shown an increase in energy expenditure at rest in patients with malignancies (Fredrix et al., 
1991). Many methods have been developed to assess nutritional status to identify malnourished 
patients or patients who are at risk of malnutrition, including the Subjective Global Assessment 
(SGA). SGA was first introduced by Baker et al. in 1982, and is used to assess malnutrition in 
patients without the need for comprehensive analysis of body composition (Detsky et al., 1987).
Malnutrition can be detected earlier from the evidence provided by the changes in cell 
membranes and fluid imbalances that precede changes in anthropometric measurements and 
biochemical markers, and which can be analysed by Bioelectrical Impedance Analysis (BIA). 
BIA analyses the composition of body fluid indirectly by noting the change in impedance of 
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electrical current in parts of the body. BIA examination is quick, non-invasive and does not 
require active participation by patients (Fredrix et al., 1990).
BIA reflects the volume of body fluids, such as total body water, extracellular water and 
intracellular water, as well as total body potassium and the nutritional status of the body. 
These measurements are provided as Body Cell Mass (BCM), Fat Free Mass (FFM), Fat 
Mass (FM), Resting Metabolic Rate (RMR), total protein, mineral and glycogen and phase 
angle (Gudivaka et al., 1999). FFM is a combination of BCM and extracellular mass or body 
mass minus FM. RMR is used to determine how quickly calories are burned in the body. 
Burning more calories than consumed will lead to weight loss, and hypermetabolism is com-
mon in cancer patients, who present with increased of metabolism of up to 50% higher than 
patients without cancer (Liedtke, n.d.).
Therefore, this study aims to determine whether there is any correlation between nutri-
tional status, as measured by SGA, and RMR and FFM, as measured by BIA, in NHL 
patients who have not received chemotherapy.
2 METHOD
This study was conducted using a cross sectional approach at RSUP Adam Malik Hospital, 
Medan. The study population consisted of 27 patients with NHL in whom evidence for cor-
relation between SGA and RMR and/or FFM was assessed and analysed. RMR and FFM 
were measured by BIA. Patients had to meet inclusion and exclusion criteria. The inclusion 
criteria for this study were NHL patients who were newly diagnosed and had not received 
chemotherapy. The exclusion criterion was those unwilling to participate in the study.
All NHL diagnoses were confirmed by histopathology examination, and nutritional sta-
tus was investigated using SGA. BIA equipment (Maltron Bio Scan 916) made by Maltron 
International Ltd, Essex, UK, was used at room temperature, with a frequency of 50 kHz 
and an amplitude of 800 μA. Electrodes were placed on each patient’s feet and hands. BIA 
examination was conducted by the researchers themselves.
3 RESULTS
This study involved a total of 27  NHL patients who were newly diagnosed and had not 
received chemotherapy. The patients consisted of 16 (59.3%) men and 11 (40.7%) women 
with a mean age of 44.7 ± 12.5 years, with the youngest being 22 years and the oldest 75 years. 
Of the subjects, 7.4% were found to be well nourished, 63% were malnourished and 29.6% 
were severely malnourished. The mean RMR and FFM were 1346.3 ± 145.7 kcal and 44.5 ± 
6.8 kg respectively (Table 1).
Table 1. Characteristics of the study population.
Characteristic Patients (n: 27)
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Only 1 (3%) patient with NHL was found to have RMR above normal. No correlation was 
found between SGA and RMR (p = 0.275) or FFM (p = 0.850) (Table 2).
4 DISCUSSION
BIA is the analysis of electrical resistance and reactance in the human body (Paeratahuls 
et al., 1999). There are several factors that can affect BIA measurements, including sex, age 
and ethnicity/race. In the study by Bailey et al. (2004) it is stated that there is a difference in 
total body mass between men and women, with men having a total body mass 8% higher 
than women. Liebelt et al. (1999) present that there are different patterns of fat distribution 
between men and women: the pattern of fat distribution in men tends to be in the area of 
the upper body and abdominal areas (upper body–abdominal pattern), whereas in women 
the pattern of fat distribution tends to be in the gluteal and femoral regions (gluteal–femoral 
pattern). RMR is lower in women than in men. In men, RMR is found to be 194 kcal/day 
compared to 125 kcal/day in women. RMR in women is lower than in men of the same age 
due to premenopausal and postmenopausal processes (Dehghan & Merchant, 2008).
A decrease in FFM has a correlation with RMR in elderly subjects. Reductions in organ/
tissue mass due to ageing and organ metabolic rates contribute to a decrease in RMR, an 
increase in FM and a decrease in FFM (Aapro et al., 2014).
SGA is a subjective, simple, inexpensive and effective method for assessing the nutritional 
status of cancer patients. SGA is also a tool that can assess the functional capacity or energy 
level of patients. Following anamnesis and physical examination patients are classified as fol-
lows: well nourished (SGA A), moderately malnourished or suspected malnourished (SGA 
B), or severely malnourished (SGA C). SGA has generally been used to assess malnutrition 
because it is simple, does not require any medical instruments and can be the first assessment 
tool for assessing functional capacity. Well nourished patients (SGA A) were found in 7.4% 
of the subjects in this study; 63% were moderately malnourished (SGA B) and 29.6% were 
severely malnourished (SGA C) (Table 1). Dewys et al. (1980) found a frequency of weight 
loss of about 31% in patients with high-risk NHL (Aapro et al, 2014).
Research in Australia by Bauer et al. (2002) using SGA scores showed that 42 out of 71 
cancer patients under treatment (59%) suffered from moderate malnutrition, and 12 patients 
(17%) suffered from severe malnutrition. Weight loss and decreased appetite are problems 
that occur in cancer patients. In research by Hopkinson et al. (2006), the prevalence of weight 
loss as a symptom ranged from 39% to 82%, while a decrease in appetite ranged from 30% to 
80%. These conditions can be related to the absence of feedback regulation caused by prod-
ucts of the tumour that affect the activity of enzymes. Most cancer patients are not able to 
meet their calorie needs, possibly as a secondary factor related to metabolic changes, fatigue 
or decreased appetite as a result of treatment for cancer (Susetyowati et al., 2010).
In this study, the mean RMR was 1346.3 ± 145.7 kcal and only 1 patient (3%) with NHL 
was found to have a RMR above normal. It may be that this may reflect ethnic RMR differ-
ences, as normal RMR in Indonesian people has not been studied. The lack of correlation 
between SGA and RMR (p = 0.275) and FFM (p = 0.094) (Table 2) is likely to be due to the 
absence of information on normal values of RMR and FM in Indonesia.
The first weakness of this study is that it does not differentiate the stages of NHL, a factor 
which allegedly affects nutritional status parameters. The second weakness is that the normal 
Table 2. Correlation between SGA and RMR as well 
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FFM and RMR values used refer to the normal value of the general population worldwide, 
not to the normal values for the Indonesian population specifically.
5 CONCLUSION
There was no correlation between SGA and RMR or FFM as measured by BIA in NHL 
patients who were newly diagnosed and had not received chemotherapy.
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Apoptotic effect of gentamicin in cochlea ototoxic rat model 
(preliminary study)
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ABSTRACT: This study aimed to show the potency of gentamicin in increasing the apop-
totic index in the cochlea lateral wall of ototoxic rat models. Eight Rattus norvegicus were 
divided into two groups: 1) control and 2) gentamicin administered. The rats were terminated 
to measure the apoptotic index using TUNEL assay of the fibroblasts of the cochlea lateral 
walls. Data were analysed by using ANOVA, with p <0.05 used as the cut-off  for statisti-
cal significance. Administration of gentamicin showed increased apoptotic index which was 
statistically significant (p <0.05). This study demonstrates that gentamicin is a pro-apoptotic 
and demonstrates its potency.
Keywords: apoptotic, cochlea, gentamicin, ototoxic
1 INTRODUCTION
Gentamicin is one of the aminoglycoside antibiotics which is important in challenging Gram-
negative bacteria (Mouedden et al., 2000), however, it is often criticised because of its neph-
rotoxicity and ototoxicity (Sardana et al., 2015; Huth et al., 2011; Petersen & Rogers, 2015).
Aminoglycoside usage induces reactive oxygen species (ROS) and caspase formation, and 
can lead to apoptosis (Glutz et al., 2015).
The patterns and mechanisms of hearing loss which are caused by aminoglycosides are not 
fully understood (Selimoglu, 2007). The aim of this research was to assess gentamicin as a 
pro-apoptotic in the cochlea lateral wall in ototoxic rat models.
2 MATERIALS AND METHODS
Eight male Rattus norvegicus of  150–250 grams in weight were used. They were separated into 
two equal-sized groups. The rats were anesthetised using 10 mg/kg of xylazine and 90 mg/kg 
of ketamine intraperitoneally (Toydemir et al., 2015). Injections of gentamicin (40 mg/ml) 
0.03–0.05  cc (Sagit et  al., 2013), guided using a microscope, were placed anterosuperior 
to the tympanic membrane. Group 1 was the control group which was not treated, while 
group 2 was injected with gentamicin. Ad libitum food, and comfortable lightning, humidity 
and room temperatures of between 20oC to 26oC were provided. The rats were terminated 
18 hours after being injected (Suzuki et al., 2008).
Temporal bone tissues were fixated with 10% formalin buffer solution and EDTA for four 
weeks and it was then possible to evaluate the apoptotic index of fibroblasts on the cochlea 
lateral wall.
The following procedural steps were carried out: the apoptotic index was evaluated using 
an Olympus XC 10  microscope with 40x magnification. Brown-stained TUNEL-positive 
markers were seen in the nuclei of cells, and counted in a masked manner. The researchers 
evaluated two fields which were randomly selected (Zhang et al., 2013).
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The data were analysed using one-way ANOVA by using IBM SPSS statistical software 
with a significance level of 0.05.
3 RESULTS
Figure 1 shows the lateral wall of the cochlea and Figure 2 shows the role of gentamicin in the 
lateral wall of the cochlea of Rattus norvegicus, observed by using the TUNEL assay method. 
Using this method the researchers assessed the fragmentation of DNA in the cell nucleus as 
indicated by brown colouration. In group 2, in which the rats were given gentamicin, the cell 
nuclei are mostly brown, compared to group 1 where far fewer are seen.
Table 1 shows significant differences (p < 0.05) between the control group and group 2. 
Gentamicin administration increased the apoptotic index in group 2.
Figure 1. Apoptosis index in each group (40x magnification). The arrows indicate TUNEL (+) cells.
A: Group 1; B: Group 2.
Figure 2. Average number of cells undergoing apoptosis in cochlea lateral wall fibroblasts for each 
treatment group.
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4 DISCUSSION
The lateral wall of the cochlea is the first the part of the cochlea in which histological change 
occurs (Fujioka et  al., 2014), and this led the researchers to investigate this site for this 
research.
In this study, the pro-apoptotic role of gentamicin as shown in the apoptotic index of the 
fibroblasts of ototoxic rat models was evaluated. Gentamicin at a dosage of 40 mg/ml was 
enough to increase the apoptotic index in lateral cochlear wall fibroblasts. Gentamicin toxic-
ity enhances stress markers (caspase 12), pro-apoptotic BAX, released caspase 3 and blocked 
anti-apoptotic Bcl-2 (Jaikumkao et al., 2016). In chinchillas exposed to gentamicin it was 
found that cochlea cell death markers increased (Ding et al., 2010). In this present study the 
method of intratympanic gentamicin injection dose to a Wistar rat used in other research 
(Sagit et al., 2013) was followed. The chosen termination time of 18 hours after exposure was 
based on the results of a study of the round window membrane in guinea pigs, which gave 
the best TUNEL results (Suzuki et al., 2008).
After exposure, aminoglycoside binds to ferric iron (FeIII) (Fetoni et al., 2012; Kurasawa 
and Steyger, 2011) leading to FeII-aminoglycoside complexes and forming ROS. ROS activate 
BAX which in turn triggers apoptosis (Kurasawa and Steyger, 2011).
5 CONCLUSION
This study showed that gentamicin is able to increase the index of apoptosis in rat models.
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Increased expression of TGF-β in the cochlear fibroblast 
of diabetic model rats
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ABSTRACT: The cochlea, as a microvascular organ, is very susceptible to conditions that 
result in a disruption of vascularisation. Transforming Growth Factor-β (TGF-β) plays a role 
in diabetic complication process, especially in microangiopathy, due to its role in thickening 
the basal membrane of the vessel. This study aims to see the TGF-β expression in cochlear 
fibroblasts diabetic model rats. Eight male Rattus norvegicus were divided into two groups> 
Group 1: control, rats were injected only with a single dose of sodium citrate intraperitoneally 
and then terminated on day 5. Group 2: rats were injected with intraperitoneal single-dose 
Streptozotocin (STZ) and terminated on day 5. Samples were terminated and necropsied for 
the removal of their cochlear tissue and their TGF-β expression determined by immunohis-
tochemical examination. There was a significant difference (p <0.05) in TGF-β expression in 
group 1 compared to group 2.
Keywords: Cochlea, Diabetes, Transforming Growth Factor-β
1 INTRODUCTION
The hyperglycaemia that happens in this disease can induce the occurrence of inflammation 
in the cells of the body (Romero, Sadidi & Feldman, 2008). This plays a role in the emergence 
of diabetic microvascular complications (Navarro and Mora, 2004), wherein inflammation 
that occurs can be through the Protein Kinase C (PKC) pathway along with Transforming 
Growth Factor-β (TGF-β) (Romero et al., 2008).
2 METHODS
Male Rattus norvegicus Wistar strain (150–250g), treated at controlled temperature (25 ± 2°C) 
with a 12-hour light/12-hour dark cycle with free access to water and food and handled fol-
lowing the standard guide for the care and use of laboratory animals.
Streptozotocin (STZ) at 60 mg/kg BW dissolved in sodium citrate (22.5 mg STZ/ml) was 
injected in a single dose intraperitoneally. Blood sugar levels were examined in peripheral blood 
taken from the rats’ tails daily using a glucometer. Forty-eight hours after the STZ injection, 
hyperglycaemia was positive if rats had blood sugar levels greater than 200 mg/dl (Patterson 
et al., 2015).
In this study, there were two groups with each consisting of four rats. Group 1 was the 
control group where they were injected only with a single dose of sodium citrate intraperito-
neally and then terminated on day 5. In group 2, the rats were injected with an intraperitoneal 
single dose of STZ and terminated on day 5. Tissue samples were taken and fixed with a 10% 
formalin buffer solution and decalcified with EDTA for four weeks and continued by cutting 
the tissue until it became a slide preparation.
Immunohistochemistry (IHC) staining used Polyclonal Anti-TGF-β1. Examined using 
a light microscope with 100x magnification, the TGF-β expression was identified by IHC 
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imaging showing cytoplasmic colour changes to brown. The TGF-β expression ratings were 
assessed by multiplication of intensity with extend of staining score (Tan and Putti, 2004), 
and the data collected was analysed with SPSS 21 (SPSS Inc., NY, USA).
3 RESULT
TGF-β expression, characterised by a brown colour on the cytoplasm, was higher in the dia-
betic group (Figure 1B) compared to the control group (Figure 1A).
The following graph shows the average TGF-β expression in each group. TGF-β is higher 
in group 2 (8.4).
The table above shows a significant result of TGF-β expression (p < 0,05) when comparing 
the control group (group 1) with the diabetic model group (group 2).
4 DISCUSSION
Hyperglycaemia is a characterised condition in diabetes as a group of chronic disease that 
can cause macrovascular (coronary artery disease, peripheral arterial disease, and stroke) 
and microvascular complications (diabetic nephropathy, neuropathy, and retinopathy) where 
Figure 1.
Figure 2. The mean value of TGF-β expression in each group.
Table 1. The test results for TGF-β expression values.
Group Group Mean difference ± standard error P value
Group 1 Group 2 −4.800 ± 1.099 0.004*
(*: p<0,05).
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aldose reductase pathway and oxidative stress, and TGF-β may play an important role in the 
cellular injury that is caused by hyperglycaemia (Fowler, 2008).
As a multi-functional cytokine, TGF-β was also increased the synthesis of extracellular 
matrix, and the increase in TGF-β expression is also known to be in line with the severity 
of glomerulosclerosis in diabetics (Chang et al., 2016). In 2013, a study showed that TGF-β 
serum level in patients suffering from diabetes with diabetic retinopathy was significantly 
higher compared to diabetic patients without diabetic retinopathy (Zorena et al., 2013).
Haemodynamic changes and microcirculation disorders that are often found in diabetic 
conditions also happened in the cochlea. The studies showed that, especially in stria vascula-
ris, vascular changes in the cochlea including thickening of the capillary walls (Xipeng et al., 
2013). The increase in extracellular matrix accumulation through the stimulation of type IV 
collagen and the production of fibronectin (Russo et al., 2007), and the increase in Connec-
tive Tissue Growth Factor (CTGF), as well as Vascular Endothelial Growth Factor (VEGF) 
(Lee, 2013), all known to be induced by TGF-β. In 2013, a study showed that the TGF-β 
serum level in patients suffering from diabetes with diabetic retinopathy was significantly 
higher compared to diabetic patients without diabetic retinopathy (Zorena et al., 2013).
In this preliminary study, we wanted to compare the expression of TGF-β in the cochlear 
fibroblast in diabetic model rats to the non-diabetic control group and found that the TGF-β 
expression was significantly higher in the cochlear of the diabetic group (p <0,05). This result 
is similar to the study which stated that TGF-β renal expression is increased after induction 
of STZ diabetes in rats (Hill et al., 2000).
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ABSTRACT: MMP-9 enhances vascular permeability resulting in oedema and the dis-
placement of inflammatory cells. Fluticasone furoate has a receptor affinity for glucocorti-
coid receptors. The objective is to find out the effect of fluticasone furoate on the expression 
of MMP-9 in nasal polyps. The research was with an experimental quasi-design of 16 nasal 
polyps. Examination of MMP-9 expression in nasal polyps was performed with immuno-
histochemistry. MMP-9 expression before fluticasone furoate showed an overexpression of 
75%, but after therapy it was 37.5%. There was a significant decrease in MMP-9 expression 
after fluticasone furoate therapy.
Keywords: fluticasone furoate, metalloproteinase-9 matrix, nasal polyp
1 INTRODUCTION
Nasal polyps are a chronic inflammatory disease of the nasal mucosa and paranasal sinuses, 
with a distinctive feature of oedematous mass, having ‘bodies’ and ‘stalks’ with slippery sur-
faces and a more yellow colour than the mucous membranes in the rice cavity and paranasal 
sinuses. The disease is known to have a high recurrence rate despite progress in its manage-
ment (Chi & Annete, 2005; Mygind & Lund, 2009).
The formation of nasal polyps is assumed to be closely related to infiltration of inflamma-
tory cells, loose connective tissue, reduced collagen, and pseudocyst formation with albumin 
and oedema accumulation. Excessive production and accumulation of extracellular matrix 
has been reported to contribute to the formation of nasal polyps (Bachert, 2005; Cincik 
et al., 2013; Callejas et al., 2015).
Corticosteroids can inhibit interstitial collagen synthesis such as blocking the production 
of degranulation of the proteinase matrix in some parts of the body (Bachert, 2005; Cincik 
et al., 2013; Callejas et al., 2015).
2 METHOD
This research is analytic with the quasi experimental design. This study will examine the 
expression of MMP-9 in nasal polyps before and after using a nasal spray of fluticasone 
furoate.
The research was conducted in the Department of THT-KL RSUP H. Adam Malik 
Medan. The immunohistochemical examination was conducted in the Department of Ana-
tomical Pathology, Faculty of Medicine, Universitas Sumatera Utara.
ISCOC17_Book.indb   309 3/21/2018   2:04:34 PM
310
3 RESULT
The research data is from all cases of nasal polyps performed biopsy and treatment at RSUP 
H. Adam Malik Medan from July 2013 to January 2015 that is as many as 16 subjects.
There was a significant difference between MMP-9 expression in nasal polyps before and 
after treatment with fluticasone furoate, p = 0.027.
There was no significant difference in MMP-9 expression in nasal polyps before or after 
therapy with fluticasone furoate, based on polyp stage, p = 0.511.
4 DISCUSSION
Immunoreactive MMP-9 scores were obtained in patients with nasal polyps before flutica-
sone furoate therapy was the group of overexpression (positive expression) with the total 
number of 12 people (75%) and negative expression group with the amount of 4 (25%). 
Lechapt-Zalcman et al. (2001) reported an increase in the expression of MMP-9 in glandular 
and blood vessel nasal polyps. Kahveci et al. (2008) and Guerra et al. (2012) obtained high 
MMP-9 expression and low TIMP-1 expression in nasal polyps. Pawankar et al. (2004) found 
high MMP-9 in nasal polyp tissue, and Lee et al. (2003) states that the ratio imbalance of 
MMP-9 and TIMP-1 contributes to the inflammatory process of nasal polyps. After get-
ting over expression therapy group (positive expression) was as many as 6 people (37.5%) 
meanwhile the negative expression group was 10 people (62, 5%). There was a significant 
correlation (p =  0.027) in MMP-9 expression before and after fluticasone furoate therapy 
decreased. The results of this research comply with Callejas et al. (2014) who examined the 
effect of corticosteroids on mucosal remodelling on chronic rhinosinusitis with nasal polyps 
and found that MMP-9 expression significantly decreased (p<0.01) at week 2 and week 12 
compared with those not obtaining intranasal budesonide therapy.
Hoshino et al. (1999) reported that corticosteroid therapy would lead to a decrease of 
subepithelial collagen accumulation in asthma patients by decreasing MMP-9 and increasing 
TIMP-1 expression.
In this research, the clinical stages of the nasal polyps were obtained before fluticasone 
furoate therapy was performed based on overexpression view of the highest MMP-9 group 




PN % n %
Negative  4  25 10 625 0.027
Positive 12  75  6 37.5
Total 16 100 16 100
Table 2. The differences in MMP-9 expression before and after treatment with fluticasone furoate, 




Negative Positive Negative Positive
n % n % n % n %
I 0  0 1 100 3 75 1 25 0.511
II 3 50 3  50 7 58 5 42
III 1 11 8  89 0  0 0  0
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stage 1 is 100%, after obtaining fluticasone furoate therapy of negative expression of MMP-9 
in the highest stage 1 group of 75%. Polyps stage 1 and two have decreased stages after ther-
apy. There was no significant difference (p = 0.51) in changes in MMP-9 expression in nasal 
polyps before and after treatment of fluticasone furoate based on the polyp stage. There are 
other factors that have an important role in the formation of nasal polyps, such as changes in 
epithelial structure, angiogenesis, and extracellular matrix degradation caused by low levels 
of TGF-β. Some inflammatory mediators and differentiation factors are also growth factors 
of nasal polyps (Cohen et al., 2011).
Naclerio and Mackay (2001) reported that using nasal spray corticosteroids for 4-6 weeks 
effectively reduces the size of nasal polyps. In this research, researchers used fluticasone furo-
ate 110 μg once daily given in two sprays (27.5 μg/spray) for each nasal polyp.
5 CONCLUSION
In this research, there is MMP-9 overexpression in nasal polyps before fluticasone furoate 
therapy and a significant decrease in MMP-9 expression in nasal polyps after therapy. There 
was no significant difference in MMP-9 expression in nasal polyps before and after treatment 
with fluticasone furoate based on polyp stage.
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ABSTRACT: The presence of the BCR-ABL1 transcript is essential in establishing a diag-
nosis of Chronic Myeloid Leukaemia (CML). In the absence of BCR-ABL1, JAK2 V617F 
mutation testing is performed to support the diagnosis of Polycythemia Vera (PV), Essential 
Thrombocythemia (ET), and primary myelofibrosis (MF). We wanted to test the feasibility 
of multiplex detection of BCR-ABL1 transcript variants and JAK2 V617F mutation simul-
taneously using the Reverse Dot-Blot Hybridisation (RDB) method. The Limit of Detection 
(LOD) or analytical sensitivity of the RDB method using cDNA specimens was 0.5% and 
6.25% in detecting BCR-ABL1 and JAK2 mutant transcripts, respectively. Diagnostic specifi-
city and sensitivity to detect BCR ABL1 and JAK2 were 100% and 85.7%; 92% and 100%, 
respectively. RDB also detected BCR-ABL1 transcripts in 22% of JAK2 V617F mutation 
positive samples (N = 36). RT-PCR RDB is a promising qualitative multiplexing method to 
detect simultaneous BCR-ABL1 and JAK2 mutant transcripts.
Keywords: BCR-ABL1, JAK2 V617F, RT-PCR RDB
1 INTRODUCTION
Myeloproliferative Neoplasms (MPN) is a group of blood disorders consisting of Chronic 
Myeloid Leukaemia (CML), Polycythemia Vera (PV), essential thrombocythemia (ET), pri-
mary myelofibrosis (PMF), chronic neutrophilic leukaemia, chronic eosinophilic leukaemia, 
hypereosinophilic syndrome, mast cell disease, and another unclassifiable disease (Tefferi & 
Vardiman, 2008). CML is caused Philadelphia Chromosome (Ph), a reciprocal translocation of 
BCR and ABL1 genes that increases tyrosine kinase activation (Järås et al., 2010). BCR-ABL1 
translocation is comprised of four groups based at the translocation breakpoint; major, minor, 
micro and nano (Burmeister & Reinhardt, 2008). Reverse Transcript RT-PCR is a common 
method to detect the presence of BCR-ABL1(Gutiérrez et al., 2010) in samples obtained from 
either peripheral blood or bone marrow of suspected MPN patients (Burmeister et al., 2010).
Mutation of JAK2 V617F has been found in and may contribute to etiology of 95%, 50%, 
and 40% of PV, ET, and MF, respectively (Vannuchi et al., 2010). Substitution of phenyla-
lanine for valine at codon 617 of JAK2 gene causes loss of autoinhibitory control leading 
to constitutive activation of JAK2 tyrosine kinase. In 2008, WHO incorporated molecular 
genetic testing of JAK2 V617F mutation into MPN diagnostic algorithm (Tefferi et al., 2009). 
To follow up BCR-ABL1 negative MPN, many laboratories use different PCR methods of 
JAK2 mutation testing such as direct DNA sequencing, ARMS, RFLP, pyrosequencing, real-
time and melting curve analyses (Didone et al., 2016; Cankovic et al., 2009).
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A recent survey suggests upfront determination of BCR-ABL1 and JAK2 would be desir-
able (Gong et al., 2013). However, performing en masse screening of both BCR-ABL1 and 
JAK2 using existing methods is not encouraged for the following reasons. First, the chance 
to find concomitant mutation is extremely rare (McCarron et al., 2012). Second, most exist-
ing methods do not allow simultaneous testing, especially when BCR-ABL1 testing cDNA 
conversion from mRNA JAK2 tests requires genomic DNA. Here we describe a simple mul-
tiplex method to test both BCR-ABL1 and JAK2 cDNAs using Reverse Transcription PCR 
(RT-PCR) followed by Reversed Dot Blot hybridisation (RDB).
To develop a feasible RT-PCR RDB test, we aimed to meet two criteria. First, the test 
should use cDNA isolated from peripheral blood. Second, the test should recognise at least 
four variants of BCR-ABL1 (M-Bcre13a2 (b2a2), M-Bcre14a2 (b3a2), m-Bcr e1a2 and μ-Bcr 
c3a2 (e19a2)) and JAK2 V617F with high specificity.
2 MATERIALS AND METHOD
2.1 Materials and patient samples
Oligonucleotides were synthesised by IDT, and the negatively charged membrane was pur-
chased from Biodyne (Pall Corporation).
RNA of K562 (BCR-ABL1 positive e14a2/b3a2 variant) and HL60 (BCR-ABL1 nega-
tive) cell lines were used as control materials. Random archived RNA was obtained from 
155 suspected MPN patients who had been referred to Kalbe Genomics Laboratory between 
2014 and 2015 for routine clinical testing of qualitative BCR-ABL1 (41 patients), quantita-
tive BCR-ABL1 (49 patients), JAK2 V617F genotyping (29 patients), combined BCR-ABL1 
and JAK2 V617F (36 patients). Archived human clinical specimens were anonymised and 
studied within the ethical policies of the Stem-Cell and Cancer Institute (SCI) IRB and by 
the Declaration of Helsinki.
Qualitative BCR-ABL1 was performed according to RT-PCR gel electrophoresis protocol 
(Burmeister & Reinhardt, 2008) and had been validated by successful participation in Leuko-
cyte Immunophenotyping proficiency testing programme organised by UKNEQAS (United 
Kingdom National External Quality Assessment Scheme). The quantitative test protocol was 
conducted using the commercial kit (Molecular MD, Portland) expressing results of major 
BCR-ABL1 transcript levels on international scales (IS). JAK2 V617F genotyping was done 
using direct DNA sequencing as described (Gonzales et al., 2014).
RT reverse transcriptase cDNA conversion. Isolated RNAs were converted into cDNA with 
reverse transcriptase enzyme and random hexamer primers using Transcriptor First Strand 
cDNA Synthesis (Roche).
PCR. BCR-ABL1 amplification used a multiplex PCR method with six primers in one 
reaction mix based on Zhang et al. (1991). JAK2 V617F PCR amplification followed the 
method described previously (Gonzales et al., 2014). All PCR primers were biotinylated.
Gel electrophoresis. Five μL of PCR amplification products were mixed with one μL load-
ing dye loaded into 2.5% agarose gel for 60 minutes at 95 volts.
Probe Immobilisation. Membranes were washed with HCl 0.1 N, then incubated with 10% 
EDC for 15 minutes while shaken at 60 rpm. Membranes were washed with ddH2O, dried at 
room temperature, spotted with 2 μM of each probe (diluted with NaHCO3 at 0.5 M), and incu-
bated for 15 minutes. Membranes were then washed with TBS 0.1% Tween for 2 minutes and 
shaken at 60 rpm, then incubated with 0.1 N NaOH to quench the reaction. Lastly, membranes 
were rinsed with H2O twice. Each spot on membranes had different probe concentrations, i.e., 
two μM for JAK2 WT, ten μM for JAK2 V617F probe and two μM for biotin probe, and two 
μM for all variants of BCR-ABL11. Probes M3, M2, m, μ, JW, and JM were designed to cap-
ture and hybridise with target transcripts BCR-ABL1 M-Bcr e14a2 (b3a2), M-Bcr e13a2 (b2a2), 
m-Bcr e1a2, micro-Bcr c3a2 (e19a2), JAK2 wild-type, and JAK2 V617F mutant, respectively.
Reverse Dot-Blot Hybridisation. Hybridisation protocol followed previous methods as 
described by Zhang et  al. (1991) with some modification where a colorimetric instead of 
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chemiluminescence method was used. Briefly, RT-PCR products were denatured at 95°C for 
5 minutes, premixed with 500 μL of hybridisation solution, and hybridised with membranes 
for 15 minutes at 45°C. Washing was done twice with 800 μL post-hybridisation solutions. 
To visualise the presence of mutants, a 500 μL blocking solution was added for five minutes, 
and a 500 μL enzymatic conjugate solution for three minutes. Wash solution was then added 
twice followed by incubation with substrate solution for 3 minutes in the dark. A final wash 
solution of 1 ml was added, and membranes were dried at room temperature.
Sequencing. Direct DNA sequencing was performed to confirm the accuracy of the RDB 
method of JAK2 genotyping using a 3500 Sequence Analyzer (Applied Biosystems).
3 RESULTS
3.1 Design of Reverse Dot-Blot (RDB) method
Sequences and RT-PCR protocols of multiplex primer set to amplify BCR-ABL1 transcript 
variants were adopted from the previous study (Burmeister & Reinhardt, 2008). Choices 
of probes to be immobilised on the membrane were based on the frequency of BCR-ABL1 
variants that had been detected in 403 BCR-ABL1 positive cDNA patients for routine clini-
cal testing in the year 2014–2015. Proportion of transcript variants in BCR-ABL1 positive 
samples was 31.39% M-Bcre13a2 (b2a2), 65.02% M-Bcre14a2 (b3a2), 1.79% m-Bcr e1a2, 
and 1.79% μ – Bcr c3a2 (e19a2). Among BCR-ABL1 M-Bcr variants, the e14a2 frequency 
was higher than e13a2 in Indonesian patients, a pattern similar to other reports in the region 
(Hassan et al., 2008; Auewarakul et al., 2006).
Oligonucleotide probes were designed to bind four BCR-ABL1 transcript variants and 
JAK2 V617F mutation. The hybridisation process (RDB) was developed based on the previ-
ous report with several modifications such as finding optimal hybridisation temperatures 
(Zhang et al., 1991). Briefly, biotinylated PCR primers were used to amplify the cDNA tem-
plate generated by reverse transcription of total RNA in blood samples. Biotinylated PCR 
products were then hybridised and retained on a nylon membrane containing oligonucleotide 
probes recognising four variants of BCR-ABL1 and mutated JAK2 V617F alleles. Oligo-
nucleotide probes were spotted and organised as shown in Figure 1A. Naked eye visualisa-
tion of specific hybridisation was achieved as the result of the colorimetric development of 
streptavidin conjugated alkaline phosphatase binding to retained biotinylated PCR products.
RDB test results were considered conclusive when the positive signal was detected in a 
biotin probe position and an IC (internal control) probe position. Positive signals from the 
Figure 1. Validation of RT-PCR primers and oligonucleotide capture probes of RDB (Reverse dot-
blot hybridisation) method.
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biotin probe indicated a good visualisation reaction, and positive signals in IC probe sug-
gested successful capture of a RT-PCR product of endogenous ABL gene expression within 
the sample. Four probes to detect BCR-ABL1, eighteen e13a2 positives, thirteen e14a2 posi-
tives, three e19a2 positives, and two e1a2 positive specimens.
3.2 Qualitative BCR-ABL1 1 RDB test validation
The limit of detection or analytical sensitivity of RDB was tested using serial dilution of K562 
cDNA harbouring BCR-ABL1 transcript variant e14a2 (b3a2) premixed with cDNA of BCR-
ABL1 negative HL60 cDNA. RDB was able to detect a BCR-ABL1 transcript signal as low as 
0.5% (Figure 2A). To determine the specificity of RDB in determining BCR-ABL1 transcript 
variant, we tested a group of 41 archived cDNA patients whose BCR-ABL1 had been previ-
ously characterised using gel electrophoresis. We had observed 100% concordance between 
the standard method and RDB in five specimens expressing no BCR-ABL1, eighteen e13a2 
positives, thirteen e14a2 positives, three e19a2 positives, and two e1a2 positive specimens.
Recent guidelines suggest that CML patients should reach Major Molecular Response 
(MMR), whereby the level of detectable BCR ABL1 transcripts is 0.1% IS or less within a 
year of imatinib mesylate treatment. Shown in Figure 2B, there were different hybridisation 
signals in samples having two different categories of BCR-ABL1 (% IS), i.e., samples with 
expression levels being less or equal to 0.1% IS (MMR positive), and more than 0.1% IS 
(Non-MMR). One cDNA sample previously judged, contained undetected BCR – ABL1 
(0% IS) and showed a specific presence of minor BCR-ABL1 transcript (Figure 2B, 0%IS*). 
Forty-nine archived cDNA specimens with known BCR-ABL1 transcript levels were then 
collected and categorised according to 0.1% IS as cut off  point of MMR. There were 28 spec-
imens with equal to or higher than 0.1% IS (or MMR negative), and 20 specimens with less 
than 0.1% are (or MMR positive). All 20 MMR positive specimens were confirmed using 
RDB. In one MMR case, micro variant BCR-ABL1 was detected because most quantitative 
BCR ABL1 kits focus on major variant only. Out of 28 MMR negative specimens, RDB 
could only detect 24  specimens. Therefore, in comparison to quantitative real-time PCR 
methods, RDB diagnostic specificity, was 100%, and sensitivity was 85.7%.
3.3 Qualitative JAK2 V617F mutation detection using RT-PCR RDB
We performed dilution of JAK2 mutation alleles and compared analytical sensitivity between 
direct DNA sequencing and RDB. Our results showed that RDB was able to detect JAK2 
Figure  2. Analytical sensitivity of RT-PCR RDB to detect BCR ABL variants from cDNA 
specimens.
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as little as 6.25% mutant allele, a level that was beyond direct DNA sequencing limit of 
detection (Figure 3). Twenty-nine cDNA specimens that had been previously tested for rou-
tine JAK2 mutation using standard RT-PCR DNA sequencing were re-tested using RT-PCR 
RDB. Overall concordance between the two methods was 97% where 28 out of 29 patients 
showed the identical result. One patient (#25), previously tested negative for JAK2 muta-
tion, was found to be positive using RDB, a method which had higher analytical sensitivity 
than direct DNA sequencing. Therefore, diagnostic sensitivity and specificity to detect JAK2 
V617F was 100% and 92%.
3.4 Concomitant BCR-ABL1 and JAK2 mutation in suspected MPN
JAK2 V617F and BCR-ABL1 mutations had been thought to be mutually exclusive, i.e., 
rarely occur within the same patient. We re-tested archived cDNAs of 36 consecutive cases 
of JAK2 V617F mutation positive, which had been determined using direct DNA sequenc-
ing. Using both the standard method (gel electrophoreses to detect BCR-ABL1) and RDB, 
we found 22% or 8 of 36 JAK2 positive specimens were found to harbour BCR-ABL1 tran-
scripts (see Figure 4 for example in specimen #), constituting six major (b3a2 or b2a2) and 
two micro (e19a2) BCR-ABL1 transcripts.
Figure 3. RT-PCR RDB JAK2 detection analytical sensitivity.
Figure 4. RT-PCR RDB multiplex JAK2 BCR ABL co-testing from cDNA specimen.
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4 DISCUSSION
Current CML guideline suggests the use of  RT-PCR for both qualitative and quantitative 
detection of  BCR-ABL1, serving diagnostic and treatment monitoring purposes respec-
tively (Foroni et al., 2011). Furthermore, JAK2 mutation testing has been recommended 
to follow up in the absence of  BCR-ABL1 in suspected MPN. Upfront testing of  both 
BCR-ABL1 and JAK2 may be desirable in certain clinical case. We demonstrated a novel 
method of  RTPCR RDB as a promising BCR ABL1/JAK2 multiplex test. This principle 
of  post PCR hybridisation has been demonstrated recently to detect multiple variants of 
leukaemic gene fusions in CML, ALL, and AML using DNA chip and electronic nano 
chip (Kang et al., 2012; Corradi et al., 2008) that are amenable to automation. However, 
to our knowledge, this is the first report showing the feasibility of  RDB detecting both 
BCR ABL1 transcript variants as well as JAK2 together from the same cDNA. The use of 
cDNA to detect JAK2 also has several advantages as described previously, which include 
higher sensitivity than genomic DNA, and direct analyses of  transcript levels in platelets 
(Merker et al., 2010).
Multiplex RDB may also be used to screen or diagnose suspected MPN patients for the 
presence of  BCR ABL1 and JAK2, because it has higher analytical sensitivity than any of 
the many widely used qualitative screening methods using conventional multiplex RT-PCR 
gel electrophoreses (Lam et al., 2013) and direct DNA sequencing (Didone et al., 2016; 
Bench et al., 2013) respectively. We demonstrated in the K562 serial dilution experiment, 
that RT-PCR RDB was able to detect BCR-ABL1 when its presence was as low as 0.5%. 
This level of  analytical sensitivity is in line with previous observations describing tran-
scripts level at diagnosis around 16.24–184.4% BCR-ABL1 (IS) (Bonecker et  al., 2015), 
with the median being 69.3% BCR-ABL1(IS) (range: 25.0–121.0%) (Huet et  al., 2014). 
RDB sensitivity limit to detect as low as 6% JAK2 V617F transcripts may be sufficient 
to help diagnose new cases of  PV and ET having average expression mutant JAK2 V617F 
relative to normal JAK2 alleles being 62% (median 61% range 8% – 98%) and 20% (median 
19%; range 3% – 50%) (Lippert et al., 2016). JAK2 mutation and BCR-ABL1 translocation 
have been thought to be mutually exclusive. On rare occasion, both JAK2 mutation and 
BCR-ABL1 translocation may occur or coexist in the same patient reflecting the dynamics 
of  the disease at baseline or progression (Zhou et al., 2015; Carranza et al., 2014). Within 
our small cohort of  36 JAK2 V617F mutation positive cases, 8 (or 22%) harboured BCR-
ABL1 positive transcripts. Our approach of  finding BCR-ABL1 in JAK2 V617F positive 
cases was different than previous reports that describe the prevalence of  concomitant 
JAK2 and BCR-ABL1 in cohorts of  total MPN, CML, or non-CML (individual PV, ET, 
or MF) cases (Cambier et al., 2008; Qin et al., 2014; Hussein et al., 2008). For example, 
retrospective studies showed the concomitant rate being 2.6% out of  314 CML cases (Pieri 
et al., 2011), 12.7% out of  142 treatment naïve MPN cases (Trejo et al., 2012), 44% out 
of  25 Pakistani CML (Tabassum et al., 2014), and 0.2% out of  total 10,875 MPN cases 
(Martin-Cabrera et al., 2016).
Nevertheless, there will be instances where clinicians would prefer to order both BCR-
ABL1 and JAK2 testing from peripheral blood at the same time [10]. For instance, patients 
with some ‘isolated’ thrombocythemia may benefit from having both BCR-ABL1 and 
JAK2 V617F to be tested (Tefferi et al., 2009). Also, simultaneous screening for both JAK2 
and BCR-ABL1 may be useful because some patients with BCR-ABL1 positive or CML 
may progress to PMF due to the pre-existing presence of  the JAK2 mutation (Yamada 
et  al., 2014). Clinicians may also consider JAK2  mutation testing in established CML 
cases who develop myeloproliferation and disease progression despite remission (Pastore 
et al., 2013).
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Effect of zinc supplementation on linear growth velocity 
of children with short stature
I.T. Pujiastuti, M. Deliana, E. Mutiara & M. Lubis
Department of Child Health, Faculty of Medicine, Universitas Sumatera Utara, Medan, 
North Sumatera, Indonesia
ABSTRACT: Short stature is still a burden in many parts of the world, and can be a result 
of long-standing malnutrition. By increasing the availability of zinc, zinc supplementation 
can facilitate growth in children. This study aims to determine the effect of zinc supplemen-
tation on linear growth velocity in children with short stature. An open label randomised 
placebo-controlled trial was conducted in Singkuang Village, Mandailing Natal Regency, 
North Sumatera from March to September 2016. Children aged 7–10 years were screened 
for short stature. Subjects were divided into two groups; the intervention group received zinc 
supplementation of 10 mg/day, six days a week, and the control group received a placebo. 
After six months of zinc supplementation, there was no statistically significant increase in 
height (p = 0.493) and linear growth velocity (p = 0.365). Conclusion: There is no significant 
increase in height and linear growth velocity after zinc supplementation for six months in 
children with short stature.
Keywords: zinc supplementation, linear growth velocity, children with short stature
1 INTRODUCTION
In the last decade, some malnutrition problems have tended to show an improvement. How-
ever, these changes were not significant, one of them is on short stature issues (WHO, 2014). 
According to the National Basic Health Survey (RISKESDAS) by the Ministry of Health of 
the Republic of Indonesia in 2013, the incidence of stunted growth in Indonesia amounted to 
37.2% (8 million children). In a preliminary study in Singkuang Village, Muara Batang Gadis 
District, Mandailing Natal Regency, North Sumatra, there was a prevalence of children with 
short stature of 40% (Hutasuhut et al., 2014).
Short stature can result from prolonged malnutrition. Macronutrients and micronutri-
ents are needed for growth, including zinc which is one of the essential micronutrients. Zinc 
deficiency can affect many organ systems including the immune, gastrointestinal, skeletal, 
reproductive, and central nervous systems. Even a slight zinc deficiency can lead to immune 
dysfunction and restriction of physical development (UNICEF, 2015; WHO, 2014; Benoist, 
2007). In one study there was an increase in growth velocity in children with zinc supplemen-
tation by 30% (Nakamura et al., 1993).
According to a review of 80 studies, zinc supplementation is associated with increased stat-
ure which was small but significant (Mayo-Wilson et al., 2014). The World Health Organiza-
tion (WHO) recommended zinc supplementation for children with diarrhoea because it is 
proven to reduce the duration and severity. However, the provision of zinc supplements to 
improve child growth is still controversial (Vakili et al., 2015; Sjarif  et al., 2014; Soetjiningih, 
2008).
The aim of this study was to determine the effect of zinc supplementation on the growth 
velocity in children with short stature.
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2 METHODS
The study protocol and the informed-consent process were approved by the Research Ethics 
Committee of the Faculty of Medicine, Universitas Sumatera Utara, Indonesia. This was a 
descriptive study with a cross sectional approach.
The research was conducted at SDN 382 and SDN 395, Singkuang, Muara Batang Gadis 
District, Mandailing Natal Regency, North Sumatra from March to September 2016. Sam-
ples were selected by simple random sampling, which included children aged 7–10 years, 
with height below the 3rd percentile on the CDC 2000 growth chart. Children with a chronic 
systemic disease including those with syndrome, protein energy malnutrition, and who had a 
history of dietary supplements during the three months before the study were excluded.
This study was analysed by SPSS software, using an independent t test, where p > 0.05 was 
considered significant.
3 RESULT
From a total of 173 children, the number of children with short stature in SDN 382 Sing-
kuang was 23, and in SDN 395 was 37. Two children from SDN 382 were excluded because 
Table 1. Baseline characteristics.
Characteristics Intervention (n = 17) Control (n = 16) P
Sex, n 0.393*
 Male   6   8
 Female  11   8
Parent’s occupation, n 0.980*
 Fisherman   4   1
 Farmer   4   8
 Labourer   2   0
 Entrepreneur   7   7
Parent’s earning, n 0.533*
 <IDR 500.000   1   2
 IDR 500.000–1.000.000  12   7
 >IDR 1.000.000   4   7
Parental education, n 0.183*
 Elementary school  12  10
 Junior high school   4   0
 Senior high school   1   6
Age, mean (SD)   8.6   8.6 1.000**
Height (cm), mean (SD) 115.9 116.2 0.857***
Weight (kg), mean (SD)  17.8  19.6 0.063***
*Chi Square, **Mann-Whitney, ***Independent t test.
Table 2. Height before and after zinc supplementation.
Height (cm) Mean (SD) t CI 95% p
Intervention Before 115.9 (4.59) −16.73 2.37–3.71 < 0.001*
After 118.9 (4.60)
Control Before 116.3 (5.76) –20.44 2.51–3.09 < 0.001*
After 119.1 (5.95)
*Independent t test.
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of severe malnutrition. Seven children did not get parental consent for the study. Fifty-one 
children were randomised, 28 children were admitted to the intervention group and 23 chil-
dren to the control group. At the end of the sixth month, nine children in the intervention 
group refused to continue the study, and two children moved out of school. Six children from 
the control group refused to continue the study. No child showed signs of puberty until the 
end of the study. No side effects were found in this study.
Based on statistical analysis, there was no significant increase in height and growth velocity 
after zinc supplementation in children with short stature.
4 DISCUSSION
Zinc supplementation is the only effective intervention strategy for treating zinc deficiency 
compared to other alternatives such as fortified foods, complimentary food and diet modi-
fications. Research in Iran in 2013 showed zinc supplementation of 5 mg for 4 months in 
healthy children aged 9–18 years without zinc deficiency increase linear growth rate (Kaseb & 
Fallah, 2013). Research in Vietnam in 1999, in children aged 6–24 months who were given 
zinc supplementation for 11 mg per day for 3 months, found a significant increase in body 
length (Nasution, 2016).
In this study, it was found that the six-month difference of height in the intervention group 
was greater than in the control group. However, the results are not statistically significant. 
The rate of linear growth, which is a better indicator for assessing a child’s linear growth, also 
showed similar results. The same was also observed in a randomised placebo-controlled trial 
study in Burkina Faso in 2003 with a larger sample, suggesting that there was no significant 
difference in height before and after zinc supplementation for six months in children with 
short stature (Muller, 2003).
This is proof that linear growth is influenced by many factors, including growth hormone 
and thyroid hormone that are not assessed in this study. In addition, multivitamin deficiency 
conditions play a greater role in linear growth, compared to zinc alone (Nasution, 2016).
5 CONCLUSION
There was no significant difference in height gain and linear growth rate after zinc supple-
mentation for six months in children with short stature compared to the control group.
Table 3. Height difference before and after zinc supplementation.
Zinc supplementation
T pYes No
Height difference (SD) 3.0 (1.3) 2.8 0.697 0.493*
*Dependent t test.
Table 4. Difference in linear growth velocity.
Zinc supplementation
T pYes No
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The outcomes of tibial fracture patients who underwent ORIF 
compared to MIPO
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ABSTRACT: Minimal Invasive Plate Osteosynthesis (MIPO) is a new technique of inter-
nal fixation that is aimed to fix the weaknesses of conventional techniques. In this study, we 
researched the outcome of patients with a tibial fracture who underwent Open Reduction 
Internal Fixation (ORIF) compared to MIPO. We found 30 patients, of which 15 had con-
ventional internal fixation surgery (ORIP) and 15 had minimally invasive internal fixation 
surgery (MIPO). The chi-square test for length of hospital stay resulted in a p value = 0.043 
(p <0.05), showing there was a difference in length of stay between the ORIP group and the 
MIPO group. From all the postoperative complications studied, the chi-square test resulted 
in p >0.05 which meant there was no difference in the variables between the ORIF group 
and the MIPO group. Meanwhile, for postoperative complications, there were no differences 
between the ORIF group and the MIPO group.
Keywords: Tibial fracture, Open Reduction Internal Fixation, Minimal Invasive Plate 
Osteosynthesis
1 INTRODUCTION
Trauma is the most common cause of death in the 16–44 years old age group worldwide. The 
largest proportion of mortality (1.2 million per year) is traffic accidents. The World Health 
Organization (WHO) predicted that by 2020, traffic injury would rank third for cause of death.
Tibial fracture is the long bone fracture that frequently occurs and is the lower extrem-
ity fracture that most commonly occurs. Tibial fracture is a complication caused by traffic 
accidents or other traumas. The incidence of long bone fracture is 11.5/100,000 people/year, 
and 40% occur on the lower extremities. There are various surgery choices which may be 
performed for the management of tibial fracture, including ORIF (Open Reduction Internal 
Fixation), intramedullary fixation, and external fixation. ORIF is the most common tech-
nique used for the majority of fracture cases. Minimal Invasive Plate Osteosynthesis (MIPO) 
is a new technique of internal fixation published by Christian Krettek et al. in 1997 that is 
aimed to fix the weaknesses of conventional techniques.
ORIF is an operation to look at the fracture directly by surgery techniques including the 
installation of plate, screw, metal or prosthesis to mobilise the fracture during healing. In the 
MIPO technique, the potential for healing is considerable, because it can avoid tissue dam-
age to cutaneous and subcutaneous skin, muscles and the vascularisation system around the 
fracture site. In this study, we researched the outcome of patients with tibial fracture who 
underwent ORIF compared to MIPO.
2 METHOD
This study is a comparative-analytic study with a cross-sectional design to search secondary 
data from medical records of patients diagnosed with a tibial fracture who underwent ORIF 
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or internal fixation minimally invasive at H. Adam Malik General Hospital in Medan during 
the period January 2015–December 2016. The exclusion criteria were patients with blood 
clotting disorders, previous kidney disorders, diabetes mellitus, and chronic obstructive pul-
monary disease. The outcomes assessed in this study were length of stay and postoperative 
complications, including pain (VAS score 0–10), bleeding, postoperative infection, sepsis, 
compartment syndrome, and death. Bivariate data analysis was carried out on secondary 
data using statistical (Chi-Square test) and parametric measurements (T-test).
3 RESULTS
We found 30 patients, whom 15 were in the conventional internal fixation surgery group 
(ORIF) and 15 were in the internal fixation surgery minimally invasive group (MIPO). In the 
ORIF group, the mean age was 19 (14–38 years old), comprising ten men and five women. 
In the MIPO group, the mean age was 17 (13–42 years old) comprising 12 men and three 
women.
For the length of stay, the chi-square test resulted in a p value = 0.043 (p < 0.05), showing 
there was a difference in length of stay between the ORIF group and the MIPO group.
From the postoperative complications studied, the chi-square test resulted in p > 0.05. These 
complications were pain intensity/VAS score (p = 0.067), amount of bleeding (p + 0.056), 
postoperative infection (p + 0.73), the presence of sepsis (p + 0.084), the presence of compart-
ment syndrome (p + 0.062), and the occurrence of death (p + 0.062), which indicated there 
were no differences in the variables between the ORIF group and the MIPO group.
4 DISCUSSION
In this study, the majority of patients involved were men (24 patients). The mean age of the 
patients that underwent internal fixation surgery was 35 years old and that for minimally 
invasive surgery was 28. The length of stay for patients who underwent internal fixation sur-
gery compared to those who underwent minimally invasive surgery was different (p < 0.05). 
There have been a lot of studies that support that the MIPO technique accelerates the heal-
ing process, such as by Ahmed Rizk in Egypt (2015), Devendra in India (2015), Zeng et al. 
in China (2014) and Gulabi in Turkey (2016). In the H. Adam Malik General Hospital, the 
MIPO technique had been performed since the beginning of 2015.
Table 1. The difference of Internal Fixation Surgery Group and Minimally invasive surgery group 
based on characteristics
Characteristic Internal fixation surgery group Minimally invasive surgery group
Mean Age 35 28
Male 12 11
Female  3  4
Table 2. The difference of Internal Fixation Surgery Group and Minimally invasive surgery group 
based on length of stay.
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The intensity of pain for patients who underwent internal fixation surgery compared to 
those who underwent minimally invasive surgery was not much different (p  >  0.05). The 
amount of bleeding for patients who underwent internal fixation surgery compared to those 
who underwent minimally invasive surgery was not much different (p >  0.05). Postopera-
tive infection in patients who underwent internal fixation surgery compared to those who 
had minimally invasive surgery were not much different (p  >  0.05). The presence of sep-
sis in patients who underwent internal fixation surgery compared to those who underwent 
minimally invasive surgery was not much different (p  >  0.05). The presence of compart-
ment syndrome in patients who underwent internal fixation surgery compared to those who 
underwent minimally invasive surgery was not much different (p > 0.05). The occurrence of 
death in patients who underwent internal fixation surgery compared to those who underwent 
minimally invasive surgery was not much different (p > 0.05).
5 CONCLUSION
From the bivariate analysis, the outcome using chi-square test, there was a difference in 
length of stay between the ORIF group and the MIPO group. Meanwhile, for postoperative 
complications, there were no differences between the ORIF group and the MIPO group.
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ABSTRACT: Hyperglycaemia causes a phagocytic injection of Polymorphonuclear Leuko-
cyte (PMN), which is associated with an increased frequency of infection. Impaired function 
of PMN phagocytosis is associated with an increased risk of infection that stimulates the 
formation of proinflammatory cytokines. In chronic worm infections, Treg cell activation 
results in IL-10 production, which plays a role in class switching antibody response in which 
IgE-producing cells switch to produce IgG4 which inhibits effector effranulation. This study 
aims to examine the correlation between Soil-Transmitted Helminth (STH) infection and 
IL-10 enzyme gene polymorphism among patients with both Diabetes Mellitus (DM) and 
Tuberculosis (Tb). The results showed that negative significant correlation between STH 
infection and IL-10 enzyme gene polymorphism among DM and Tb patients.
Keywords: soil-transmitted helminth, IL-10, diabetes mellitus, tuberculosis
1 INTRODUCTION
Diabetes Mellitus (DM) is a metabolic disorder in the body characterised by elevated blood 
glucose levels. A global survey in 2008 conducted by the World Health Organization (WHO) 
shows that there are 347 million people with DM, and this continues to increase. Based on 
the pattern of population growth, it is estimated that by 2030 there will be 194 million Indo-
nesians aged over 20 years suffering from DM (Riskesdas, 2013; WHO, 2011).
Since the beginning of the 20th century, clinicians have observed an association between 
DM and Tuberculosis (Tb). Some hypotheses about the role of cytokines in DM patients as 
important molecules in the human defence mechanism against Tb. Hyperglycaemia causes 
a phagocytic injection of polymorphonuclear leukocyte (PMN), which is associated with an 
increased frequency of infection. Impaired function of PMN phagocytosis is associated with 
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an increased risk of infection that stimulates the formation of proinflammatory cytokines. 
Several studies have shown that there is an increased expression of cytokines in vitro in peo-
ple with diabetes one IL-10. The production of IL-10 cytokines is controlled at the tran-
scriptional level depending on the regulatory factor bond with the introduction of a specific 
sequence on the promoter (Almeras & Print, 2006; Beamen, 2008; Oh et al., 2007; Sharma 
& Bose, 2001).
As a tropical country, the spread of infectious diseases in Indonesia is still a public health 
problem and one of these is Soil-Transmitted Helminth (STH) infection. The disease is 
chronic with the absence of clear clinical symptoms, and its effects are only seen in the long 
term. Such effects include increasing susceptibility to other infectious diseases such as Tb 
(Bethony et al., 2006; Kurniawan, 2010; Markell et al., 1996).
Based on the background presented above, this study aims to determine the relationship of 
IL-10 enzyme gene polymorphism in patients with DM and Tb with STH infection.
2 METHODS
Ethical approval was received from the Health Research Ethical Committee, Faculty of Med-
icine, Universitas Sumatera Utara, Medan, Indonesia. The research was conducted during 
the period of June 2017 to September 2017 at the Tuberculosis Disease Centre and recruited 
40 consecutive samples from patients diagnosed with both DM and Tb. Exclusion criteria in 
this study included DM without Tb.
Informed consent was gained from the patients (or their legal representative if  the patient 
could not give consent) before collection of 3 ml of venous blood samples. Determining the 
level of IL-10 was carried out using the ELISA technique (Oh et al., 2007). Stool examination 
was by the Kato method.
Data were collected and calculated using Fischer’s exact test on more than 40  study 
samples.
3 RESULTS
This study obtained the results of STH infection suffered by one person (2.5%) male patients 
with DM+Tb in the age range 41–45 years. Variable characteristics of the patients are shown 
in Table 1.
Table 2 shows no correlation of ascariasis with IL-10 enzyme gene polymorphism among 
DM patients with Tb.




n % n % n %
Gender
 Male 28 70.0 1 2.5 29 72.5
 Female 11 27.5 0 0 11 27.5
Age
 30–40  9 22.5 0 0  9 22.5
 41–45 12 30 1 2.5 13 32.5
 46–50  6 15.0 0 0  6 15.0
 51–55  6 15.0 0 0  6 15.0
 56–60  4 10.0 0 0  4 10.0
 >60  2  5.0 0 0  0  5.0
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Of the 40 DM patients with Tb who were examined, one person suffered from ascariasis 
with high levels of IL-10.
Of the 40 patients with DM+Tb who were examined, one person suffering from STH 
infection and had high levels of IL-10 (Table 3).
Polymorphism of DM+Tb patients can be seen in Figure 1 dominated by a genotype AA 
of 52.5%.
4 DISCUSSION
The results of this study found one person (2.5%) male respondents with DM+Tb suffer-
ing from ascariasis. This is in line with Bethony et al.’s (2006) statement which says worm 
infections can increase susceptibility to other important diseases such as Tb, diarrhoea and 
anaemia. However, Rusjdi’s (2009) study did not find correlation between STH infection and 
IL-10 levels among DM+Tb patients.
5 CONCLUSION
In conclusion, our results suggest that there is no correlation between STH infection and 
IL-10-592A/C genotype among DM+Tb patients.
Table  2. The genotype and allele frequency of IL-10 polymor-





n % n % n %
IL-10-592A/C
 CC  4 10.0 0  0.0  4 10.0 >0.05
 AA 21 52.5 1  2.5 22 55.0
 AC 14 35.0 0 35.0 14 35.0
Table 3. Association between IL-10 and ascariasis.
STH infection
p-valuePositive Negative
IL-10 High 1  5 0,23
Low – 34
Figure 1. PCR-RFLP assay of DM+Tb patients.
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aggregation
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ABSTRACT: The adverse side-effects of Acetyl Salicylic Acid (ASA) are mainly gastro-
intestinal bleeding. The objective is to determine if  50  mg ASA is as effective as 100  mg 
when used in normal healthy subjects. The 18 normal subjects had a normal platelet count of 
mean 301 ± 72.3 × 109/L. Significant (P = <0.001) platelet inhibition was seen in 15 subjects 
ingesting 50 mg ASA (mean 50.3 ± 21.9%) and 100 mg ASA (mean 75.7 ± 19.3%). Further 
significantly enhanced (P = <0.001) inhibition was seen in 100 mg ASA compared to 50 mg. 
Three subjects were non-responders to 50 mg ASA (16.7%) and two to 100 mg (11.1%). The 
study showed that a 100 mg ASA dose is better suited for antiplatelet therapy compared with 
50 mg. Significantly greater platelet inhibition was seen with 100 mg ASA with no gastro-
intestinal bleeding or other side-effects reported. ASA resistance was seen in 16.7% of sub-
jects ingesting 50 mg ASA and 11.1% ingesting the 100 mg dose.
Keywords: Acetyl Salicylic Acid (ASA), inhibition in normal subjects, resistance
1 INTRODUCTION
Platelets play an important role in the pathogenesis of arterial thrombosis, activated plate-
let initiate thrombus formation and antiplatelet therapy modifies these properties involving 
aspirin (acetyl salicylic acid, ASA) (Oesman, 2009; Setiabudi, 2009). ASA is widely used as 
an antiplatelet agent to reduce the risk of non-fatal stroke, non-fatal myocardial infarction 
and vascular death in patients at high risk of arterial thrombosis. It was reported to reduce 
mortality in acute coronary syndrome (ACS) and to improve the condition (Setiabudi, 2006). 
However, ASA failed to inhibit platelet aggregation in acute myocardial infarction (AMI) 
(Poulsen et al., 2007) and their use in AMI is of little or no use (Borna et al., 2005). ASA 
resistance is of unknown etiological phenomenon describing decreased platelet activation by 
ASA. The existence of ASA resistance affects more than 50% of patients with cardiovascular 
disease (Oesman, 2009; Setiabudi, 2009) and 25.8% in severe symptomatic Peripheral Artery 
Disease (PAD) (Chen et al., 2007). In stable Coronary Artery Disease (CAD), it has been 
reported that 36% of Asian Indian patients were non-responders to ASA (Chadha et al., 
2016). Abnormal platelet aggregation studies due to aspirin-like defect were seen in up to 9% 
of platelet donors (Stohlawerz et al., 2001). The adverse effects of ASA are mainly gastro-
intestinal bleeding, and this effect is greater with daily 300 mg ASA use (Taneja et al., 2004). 
Very low doses of ASA spare prostacyclin formation and reduce gastro-intestinal side-effects 
but are less effective in inhibiting platelet aggregation. Doses of 100 mg and 162.5 mg ASA 
had shown greater inhibition than lower doses (Maree et al., 2005). For doses higher than 
162 mg ASA, only 6% did not show any response in another study (Dengo et al., 2016). Aspi-
rin resistance is associated with an increased risk of severe stroke, and a large infarct volume 
in patients taking aspirin before stroke onset (Oh et al., 2016) and between 5% to 65% was 
seen in patients with ischaemic stroke (Ozben et al., 2011).
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Platelet aggregation is performed to identify and quantify platelet response and moni-
tor platelet inhibition by drug therapy. It is based on the addition of a platelet agonist to a 
blood sample (usually platelet-rich plasma). It may be assessed using various agonists such 
as adenosine di-phosphate (ADP), collagen and others. Arachidonic acid (AA), a precursor 
of thromboxane A2 and hydroxyl fatty acids liberated from human platelets on activation, 
converts the enzyme cyclooxygenase-1 (COX-1) into a potent inducer of platelet aggrega-
tion. Ingestion of ASA inhibits COX-1 thus inhibits platelet aggregation. The aggregation of 
platelets is an essential physiologic life-saving process of blood coagulation. The role of plate-
lets in haemostasis involves adherence to sites of injury, activation of internal signalling path-
ways, aggregation to form plugs and the acceleration of the coagulation reactions to form 
thrombin. Platelet aggregation, particularly at the site of plaque rupture, results in thrombus 
formation blocking normal blood circulation in the heart musculature in ACS (Fuster et al., 
1996). Platelet function may be impaired if  any of the pathways mediated by the activation 
process by agonists are defective. The objective of this small cohort study is to determine 
whether an ASA of 50 mg dose is as effective as a 100 mg dose in normal healthy subjects.
2 METHODS
The study received ethical approval from the Health Research Ethical Committee of North 
Sumatera (No: 357/KOMET/FK USU2013), Medical School, University of Sumatera Utara, 
Medan, Indonesia. It was conducted at the Department of Clinical Pathology, Faculty of 
Medicine, University of North Sumatera/Haj Adam Malik Hospital. The inclusion criteria 
for the study: age above 18 years old, not on any medication for the past ten days, and agreed 
to give informed consent. The exclusion criteria: body mass index (BMI) > 30, known medi-
cal disorders.
Subjects: Initially, 46 subjects gave their informed consent, but 12 failed to turn up for the 
study. Of the remaining 34 subjects, only 18 completed the protocol study whilst the remain-
der failed to turn up for the 100 mg ASA protocol and therefore were excluded from the 
analysis. Data from the 18 subjects (female n = 15, male n = 3) who completed the 50 mg and 
100 mg ASA protocol were therefore analysed. Their mean age was 41.7 ± 7.4 years ranging 
between 31 years and 50 years old. The study subjects were healthy individuals recruited from 
within the institution, they had no known medical history and had given written informed 
consent to participate in the study.
Blood sampling: After having fasted overnight, a clean venepuncture was performed and 
blood collected into EDTA anticoagulant (2 mL, BD Vacutainer) for platelets and 3.6 mL 
blood into 0.4 mL 3.8% sodium citrate for preparation of Platelet-Rich Plasma (PRP). Blood 
sampling was performed pre-ASA ingestion and three days later after daily ingestion of 
50 mg ASA. A wash-out period of 7 days was instituted before another blood sampling was 
performed after daily ingestion of 100 mg ASA for three days. Citrated blood was centri-
fuged at room temperature at 150 g for 10 mins for PRP and again centrifuged at 2000 g for 
15 minutes to obtain poor platelet plasma (PPP). Platelet aggregation was performed within 
two to three hours from blood sampling.
Laboratory analysis: Platelets (EDTA blood) and PRP were determined in the automatic 
cell counter Sysmex XT 4000 (Kobe, Japan). The ex-vivo platelet aggregation studies were 
performed using arachidonic acid (AA, PT Helena Laboratories (Australia) Pte Ltd, prod-
uct 5364) as an agonist at a final concentration of 500 μg/mL to the PRP in the platelet 
aggregometer, Aggregation Remote Analyzer (Helena Laboratories, model SUF52001). PPP 
was calibrated as maximum transmission at 100%.
Statistical analysis: The Statistical Package for Social Sciences (SPSS 22 IBM Corp. USA) 
was used to perform statistical analysis. On paired samples a t-test was performed to compare 
differences in platelet aggregation inhibition with 50 mg and 100 mg. Three subjects were 
considered non-responders to 50 mg ASA and remaining two to both 50 mg and 100 mg 
ASA. They were excluded from the final analysis. A P value of less than 0.05 was considered 
statistically significant.
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3 RESULT
3.1 Platelets and platelet-rich plasma
Platelet numbers of the 18 normal subjects were a mean of 301 ± 72.3 × 109/L and ranged 
between 204 and 448 × 109/L. The mean platelet number in PRP was 240 ± 56.3 × 109/L and 
ranged between 185 and 360 × 109/L. For platelet aggregation studies, the platelet numbers in 
the PRP sample should be in the region of 150 to 400 × 109/L.
Platelet aggregation (T max%) and inhibition to 50 mg and 100 mg acetyl salicylic acid 
(ASA) in normal healthy subjects was compared with that pre-ASA (excluding three non-
responders to ASA).
Significant inhibition (P  =  <0.001) of ex-vivo platelet aggregation to 50  mg ASA (mean 
50.3%, ranged from 10.6% to 85.5%) and 100 mg dose (mean 75.7%, ranged from 11.8% to 
93.6%) compared with pre-ASA state in the 15 normal subjects was seen. Further enhanced 
inhibition (P = <0.001) with the 100 mg dose compared to the 50 mg dose was also seen (Table 1).
Non-responders or resistance to 50 mg ASA (16.7%) was seen in 3 normal subjects. One 
subject was resistant to 50 mg ASA only but responded to the 100 mg dose (77.4% inhibi-
tion). With 100 mg ASA, the resistance rate is 11.1% (2/18) in this small cohort study. Their 
results (T max%) are shown in Table 2.
4 DISCUSSION
Aspirin (ASA) is widely used as an antiplatelet agent to reduce the risk of non-fatal stroke, 
non-fatal myocardial infarction and vascular death in patients at high risk of arterial throm-
bosis. It was reported to reduce mortality in ACS and improve the condition (Setiabudi, 2006). 
However, ASA failed to inhibit platelet aggregation in AMI (Poulsen et al., 2007) and its use 
in AMI is of little or no use (Borna et al., 2005). ASA resistance has been shown to be associ-
ated with an increased risk of severe stroke and large infarct volume in patients taking aspirin 
before stroke onset (Oh et al., 2016). High platelet activity contributes to poor prognosis, but 
the mechanism of ASA resistance describing decreased platelet activation remains unclear 
(Hankey & Eikelboom, 2006). Ingestion of ASA inhibits COX-1 activity thus inhibits platelet 
aggregation. Abnormal platelet aggregation studies due to an aspirin-like defect were seen in 
up to 9% of platelet donors (Taneja et al., 2004). The adverse effects of ASA are mainly gastro-
intestinal bleeding, and this effect is greater with daily 300 mg ASA use (Taneja et al., 2004). In 
our small study, the subjects had normal platelet counts and had no known medical history to 
report, but only 88.9% responded to 100 mg ASA and 83.3% to 50 mg ASA. Greater inhibi-
tion of platelet aggregation was seen at 100 mg compared to 50 mg ASA suggesting 100 mg 
ASA is better suited for therapy as an antiplatelet agent. We report here that 11.1% of normal 
subjects are ASA resistance to 100 mg ASA and 16.7% to 50 mg ASA dose which is much 
higher than reported for platelet donors, up to 9% in one study (Stohlawerz et al., 2001) and 
6% in another study with 162 mg ASA (Dengo et al., 2016). In stable coronary artery disease 
in Asian Indian patients it has been reported that 36% were non-responders to ASA therapy 
(Chadha et al., 2016). There were no reports of gastro-intestinal bleeding or other side-effects 
in the study subjects probably due to the short duration of ASA use.
In conclusion, the study showed that a 100 mg ASA dose is better suited for antiplatelet 
therapy compared to a 50 mg dose. Significantly greater platelet inhibition was seen with 
100  mg ASA use, with no gastro-intestinal bleeding or other side-effects reported. ASA 
resistance was seen in 16.7% of subjects ingesting 50 mg ASA and 11.1% in 100 mg ASA in 
this short duration study.
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